data_5z4f_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5z4f _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 121.454 0.522 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.669 ' CB ' ' HG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.662 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.479 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' H ' HD11 ' A' ' 62' ' ' ILE . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.401 HG21 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 57' ' ' TYR . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' CA ' ' A' ' 54' ' ' GLY . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.481 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 137' ' ' ALA . 5.6 m-90 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.486 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.669 ' HG1' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.636 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.412 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.471 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.362 0.484 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.436 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.436 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.061 0.458 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 47' ' ' LEU . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.451 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' H ' HD12 ' A' ' 62' ' ' ILE . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.492 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.609 0.718 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.473 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.462 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.0 m-90 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.431 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.629 0.728 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.591 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 154' ' ' ILE . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 N--CA 1.492 1.441 0 CA-C-O 121.344 0.477 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 109' ' ' PRO . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.808 0.337 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.673 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.597 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' H ' HD12 ' A' ' 62' ' ' ILE . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.472 ' H ' ' CG2' ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 67' ' ' ILE . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.644 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.497 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.6 m95 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.698 0.761 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.422 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.474 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.694 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.694 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' OD2' ' N ' ' A' ' 89' ' ' GLY . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.429 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.576 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 3.5 m-90 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.433 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' CE2' ' CG1' ' A' ' 105' ' ' VAL . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.403 ' N ' HG13 ' A' ' 18' ' ' VAL . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.676 ' HD1' ' CD2' ' A' ' 124' ' ' LEU . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.401 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 121.28 0.45 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.692 ' HG ' ' H ' ' A' ' 20' ' ' HIS . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.692 ' H ' ' HG ' ' A' ' 17' ' ' SER . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.406 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.766 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.414 ' H ' HD11 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.495 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' H ' ' CG2' ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.766 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.801 0.81 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.467 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 70' ' ' GLY . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 3.7 m-90 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.477 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.679 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.679 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.42 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.427 0.632 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HG3' ' H ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.633 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.492 1.431 0 CA-C-O 121.205 0.419 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.14 0.495 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.706 ' NE ' ' HH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.706 ' HH ' ' NE ' ' A' ' 56' ' ' ARG . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.675 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.635 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.468 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.675 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.758 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' CD2' ' OG1' ' A' ' 84' ' ' THR . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 51.5 ttt-85 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.801 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.47 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.758 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.521 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 7.8 m-90 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.495 ' H ' ' HG ' ' A' ' 101' ' ' SER . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.691 ' HD1' ' CD2' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.523 ' O ' ' OG ' ' A' ' 101' ' ' SER . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.691 ' CD2' ' HD1' ' A' ' 121' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.101 0.477 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.419 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.2 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.554 0.692 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.592 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.567 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 121.409 0.504 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.188 0.518 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.708 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.6 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.718 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.468 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' H ' HD11 ' A' ' 62' ' ' ILE . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' H ' ' CG2' ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.718 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.592 ' C ' ' O ' ' A' ' 84' ' ' THR . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.501 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.605 0.717 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.494 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.48 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.478 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.2 m-90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 116' ' ' ARG . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.579 ' CD2' ' C ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.649 ' ND1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.447 ' HB1' ' NE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.485 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.472 HG12 ' HE2' ' A' ' 20' ' ' HIS . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 121.47 0.529 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.085 0.469 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.709 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.592 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.474 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.627 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.486 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' A' ' 84' ' ' THR . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.502 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.831 0.824 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 70' ' ' GLY . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.481 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 9.2 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 . . . . . 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.421 ' C ' ' HG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.666 0.746 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.523 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 121.337 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.049 0.452 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.712 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.644 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.402 HG21 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.712 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.766 0.793 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.419 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.3 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 22.4 t-20 . . . . . 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.124 0.488 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.409 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.459 0.647 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.593 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 121.293 0.455 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.46 0.647 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.459 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 64' ' ' GLY . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.424 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 66' ' ' GLU . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 68' ' ' VAL . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' HH11 ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' THR . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.495 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 122.079 0.943 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.484 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.433 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 70' ' ' GLY . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.1 m-90 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 81' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.425 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.567 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.637 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.844 0.355 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.43 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.599 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.531 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.491 1.339 0 CA-C-O 121.348 0.478 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.612 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.484 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.962 0.411 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.652 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.69 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 64' ' ' GLY . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' H ' HD12 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.69 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.594 ' C ' ' O ' ' A' ' 84' ' ' THR . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.532 ' CG1' ' HH ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.538 0.685 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.471 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.436 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 39.7 m95 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 81' ' ' LEU . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.455 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.563 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.713 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.503 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.863 0.363 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.48 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.455 0.645 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.443 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.585 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.612 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 121.344 0.477 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HZ1' ' A' ' 10' ' ' LYS . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' HZ1' ' CG2' ' A' ' 8' ' ' VAL . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.139 0.495 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.656 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.713 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.738 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.738 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.587 ' C ' ' O ' ' A' ' 84' ' ' THR . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.623 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 7.5 m-90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.623 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.492 ' O ' ' OG ' ' A' ' 11' ' ' SER . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.422 ' CB ' ' CE2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.402 ' H ' ' CD1' ' A' ' 147' ' ' LEU . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 154' ' ' ILE . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 121.335 0.473 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.512 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.445 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.345 0.593 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.671 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.661 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.477 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' H ' HD11 ' A' ' 62' ' ' ILE . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.58 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.614 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.798 0.809 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.407 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.454 ' CE2' ' CD1' ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.51 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 7.0 m-90 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.53 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.703 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.703 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.489 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.42 ' CB ' ' CE2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.609 0.719 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.674 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.326 0.469 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.578 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.098 0.475 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.642 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.691 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.569 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.748 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CH2' ' OE2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.748 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' THR . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.491 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.145 0.974 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.431 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 70' ' ' GLY . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.653 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.7 m-90 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.653 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.544 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' NE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.496 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.5 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.578 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.186 0.411 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.404 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.503 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.422 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.305 0.574 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.667 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.603 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.704 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.489 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 68' ' ' VAL . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.743 0.783 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.458 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.535 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.0 m-90 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.532 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.935 0.398 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.535 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.409 ' HG3' ' H ' ' A' ' 150' ' ' PHE . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 CA-C-O 121.362 0.484 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.053 0.454 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.48 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.638 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 84' ' ' THR . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.497 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.401 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.91 0.862 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 70' ' ' GLY . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 9.5 m-90 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.633 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.418 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.517 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.491 1.337 0 CA-C-O 121.291 0.455 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 109' ' ' PRO . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.669 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.708 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.671 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.531 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.531 ' H ' ' CG2' ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.671 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 84' ' ' THR . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CG1' ' HH ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 50.4 m95 . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.602 0.715 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.519 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 70' ' ' GLY . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.6 m-90 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.408 ' CE2' ' CG1' ' A' ' 105' ' ' VAL . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.401 ' N ' HG13 ' A' ' 18' ' ' VAL . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.417 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 53.0 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.403 HD11 ' H ' ' A' ' 147' ' ' LEU . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.457 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.402 0.501 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' CG2' ' HG1' ' A' ' 115' ' ' THR . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.541 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.709 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.523 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.531 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.523 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.575 0.702 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.469 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.426 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.709 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 2.8 m-90 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.542 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.408 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.415 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 76.1 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.639 0.733 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.541 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.363 0.485 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HE2' HG12 ' A' ' 154' ' ' ILE . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.127 0.489 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.58 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.733 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.491 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.51 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.733 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.579 ' C ' ' O ' ' A' ' 84' ' ' THR . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.702 0.763 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.454 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.484 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CZ2' ' CB ' ' A' ' 137' ' ' ALA . 6.8 m-90 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.524 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.705 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.464 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.421 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.481 0.658 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.368 0.487 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.479 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HG ' ' CB ' ' A' ' 20' ' ' HIS . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.684 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.597 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' H ' HD11 ' A' ' 62' ' ' ILE . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.677 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.5 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' NE ' ' OD2' ' A' ' 106' ' ' ASP . 62.5 ttt-85 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.427 ' CD1' ' CD1' ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.677 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.493 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 8.4 m-90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.405 ' CE2' ' CG1' ' A' ' 105' ' ' VAL . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.112 0.482 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.425 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.487 HG12 ' HE2' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 121.405 0.502 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.675 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.706 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.559 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.725 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.448 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' H ' HD12 ' A' ' 62' ' ' ILE . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.501 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' H ' ' CG2' ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.725 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.744 0.783 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.456 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.624 ' HE1' ' HG ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.5 m-90 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 85' ' ' TRP . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.449 ' CE2' ' CG1' ' A' ' 105' ' ' VAL . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.43 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.637 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.481 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.932 0.396 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.594 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.421 HG12 ' HE2' ' A' ' 20' ' ' HIS . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.53 152.64 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.669 ' CB ' ' HG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.544 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.624 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 32' ' ' TRP . 42.3 t0 -55.2 -25.2 31.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 12.3 m0 -42.34 -31.87 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.752 -1.217 . . . . 0.0 108.959 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.523 ' CE2' ' O ' ' A' ' 34' ' ' PRO . 17.3 t90 -48.73 126.86 13.64 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.717 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.523 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 72.2 Cg_endo -77.51 160.42 31.87 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.34 2.026 . . . . 0.0 112.34 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.62 -23.57 74.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.867 2.378 . . . . 0.0 112.483 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 37' ' ' HIS . 49.6 m -117.13 148.07 41.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.406 -0.809 . . . . 0.0 109.39 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.515 ' O ' ' O ' ' A' ' 36' ' ' SER . 76.4 t60 57.9 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 108.963 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HA ' ' HE1' ' A' ' 33' ' ' TRP . 27.9 t -103.26 123.53 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.205 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.89 -30.74 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.51 -0.744 . . . . 0.0 109.309 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG21 HH11 ' A' ' 44' ' ' ARG . 94.4 t -102.03 130.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.752 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -62.17 -37.39 85.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -89.21 145.96 25.07 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -85.44 114.31 22.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.979 -1.075 . . . . 0.0 109.755 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.417 HH11 HG21 ' A' ' 40' ' ' VAL . 82.5 mtt180 -62.85 141.76 58.53 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.6 -48.46 2.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.846 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.662 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.479 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' H ' HD11 ' A' ' 62' ' ' ILE . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.401 HG21 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 57' ' ' TYR . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' CA ' ' A' ' 54' ' ' GLY . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -102.62 120.35 40.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -103.49 128.31 27.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.1 Cg_exo -30.1 153.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.676 2.251 . . . . 0.0 112.528 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.1 Cg_exo -28.83 78.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 123.364 2.709 . . . . 0.0 112.495 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -176.84 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.516 -0.74 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 47.6 ttp180 -153.0 138.76 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.511 -1.368 . . . . 0.0 111.74 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.481 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 137' ' ' ALA . 5.6 m-90 55.16 47.36 21.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 23.9 mt-30 -122.0 154.74 36.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -98.84 151.46 20.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 157.15 51.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 109.041 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.45 -30.6 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.529 2.153 . . . . 0.0 111.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.76 150.32 20.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 0.0 108.8 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -105.45 117.29 33.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.282 -0.887 . . . . 0.0 109.991 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.24 -24.12 51.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.731 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.486 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 -119.57 126.11 50.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.79 172.77 0.08 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 -23.54 67.38 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -1.117 . . . . 0.0 109.126 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.75 50.34 0.8 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.337 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -133.5 134.77 7.66 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.669 ' HG1' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.54 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.77 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -82.28 -25.64 33.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.77 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 36.0 -147.06 0.05 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 19.4 t70 49.04 -133.29 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.47 -1.018 . . . . 0.0 109.61 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -79.87 47.08 3.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -59.47 -57.21 13.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.366 -1.079 . . . . 0.0 109.824 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . -64.78 -44.76 88.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.49 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 88.4 mt -68.99 -28.59 66.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.91 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.479 0.657 . . . . 0.0 111.476 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -130.17 75.38 0.43 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 144' ' ' GLY . 31.4 Cg_exo -55.13 142.14 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -56.67 -45.95 99.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.56 -30.08 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.567 2.178 . . . . 0.0 112.353 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.34 134.76 6.05 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.08 173.26 6.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.403 ' CG2' ' OAP' ' A' ' 201' ' ' 96F . 18.9 m -57.41 -35.36 69.95 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.412 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.471 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.612 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.635 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.2 Cg_exo -61.89 147.08 95.97 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.673 2.249 . . . . 0.0 112.272 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.436 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.436 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' TRP . 59.5 t0 -54.61 -18.26 4.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 9.9 m0 -44.95 -38.01 4.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.767 -1.208 . . . . 0.0 109.34 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -100.45 114.96 65.87 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.11 161.03 29.73 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.012 1.808 . . . . 0.0 111.815 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.7 -25.28 59.36 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.841 2.361 . . . . 0.0 112.498 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -58.9 -39.55 81.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.618 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -160.09 120.38 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.138 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.571 ' CG1' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -135.07 138.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.8 mt -71.02 -34.73 71.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -69.56 123.19 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 109.501 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -62.69 -37.99 88.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 34.8 ttpt -82.13 143.26 31.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -89.21 124.2 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.081 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.68 ' H ' ' CD ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.46 142.48 50.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.5 -44.48 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.865 . . . . 0.0 110.653 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.436 ' C ' ' CD1' ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 47' ' ' LEU . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.451 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' H ' HD12 ' A' ' 62' ' ' ILE . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.511 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -107.45 130.27 54.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.62 138.21 31.76 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.131 . . . . 0.0 109.254 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.0 Cg_exo -43.12 -53.82 3.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.2 2.6 . . . . 0.0 114.331 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 77' ' ' PRO . 17.8 Cg_endo -56.62 -111.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 120.906 1.071 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -137.64 59.39 1.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 -136.38 138.53 41.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.472 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.473 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.462 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.5 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.0 m-90 55.07 40.7 32.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.9 mt-30 -113.74 154.08 27.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 109.143 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -95.75 139.86 31.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.17 156.9 73.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 109.068 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.38 -32.76 43.5 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.561 2.174 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -160.48 148.51 16.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 90.1 m-20 -105.84 117.65 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -73.14 -23.73 60.5 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.307 -0.87 . . . . 0.0 108.675 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.686 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.488 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 -113.79 127.56 56.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.25 171.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 m -60.42 -31.53 70.49 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 109.149 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -130.64 49.21 0.93 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.543 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.13 136.08 8.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.533 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -74.37 -11.44 60.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.33 -170.99 41.56 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.286 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -71.96 150.42 44.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -1.046 . . . . 0.0 109.751 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.28 -7.77 60.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.416 -1.049 . . . . 0.0 109.33 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.503 ' CH2' ' N ' ' A' ' 1' ' ' MET . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.431 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . -66.75 -44.51 81.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.504 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 89.9 mt -66.61 -29.79 69.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.75 97.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.478 ' O ' ' HBA' ' A' ' 201' ' ' 96F . . . -134.29 71.86 0.48 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 144' ' ' GLY . 38.5 Cg_exo -56.69 143.72 88.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.294 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -55.3 -46.39 99.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.386 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.79 -31.57 88.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.573 2.182 . . . . 0.0 112.192 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -139.41 130.33 4.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -98.9 172.0 7.7 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.747 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.413 ' CG2' ' OAP' ' A' ' 201' ' ' 96F . 28.9 m -57.4 -35.77 70.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.29 -0.881 . . . . 0.0 109.083 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.591 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.445 HG21 HD11 ' A' ' 154' ' ' ILE . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.608 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.68 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.8 Cg_exo -61.44 147.12 96.28 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.437 2.091 . . . . 0.0 112.358 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 109' ' ' PRO . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.6 -31.93 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.63 -10.21 25.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.643 -1.286 . . . . 0.0 111.386 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.699 ' CZ3' ' NH2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -52.85 -41.86 86.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.494 -1.379 . . . . 0.0 110.722 -178.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 90.8 Cg_endo -101.44 73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.729 2.953 . . . . 0.0 113.272 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 36' ' ' SER . 36.2 Cg_endo -66.67 -43.43 7.47 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.208 1.939 . . . . 0.0 111.896 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER 158.32 -61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -55.3 -37.04 66.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.03 132.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 mt -109.84 153.35 24.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.5 p -103.85 142.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.63 -38.27 84.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.889 -1.132 . . . . 0.0 108.946 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' H ' HG22 ' A' ' 40' ' ' VAL . 10.2 pttt -121.19 143.51 49.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -83.74 123.48 29.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 110.45 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.699 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 61.9 mtt180 -74.28 142.52 45.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 -47.86 2.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.114 -0.991 . . . . 0.0 111.901 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.673 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.597 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' OE2' ' CZ ' ' A' ' 44' ' ' ARG . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' H ' HD12 ' A' ' 62' ' ' ILE . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.472 ' H ' ' CG2' ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 67' ' ' ILE . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.644 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.497 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -101.44 130.75 47.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -95.2 122.16 60.46 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 108.928 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 78' ' ' PRO . 83.0 Cg_exo -34.26 -51.88 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 123.088 2.525 . . . . 0.0 113.514 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.2 Cg_endo -54.95 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.192 1.104 . . . . 0.0 109.691 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -103.0 49.32 0.83 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 178.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.3 ttt-85 -136.09 146.33 46.91 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.488 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.422 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.474 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.694 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.694 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.576 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 3.5 m-90 55.57 48.29 19.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 80.8 mt-30 -125.84 162.04 26.05 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m -103.96 146.21 29.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.024 -1.047 . . . . 0.0 109.818 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.05 156.81 75.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.0 108.939 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -52.58 -31.63 50.28 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.392 2.061 . . . . 0.0 111.456 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -161.93 148.59 13.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -105.51 117.32 33.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.241 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.23 -25.52 61.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.433 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.673 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.485 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 -119.21 120.03 35.83 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 53.98 169.14 0.04 OUTLIER Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.3 p -64.46 -19.19 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 108.863 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.85 47.16 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.592 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -142.67 132.3 5.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.527 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.676 ' HD1' ' CD2' ' A' ' 124' ' ' LEU . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.13 -18.18 60.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.406 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 90.97 -172.07 36.43 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.582 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.45 150.88 47.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.999 . . . . 0.0 109.969 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.56 -7.29 63.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.35 -44.62 94.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.47 -1.018 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.68 ' CH2' ' N ' ' A' ' 1' ' ' MET . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.454 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . -64.34 -44.52 91.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 60.9 mt -67.11 -29.41 69.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 1.3 t70 78.35 102.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.646 -0.659 . . . . 0.0 111.559 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.72 148.55 38.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.477 ' CG ' ' HA1' ' A' ' 201' ' ' 96F . 33.5 Cg_endo -67.17 143.38 64.65 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.537 2.158 . . . . 0.0 113.13 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -53.12 179.74 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 142' ' ' SER . 71.4 Cg_exo -39.53 -19.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.452 1.435 . . . . 0.0 111.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -81.0 -178.36 52.37 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 77.2 mm-40 -98.3 162.08 13.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.028 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.492 ' HG1' ' CAV' ' A' ' 201' ' ' 96F . 31.5 m -57.14 -35.22 69.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 108.55 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.46 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.527 ' HAF' ' CG2' ' A' ' 117' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.09 146.72 95.51 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.698 2.265 . . . . 0.0 112.081 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.692 ' HG ' ' H ' ' A' ' 20' ' ' HIS . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.692 ' H ' ' HG ' ' A' ' 17' ' ' SER . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 33' ' ' TRP . 59.8 t0 -54.05 -28.7 40.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 15.0 m0 -42.35 -24.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -111.92 89.05 10.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.465 -0.772 . . . . 0.0 109.672 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -77.28 163.65 29.95 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.257 1.971 . . . . 0.0 111.869 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -44.08 130.85 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -154.31 171.34 19.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -51.26 -31.33 20.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -102.78 136.81 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 109.542 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.6 mt -82.32 154.08 25.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.705 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 42' ' ' LYS . 21.9 m -50.17 146.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.358 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.24 -36.37 79.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 8.7 ttpt -115.24 149.76 37.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' O ' ' CE ' ' A' ' 42' ' ' LYS . 96.4 mt-10 -63.35 114.26 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.714 HH12 ' NH1' ' A' ' 149' ' ' ARG . 79.4 mtt180 -123.42 141.09 52.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 108.814 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.92 -47.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.531 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.766 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.414 ' H ' HD11 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.495 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' H ' ' CG2' ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.766 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -108.62 129.51 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -112.15 124.06 33.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.629 ' O ' ' N ' ' A' ' 79' ' ' HIS . 34.2 Cg_exo -30.82 154.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.731 2.287 . . . . 0.0 112.795 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.6 Cg_exo -29.04 79.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.448 2.766 . . . . 0.0 112.441 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.629 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.49 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.683 -0.636 . . . . 0.0 109.291 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 40.1 ttp180 -155.62 151.95 28.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.502 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.467 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.48 ' NH1' ' O ' ' A' ' 94' ' ' VAL . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 3.7 m-90 55.96 32.94 20.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.436 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -106.23 153.87 21.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.8 t -100.72 139.44 36.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -134.27 157.52 77.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 108.98 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.23 -31.4 22.0 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.525 2.15 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -157.21 147.76 21.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.463 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 87.1 m-20 -106.14 117.61 34.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -74.88 -22.23 58.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 79' ' ' HIS . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -119.41 145.79 45.93 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.29 -175.57 26.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 59.22 15.41 4.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -1.132 . . . . 0.0 109.583 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.16 1.29 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.63 140.7 10.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.411 ' CB ' ' HAF' ' A' ' 201' ' ' 96F . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.477 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.679 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.679 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.3 -32.91 29.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.635 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 33.97 -153.56 0.01 OUTLIER Glycine 0 N--CA 1.499 2.849 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 128' ' ' GLY . 60.8 t0 43.39 71.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -1.125 . . . . 0.0 109.973 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.94 33.05 58.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -61.9 -57.24 12.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.545 -0.974 . . . . 0.0 110.209 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.42 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . -64.43 -43.46 94.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 95.7 mt -70.13 -4.94 23.7 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.98 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.453 0.644 . . . . 0.0 110.555 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -118.73 67.79 0.36 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 144' ' ' GLY . 12.1 Cg_endo -60.59 141.13 94.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.193 1.928 . . . . 0.0 112.377 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.567 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -71.64 -45.85 12.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.952 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.4 Cg_exo -55.03 -31.88 76.65 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.623 2.215 . . . . 0.0 112.532 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.96 167.05 26.9 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -115.57 175.91 5.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -1.012 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.45 ' CG2' ' OAP' ' A' ' 201' ' ' 96F . 20.1 m -57.55 -35.0 69.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.229 -0.92 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.714 ' NH1' HH12 ' A' ' 44' ' ' ARG . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.633 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.614 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -66.5 144.48 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.728 2.285 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 22.7 t70 -54.31 -32.51 56.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.39 111.95 24.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.979 -1.075 . . . . 0.0 108.103 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.587 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.99 179.62 0.77 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 22.5 Cg_exo -60.71 158.7 31.59 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.471 2.114 . . . . 0.0 111.582 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.99 158.92 2.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.664 2.242 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -52.83 -29.6 28.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -53.37 -41.34 65.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.065 -1.022 . . . . 0.0 109.364 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.04 131.11 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.376 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.1 mt -111.19 142.69 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 42' ' ' LYS . 11.4 p -61.49 139.13 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -61.39 -38.23 86.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 0.0 109.295 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 40' ' ' VAL . 19.5 pttt -118.41 145.64 45.04 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.01 123.75 28.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.96 -1.087 . . . . 0.0 109.622 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -65.32 143.2 57.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 108.834 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.72 -47.77 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.706 ' NE ' ' HH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.706 ' HH ' ' NE ' ' A' ' 56' ' ' ARG . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.675 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.635 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.468 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.675 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.758 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.508 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' CD2' ' OG1' ' A' ' 84' ' ' THR . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -101.84 130.59 48.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 1.4 t0 -93.94 122.0 62.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 108.927 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 78' ' ' PRO . 31.7 Cg_exo -41.53 -43.08 5.99 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.798 2.332 . . . . 0.0 113.919 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 34.9 Cg_exo -60.83 -132.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 108.843 -1.253 . . . . 0.0 108.843 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.667 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.27 53.76 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 51.5 ttt-85 -136.75 141.33 43.0 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.201 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.47 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.758 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.603 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 93' ' ' SER . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.521 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 7.8 m-90 56.36 25.78 9.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 170.35 77.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 0.0 109.121 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.469 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 14.0 t -124.05 -77.94 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.302 -0.874 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.1 m -126.59 150.5 71.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.836 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.86 -34.56 81.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.403 2.068 . . . . 0.0 112.1 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -109.24 146.87 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 0.0 109.011 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 94.4 m-20 -105.47 117.93 35.27 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.558 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -88.7 -9.39 52.16 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.495 ' H ' ' HG ' ' A' ' 101' ' ' SER . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.667 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.493 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -119.1 144.85 46.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.43 -175.83 23.29 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.81 15.24 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -1.142 . . . . 0.0 109.52 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 70.04 1.3 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.31 140.14 9.42 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.423 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.691 ' HD1' ' CD2' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.523 ' O ' ' OG ' ' A' ' 101' ' ' SER . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.691 ' CD2' ' HD1' ' A' ' 121' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.74 -15.21 59.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.422 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 89.15 -166.5 33.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 129' ' ' ASP . 53.0 p30 -73.81 161.3 30.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 -6.44 83.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.496 -1.002 . . . . 0.0 110.156 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.419 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.53 -44.46 86.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.524 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 84.8 mt -67.24 -26.85 66.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER 79.91 105.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.727 -0.608 . . . . 0.0 110.882 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.6 79.91 0.35 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 35.9 Cg_exo -54.46 148.78 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.814 2.343 . . . . 0.0 112.376 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.607 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -95.77 -43.82 0.27 Allowed Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.1 Cg_exo -57.62 -24.69 63.77 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.607 2.205 . . . . 0.0 112.383 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.79 173.59 21.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -105.51 164.59 11.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -1.037 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.606 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 47.2 m -57.86 -36.0 71.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.435 ' CD2' ' OAO' ' A' ' 201' ' ' 96F . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.592 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.567 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.606 ' CAW' ' HG1' ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.9 ptt? . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 1' ' ' MET . 14.8 Cg_endo -61.02 154.81 54.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.84 2.36 . . . . 0.0 112.288 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.57 -33.24 69.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -69.6 -37.64 76.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.085 -1.634 . . . . 0.0 110.009 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.569 ' NE1' ' NH2' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -49.0 108.76 1.02 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.654 -1.279 . . . . 0.0 108.975 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.8 155.64 11.7 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.288 1.992 . . . . 0.0 112.829 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.34 -16.67 55.5 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.615 2.21 . . . . 0.0 111.989 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.7 p -65.29 168.12 7.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.696 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 57.76 -120.92 1.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.46 -0.775 . . . . 0.0 109.546 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' CZ3' ' A' ' 33' ' ' TRP . 47.1 t -107.14 134.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 109.472 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.56 147.25 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG21 ' H ' ' A' ' 42' ' ' LYS . 7.1 p -48.65 142.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.917 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.17 -38.96 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.076 -1.015 . . . . 0.0 109.467 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' H ' HG21 ' A' ' 40' ' ' VAL . 46.5 pttt -114.22 143.68 44.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.01 123.05 19.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 109.649 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -71.53 142.45 50.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.095 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.13 -48.18 1.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.465 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.708 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.6 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.718 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.468 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' H ' HD11 ' A' ' 62' ' ' ILE . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' H ' ' CG2' ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.718 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.592 ' C ' ' O ' ' A' ' 84' ' ' THR . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.501 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 -108.07 130.23 55.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.39 130.53 45.37 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 108.851 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.35 -46.17 9.72 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.504 2.136 . . . . 0.0 112.992 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 77' ' ' PRO . 35.4 Cg_exo -57.1 -126.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.19 1.26 . . . . 0.0 109.21 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -126.41 55.11 1.52 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 -136.66 134.35 37.18 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.443 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.494 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.48 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.505 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.478 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.2 m-90 55.96 36.08 26.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.435 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.6 mt-30 -110.33 156.62 20.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 108.959 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -101.34 140.04 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.47 157.0 66.63 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.485 -0.76 . . . . 0.0 109.195 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.78 -32.72 67.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.572 2.182 . . . . 0.0 111.598 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -157.11 147.4 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -106.63 117.83 35.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.347 -0.846 . . . . 0.0 110.816 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -80.2 -14.65 58.28 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.476 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.58 145.15 46.66 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.3 -177.28 33.56 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.17 11.37 4.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -1.179 . . . . 0.0 109.409 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.25 70.97 1.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.78 140.03 9.5 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 116' ' ' ARG . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.579 ' CD2' ' C ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.649 ' ND1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -79.55 -32.87 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.603 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 29.43 -146.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 128' ' ' GLY . 59.8 t0 43.42 61.14 2.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -1.088 . . . . 0.0 109.66 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.16 33.99 38.62 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -57.3 -52.43 65.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.504 -0.998 . . . . 0.0 109.772 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.447 ' HB1' ' NE1' ' A' ' 91' ' ' TRP . . . -65.03 -44.09 90.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 75.4 mt -65.37 -24.35 67.22 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 9.8 t0 85.91 98.17 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.308 0.575 . . . . 0.0 110.987 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -114.88 80.73 0.29 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.414 ' O ' ' HBA' ' A' ' 201' ' ' 96F . 19.4 Cg_endo -65.34 140.83 65.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.884 1.723 . . . . 0.0 112.39 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -80.54 -44.46 1.33 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 110.072 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.6 Cg_exo -57.82 -71.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.552 2.168 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.53 179.71 44.77 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -119.54 164.3 16.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.6 -0.941 . . . . 0.0 109.121 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.603 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 21.4 m -57.68 -38.08 74.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.485 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.569 ' NH2' ' NE1' ' A' ' 33' ' ' TRP . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.472 HG12 ' HE2' ' A' ' 20' ' ' HIS . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.607 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.1 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 1' ' ' MET . 15.0 Cg_endo -61.59 152.58 72.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -53.33 -32.41 48.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -98.1 109.58 22.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.892 -1.13 . . . . 0.0 108.107 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.91 162.94 19.35 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.111 -0.993 . . . . 0.0 109.956 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.08 154.67 47.4 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.845 2.363 . . . . 0.0 111.966 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 36' ' ' SER . 51.3 Cg_endo -72.7 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.452 2.102 . . . . 0.0 111.969 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' PRO . 38.4 t 49.03 177.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.832 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -58.23 -43.74 87.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.2 t -119.44 131.49 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.393 -0.817 . . . . 0.0 109.12 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.09 -45.53 92.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.497 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 42' ' ' LYS . 8.3 p -159.8 143.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.89 -38.75 89.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.871 -1.143 . . . . 0.0 109.013 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' H ' HG22 ' A' ' 40' ' ' VAL . 17.8 pttt -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -85.51 123.72 31.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.85 -1.156 . . . . 0.0 110.028 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.401 HH21 ' HA ' ' A' ' 30' ' ' ALA . 90.0 mtt180 -65.2 143.22 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.99 -48.5 2.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.982 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.709 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.592 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.474 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.627 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.486 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.588 ' C ' ' O ' ' A' ' 84' ' ' THR . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.502 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -102.42 130.52 49.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.74 129.32 47.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 0.0 109.016 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.1 -46.09 9.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.733 2.289 . . . . 0.0 113.471 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 77' ' ' PRO . 38.8 Cg_exo -58.86 -133.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.01 1.14 . . . . 0.0 109.141 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -118.65 53.61 0.98 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 177.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 -136.42 141.82 43.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.148 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 95' ' ' PRO . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.601 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 93' ' ' SER . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' H ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.481 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 9.2 m-90 56.93 26.17 11.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 173.53 11.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.843 . . . . 0.0 109.127 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.413 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 7.6 t -58.34 -56.82 17.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 110.497 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 11.6 m -146.72 150.89 41.13 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.802 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.518 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 25.3 Cg_endo -65.14 -37.83 30.57 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.436 2.091 . . . . 0.0 112.095 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.53 147.01 33.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 109.303 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.3 m-20 -105.57 117.99 35.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -90.27 -8.88 49.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -117.93 143.94 45.92 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.83 -175.98 21.05 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.37 13.66 4.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -1.094 . . . . 0.0 109.458 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.28 70.77 1.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.26 140.11 9.11 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.421 ' C ' ' HG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.817 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -82.88 -24.24 33.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.817 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 30.51 -142.85 0.02 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 131' ' ' ALA . 79.0 m-20 42.77 -145.75 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -1.009 . . . . 0.0 109.556 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.76 47.12 0.96 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 129' ' ' ASP . . . -58.99 -46.69 87.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.291 -1.123 . . . . 0.0 109.472 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.403 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . -66.37 -44.07 84.18 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.483 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 77.4 mt -66.56 -27.01 67.39 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 135' ' ' HIS . 0.6 OUTLIER 75.71 106.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.52 80.96 0.34 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.477 ' O ' ' HBA' ' A' ' 201' ' ' 96F . 37.9 Cg_exo -54.03 145.11 54.29 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.771 2.314 . . . . 0.0 112.49 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.621 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -86.9 -43.45 0.54 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.485 -0.759 . . . . 0.0 109.809 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 142' ' ' SER . 32.3 Cg_exo -56.71 -27.72 72.22 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.745 2.296 . . . . 0.0 112.486 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.33 173.4 23.05 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 73.8 mm-40 -108.22 165.67 11.32 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -1.043 . . . . 0.0 109.204 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.607 ' HG1' ' HA1' ' A' ' 201' ' ' 96F . 25.9 m -57.62 -35.66 70.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 109.202 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.419 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.523 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.608 ' CAD' ' CE2' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.621 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 26.0 Cg_exo -59.65 148.91 85.65 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.751 2.3 . . . . 0.0 112.278 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.593 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HA ' ' CZ3' ' A' ' 32' ' ' TRP . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -62.76 -33.17 74.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -66.61 -30.55 70.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.094 -1.629 . . . . 0.0 109.779 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -49.08 109.88 1.35 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.833 -1.167 . . . . 0.0 108.563 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.68 133.83 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.94 1.76 . . . . 0.0 112.193 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.99 -19.38 23.23 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.408 2.072 . . . . 0.0 112.649 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' HIS . 54.0 p -65.64 154.91 37.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.056 -1.028 . . . . 0.0 109.298 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.734 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 66.4 t60 39.98 -162.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.471 -0.768 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.734 ' H ' ' CG ' ' A' ' 37' ' ' HIS . 45.0 t -126.57 119.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' O ' ' OD2' ' A' ' 139' ' ' ASP . 52.2 mt -110.42 0.89 18.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.608 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 42' ' ' LYS . 13.6 p -129.57 139.59 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.798 . . . . 0.0 109.054 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -61.88 -38.51 88.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 108.964 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 40' ' ' VAL . 54.5 pttt -119.65 145.12 46.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -77.98 111.56 13.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.933 -1.104 . . . . 0.0 109.654 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.85 142.86 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.85 -47.99 1.51 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.186 -0.946 . . . . 0.0 111.253 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.643 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.712 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.644 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.402 HG21 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.712 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.503 ' CD1' ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 -106.15 121.25 43.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -105.83 128.37 26.58 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.0 Cg_exo -30.15 153.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.749 2.299 . . . . 0.0 112.655 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' PRO . 88.5 Cg_exo -29.61 79.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.215 2.61 . . . . 0.0 112.269 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.61 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.575 -0.703 . . . . 0.0 109.77 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.8 ttp180 -150.5 138.79 20.35 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.065 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.419 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.3 m-90 55.14 46.02 24.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 83.7 mt-30 -120.71 157.35 29.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.1 t -101.25 138.33 38.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.476 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -132.58 156.67 79.82 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.387 -0.82 . . . . 0.0 109.122 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.52 -32.1 51.84 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.521 2.148 . . . . 0.0 111.751 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -155.09 147.92 24.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.847 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -106.03 117.51 34.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 110.333 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -75.49 -24.53 56.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.659 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' HIS . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 111' ' ' GLY . 22.4 t-20 -117.19 124.81 50.01 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.18 172.04 0.02 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.8 m -60.53 -30.92 70.04 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -1.105 . . . . 0.0 109.25 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -129.57 51.22 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.841 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -136.66 131.91 5.83 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.541 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.803 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -81.27 -33.86 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.803 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 30.54 -149.98 0.01 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 51.31 48.88 22.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -1.124 . . . . 0.0 110.248 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.12 27.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -54.82 -44.62 74.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.7 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.614 ' CH2' ' N ' ' A' ' 1' ' ' MET . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.409 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . -67.59 -44.81 77.26 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.495 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.85 -30.96 71.66 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 66.88 101.26 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 111.393 178.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.471 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -125.53 78.92 0.37 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.411 ' O ' ' HBC' ' A' ' 201' ' ' 96F . 32.1 Cg_exo -54.68 144.25 65.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.942 2.428 . . . . 0.0 112.739 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.4 OUTLIER -64.42 -64.0 3.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.415 -0.803 . . . . 0.0 109.895 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 142' ' ' SER . 12.0 Cg_endo -57.58 -33.99 97.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.344 2.029 . . . . 0.0 111.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -114.3 117.39 4.09 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -93.31 169.04 10.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.176 -1.19 . . . . 0.0 109.718 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.415 ' CG2' ' OAP' ' A' ' 201' ' ' 96F . 60.8 m -57.47 -38.47 74.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.791 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.498 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.593 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.541 ' HAF' ' CG2' ' A' ' 117' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -61.55 146.43 96.96 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.728 2.286 . . . . 0.0 112.177 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -55.56 -32.57 63.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.666 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.07 108.06 20.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -0.993 . . . . 0.0 108.36 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.68 160.51 30.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.72 154.28 54.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.624 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.56 110.01 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.267 1.978 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.1 p -154.57 163.56 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -54.57 -31.96 57.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.156 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.11 140.45 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.194 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -47.72 -41.99 24.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.371 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.51 124.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.286 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -62.48 -36.55 82.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 151.65 21.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.502 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 96.9 mt-10 -76.15 103.22 6.08 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.872 -1.142 . . . . 0.0 110.034 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 59' ' ' GLU . 84.7 mtt180 -123.73 132.49 53.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -133.34 -41.25 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 110.16 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.459 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.691 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' O ' ' A' ' 43' ' ' GLU . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' CD ' ' O ' ' A' ' 66' ' ' GLU . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 68' ' ' VAL . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' HH11 ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.615 ' C ' ' O ' ' A' ' 84' ' ' THR . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.495 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 -134.56 111.95 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -115.42 96.19 45.17 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 16.6 Cg_exo -57.39 -43.52 51.07 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.532 2.155 . . . . 0.0 114.788 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 58.5 Cg_endo -76.55 11.27 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.81 1.673 . . . . 0.0 115.21 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 107' ' ' PHE . 1.2 t-80 -176.78 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 119.765 -1.834 . . . . 0.0 113.54 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 21.9 ttm180 -144.24 144.74 31.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.156 -1.59 . . . . 0.0 113.061 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.484 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.433 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.556 ' NH1' ' O ' ' A' ' 95' ' ' PRO . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.525 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.1 m-90 55.82 26.64 9.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -98.59 150.51 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 109.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.4 p -86.22 150.58 24.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -146.45 156.73 49.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.114 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 9.7 Cg_endo -55.19 -32.94 82.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.445 2.097 . . . . 0.0 111.69 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 56.1 m-20 -159.27 146.93 17.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 87.3 m-20 -105.69 117.85 35.08 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.1 -26.37 62.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 108.835 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 81' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' HIS . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.42 140.64 50.08 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.95 -179.77 21.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.15 12.75 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -1.08 . . . . 0.0 109.582 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.08 67.44 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.23 10.87 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.473 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.567 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.752 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -86.53 -27.17 24.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.752 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 38.23 -147.37 0.11 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 131' ' ' ALA . 79.8 m-20 48.92 -140.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 109.285 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.16 44.6 0.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 129' ' ' ASP . . . -57.95 -57.09 14.34 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.627 -0.925 . . . . 0.0 110.412 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . . . -66.05 -43.63 86.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 93.6 mt -67.64 -6.61 21.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 61.99 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.593 0.711 . . . . 0.0 111.575 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.5 82.09 0.34 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.8 145.11 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.711 2.274 . . . . 0.0 112.466 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -83.03 -41.96 0.85 Allowed Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 142' ' ' SER . 7.3 Cg_exo -69.62 -68.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.69 2.26 . . . . 0.0 112.132 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -90.78 179.78 43.04 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -120.03 171.69 8.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.474 -1.015 . . . . 0.0 109.392 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.5 m -57.88 -36.75 72.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.491 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.599 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.531 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.491 ' CAG' ' CD2' ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.96 146.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.705 2.27 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.612 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -56.23 -32.01 64.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.12 111.59 23.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.601 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.3 p90 -112.5 153.53 44.88 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 33' ' ' TRP . 59.3 Cg_exo -31.28 155.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.67 2.246 . . . . 0.0 112.754 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.1 -30.13 89.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.483 2.122 . . . . 0.0 112.545 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -66.61 153.02 44.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.369 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.55 -44.09 84.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.022 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.84 140.36 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 108.95 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.0 tp -169.52 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.118 -0.989 . . . . 0.0 110.088 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.07 128.05 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.952 -1.093 . . . . 0.0 109.109 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -62.3 -34.76 77.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -117.73 143.8 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.503 -0.748 . . . . 0.0 109.222 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.51 117.86 20.84 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.95 -1.094 . . . . 0.0 109.48 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 30' ' ' ALA . 83.3 mtt180 -70.84 142.21 51.26 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.53 -48.0 1.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -0.965 . . . . 0.0 111.114 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.652 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.69 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.483 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 64' ' ' GLY . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' N ' ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' H ' HD12 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.588 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.69 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.594 ' C ' ' O ' ' A' ' 84' ' ' THR . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.532 ' CG1' ' HH ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 -105.31 121.76 44.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -100.77 130.59 25.01 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 79' ' ' HIS . 46.4 Cg_exo -30.0 153.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.69 2.26 . . . . 0.0 112.459 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.9 Cg_exo -29.38 78.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.34 2.693 . . . . 0.0 112.373 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.98 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.602 -0.686 . . . . 0.0 109.841 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 35.4 ttm180 -152.31 139.74 19.56 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.706 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.471 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.436 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.602 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.587 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.587 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 39.7 m95 56.07 47.78 18.99 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 93' ' ' SER . 84.3 mt-30 -117.93 -88.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.825 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 t 153.04 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.77 62.25 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.337 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.96 -31.73 94.04 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.163 . . . . 0.0 111.747 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -155.13 150.81 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.8 m-20 -105.68 117.63 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 110.427 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.28 -23.58 57.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 108.542 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 81' ' ' LEU . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' HIS . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 -119.19 126.16 50.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.39 173.31 0.03 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.3 p -64.38 -22.37 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.35 -1.088 . . . . 0.0 109.283 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.47 49.83 0.86 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -135.91 130.78 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.488 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.563 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.832 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -80.19 -30.72 38.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.832 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 33.96 28.17 0.01 OUTLIER Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.566 -0.709 . . . . 0.0 111.337 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 127' ' ' HIS . 60.2 t0 -140.0 110.6 6.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.837 -1.39 . . . . 0.0 109.445 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.89 39.67 3.77 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.503 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -62.61 -57.81 9.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.756 -0.849 . . . . 0.0 111.203 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.48 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -70.15 -43.13 71.53 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.486 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 91.8 mt -61.66 -28.1 69.15 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 59.46 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.405 0.621 . . . . 0.0 110.961 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -121.02 82.37 0.35 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 144' ' ' GLY . 45.9 Cg_exo -53.66 141.87 62.86 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.707 2.272 . . . . 0.0 112.641 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -71.2 -43.55 12.95 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.472 -0.768 . . . . 0.0 110.161 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 142' ' ' SER . 43.2 Cg_exo -55.51 -31.9 80.35 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.691 2.261 . . . . 0.0 112.563 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -147.56 172.88 27.84 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -118.04 174.24 6.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.422 ' CG2' ' OAP' ' A' ' 201' ' ' 96F . 28.1 m -57.72 -35.98 71.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.585 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.612 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.519 ' CAG' ' CD2' ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.1 147.68 92.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.776 2.317 . . . . 0.0 112.124 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' CG2' ' HZ1' ' A' ' 10' ' ' LYS . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' HZ1' ' CG2' ' A' ' 8' ' ' VAL . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.34 -32.25 48.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.678 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -96.87 105.93 18.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 108.338 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 9.7 p90 -112.86 149.99 42.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.031 -1.043 . . . . 0.0 108.889 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.16 123.16 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.15 1.9 . . . . 0.0 112.141 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.89 128.99 10.37 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.025 1.816 . . . . 0.0 111.854 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 p -157.08 171.23 20.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.501 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -55.11 -34.87 64.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.05 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.29 136.09 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' VAL . 54.3 mt -79.02 159.57 27.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' LEU . 13.9 p -41.13 136.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.257 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.31 -37.45 83.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 109.309 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 59' ' ' GLU . 1.3 pttt -117.81 143.35 46.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -86.25 123.17 31.21 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.084 -1.01 . . . . 0.0 109.767 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH21 ' HA ' ' A' ' 30' ' ' ALA . 75.9 mtt180 -66.36 143.27 57.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.112 -0.992 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.56 -48.15 2.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.656 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.713 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.588 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.738 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.738 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.587 ' C ' ' O ' ' A' ' 84' ' ' THR . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 -108.07 125.24 51.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.508 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -108.63 128.81 24.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.8 Cg_exo -30.41 154.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 122.748 2.299 . . . . 0.0 112.601 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' PRO . 69.5 Cg_exo -27.67 78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.411 2.74 . . . . 0.0 112.491 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -178.08 -42.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.55 -0.719 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 44.3 ttp180 -153.36 138.1 17.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.049 -1.461 . . . . 0.0 112.087 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.623 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.606 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 94' ' ' VAL . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 7.5 m-90 57.54 25.7 11.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 176.43 9.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.367 -0.833 . . . . 0.0 108.961 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.2 t -56.99 -56.79 17.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 5.1 m -146.91 151.44 41.78 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 109.701 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.38 -38.16 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.405 2.07 . . . . 0.0 112.054 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -109.87 147.35 33.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.838 . . . . 0.0 109.228 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 92.0 m-20 -105.14 118.2 35.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.98 -9.11 49.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.623 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' HIS . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 -119.8 115.75 24.5 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . 64.01 25.92 69.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER 46.53 12.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 108.976 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 111' ' ' GLY . . . -146.96 6.33 1.14 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -130.3 126.11 4.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.552 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' O ' ' OG ' ' A' ' 101' ' ' SER . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.59 -22.8 56.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.548 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 87.85 -166.99 36.1 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.649 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.11 151.24 47.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -1.013 . . . . 0.0 109.992 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.06 63.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.52 -40.72 97.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.513 -0.993 . . . . 0.0 109.546 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.422 ' CB ' ' CE2' ' A' ' 91' ' ' TRP . . . -64.1 -43.68 94.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 89.4 mt -67.27 -23.03 65.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 4.9 t0 81.61 100.49 0.05 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.327 0.584 . . . . 0.0 110.712 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.442 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -117.6 70.5 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.478 ' O ' ' HBB' ' A' ' 201' ' ' 96F . 11.8 Cg_endo -59.76 137.76 78.79 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.057 1.838 . . . . 0.0 112.3 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.635 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -83.54 -41.81 0.8 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 109.969 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.54 -26.45 54.72 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.632 2.221 . . . . 0.0 112.386 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.93 168.58 25.0 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -103.87 164.23 11.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.254 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.403 ' OG1' ' CAW' ' A' ' 201' ' ' 96F . 82.0 m -57.75 -38.33 75.19 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.156 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.443 ' CD2' ' OAO' ' A' ' 201' ' ' 96F . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 154' ' ' ILE . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.552 ' HAF' ' CG2' ' A' ' 117' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.76 147.32 92.72 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.733 2.289 . . . . 0.0 112.197 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG12 ' HE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.674 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.512 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.445 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -60.27 -32.7 71.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.564 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -75.45 -24.85 57.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.177 -1.577 . . . . 0.0 110.153 -178.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.602 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -49.69 -58.12 10.18 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 110.847 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 33' ' ' TRP . 1.6 Cg_endo -48.62 -57.95 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.066 1.844 . . . . 0.0 114.024 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.19 -23.58 70.05 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.495 1.463 . . . . 0.0 111.927 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 33' ' ' TRP . 54.3 p -73.12 162.81 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.475 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 37' ' ' HIS . 58.2 t-80 -92.29 16.14 12.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 109.554 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.45 136.34 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.49 157.0 16.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.8 p -117.24 142.17 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.27 -38.77 87.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 109.11 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.457 ' H ' HG22 ' A' ' 40' ' ' VAL . 55.1 pttt -117.8 142.91 46.76 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -82.75 121.34 26.77 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.856 -1.153 . . . . 0.0 109.449 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.06 142.5 41.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.75 -47.93 1.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.254 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.671 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.661 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.477 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' H ' HD11 ' A' ' 62' ' ' ILE . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.58 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.614 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -104.57 130.27 52.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.7 t70 -90.49 131.96 36.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.035 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.7 Cg_exo -42.67 -46.09 8.34 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.671 2.247 . . . . 0.0 113.434 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 77' ' ' PRO . 36.6 Cg_exo -58.98 -132.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.072 1.181 . . . . 0.0 109.058 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.19 52.93 1.04 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 -136.18 132.86 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.663 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.407 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.454 ' CE2' ' CD1' ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.492 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 94' ' ' VAL . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.51 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 7.0 m-90 57.53 26.37 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.16 3.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.221 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -59.1 -58.68 7.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.272 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.488 ' O ' ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -146.94 157.03 47.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.6 -29.63 51.38 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.482 2.121 . . . . 0.0 111.375 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 97' ' ' ASP . 39.9 t0 -149.9 147.85 28.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 108.92 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 74.2 m-20 -106.21 120.59 42.22 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.289 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.57 -15.05 49.15 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 -114.61 126.27 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.69 171.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.0 p -64.89 -21.78 66.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -1.142 . . . . 0.0 109.022 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.77 45.75 1.08 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.425 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.75 132.18 6.34 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.53 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.703 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.703 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -87.14 -34.63 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.682 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 33.97 -154.11 0.01 OUTLIER Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 52.96 53.18 12.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.049 -1.265 . . . . 0.0 110.42 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.43 29.86 35.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.489 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -57.19 -49.02 77.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.655 -0.909 . . . . 0.0 109.775 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.42 ' CB ' ' CE2' ' A' ' 91' ' ' TRP . . . -63.74 -43.21 97.15 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 93.5 mt -66.67 -16.38 64.17 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.581 ' OD2' ' NH1' ' A' ' 149' ' ' ARG . 6.2 t0 86.24 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.438 0.637 . . . . 0.0 110.576 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.52 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -115.12 84.5 0.37 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.26 142.95 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.475 2.117 . . . . 0.0 112.257 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.634 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -80.83 -42.83 1.24 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' SER . 18.1 Cg_exo -63.35 -70.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.635 2.223 . . . . 0.0 112.451 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.64 -178.98 45.03 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 78.0 mm-40 -122.3 165.99 15.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.478 -1.013 . . . . 0.0 109.235 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 42.0 m -57.96 -36.78 73.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.486 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.674 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.592 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.69 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.8 Cg_exo -59.35 149.49 80.87 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.438 2.092 . . . . 0.0 112.368 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.578 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.591 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' TRP . 37.4 t0 -55.61 -9.34 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.591 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 2.7 m0 -42.26 -40.37 2.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.637 -1.29 . . . . 0.0 109.956 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.633 ' O ' ' CD2' ' A' ' 33' ' ' TRP . 63.8 p-90 -78.9 117.49 67.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.924 -1.11 . . . . 0.0 110.281 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 36' ' ' SER . 88.2 Cg_endo -82.75 161.63 16.38 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.138 1.892 . . . . 0.0 111.098 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -40.25 83.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.312 2.008 . . . . 0.0 111.72 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 34' ' ' PRO . 95.5 p -129.72 158.76 38.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 109.92 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -56.03 -34.86 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.513 -0.742 . . . . 0.0 110.202 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -121.42 141.12 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.433 -0.792 . . . . 0.0 109.759 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -158.8 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.636 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' H ' ' CG ' ' A' ' 39' ' ' LEU . 53.4 t -115.9 140.32 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.5 -36.34 78.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 108.671 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 35.5 pttt -109.11 143.21 38.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -71.27 123.39 22.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.957 -1.089 . . . . 0.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.666 ' NH1' HH12 ' A' ' 149' ' ' ARG . 80.3 mtt180 -84.74 141.44 30.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.96 -48.17 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.762 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.642 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.691 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.569 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.748 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CH2' ' OE2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 62' ' ' ILE . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' OE2' ' CH2' ' A' ' 60' ' ' TRP . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.748 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.613 ' C ' ' O ' ' A' ' 84' ' ' THR . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.491 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 -114.52 112.6 23.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' H ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -114.45 96.27 42.62 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.495 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 10.2 Cg_exo -57.49 -43.03 54.93 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.271 1.98 . . . . 0.0 114.003 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 77.1 Cg_exo -47.34 -17.57 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.492 2.128 . . . . 0.0 114.753 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 178.46 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.942 -1.724 . . . . 0.0 112.895 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 34.6 ttm180 -151.14 141.9 22.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.899 -1.751 . . . . 0.0 113.427 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 76' ' ' ASP . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.431 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 94' ' ' VAL . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.653 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.436 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 5.7 m-90 56.9 25.99 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.56 106.2 16.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.066 -1.021 . . . . 0.0 108.937 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -48.32 138.83 9.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.002 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -124.99 156.86 68.6 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -51.77 -29.56 34.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.4 2.067 . . . . 0.0 111.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.62 149.89 20.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -105.38 117.86 35.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.15 -8.98 58.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.653 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 105' ' ' VAL . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 -119.44 125.03 47.96 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.89 173.91 0.09 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -64.5 -23.6 67.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -1.086 . . . . 0.0 109.269 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.7 50.04 0.81 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.404 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -132.35 131.16 6.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.544 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.503 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.35 -23.4 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.522 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 89.35 -166.12 33.09 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.485 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -65.3 151.21 46.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.47 -1.018 . . . . 0.0 110.15 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.51 62.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.61 -39.64 94.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -1.071 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.69 ' CH2' ' N ' ' A' ' 1' ' ' MET . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' NE1' ' A' ' 91' ' ' TRP . . . -65.56 -44.49 86.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.476 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 19.3 mt -67.35 -25.44 65.99 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 59.02 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 111.675 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.497 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -127.66 78.47 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' GLY . 39.0 Cg_exo -53.83 138.86 69.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.819 2.346 . . . . 0.0 112.62 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -60.21 -45.57 97.74 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.92 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 142' ' ' SER . 42.7 Cg_exo -55.06 -29.79 66.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.64 2.227 . . . . 0.0 112.385 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -142.89 136.38 7.06 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.42 173.92 6.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m -57.36 -36.29 71.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.271 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.496 ' CD1' ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.666 HH12 ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.5 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.578 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.601 ' CAD' ' CE1' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -60.69 147.02 96.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.76 2.306 . . . . 0.0 112.126 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.404 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.503 ' CE1' ' CG2' ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' CG2' ' CE1' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.422 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 32' ' ' TRP . 20.5 t0 -57.63 -9.62 1.24 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.602 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 3.0 m0 -43.24 -37.79 2.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.638 -1.289 . . . . 0.0 109.47 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.56 139.53 96.08 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.05 152.42 45.86 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.184 1.923 . . . . 0.0 112.05 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.84 134.27 39.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.355 2.036 . . . . 0.0 111.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -151.41 159.17 44.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.95 -33.19 64.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.296 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.8 140.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 40' ' ' VAL . 40.9 tp -85.21 143.36 28.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 39' ' ' LEU . 24.2 m -43.45 145.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -61.5 -35.84 78.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -89.15 142.35 27.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.283 -0.886 . . . . 0.0 108.721 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 96.9 mt-10 -72.32 104.88 3.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.907 -1.121 . . . . 0.0 109.905 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' NH1' ' OD2' ' A' ' 139' ' ' ASP . 84.6 mtt180 -122.61 139.24 54.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -0.883 . . . . 0.0 110.252 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.667 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.603 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.704 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.489 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 68' ' ' VAL . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.704 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 ' CG ' ' HG1' ' A' ' 84' ' ' THR . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 -106.61 128.15 53.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -110.5 128.64 25.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.4 Cg_exo -29.81 153.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 122.66 2.24 . . . . 0.0 112.86 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' PRO . 99.8 Cg_exo -29.52 79.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.347 2.698 . . . . 0.0 112.225 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -179.17 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.707 -0.62 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 72.1 ttt180 -152.97 144.98 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.434 -1.307 . . . . 0.0 111.877 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.458 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.535 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.0 m-90 55.06 47.14 22.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.437 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 89.5 mt-30 -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -97.91 139.95 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 0.0 109.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.63 157.1 79.09 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.761 . . . . 0.0 109.095 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -53.04 -31.09 52.16 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.534 2.156 . . . . 0.0 111.306 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.09 147.7 14.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -105.69 118.96 37.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -68.66 -27.98 66.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 108.492 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 79' ' ' HIS . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 -116.89 126.41 52.95 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.72 172.12 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.5 p -64.51 -22.33 66.93 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.314 -1.11 . . . . 0.0 109.146 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.2 46.97 0.99 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.392 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.54 132.89 6.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.469 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.532 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.787 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -82.57 -25.06 33.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.787 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 36.5 -145.31 0.09 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 44.89 -147.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -1.072 . . . . 0.0 109.384 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.0 53.78 1.38 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.16 -54.41 38.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.365 -1.079 . . . . 0.0 110.202 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.535 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.523 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . -73.2 -30.94 63.88 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -59.84 -32.9 71.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 44' ' ' ARG . 49.6 t0 -173.1 -56.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.737 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.01 64.23 4.14 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 142' ' ' SER . 36.9 Cg_endo -70.77 150.09 61.53 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.884 2.389 . . . . 0.0 113.188 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -51.76 -177.55 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.1 -12.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.329 1.352 . . . . 0.0 111.212 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -68.39 152.32 52.33 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 74.9 mm-40 -96.53 165.33 12.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.189 -1.183 . . . . 0.0 109.082 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 m -57.14 -37.7 72.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.038 -1.039 . . . . 0.0 108.825 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.585 ' NH1' ' OD1' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.403 HG23 ' CD1' ' A' ' 32' ' ' TRP . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.455 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.617 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.62 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.4 Cg_exo -60.52 147.88 92.9 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.642 2.228 . . . . 0.0 112.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.98 -32.2 63.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.95 111.54 23.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 109.086 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.434 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -111.92 156.15 42.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 108.893 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -38.92 98.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.042 2.495 . . . . 0.0 112.702 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.68 -7.18 8.58 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.289 1.992 . . . . 0.0 111.693 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.6 p -59.57 170.55 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.759 . . . . 0.0 110.016 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -52.4 -31.05 32.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 109.858 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.19 130.31 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.011 -1.055 . . . . 0.0 109.792 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.77 156.38 24.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.694 . . . . 0.0 109.22 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.4 t -53.71 130.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 0.0 108.756 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -61.67 -37.39 83.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.109 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -95.59 144.08 26.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -94.48 122.76 37.39 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.92 -1.112 . . . . 0.0 109.327 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.1 mmt-85 -62.7 142.42 58.12 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.612 -1.305 . . . . 0.0 107.916 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.29 -47.93 3.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 111.038 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD1' ' CE1' ' A' ' 49' ' ' PHE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.48 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.638 ' CD1' ' H ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.573 ' C ' ' O ' ' A' ' 84' ' ' THR . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.497 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.401 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 -102.06 130.23 48.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.9 t0 -91.6 130.86 37.65 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 108.917 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 78' ' ' PRO . 7.0 Cg_exo -42.06 -46.16 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.7 2.266 . . . . 0.0 113.499 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 32.5 Cg_exo -60.01 -133.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 109.01 -1.188 . . . . 0.0 109.01 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.663 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -118.4 54.14 0.95 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 -135.82 134.77 39.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.539 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 95' ' ' PRO . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.607 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 94' ' ' VAL . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.508 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 9.5 m-90 57.31 26.11 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 176.23 11.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.221 -0.924 . . . . 0.0 109.051 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 5.7 t -58.94 -66.24 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.36 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 1.5 m -146.57 153.47 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.011 . . . . 0.0 109.867 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 18.1 Cg_endo -62.34 -29.66 79.95 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.186 . . . . 0.0 112.414 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 87.8 m-20 -109.03 146.91 33.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -105.79 117.7 34.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.397 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -90.68 -8.86 48.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.359 -0.838 . . . . 0.0 108.806 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.663 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -115.77 136.95 52.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.49 -176.75 5.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.92 11.04 3.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -1.128 . . . . 0.0 109.426 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.23 1.31 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 140.4 9.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.539 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.51 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.811 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -83.77 -24.01 31.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.811 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 33.65 -151.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 131' ' ' ALA . 78.3 m-20 50.11 -144.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.992 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.63 48.24 1.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -59.67 -48.94 79.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.441 -1.034 . . . . 0.0 109.763 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.506 ' CH2' ' N ' ' A' ' 1' ' ' MET . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . -65.96 -43.86 86.68 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 80.6 mt -65.82 -25.83 67.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 81.29 103.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.368 0.604 . . . . 0.0 110.947 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -116.68 75.08 0.27 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' O ' ' HBC' ' A' ' 201' ' ' 96F . 19.5 Cg_endo -64.22 138.4 61.14 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.784 . . . . 0.0 112.44 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.61 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -82.6 -43.45 0.94 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.08 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 142' ' ' SER . 47.1 Cg_exo -54.68 -28.35 56.15 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.643 2.229 . . . . 0.0 112.492 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.76 168.68 25.17 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 77.9 mm-40 -105.17 164.59 11.71 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.502 -0.999 . . . . 0.0 109.167 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.462 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 62.0 m -57.61 -39.53 77.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.443 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.517 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.51 ' HAF' ' CG2' ' A' ' 117' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 145.82 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.695 2.263 . . . . 0.0 112.216 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' NH1' ' OE2' ' A' ' 118' ' ' GLU . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 109' ' ' PRO . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.596 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.47 -31.97 56.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.649 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -92.4 -5.91 51.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.448 -1.408 . . . . 0.0 111.178 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.664 ' HE1' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -48.23 -44.16 61.22 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.403 -1.436 . . . . 0.0 110.635 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 14.8 Cg_exo -68.38 112.25 2.75 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.483 2.122 . . . . 0.0 112.731 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.49 -67.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.234 1.956 . . . . 0.0 111.884 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 38' ' ' VAL . 31.4 t -172.61 142.76 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.549 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 83.0 t60 57.81 -2.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.596 -0.69 . . . . 0.0 111.661 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' SER . 13.5 p -134.95 137.12 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.784 -1.197 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.19 147.24 49.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.664 ' H ' ' HE1' ' A' ' 33' ' ' TRP . 2.7 p -58.27 145.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -61.12 -38.96 88.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 109.291 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 40' ' ' VAL . 29.2 mtmt -94.19 143.86 26.01 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -87.26 110.08 19.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.74 -1.225 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -62.75 142.49 58.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.94 -48.04 2.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 111.09 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.669 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.708 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.671 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.531 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' H ' ' CG2' ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' CG2' ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.671 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 84' ' ' THR . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' CG1' ' HH ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -101.36 130.55 47.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -92.91 123.98 59.76 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 78' ' ' PRO . 82.6 Cg_exo -33.74 -51.95 0.52 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 122.867 2.378 . . . . 0.0 113.349 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.9 Cg_endo -55.61 -149.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.147 1.088 . . . . 0.0 109.471 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.675 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.81 50.52 0.78 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 38.3 ttp180 -135.37 141.43 45.54 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.414 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.519 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.577 HH11 ' C ' ' A' ' 94' ' ' VAL . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.513 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.6 m-90 55.5 34.59 23.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.7 mt-30 -107.15 151.7 25.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.144 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -98.43 140.17 33.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.577 ' C ' HH11 ' A' ' 86' ' ' ARG . 0.0 OUTLIER -138.08 157.17 73.43 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.808 . . . . 0.0 109.077 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.51 -32.14 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.588 2.192 . . . . 0.0 111.742 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.89 147.62 24.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.812 . . . . 0.0 108.901 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 85.1 m-20 -106.32 118.33 36.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.413 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -69.29 -26.32 64.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.675 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 -116.25 117.9 31.31 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.09 168.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -64.9 -17.07 64.0 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.261 -1.14 . . . . 0.0 108.917 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.09 45.0 1.15 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.759 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -144.08 133.1 5.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -76.45 -21.23 56.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.435 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 90.75 -168.65 33.18 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.507 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.8 151.5 47.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.46 -11.38 65.09 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.66 -42.31 98.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.573 -0.957 . . . . 0.0 109.932 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.439 ' HB1' ' NE1' ' A' ' 91' ' ' TRP . . . -68.47 -44.39 74.91 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.489 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -64.92 -28.99 69.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.28 100.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.613 -0.679 . . . . 0.0 110.999 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.36 85.06 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 51.7 Cg_exo -53.11 148.15 31.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.78 2.32 . . . . 0.0 112.619 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -93.83 -42.13 0.32 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.44 -0.788 . . . . 0.0 110.213 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.21 -29.77 68.29 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.457 2.105 . . . . 0.0 112.327 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.68 122.18 2.99 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -53.93 151.68 6.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.33 -1.1 . . . . 0.0 109.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.633 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 53.0 m -56.53 -37.84 71.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.417 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.549 ' NH2' ' CZ2' ' A' ' 32' ' ' TRP . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.457 ' CD1' ' CE2' ' A' ' 150' ' ' PHE . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.633 ' CAW' ' HG1' ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' CB ' ' CE2' ' A' ' 132' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -60.63 147.25 95.31 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.872 2.381 . . . . 0.0 112.253 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' CG2' ' HG1' ' A' ' 115' ' ' THR . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.542 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.541 ' HE2' ' CD1' ' A' ' 154' ' ' ILE . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 76.8 m-20 -56.31 -32.8 64.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.648 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.79 111.4 23.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.996 -1.065 . . . . 0.0 108.923 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -112.51 154.35 44.64 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 109.257 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 2.8 Cg_endo -48.48 -54.72 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.446 2.097 . . . . 0.0 113.178 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 18.6 Cg_endo -59.51 139.98 91.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.84 1.693 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -62.02 -36.46 81.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.68 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 85.0 t60 -167.23 47.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.839 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.6 t -120.63 140.44 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 38' ' ' VAL . 38.5 tp -43.96 129.62 5.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.016 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 m -66.61 130.07 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.93 -35.66 79.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.038 -1.039 . . . . 0.0 108.657 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HD2' ' HE ' ' A' ' 44' ' ' ARG . 47.0 pttt -73.5 173.89 9.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -116.91 104.35 11.21 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.191 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.542 ' CZ ' ' OE2' ' A' ' 59' ' ' GLU . 30.8 mmt180 -125.77 141.14 52.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -135.2 -47.9 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.381 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.709 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.542 ' OE2' ' CZ ' ' A' ' 44' ' ' ARG . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.41 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.531 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.471 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.523 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -106.08 123.47 48.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -107.06 127.3 28.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.7 Cg_exo -30.15 153.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.642 2.228 . . . . 0.0 112.761 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' PRO . 85.8 Cg_exo -28.46 79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.412 2.742 . . . . 0.0 112.331 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.83 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.646 -0.659 . . . . 0.0 109.68 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 49.2 ttp180 -152.47 140.28 19.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.81 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.469 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.426 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.709 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 2.8 m-90 55.78 38.71 30.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 84.8 mt-30 -114.44 158.14 21.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.0 t -105.02 139.82 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.431 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -130.66 156.54 79.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.033 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 7.5 Cg_endo -52.74 -37.08 75.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.396 2.064 . . . . 0.0 111.693 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 80.2 m-20 -147.11 146.54 29.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 108.979 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -105.88 117.46 34.08 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.191 -0.943 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -76.56 -23.33 53.57 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.49 ' O ' ' O ' ' A' ' 79' ' ' HIS . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 -119.15 126.34 51.36 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.97 171.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.2 p -64.08 -22.75 67.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.317 -1.108 . . . . 0.0 109.125 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.94 47.13 0.99 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -134.32 132.7 6.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.542 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.533 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.7 -18.7 60.97 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.438 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 88.37 -171.96 40.77 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.908 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.4 150.67 48.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.572 -0.957 . . . . 0.0 109.809 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.16 64.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.2 -39.15 93.81 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -1.021 . . . . 0.0 109.372 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.473 ' CE2' ' CB ' ' A' ' 1' ' ' MET . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . . . -66.74 -43.54 83.92 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.484 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 65.1 mt -68.1 -15.97 63.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 61.76 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.688 . . . . 0.0 111.173 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.407 ' HA3' ' CE1' ' A' ' 135' ' ' HIS . . . -122.52 81.91 0.35 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -53.6 138.35 66.83 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.622 2.215 . . . . 0.0 112.304 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -73.13 -44.12 7.85 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 0.0 110.064 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 142' ' ' SER . 35.2 Cg_exo -58.32 -70.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.426 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.78 -179.23 44.77 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -115.19 164.41 14.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.521 -0.988 . . . . 0.0 109.251 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.594 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 76.1 m -57.8 -38.36 75.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.432 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.541 ' CD1' ' HE2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.594 ' CAW' ' HG1' ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HG2' ' HE1' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -64.29 145.0 87.85 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.724 2.283 . . . . 0.0 112.169 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 13' ' ' VAL . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HE2' HG12 ' A' ' 154' ' ' ILE . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.593 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 31.7 t0 -60.2 -31.44 70.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.623 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -91.66 120.21 32.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.813 -1.179 . . . . 0.0 110.722 -178.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.593 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.35 179.32 0.82 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 35.4 Cg_exo -56.2 139.29 85.59 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.172 1.915 . . . . 0.0 111.811 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.81 -28.05 30.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.546 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 37' ' ' HIS . 27.4 t -118.39 139.42 51.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' SER . 87.3 m-70 49.74 177.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.1 t -117.89 123.63 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' O ' ' CG ' ' A' ' 139' ' ' ASP . 67.4 mt -104.95 -1.69 25.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 40' ' ' VAL . 9.4 p -91.35 105.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.94 -1.1 . . . . 0.0 109.364 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.654 ' CD ' ' HZ2' ' A' ' 136' ' ' LYS . 35.8 mttp -62.84 -37.8 88.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -98.88 150.12 22.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.925 . . . . 0.0 109.027 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 123.42 29.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.504 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -66.85 138.52 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 108.646 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -46.43 3.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.876 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.58 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.733 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.491 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.51 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' H ' ' CG2' ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.733 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.579 ' C ' ' O ' ' A' ' 84' ' ' THR . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.493 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 -106.5 125.91 51.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -107.95 128.23 26.17 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 79' ' ' HIS . 37.0 Cg_exo -29.88 153.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.769 2.313 . . . . 0.0 112.719 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.6 Cg_exo -29.25 79.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.304 2.669 . . . . 0.0 112.194 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.37 -41.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.654 -0.654 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 65.5 ttt180 -153.91 142.28 20.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.961 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.454 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.57 HH11 ' C ' ' A' ' 95' ' ' PRO . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.484 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CZ2' ' CB ' ' A' ' 137' ' ' ALA . 6.8 m-90 56.23 26.45 10.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -100.67 123.84 45.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 109.218 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 p -64.69 151.51 44.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -146.65 157.29 48.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.242 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.57 ' C ' HH11 ' A' ' 86' ' ' ARG . 8.5 Cg_endo -53.39 -31.61 58.26 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.67 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -158.73 147.93 18.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 88.6 m-20 -106.02 117.94 35.32 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 110.315 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -72.23 -26.11 61.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.277 -0.89 . . . . 0.0 108.884 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' HIS . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 -118.91 127.17 53.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 51.87 172.9 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.2 p -64.81 -22.93 67.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.235 -1.156 . . . . 0.0 109.138 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.67 46.94 1.0 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -134.3 135.21 7.84 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.535 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.524 ' ND1' ' CD1' ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.705 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.758 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -78.32 -32.65 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.758 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 34.43 38.71 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 130' ' ' GLY . 60.5 t0 -146.46 95.57 2.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.345 . . . . 0.0 109.886 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.38 38.09 2.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -61.53 -48.62 80.21 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.528 -0.983 . . . . 0.0 110.397 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.402 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.654 ' HZ2' ' CD ' ' A' ' 41' ' ' LYS . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.464 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.92 -44.72 79.95 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.72 -27.09 68.07 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 1.3 m-20 60.32 99.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.667 -0.645 . . . . 0.0 110.756 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.512 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -93.67 132.7 11.32 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.491 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 46.1 Cg_endo -71.44 146.86 51.13 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.218 1.946 . . . . 0.0 112.383 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -110.57 -44.39 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.755 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.609 ' CD ' ' H ' ' A' ' 142' ' ' SER . 23.4 Cg_exo -61.97 -24.22 76.64 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' O ' ' HBC' ' A' ' 201' ' ' 96F . . . -142.02 178.0 21.03 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -95.81 162.56 13.54 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.268 -1.136 . . . . 0.0 109.135 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.516 ' HG1' ' CAV' ' A' ' 201' ' ' 96F . 66.2 m -57.68 -39.89 78.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.977 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.535 ' HAF' ' CG2' ' A' ' 117' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.2 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -62.53 153.68 69.71 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.799 2.333 . . . . 0.0 112.432 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.479 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HG ' ' CB ' ' A' ' 20' ' ' HIS . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -56.51 -32.21 64.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.611 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.0 -10.78 46.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.568 -1.332 . . . . 0.0 110.534 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.637 ' CZ3' ' NH2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -60.88 -51.25 80.73 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 120.561 -1.337 . . . . 0.0 110.729 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 2.3 Cg_endo -50.82 -55.48 4.03 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.369 1.379 . . . . 0.0 113.679 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 12.7 Cg_endo -58.69 -14.71 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.7 1.6 . . . . 0.0 112.324 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.579 ' OG ' ' NE ' ' A' ' 149' ' ' ARG . 31.9 t -63.11 156.05 26.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -51.71 -35.96 44.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.81 134.72 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.023 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 34' ' ' PRO . 43.7 mt -95.35 141.31 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG13 ' H ' ' A' ' 42' ' ' LYS . 97.6 t -61.99 137.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -60.12 -38.87 84.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.873 -1.142 . . . . 0.0 108.501 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' H ' HG13 ' A' ' 40' ' ' VAL . 42.7 mtmt -99.37 143.61 29.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.43 106.91 15.56 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.742 -1.223 . . . . 0.0 109.532 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.637 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 68.5 mtt180 -63.52 142.14 58.51 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.08 -47.66 2.26 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.138 -0.977 . . . . 0.0 111.697 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.682 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.684 ' CD2' ' CE2' ' A' ' 49' ' ' PHE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.597 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' H ' HD11 ' A' ' 62' ' ' ILE . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.677 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.5 ' CG2' ' N ' ' A' ' 73' ' ' LEU . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.5 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -101.17 130.56 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -96.89 121.51 59.17 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 108.953 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 78' ' ' PRO . 80.2 Cg_exo -34.86 -51.58 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.994 2.463 . . . . 0.0 113.463 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.5 Cg_endo -55.08 -149.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.219 1.114 . . . . 0.0 109.72 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.0 50.8 0.79 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 62.5 ttt-85 -135.84 144.78 45.85 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 -177.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.427 ' CD1' ' CD1' ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.677 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.493 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 8.4 m-90 56.17 26.91 10.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 93' ' ' SER . 94.0 mt-30 -98.03 6.19 47.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.858 -1.151 . . . . 0.0 110.602 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 50.68 105.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.68 156.49 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.09 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.12 -31.59 65.82 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.598 2.199 . . . . 0.0 111.734 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -155.36 150.27 26.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -105.5 117.81 34.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 110.384 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -90.14 -8.78 50.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -119.41 143.57 47.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.8 -177.48 24.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.97 11.22 4.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -1.106 . . . . 0.0 109.418 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.17 71.89 1.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.33 139.62 8.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.53 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.535 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.93 -16.35 58.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 87.36 -164.91 35.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 129' ' ' ASP . 52.8 p30 -72.5 160.75 31.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -1.045 . . . . 0.0 109.806 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.5 77.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.53 -44.8 93.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.647 -0.914 . . . . 0.0 109.926 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.425 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.88 -44.37 81.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.515 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -66.01 -26.43 67.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 136' ' ' LYS . 1.2 m-20 61.12 98.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.681 -0.637 . . . . 0.0 110.769 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.493 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -95.37 140.29 14.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.11 143.03 70.11 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.106 1.871 . . . . 0.0 112.229 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.626 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -101.08 -42.89 0.21 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.927 . . . . 0.0 109.455 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 142' ' ' SER . 2.4 Cg_endo -77.88 -66.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.78 2.32 . . . . 0.0 111.754 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -85.75 -178.74 50.23 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.473 ' OE2' ' HBB' ' A' ' 201' ' ' 96F . 78.2 mm-40 -105.87 160.82 14.96 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.289 -1.124 . . . . 0.0 109.093 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.429 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 52.7 m -57.47 -38.54 74.69 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.223 -0.923 . . . . 0.0 108.92 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' CD2' ' CAG' ' A' ' 201' ' ' 96F . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.613 HH22 ' HE1' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.487 HG12 ' HE2' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.57 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.688 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 1' ' ' MET . 24.3 Cg_exo -59.94 148.12 90.02 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.567 2.178 . . . . 0.0 112.242 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.503 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -54.84 -32.54 60.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.662 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.91 108.78 20.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.825 -1.172 . . . . 0.0 108.549 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.406 ' CD1' ' NE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -112.66 156.86 41.8 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 108.839 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' VAL . 75.0 Cg_exo -40.25 100.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.595 2.197 . . . . 0.0 111.954 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 152' ' ' ASN . 55.6 Cg_endo -83.49 -0.15 9.69 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.473 2.116 . . . . 0.0 112.291 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.591 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 23.0 m -55.55 -37.05 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER 163.67 2.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' PRO . 13.7 p -133.47 140.01 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 40' ' ' VAL . 53.3 mt -111.03 150.64 29.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.743 . . . . 0.0 109.017 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.579 ' CG1' ' HE ' ' A' ' 44' ' ' ARG . 3.3 p -45.47 135.44 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.907 -1.121 . . . . 0.0 108.773 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -61.53 -38.13 86.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.955 -1.091 . . . . 0.0 108.943 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 61' ' ' ASP . 32.6 ttpt -88.09 143.16 27.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.7 124.29 32.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.862 -1.149 . . . . 0.0 110.025 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HE ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.67 141.58 42.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.62 -47.06 3.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.376 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.675 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.706 ' CD2' ' CE1' ' A' ' 49' ' ' PHE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.559 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.725 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' H ' HD12 ' A' ' 62' ' ' ILE . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.501 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' H ' ' CG2' ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.725 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 55' ' ' GLY . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 -106.49 127.42 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -108.34 130.09 23.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.7 Cg_exo -30.17 153.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.802 2.334 . . . . 0.0 112.634 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.4 Cg_exo -29.21 79.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.293 2.662 . . . . 0.0 112.305 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' N ' ' O ' ' A' ' 77' ' ' PRO . 1.9 t-80 -179.3 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.586 -0.696 . . . . 0.0 109.917 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 75.4 ttt180 -151.44 143.22 23.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.162 -1.415 . . . . 0.0 112.118 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.456 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.624 ' HE1' ' HG ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 134' ' ' ILE . 4.5 m-90 56.06 29.61 14.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.4 mt-30 -101.45 154.21 19.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.072 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -100.79 139.46 36.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.03 156.78 78.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' O ' ' OD2' ' A' ' 96' ' ' ASP . 6.2 Cg_endo -51.67 -37.32 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.354 2.036 . . . . 0.0 111.757 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' OD2' ' O ' ' A' ' 95' ' ' PRO . 82.8 m-20 -145.99 146.57 31.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.897 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 77.3 m-20 -106.02 117.57 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.174 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -70.67 -27.77 64.28 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.88 . . . . 0.0 108.685 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.624 ' HG ' ' HE1' ' A' ' 85' ' ' TRP . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 ' CG1' ' CE2' ' A' ' 107' ' ' PHE . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' HIS . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -119.41 144.97 46.63 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.51 -176.22 28.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.53 14.39 4.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.514 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.99 70.27 1.28 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.65 140.76 9.78 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.43 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' CG2' ' HAF' ' A' ' 201' ' ' 96F . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.792 ' HD1' ' H ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -82.68 -25.36 33.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.792 ' H ' ' HD1' ' A' ' 127' ' ' HIS . . . 36.76 -146.3 0.08 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.584 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 48.8 t0 48.9 -138.67 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.514 -0.992 . . . . 0.0 109.765 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -82.99 51.55 4.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.481 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -59.21 -50.93 72.15 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -1.02 . . . . 0.0 109.941 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.688 ' CH2' ' N ' ' A' ' 1' ' ' MET . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 91' ' ' TRP . . . -67.63 -44.78 77.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.517 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 60.7 mt -65.86 -29.67 70.16 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.43 96.29 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.582 -0.699 . . . . 0.0 111.484 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -131.99 75.22 0.43 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.05 137.99 70.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.701 2.268 . . . . 0.0 112.467 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -62.99 -45.52 86.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.984 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.2 Cg_exo -56.65 -31.34 87.01 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.585 2.19 . . . . 0.0 112.332 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.58 104.32 0.88 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -54.65 153.01 6.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -1.126 . . . . 0.0 109.005 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.546 ' HG1' ' CAW' ' A' ' 201' ' ' 96F . 58.3 m -56.68 -38.27 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' CD1' ' CAK' ' A' ' 201' ' ' 96F . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.594 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.421 HG12 ' HE2' ' A' ' 20' ' ' HIS . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' 96F . . . . . 0.546 ' CAW' ' HG1' ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 121.454 0.522 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.733 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.733 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 ' CD2' ' A' ' 121' ' ' HIS . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG23 ' HG1' ' A' ' 115' ' ' THR . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.755 ' NE2' HG21 ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' NE2' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 59' ' ' GLU . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.733 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.823 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.513 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 HG23 ' A' ' 134' ' ' ILE . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.739 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.6 m-90 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.708 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.767 HG23 HD13 ' A' ' 87' ' ' ILE . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.739 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.778 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.526 ' OD1' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.526 HG13 ' OD1' ' A' ' 152' ' ' ASN . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.416 ' N ' HG23 ' A' ' 153' ' ' VAL . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.362 0.484 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.59 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.59 HG21 ' NE2' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.552 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.061 0.458 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.779 HD12 ' C ' ' A' ' 46' ' ' GLY . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 91' ' ' TRP . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.583 ' O ' HG13 ' A' ' 53' ' ' VAL . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.7 p-90 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.609 0.718 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.503 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 103' ' ' ILE . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.658 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.841 ' O ' HD13 ' A' ' 67' ' ' ILE . 5.0 m-90 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.511 HD12 ' NE1' ' A' ' 85' ' ' TRP . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.658 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.778 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.629 0.728 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.441 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.508 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.428 ' N ' HG23 ' A' ' 153' ' ' VAL . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 N--CA 1.492 1.441 0 CA-C-O 121.344 0.477 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.57 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.536 ' HB2' HG12 ' A' ' 122' ' ' VAL . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 147' ' ' LEU . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 19' ' ' GLU . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.667 HG22 ' CD2' ' A' ' 49' ' ' PHE . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' HD22 ' A' ' 47' ' ' LEU . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.808 0.337 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.897 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 73' ' ' LEU . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.905 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 66' ' ' GLU . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.741 ' H ' HG22 ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 67' ' ' ILE . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 72' ' ' ILE . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.701 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 62.6 m95 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.407 HH11 ' CD ' ' A' ' 104' ' ' GLU . 53.3 ttt-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.698 0.761 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.727 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.727 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 89' ' ' GLY . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.775 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.5 m-90 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 105' ' ' VAL . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.604 ' NE2' HG12 ' A' ' 8' ' ' VAL . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.621 ' CG2' HD13 ' A' ' 87' ' ' ILE . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.727 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 121.28 0.45 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.621 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.621 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 122' ' ' VAL . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.651 ' NE2' HG21 ' A' ' 24' ' ' VAL . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 ' NE2' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 73' ' ' LEU . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.753 ' CE1' HD11 ' A' ' 72' ' ' ILE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.751 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.797 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.733 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.733 ' H ' HG22 ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.797 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 57' ' ' TYR . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.801 0.81 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.507 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 70' ' ' GLY . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.603 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.806 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.7 m-90 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 105' ' ' VAL . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.739 ' ND1' HD12 ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.739 HD12 ' ND1' ' A' ' 121' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.899 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.899 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.432 ' N ' HD11 ' A' ' 5' ' ' ILE . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.603 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.427 0.632 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 154' ' ' ILE . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.543 HD13 ' NE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.492 1.431 0 CA-C-O 121.205 0.419 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.54 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 122' ' ' VAL . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' HD22 ' A' ' 147' ' ' LEU . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 19' ' ' GLU . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.483 HG22 ' HD1' ' A' ' 49' ' ' PHE . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.14 0.495 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.909 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.831 ' CE2' HG22 ' A' ' 68' ' ' VAL . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.699 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.651 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.831 HG22 ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.699 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.795 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.909 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.746 ' O ' HG13 ' A' ' 53' ' ' VAL . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.403 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 57.9 p-90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 51.5 ttt-85 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.801 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.588 ' N ' HD12 ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.616 ' OG1' HD21 ' A' ' 73' ' ' LEU . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.592 ' CD1' HD12 ' A' ' 103' ' ' ILE . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.795 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.777 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.8 m-90 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HG3' HD11 ' A' ' 73' ' ' LEU . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.538 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.101 0.477 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.401 ' N ' HD11 ' A' ' 5' ' ' ILE . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.777 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.418 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 47.2 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.554 0.692 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.667 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.452 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.498 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 121.409 0.504 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.72 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' N ' HG12 ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' HG21 ' A' ' 115' ' ' THR . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 49' ' ' PHE . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' VAL . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.188 0.518 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.885 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.799 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.749 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.478 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.697 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.792 ' H ' HG22 ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.751 ' C ' HD12 ' A' ' 72' ' ' ILE . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.885 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.605 0.717 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.525 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.804 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.2 m-90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 120' ' ' ALA . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 107' ' ' PHE . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 105' ' ' VAL . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.443 ' HB3' HG13 ' A' ' 108' ' ' VAL . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.816 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.816 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.532 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.804 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.424 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 21.4 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 121.47 0.529 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.824 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' A' ' 122' ' ' VAL . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 121' ' ' HIS . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.506 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 115' ' ' THR . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 49' ' ' PHE . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.085 0.469 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.907 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.823 ' CE1' HG22 ' A' ' 68' ' ' VAL . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.667 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.492 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.667 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.907 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 26.3 p-90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.831 0.824 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.531 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' NH1' HG21 ' A' ' 68' ' ' VAL . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.446 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.2 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 120' ' ' ALA . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 119' ' ' LEU . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 . . . . . 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.615 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.607 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.441 ' HE3' HD12 ' A' ' 5' ' ' ILE . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 89' ' ' GLY . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.666 0.746 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.47 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 121.337 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.739 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 19' ' ' GLU . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.477 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' NE2' HG21 ' A' ' 24' ' ' VAL . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 115' ' ' THR . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.552 HG21 ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.681 HG22 ' CD1' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 47' ' ' LEU . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.049 0.452 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.914 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.681 ' CD1' HG22 ' A' ' 26' ' ' THR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.728 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.942 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.675 ' H ' HG22 ' A' ' 65' ' ' THR . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.763 HD13 ' O ' ' A' ' 91' ' ' TRP . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.556 ' N ' HG22 ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.728 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.942 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.766 0.793 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.497 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.535 HD13 ' CG2' ' A' ' 134' ' ' ILE . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.79 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.3 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 124' ' ' LEU . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' A' ' 119' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE1' HG12 ' A' ' 105' ' ' VAL . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 22.4 t-20 . . . . . 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.124 0.488 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.43 ' N ' HD11 ' A' ' 5' ' ' ILE . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.535 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.79 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.459 0.647 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.699 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 149' ' ' ARG . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.462 HD13 ' NE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 121.293 0.455 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' HG13 ' A' ' 8' ' ' VAL . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' NE2' ' A' ' 121' ' ' HIS . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.592 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.656 HG22 ' CD2' ' A' ' 49' ' ' PHE . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.46 0.647 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HE ' HG21 ' A' ' 68' ' ' VAL . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.858 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 64' ' ' GLY . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.912 HG21 ' O ' ' A' ' 91' ' ' TRP . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG21 ' HE ' ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.858 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 122.079 0.943 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.517 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 70' ' ' GLY . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 91' ' ' TRP . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 89' ' ' GLY . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.912 ' O ' HG21 ' A' ' 67' ' ' ILE . 4.1 m-90 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.441 HD12 ' NE1' ' A' ' 85' ' ' TRP . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG22 ' HG ' ' A' ' 119' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CE1' HG12 ' A' ' 105' ' ' VAL . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.721 ' ND1' HD12 ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD12 ' ND1' ' A' ' 121' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.796 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.796 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.844 0.355 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.427 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 47.5 m . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.762 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.449 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.482 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.491 1.339 0 CA-C-O 121.348 0.478 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.792 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.63 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' SER . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 115' ' ' THR . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG21 ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 49' ' ' PHE . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.962 0.411 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.932 HG13 ' O ' ' A' ' 73' ' ' LEU . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.719 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.851 ' OD1' HD13 ' A' ' 62' ' ' ILE . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.851 HD13 ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.7 ' H ' HD13 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 70' ' ' GLY . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.693 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.538 0.685 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' CD1' HD12 ' A' ' 103' ' ' ILE . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 134' ' ' ILE . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.596 ' CZ3' HD11 ' A' ' 87' ' ' ILE . 39.7 m95 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 107' ' ' PHE . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 105' ' ' VAL . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.613 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.714 ' NE2' HG12 ' A' ' 8' ' ' VAL . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.713 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.863 0.363 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 87' ' ' ILE . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.537 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.455 0.645 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.844 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.494 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 121.344 0.477 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.602 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 122' ' ' VAL . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 147' ' ' LEU . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 115' ' ' THR . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 154' ' ' ILE . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 49' ' ' PHE . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.139 0.495 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' NH2' ' A' ' 71' ' ' ARG . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.809 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.769 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.416 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.769 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 72' ' ' ILE . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.809 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.713 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.732 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.5 m-90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.713 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 120' ' ' ALA . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' HG12 ' A' ' 105' ' ' VAL . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.754 HG21 ' SG ' ' A' ' 21' ' ' CYS . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' A' ' 11' ' ' SER . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 5' ' ' ILE . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.732 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.783 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 149' ' ' ARG . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 24' ' ' VAL . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 121.335 0.473 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.778 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.778 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG12 ' NE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.488 HG22 HH21 ' A' ' 116' ' ' ARG . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.617 ' NE2' HG21 ' A' ' 24' ' ' VAL . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 115' ' ' THR . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG21 ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.716 HG22 ' CD2' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD2' HD22 ' A' ' 47' ' ' LEU . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.345 0.593 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.716 ' CD2' HG22 ' A' ' 26' ' ' THR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 72' ' ' ILE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.832 ' CE1' HG22 ' A' ' 68' ' ' VAL . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.832 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.662 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.805 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 24.2 p-90 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.798 0.809 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.683 ' NE1' HD12 ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 134' ' ' ILE . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.0 m-90 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 127' ' ' HIS . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.683 HD12 ' NE1' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 119' ' ' LEU . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.456 ' CD1' HG22 ' A' ' 117' ' ' VAL . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.615 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.488 HH21 HG22 ' A' ' 13' ' ' VAL . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 107' ' ' PHE . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.882 ' ND1' HD12 ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.882 HD12 ' ND1' ' A' ' 121' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.82 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.82 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.413 ' HE3' HD12 ' A' ' 5' ' ' ILE . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.609 0.719 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.712 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 149' ' ' ARG . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.534 HD13 ' NE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.326 0.469 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.673 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.673 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' OG1' ' A' ' 115' ' ' THR . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.768 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' HG21 ' A' ' 115' ' ' THR . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.768 HG21 ' NE2' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.098 0.475 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.776 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.74 ' H ' HG22 ' A' ' 65' ' ' THR . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 91' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.776 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.646 ' C ' HD12 ' A' ' 72' ' ' ILE . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.145 0.974 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 107' ' ' PHE . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 70' ' ' GLY . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.466 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.723 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.7 m-90 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.723 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 81' ' ' LEU . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.675 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 108' ' ' VAL . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.904 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.444 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.502 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.186 0.411 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.633 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 8' ' ' VAL . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG22 ' NE2' ' A' ' 121' ' ' HIS . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.443 ' N ' HG12 ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.731 ' NE2' HG21 ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.731 HG21 ' NE2' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.305 0.574 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.912 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.605 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.825 ' CE2' HG22 ' A' ' 68' ' ' VAL . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.729 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.702 ' H ' HG22 ' A' ' 65' ' ' THR . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.825 HG22 ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.729 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.635 HD11 ' CE1' ' A' ' 57' ' ' TYR . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.743 0.783 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.488 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 137' ' ' ALA . 4.0 m-90 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.405 ' CE1' HG12 ' A' ' 105' ' ' VAL . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.597 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.709 ' NE2' HG22 ' A' ' 8' ' ' VAL . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.756 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.935 0.398 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.45 ' N ' HD11 ' A' ' 5' ' ' ILE . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.737 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 153' ' ' VAL . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.424 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 CA-C-O 121.362 0.484 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.706 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.706 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 11' ' ' SER . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 19' ' ' GLU . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 HG22 ' HD1' ' A' ' 49' ' ' PHE . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.053 0.454 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.867 ' CE2' HD11 ' A' ' 72' ' ' ILE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' TYR . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.49 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.734 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.867 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.415 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.91 0.862 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD12 ' A' ' 103' ' ' ILE . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 70' ' ' GLY . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.573 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.707 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.5 m-90 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' HD12 ' A' ' 124' ' ' LEU . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' TRP . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.551 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.687 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.687 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.401 ' HE3' HD12 ' A' ' 5' ' ' ILE . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.573 ' CG2' HD13 ' A' ' 87' ' ' ILE . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.451 HD13 ' NE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.491 1.337 0 CA-C-O 121.291 0.455 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.649 ' HB2' HG12 ' A' ' 122' ' ' VAL . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.587 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 115' ' ' THR . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.931 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.815 ' CE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.684 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.784 ' H ' HG22 ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.684 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.756 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.931 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.402 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 50.4 m95 . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.602 0.715 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 70' ' ' GLY . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.789 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.6 m-90 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' HG ' ' A' ' 119' ' ' LEU . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.483 ' CE2' HG12 ' A' ' 105' ' ' VAL . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.404 ' N ' HD11 ' A' ' 5' ' ' ILE . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.789 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.647 HG23 ' NH1' ' A' ' 149' ' ' ARG . 53.0 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' A' ' 146' ' ' THR . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 20' ' ' HIS . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.402 0.501 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.684 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.684 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' NE2' ' A' ' 121' ' ' HIS . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.486 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 115' ' ' THR . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' CD1' ' A' ' 49' ' ' PHE . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 73' ' ' LEU . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.723 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 70' ' ' GLY . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 68' ' ' VAL . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 72' ' ' ILE . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.841 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.575 0.702 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 103' ' ' ILE . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.723 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.645 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.773 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 2.8 m-90 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 124' ' ' LEU . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 85' ' ' TRP . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.629 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.408 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.645 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.452 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 76.1 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.639 0.733 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 149' ' ' ARG . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.363 0.485 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.558 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.558 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.688 ' HB2' HG12 ' A' ' 122' ' ' VAL . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' NE2' ' A' ' 121' ' ' HIS . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD22 ' A' ' 147' ' ' LEU . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG23 ' CB ' ' A' ' 151' ' ' ALA . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 20' ' ' HIS . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 115' ' ' THR . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.067 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.127 0.489 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.792 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.067 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.87 ' CE1' HD11 ' A' ' 72' ' ' ILE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.758 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.775 HG22 ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.758 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.788 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 57' ' ' TYR . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 104' ' ' GLU . 65.5 ttt180 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.702 0.763 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.489 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 6.8 m-90 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.544 ' CE1' HG12 ' A' ' 105' ' ' VAL . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.668 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.792 ' ND1' HD12 ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.792 HD12 ' ND1' ' A' ' 121' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.611 HD11 ' HA2' ' A' ' 89' ' ' GLY . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.481 0.658 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.761 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.368 0.487 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.498 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HB2' HG12 ' A' ' 122' ' ' VAL . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' HG21 ' A' ' 115' ' ' THR . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.675 HG22 ' CD2' ' A' ' 49' ' ' PHE . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.937 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.707 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.711 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.711 ' H ' HG22 ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.697 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.882 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 60.3 p-90 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' NE ' ' OD2' ' A' ' 106' ' ' ASP . 62.5 ttt-85 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CE2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CD1' HD12 ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.697 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.75 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 8.4 m-90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.557 ' CE2' HD11 ' A' ' 81' ' ' LEU . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.621 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.112 0.482 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.75 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.762 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 121.405 0.502 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.751 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.751 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG12 ' CD2' ' A' ' 121' ' ' HIS . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' NZ ' HG21 ' A' ' 8' ' ' VAL . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.44 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' PRO . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 18' ' ' VAL . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 115' ' ' THR . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 154' ' ' ILE . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' HD1' ' A' ' 49' ' ' PHE . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 60' ' ' TRP . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.724 ' CE2' HD11 ' A' ' 72' ' ' ILE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CE1' HG22 ' A' ' 68' ' ' VAL . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.77 ' H ' HG22 ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.85 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.751 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.724 HD11 ' CE2' ' A' ' 57' ' ' TYR . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.744 0.783 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.5 m-90 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 119' ' ' LEU . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 105' ' ' VAL . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 18' ' ' VAL . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.44 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.653 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.932 0.396 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.408 ' HE3' HD12 ' A' ' 5' ' ' ILE . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.807 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.792 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.445 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.497 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 24' ' ' VAL . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.53 152.64 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.733 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.733 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 ' CD2' ' A' ' 121' ' ' HIS . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG23 ' HG1' ' A' ' 115' ' ' THR . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.755 ' NE2' HG21 ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' NE2' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.624 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 32' ' ' TRP . 42.3 t0 -55.2 -25.2 31.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 12.3 m0 -42.34 -31.87 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.752 -1.217 . . . . 0.0 108.959 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.602 ' HE1' HG22 ' A' ' 38' ' ' VAL . 17.3 t90 -48.73 126.86 13.64 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.717 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.523 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 72.2 Cg_endo -77.51 160.42 31.87 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.34 2.026 . . . . 0.0 112.34 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.62 -23.57 74.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.867 2.378 . . . . 0.0 112.483 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 37' ' ' HIS . 49.6 m -117.13 148.07 41.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.406 -0.809 . . . . 0.0 109.39 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.515 ' O ' ' O ' ' A' ' 36' ' ' SER . 76.4 t60 57.9 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 108.963 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG22 ' HE1' ' A' ' 33' ' ' TRP . 27.9 t -103.26 123.53 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.205 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.89 -30.74 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.51 -0.744 . . . . 0.0 109.309 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HE ' ' A' ' 44' ' ' ARG . 94.4 t -102.03 130.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.752 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -62.17 -37.39 85.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 48.6 mtmt -89.21 145.96 25.07 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -85.44 114.31 22.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.979 -1.075 . . . . 0.0 109.755 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.809 ' HE ' HG21 ' A' ' 40' ' ' VAL . 82.5 mtt180 -62.85 141.76 58.53 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -115.6 -48.46 2.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.846 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 92' ' ' GLN . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 59' ' ' GLU . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.733 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.823 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -102.62 120.35 40.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -103.49 128.31 27.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.1 Cg_exo -30.1 153.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.676 2.251 . . . . 0.0 112.528 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.1 Cg_exo -28.83 78.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 123.364 2.709 . . . . 0.0 112.495 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -176.84 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.516 -0.74 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 47.6 ttp180 -153.0 138.76 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.511 -1.368 . . . . 0.0 111.74 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.513 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 HG23 ' A' ' 134' ' ' ILE . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.554 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.739 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.6 m-90 55.16 47.36 21.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 77.3 mt-30 -122.0 154.74 36.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -98.84 151.46 20.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 157.15 51.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 109.041 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.45 -30.6 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.529 2.153 . . . . 0.0 111.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.76 150.32 20.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 0.0 108.8 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 92.5 m-20 -105.45 117.29 33.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.282 -0.887 . . . . 0.0 109.991 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.24 -24.12 51.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.731 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 -119.57 126.11 50.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.79 172.77 0.08 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 -23.54 67.38 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -1.117 . . . . 0.0 109.126 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.75 50.34 0.8 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.337 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -133.5 134.77 7.66 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG21 ' CAF' ' A' ' 201' ' ' 96F . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.708 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.28 -25.64 33.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.0 -147.06 0.05 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 19.4 t70 49.04 -133.29 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.47 -1.018 . . . . 0.0 109.61 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -79.87 47.08 3.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -59.47 -57.21 13.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.366 -1.079 . . . . 0.0 109.824 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.767 HG23 HD13 ' A' ' 87' ' ' ILE . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.739 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.78 -44.76 88.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.541 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 88.4 mt -68.99 -28.59 66.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 135' ' ' HIS . 0.8 OUTLIER 61.91 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.479 0.657 . . . . 0.0 111.476 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -130.17 75.38 0.43 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 144' ' ' GLY . 31.4 Cg_exo -55.13 142.14 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -56.67 -45.95 99.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.56 -30.08 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.567 2.178 . . . . 0.0 112.353 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.34 134.76 6.05 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.08 173.26 6.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.522 HG21 ' OAP' ' A' ' 201' ' ' 96F . 18.9 m -57.41 -35.36 69.95 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.815 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.438 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.526 ' OD1' HG13 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 32' ' ' TRP . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.416 ' N ' HG23 ' A' ' 153' ' ' VAL . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.815 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.635 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.2 Cg_exo -61.89 147.08 95.97 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.673 2.249 . . . . 0.0 112.272 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 79' ' ' HIS . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.59 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.59 HG21 ' NE2' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.552 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' TRP . 59.5 t0 -54.61 -18.26 4.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 9.9 m0 -44.95 -38.01 4.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.767 -1.208 . . . . 0.0 109.34 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' HG23 ' A' ' 38' ' ' VAL . 52.7 m95 -100.45 114.96 65.87 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.11 161.03 29.73 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.012 1.808 . . . . 0.0 111.815 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.7 -25.28 59.36 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.841 2.361 . . . . 0.0 112.498 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -58.9 -39.55 81.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.618 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -160.09 120.38 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.138 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -135.07 138.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.8 mt -71.02 -34.73 71.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.1 t -69.56 123.19 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 109.501 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -62.69 -37.99 88.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.558 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 34.8 ttpt -82.13 143.26 31.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -89.21 124.2 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.081 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.46 142.48 50.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -109.5 -44.48 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.865 . . . . 0.0 110.653 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.779 HD12 ' C ' ' A' ' 46' ' ' GLY . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 91' ' ' TRP . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.583 ' O ' HG13 ' A' ' 53' ' ' VAL . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.7 p-90 -107.45 130.27 54.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.62 138.21 31.76 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.131 . . . . 0.0 109.254 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.0 Cg_exo -43.12 -53.82 3.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.2 2.6 . . . . 0.0 114.331 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 77' ' ' PRO . 17.8 Cg_endo -56.62 -111.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 120.906 1.071 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -137.64 59.39 1.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 -136.38 138.53 41.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.472 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.503 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 103' ' ' ILE . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.658 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.841 ' O ' HD13 ' A' ' 67' ' ' ILE . 5.0 m-90 55.07 40.7 32.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.9 mt-30 -113.74 154.08 27.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 109.143 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -95.75 139.86 31.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -138.17 156.9 73.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 109.068 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.38 -32.76 43.5 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.561 2.174 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -160.48 148.51 16.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 90.1 m-20 -105.84 117.65 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -73.14 -23.73 60.5 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.307 -0.87 . . . . 0.0 108.675 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.511 HD12 ' NE1' ' A' ' 85' ' ' TRP . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.686 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.488 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 -113.79 127.56 56.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.25 171.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 m -60.42 -31.53 70.49 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 109.149 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -130.64 49.21 0.93 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.543 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.13 136.08 8.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG21 ' CAF' ' A' ' 201' ' ' 96F . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -74.37 -11.44 60.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.33 -170.99 41.56 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.286 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -71.96 150.42 44.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -1.046 . . . . 0.0 109.751 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.28 -7.77 60.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.416 -1.049 . . . . 0.0 109.33 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.503 ' CH2' ' N ' ' A' ' 1' ' ' MET . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.658 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.778 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.75 -44.51 81.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.559 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 89.9 mt -66.61 -29.79 69.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER 67.75 97.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -134.29 71.86 0.48 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 144' ' ' GLY . 38.5 Cg_exo -56.69 143.72 88.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.294 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -55.3 -46.39 99.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.386 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.79 -31.57 88.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.573 2.182 . . . . 0.0 112.192 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -139.41 130.33 4.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -98.9 172.0 7.7 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.747 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.497 HG21 ' OAP' ' A' ' 201' ' ' 96F . 28.9 m -57.4 -35.77 70.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.29 -0.881 . . . . 0.0 109.083 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.809 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.441 ' O ' ' OD1' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.508 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.428 ' N ' HG23 ' A' ' 153' ' ' VAL . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.809 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.68 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.8 Cg_exo -61.44 147.12 96.28 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.437 2.091 . . . . 0.0 112.358 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.57 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.536 ' HB2' HG12 ' A' ' 122' ' ' VAL . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 147' ' ' LEU . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 19' ' ' GLU . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.667 HG22 ' CD2' ' A' ' 49' ' ' PHE . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.6 -31.93 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.63 -10.21 25.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.643 -1.286 . . . . 0.0 111.386 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.699 ' CZ3' ' NH2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -52.85 -41.86 86.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.494 -1.379 . . . . 0.0 110.722 -178.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 90.8 Cg_endo -101.44 73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.729 2.953 . . . . 0.0 113.272 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 36' ' ' SER . 36.2 Cg_endo -66.67 -43.43 7.47 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.208 1.939 . . . . 0.0 111.896 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER 158.32 -61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -55.3 -37.04 66.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG11 ' NH1' ' A' ' 149' ' ' ARG . 45.9 t -108.03 132.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 mt -109.84 153.35 24.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.5 p -103.85 142.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.63 -38.27 84.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.889 -1.132 . . . . 0.0 108.946 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.608 ' NZ ' ' HB1' ' A' ' 137' ' ' ALA . 10.2 pttt -121.19 143.51 49.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -83.74 123.48 29.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 110.45 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.699 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 61.9 mtt180 -74.28 142.52 45.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 -47.86 2.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.114 -0.991 . . . . 0.0 111.901 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.897 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 73' ' ' LEU . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.905 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' OE2' ' CZ ' ' A' ' 44' ' ' ARG . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 66' ' ' GLU . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.741 ' H ' HG22 ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG12 ' OG ' ' A' ' 93' ' ' SER . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 72' ' ' ILE . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.701 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 62.6 m95 -101.44 130.75 47.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -95.2 122.16 60.46 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 108.928 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 78' ' ' PRO . 83.0 Cg_exo -34.26 -51.88 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 123.088 2.525 . . . . 0.0 113.514 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.2 Cg_endo -54.95 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.192 1.104 . . . . 0.0 109.691 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -103.0 49.32 0.83 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 178.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.3 ttt-85 -136.09 146.33 46.91 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.488 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.727 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.727 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.587 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.775 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.5 m-90 55.57 48.29 19.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.587 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 80.8 mt-30 -125.84 162.04 26.05 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.554 ' OG ' HG12 ' A' ' 68' ' ' VAL . 53.7 m -103.96 146.21 29.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.024 -1.047 . . . . 0.0 109.818 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.538 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -137.05 156.81 75.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.0 108.939 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -52.58 -31.63 50.28 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.392 2.061 . . . . 0.0 111.456 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -161.93 148.59 13.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 85.8 m-20 -105.51 117.32 33.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.23 -25.52 61.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.673 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.485 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 -119.21 120.03 35.83 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 53.98 169.14 0.04 OUTLIER Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.3 p -64.46 -19.19 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 108.863 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.85 47.16 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.592 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -142.67 132.3 5.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.422 ' CG1' ' OAO' ' A' ' 201' ' ' 96F . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.604 ' NE2' HG12 ' A' ' 8' ' ' VAL . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.13 -18.18 60.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.97 -172.07 36.43 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.582 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.45 150.88 47.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.999 . . . . 0.0 109.969 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.56 -7.29 63.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.35 -44.62 94.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.47 -1.018 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.68 ' CH2' ' N ' ' A' ' 1' ' ' MET . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.621 ' CG2' HD13 ' A' ' 87' ' ' ILE . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.34 -44.52 91.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.558 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 60.9 mt -67.11 -29.41 69.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 1.3 t70 78.35 102.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.646 -0.659 . . . . 0.0 111.559 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.72 148.55 38.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 142' ' ' SER . 33.5 Cg_endo -67.17 143.38 64.65 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.537 2.158 . . . . 0.0 113.13 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -53.12 179.74 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 142' ' ' SER . 71.4 Cg_exo -39.53 -19.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.452 1.435 . . . . 0.0 111.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -81.0 -178.36 52.37 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 77.2 mm-40 -98.3 162.08 13.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.028 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.456 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 31.5 m -57.14 -35.22 69.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 108.55 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.922 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.709 ' NH1' HG11 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.922 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.09 146.72 95.51 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.698 2.265 . . . . 0.0 112.081 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.621 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.621 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 122' ' ' VAL . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.651 ' NE2' HG21 ' A' ' 24' ' ' VAL . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 ' NE2' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 33' ' ' TRP . 59.8 t0 -54.05 -28.7 40.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 15.0 m0 -42.35 -24.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -111.92 89.05 10.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.465 -0.772 . . . . 0.0 109.672 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -77.28 163.65 29.95 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.257 1.971 . . . . 0.0 111.869 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -44.08 130.85 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -154.31 171.34 19.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -51.26 -31.33 20.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -102.78 136.81 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 109.542 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.6 mt -82.32 154.08 25.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.705 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' LYS . 21.9 m -50.17 146.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.358 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.24 -36.37 79.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 8.7 ttpt -115.24 149.76 37.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' O ' ' CE ' ' A' ' 42' ' ' LYS . 96.4 mt-10 -63.35 114.26 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.729 HH12 ' NH1' ' A' ' 149' ' ' ARG . 79.4 mtt180 -123.42 141.09 52.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 108.814 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -134.92 -47.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 73' ' ' LEU . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.753 ' CE1' HD11 ' A' ' 72' ' ' ILE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.751 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.797 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.733 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.733 ' H ' HG22 ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.797 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 57' ' ' TYR . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -108.62 129.51 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -112.15 124.06 33.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.629 ' O ' ' N ' ' A' ' 79' ' ' HIS . 34.2 Cg_exo -30.82 154.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.731 2.287 . . . . 0.0 112.795 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.6 Cg_exo -29.04 79.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.448 2.766 . . . . 0.0 112.441 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.629 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.49 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.683 -0.636 . . . . 0.0 109.291 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 40.1 ttp180 -155.62 151.95 28.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.502 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.507 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 70' ' ' GLY . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.603 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.806 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.7 m-90 55.96 32.94 20.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -106.23 153.87 21.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.8 t -100.72 139.44 36.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -134.27 157.52 77.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 108.98 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.23 -31.4 22.0 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.525 2.15 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -157.21 147.76 21.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 87.1 m-20 -106.14 117.61 34.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -74.88 -22.23 58.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 79' ' ' HIS . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -119.41 145.79 45.93 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.29 -175.57 26.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 59.22 15.41 4.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -1.132 . . . . 0.0 109.583 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.16 1.29 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.63 140.7 10.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.739 ' ND1' HD12 ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.739 HD12 ' ND1' ' A' ' 121' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.899 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.3 -32.91 29.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 127' ' ' HIS . . . 33.97 -153.56 0.01 OUTLIER Glycine 0 N--CA 1.499 2.849 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 128' ' ' GLY . 60.8 t0 43.39 71.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -1.125 . . . . 0.0 109.973 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.94 33.05 58.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.899 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -61.9 -57.24 12.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.545 -0.974 . . . . 0.0 110.209 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.432 ' N ' HD11 ' A' ' 5' ' ' ILE . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.603 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.43 -43.46 94.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 95.7 mt -70.13 -4.94 23.7 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.98 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.453 0.644 . . . . 0.0 110.555 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 135' ' ' HIS . . . -118.73 67.79 0.36 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 144' ' ' GLY . 12.1 Cg_endo -60.59 141.13 94.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.193 1.928 . . . . 0.0 112.377 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.567 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -71.64 -45.85 12.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.952 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.4 Cg_exo -55.03 -31.88 76.65 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.623 2.215 . . . . 0.0 112.532 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.96 167.05 26.9 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -115.57 175.91 5.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -1.012 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.518 HG21 ' OAP' ' A' ' 201' ' ' 96F . 20.1 m -57.55 -35.0 69.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.229 -0.92 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.729 ' NH1' HH12 ' A' ' 44' ' ' ARG . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 32' ' ' TRP . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.543 HD13 ' NE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.7 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -66.5 144.48 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.728 2.285 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.54 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 122' ' ' VAL . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' HD22 ' A' ' 147' ' ' LEU . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 79' ' ' HIS . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.483 HG22 ' HD1' ' A' ' 49' ' ' PHE . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 22.7 t70 -54.31 -32.51 56.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.39 111.95 24.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.979 -1.075 . . . . 0.0 108.103 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.587 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.99 179.62 0.77 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 22.5 Cg_exo -60.71 158.7 31.59 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.471 2.114 . . . . 0.0 111.582 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.99 158.92 2.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.664 2.242 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -52.83 -29.6 28.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -53.37 -41.34 65.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.065 -1.022 . . . . 0.0 109.364 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.04 131.11 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.376 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.1 mt -111.19 142.69 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 42' ' ' LYS . 11.4 p -61.49 139.13 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -61.39 -38.23 86.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 0.0 109.295 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 40' ' ' VAL . 19.5 pttt -118.41 145.64 45.04 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.01 123.75 28.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.96 -1.087 . . . . 0.0 109.622 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -65.32 143.2 57.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 108.834 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -108.72 -47.77 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.909 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.831 ' CE2' HG22 ' A' ' 68' ' ' VAL . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.699 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.831 HG22 ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.699 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.795 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.909 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.746 ' O ' HG13 ' A' ' 53' ' ' VAL . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.403 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 57.9 p-90 -101.84 130.59 48.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 1.4 t0 -93.94 122.0 62.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 108.927 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 78' ' ' PRO . 31.7 Cg_exo -41.53 -43.08 5.99 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.798 2.332 . . . . 0.0 113.919 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 34.9 Cg_exo -60.83 -132.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 108.843 -1.253 . . . . 0.0 108.843 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.667 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.27 53.76 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 51.5 ttt-85 -136.75 141.33 43.0 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.201 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.588 ' N ' HD12 ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.616 ' OG1' HD21 ' A' ' 73' ' ' LEU . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.592 ' CD1' HD12 ' A' ' 103' ' ' ILE . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.795 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.603 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 93' ' ' SER . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.777 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.8 m-90 56.36 25.78 9.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 170.35 77.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 0.0 109.121 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.491 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 14.0 t -124.05 -77.94 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.302 -0.874 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' ASP . 25.1 m -126.59 150.5 71.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.836 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.86 -34.56 81.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.403 2.068 . . . . 0.0 112.1 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 94' ' ' VAL . 89.6 m-20 -109.24 146.87 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 0.0 109.011 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 94.4 m-20 -105.47 117.93 35.27 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.558 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -88.7 -9.39 52.16 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HG3' HD11 ' A' ' 73' ' ' LEU . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.667 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.493 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -119.1 144.85 46.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.43 -175.83 23.29 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.81 15.24 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -1.142 . . . . 0.0 109.52 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 70.04 1.3 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.31 140.14 9.42 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG21 ' CAF' ' A' ' 201' ' ' 96F . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.538 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.74 -15.21 59.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.15 -166.5 33.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 129' ' ' ASP . 53.0 p30 -73.81 161.3 30.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 -6.44 83.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.496 -1.002 . . . . 0.0 110.156 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.401 ' N ' HD11 ' A' ' 5' ' ' ILE . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.777 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.53 -44.46 86.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 84.8 mt -67.24 -26.85 66.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER 79.91 105.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.727 -0.608 . . . . 0.0 110.882 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.413 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -123.6 79.91 0.35 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 35.9 Cg_exo -54.46 148.78 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.814 2.343 . . . . 0.0 112.376 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.607 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -95.77 -43.82 0.27 Allowed Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.1 Cg_exo -57.62 -24.69 63.77 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.607 2.205 . . . . 0.0 112.383 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.79 173.59 21.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -105.51 164.59 11.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -1.037 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.527 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 47.2 m -57.86 -36.0 71.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.86 HD21 ' OAO' ' A' ' 201' ' ' 96F . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.465 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.498 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.86 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.9 ptt? . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 1' ' ' MET . 14.8 Cg_endo -61.02 154.81 54.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.84 2.36 . . . . 0.0 112.288 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.72 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' N ' HG12 ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 79' ' ' HIS . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' HG21 ' A' ' 115' ' ' THR . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 49' ' ' PHE . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' VAL . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.57 -33.24 69.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -69.6 -37.64 76.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.085 -1.634 . . . . 0.0 110.009 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.569 ' NE1' ' NH2' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -49.0 108.76 1.02 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.654 -1.279 . . . . 0.0 108.975 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.8 155.64 11.7 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.288 1.992 . . . . 0.0 112.829 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.34 -16.67 55.5 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.615 2.21 . . . . 0.0 111.989 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.7 p -65.29 168.12 7.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.696 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.7 m80 57.76 -120.92 1.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.46 -0.775 . . . . 0.0 109.546 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' CZ3' ' A' ' 33' ' ' TRP . 47.1 t -107.14 134.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 109.472 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 39' ' ' LEU . 4.7 mp -92.56 147.25 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 42' ' ' LYS . 7.1 p -48.65 142.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.917 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.17 -38.96 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.076 -1.015 . . . . 0.0 109.467 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 40' ' ' VAL . 46.5 pttt -114.22 143.68 44.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.01 123.05 19.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 109.649 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -71.53 142.45 50.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.095 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.13 -48.18 1.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.465 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.885 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.799 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.749 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.478 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.697 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.792 ' H ' HG22 ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.751 ' C ' HD12 ' A' ' 72' ' ' ILE . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.885 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 -108.07 130.23 55.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.39 130.53 45.37 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 108.851 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.35 -46.17 9.72 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.504 2.136 . . . . 0.0 112.992 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 77' ' ' PRO . 35.4 Cg_exo -57.1 -126.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.19 1.26 . . . . 0.0 109.21 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -126.41 55.11 1.52 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 -136.66 134.35 37.18 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.443 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.525 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.804 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.2 m-90 55.96 36.08 26.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.533 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.6 mt-30 -110.33 156.62 20.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 108.959 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -101.34 140.04 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.567 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -124.47 157.0 66.63 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.485 -0.76 . . . . 0.0 109.195 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.78 -32.72 67.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.572 2.182 . . . . 0.0 111.598 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -157.11 147.4 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' OD1' HG23 ' A' ' 94' ' ' VAL . 86.9 m-20 -106.63 117.83 35.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.347 -0.846 . . . . 0.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -80.2 -14.65 58.28 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 120' ' ' ALA . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 107' ' ' PHE . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.476 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.58 145.15 46.66 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.3 -177.28 33.56 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.17 11.37 4.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -1.179 . . . . 0.0 109.409 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.25 70.97 1.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.78 140.03 9.5 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.443 ' HB3' HG13 ' A' ' 108' ' ' VAL . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.503 HG21 ' CAF' ' A' ' 201' ' ' 96F . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.617 ' CE1' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.816 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -79.55 -32.87 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 29.43 -146.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 128' ' ' GLY . 59.8 t0 43.42 61.14 2.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -1.088 . . . . 0.0 109.66 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.16 33.99 38.62 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.816 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.3 -52.43 65.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.504 -0.998 . . . . 0.0 109.772 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.532 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.804 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.03 -44.09 90.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 75.4 mt -65.37 -24.35 67.22 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 9.8 t0 85.91 98.17 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.308 0.575 . . . . 0.0 110.987 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -114.88 80.73 0.29 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.34 140.83 65.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.884 1.723 . . . . 0.0 112.39 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -80.54 -44.46 1.33 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 110.072 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.6 Cg_exo -57.82 -71.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.552 2.168 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.53 179.71 44.77 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -119.54 164.3 16.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.6 -0.941 . . . . 0.0 109.121 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.563 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 21.4 m -57.68 -38.08 74.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.569 ' NH2' ' NE1' ' A' ' 33' ' ' TRP . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.688 ' CAL' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.1 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 1' ' ' MET . 15.0 Cg_endo -61.59 152.58 72.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.824 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' A' ' 122' ' ' VAL . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 121' ' ' HIS . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 79' ' ' HIS . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.506 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 115' ' ' THR . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 49' ' ' PHE . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -53.33 -32.41 48.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -98.1 109.58 22.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.892 -1.13 . . . . 0.0 108.107 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.91 162.94 19.35 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.111 -0.993 . . . . 0.0 109.956 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.08 154.67 47.4 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.845 2.363 . . . . 0.0 111.966 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 36' ' ' SER . 51.3 Cg_endo -72.7 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.452 2.102 . . . . 0.0 111.969 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' PRO . 38.4 t 49.03 177.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.832 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -58.23 -43.74 87.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.2 t -119.44 131.49 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.393 -0.817 . . . . 0.0 109.12 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.09 -45.53 92.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.497 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' LYS . 8.3 p -159.8 143.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.89 -38.75 89.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.871 -1.143 . . . . 0.0 109.013 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' H ' HG22 ' A' ' 40' ' ' VAL . 17.8 pttt -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -85.51 123.72 31.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.85 -1.156 . . . . 0.0 110.028 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 30' ' ' ALA . 90.0 mtt180 -65.2 143.22 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -113.99 -48.5 2.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.982 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.907 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.823 ' CE1' HG22 ' A' ' 68' ' ' VAL . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.667 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.492 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.667 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.907 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 26.3 p-90 -102.42 130.52 49.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.74 129.32 47.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 0.0 109.016 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.1 -46.09 9.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.733 2.289 . . . . 0.0 113.471 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 77' ' ' PRO . 38.8 Cg_exo -58.86 -133.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.01 1.14 . . . . 0.0 109.141 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -118.65 53.61 0.98 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 177.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 -136.42 141.82 43.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.148 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.531 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' NH1' HG21 ' A' ' 68' ' ' VAL . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.601 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 93' ' ' SER . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.449 ' H ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.2 m-90 56.93 26.17 11.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 93' ' ' SER . 1.4 pt20 173.53 11.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.843 . . . . 0.0 109.127 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 7.6 t -58.34 -56.82 17.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 110.497 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 11.6 m -146.72 150.89 41.13 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.802 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.518 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 25.3 Cg_endo -65.14 -37.83 30.57 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.436 2.091 . . . . 0.0 112.095 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.53 147.01 33.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 109.303 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.3 m-20 -105.57 117.99 35.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -90.27 -8.88 49.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 120' ' ' ALA . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 119' ' ' LEU . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -117.93 143.94 45.92 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.83 -175.98 21.05 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.37 13.66 4.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -1.094 . . . . 0.0 109.458 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.28 70.77 1.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.26 140.11 9.11 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.615 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.88 -24.24 33.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' N ' ' ND1' ' A' ' 127' ' ' HIS . . . 30.51 -142.85 0.02 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 128' ' ' GLY . 79.0 m-20 42.77 -145.75 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -1.009 . . . . 0.0 109.556 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.76 47.12 0.96 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.607 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -58.99 -46.69 87.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.291 -1.123 . . . . 0.0 109.472 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.441 ' HE3' HD12 ' A' ' 5' ' ' ILE . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 89' ' ' GLY . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.37 -44.07 84.18 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 77.4 mt -66.56 -27.01 67.39 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 135' ' ' HIS . 0.6 OUTLIER 75.71 106.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.423 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -122.52 80.96 0.34 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.424 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 37.9 Cg_exo -54.03 145.11 54.29 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.771 2.314 . . . . 0.0 112.49 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.621 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -86.9 -43.45 0.54 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.485 -0.759 . . . . 0.0 109.809 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 142' ' ' SER . 32.3 Cg_exo -56.71 -27.72 72.22 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.745 2.296 . . . . 0.0 112.486 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.33 173.4 23.05 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 73.8 mm-40 -108.22 165.67 11.32 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -1.043 . . . . 0.0 109.204 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.502 ' OG1' ' CAW' ' A' ' 201' ' ' 96F . 25.9 m -57.62 -35.66 70.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 109.202 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.47 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.719 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.621 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 26.0 Cg_exo -59.65 148.91 85.65 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.751 2.3 . . . . 0.0 112.278 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.739 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 19' ' ' GLU . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.477 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' NE2' HG21 ' A' ' 24' ' ' VAL . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 115' ' ' THR . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.552 HG21 ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.681 HG22 ' CD1' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -62.76 -33.17 74.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -66.61 -30.55 70.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.094 -1.629 . . . . 0.0 109.779 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -49.08 109.88 1.35 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.833 -1.167 . . . . 0.0 108.563 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.68 133.83 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.94 1.76 . . . . 0.0 112.193 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.99 -19.38 23.23 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.408 2.072 . . . . 0.0 112.649 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' HIS . 54.0 p -65.64 154.91 37.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.056 -1.028 . . . . 0.0 109.298 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.697 ' CG ' ' H ' ' A' ' 38' ' ' VAL . 21.3 t-80 39.98 -162.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.471 -0.768 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.697 ' H ' ' CG ' ' A' ' 37' ' ' HIS . 45.0 t -126.57 119.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' O ' ' OD2' ' A' ' 139' ' ' ASP . 52.2 mt -110.42 0.89 18.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.608 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 42' ' ' LYS . 13.6 p -129.57 139.59 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.798 . . . . 0.0 109.054 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -61.88 -38.51 88.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 108.964 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 40' ' ' VAL . 54.5 pttt -119.65 145.12 46.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -77.98 111.56 13.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.933 -1.104 . . . . 0.0 109.654 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.85 142.86 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.85 -47.99 1.51 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.186 -0.946 . . . . 0.0 111.253 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.914 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.681 ' CD1' HG22 ' A' ' 26' ' ' THR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.728 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.942 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.675 ' H ' HG22 ' A' ' 65' ' ' THR . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.763 HD13 ' O ' ' A' ' 91' ' ' TRP . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.556 ' N ' HG22 ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.728 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.942 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 -106.15 121.25 43.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -105.83 128.37 26.58 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.0 Cg_exo -30.15 153.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.749 2.299 . . . . 0.0 112.655 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' PRO . 88.5 Cg_exo -29.61 79.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.215 2.61 . . . . 0.0 112.269 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.61 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.575 -0.703 . . . . 0.0 109.77 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.8 ttp180 -150.5 138.79 20.35 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.065 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.497 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.535 HD13 ' CG2' ' A' ' 134' ' ' ILE . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.79 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.3 m-90 55.14 46.02 24.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.564 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 83.7 mt-30 -120.71 157.35 29.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.1 t -101.25 138.33 38.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.496 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -132.58 156.67 79.82 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.387 -0.82 . . . . 0.0 109.122 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.52 -32.1 51.84 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.521 2.148 . . . . 0.0 111.751 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -155.09 147.92 24.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.847 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 92.4 m-20 -106.03 117.51 34.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 110.333 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -75.49 -24.53 56.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.659 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 124' ' ' LEU . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' A' ' 119' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE1' HG12 ' A' ' 105' ' ' VAL . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 111' ' ' GLY . 22.4 t-20 -117.19 124.81 50.01 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.18 172.04 0.02 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.8 m -60.53 -30.92 70.04 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -1.105 . . . . 0.0 109.25 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -129.57 51.22 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.841 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -136.66 131.91 5.83 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.471 HG21 ' CAF' ' A' ' 201' ' ' 96F . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.27 -33.86 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 30.54 -149.98 0.01 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 51.31 48.88 22.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -1.124 . . . . 0.0 110.248 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.12 27.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -54.82 -44.62 74.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.7 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.614 ' CH2' ' N ' ' A' ' 1' ' ' MET . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.535 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.79 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -67.59 -44.81 77.26 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.536 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.85 -30.96 71.66 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 66.88 101.26 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 111.393 178.112 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.471 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -125.53 78.92 0.37 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 144' ' ' GLY . 32.1 Cg_exo -54.68 144.25 65.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.942 2.428 . . . . 0.0 112.739 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.4 OUTLIER -64.42 -64.0 3.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.415 -0.803 . . . . 0.0 109.895 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 142' ' ' SER . 12.0 Cg_endo -57.58 -33.99 97.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.344 2.029 . . . . 0.0 111.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -114.3 117.39 4.09 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -93.31 169.04 10.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.176 -1.19 . . . . 0.0 109.718 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.45 HG21 ' OAP' ' A' ' 201' ' ' 96F . 60.8 m -57.47 -38.47 74.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.791 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.802 HD11 ' CAK' ' A' ' 201' ' ' 96F . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 149' ' ' ARG . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.462 HD13 ' NE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.802 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -61.55 146.43 96.96 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.728 2.286 . . . . 0.0 112.177 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' HG13 ' A' ' 8' ' ' VAL . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' NE2' ' A' ' 121' ' ' HIS . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.592 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.656 HG22 ' CD2' ' A' ' 49' ' ' PHE . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -55.56 -32.57 63.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.666 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.07 108.06 20.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -0.993 . . . . 0.0 108.36 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.851 ' CZ2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.68 160.51 30.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.72 154.28 54.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.624 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.56 110.01 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.267 1.978 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.1 p -154.57 163.56 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -54.57 -31.96 57.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.156 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 40' ' ' VAL . 47.8 t -100.11 140.45 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.194 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.851 HD11 ' CZ2' ' A' ' 33' ' ' TRP . 41.2 tp -47.72 -41.99 24.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.371 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 33' ' ' TRP . 30.1 m -134.51 124.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -62.48 -36.55 82.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 151.65 21.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.502 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 96.9 mt-10 -76.15 103.22 6.08 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.872 -1.142 . . . . 0.0 110.034 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 59' ' ' GLU . 84.7 mtt180 -123.73 132.49 53.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -133.34 -41.25 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 110.16 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HE ' HG21 ' A' ' 68' ' ' VAL . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.858 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' O ' ' A' ' 43' ' ' GLU . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.912 HG21 ' O ' ' A' ' 91' ' ' TRP . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG21 ' HE ' ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.858 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 -134.56 111.95 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -115.42 96.19 45.17 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 16.6 Cg_exo -57.39 -43.52 51.07 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.532 2.155 . . . . 0.0 114.788 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 58.5 Cg_endo -76.55 11.27 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.81 1.673 . . . . 0.0 115.21 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 107' ' ' PHE . 1.2 t-80 -176.78 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 119.765 -1.834 . . . . 0.0 113.54 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 21.9 ttm180 -144.24 144.74 31.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.156 -1.59 . . . . 0.0 113.061 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.517 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 70' ' ' GLY . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 91' ' ' TRP . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.912 ' O ' HG21 ' A' ' 67' ' ' ILE . 4.1 m-90 55.82 26.64 9.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -98.59 150.51 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 109.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.4 p -86.22 150.58 24.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -146.45 156.73 49.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.114 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 9.7 Cg_endo -55.19 -32.94 82.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.445 2.097 . . . . 0.0 111.69 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 56.1 m-20 -159.27 146.93 17.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 87.3 m-20 -105.69 117.85 35.08 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.1 -26.37 62.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 108.835 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.441 HD12 ' NE1' ' A' ' 85' ' ' TRP . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG22 ' HG ' ' A' ' 119' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' HIS . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.42 140.64 50.08 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.95 -179.77 21.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.15 12.75 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -1.08 . . . . 0.0 109.582 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.08 67.44 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.23 10.87 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.412 HG21 ' CAF' ' A' ' 201' ' ' 96F . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.721 ' ND1' HD12 ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD12 ' ND1' ' A' ' 121' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.796 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -86.53 -27.17 24.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 131' ' ' ALA . . . 38.23 -147.37 0.11 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 131' ' ' ALA . 79.8 m-20 48.92 -140.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 109.285 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.16 44.6 0.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.796 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.95 -57.09 14.34 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.627 -0.925 . . . . 0.0 110.412 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.05 -43.63 86.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 93.6 mt -67.64 -6.61 21.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 61.99 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.593 0.711 . . . . 0.0 111.575 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.5 82.09 0.34 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.8 145.11 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.711 2.274 . . . . 0.0 112.466 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -83.03 -41.96 0.85 Allowed Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 142' ' ' SER . 7.3 Cg_exo -69.62 -68.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.69 2.26 . . . . 0.0 112.132 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -90.78 179.78 43.04 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -120.03 171.69 8.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.474 -1.015 . . . . 0.0 109.392 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.481 HG21 ' OAP' ' A' ' 201' ' ' 96F . 47.5 m -57.88 -36.75 72.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.935 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.452 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.482 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.935 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.96 146.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.705 2.27 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.792 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.63 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' SER . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 115' ' ' THR . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG21 ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 49' ' ' PHE . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -56.23 -32.01 64.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.12 111.59 23.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.601 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.3 p90 -112.5 153.53 44.88 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 33' ' ' TRP . 59.3 Cg_exo -31.28 155.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.67 2.246 . . . . 0.0 112.754 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.1 -30.13 89.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.483 2.122 . . . . 0.0 112.545 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -66.61 153.02 44.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.369 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.55 -44.09 84.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.022 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.84 140.36 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 108.95 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.0 tp -169.52 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.118 -0.989 . . . . 0.0 110.088 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 40' ' ' VAL . 9.8 p -60.07 128.05 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.952 -1.093 . . . . 0.0 109.109 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -62.3 -34.76 77.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 40' ' ' VAL . 55.5 pttt -117.73 143.8 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.503 -0.748 . . . . 0.0 109.222 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HB2' HD12 ' A' ' 62' ' ' ILE . 96.6 mt-10 -79.51 117.86 20.84 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.95 -1.094 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 30' ' ' ALA . 83.3 mtt180 -70.84 142.21 51.26 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.53 -48.0 1.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -0.965 . . . . 0.0 111.114 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.932 HG13 ' O ' ' A' ' 73' ' ' LEU . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.719 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.851 ' OD1' HD13 ' A' ' 62' ' ' ILE . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.851 HD13 ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.7 ' H ' HD13 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 70' ' ' GLY . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.693 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 -105.31 121.76 44.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -100.77 130.59 25.01 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 79' ' ' HIS . 46.4 Cg_exo -30.0 153.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.69 2.26 . . . . 0.0 112.459 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.9 Cg_exo -29.38 78.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.34 2.693 . . . . 0.0 112.373 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.98 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.602 -0.686 . . . . 0.0 109.841 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 35.4 ttm180 -152.31 139.74 19.56 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.706 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' CD1' HD12 ' A' ' 103' ' ' ILE . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 134' ' ' ILE . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.596 ' CZ3' HD11 ' A' ' 87' ' ' ILE . 39.7 m95 56.07 47.78 18.99 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 93' ' ' SER . 84.3 mt-30 -117.93 -88.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.825 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 t 153.04 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.77 62.25 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.337 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.96 -31.73 94.04 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.163 . . . . 0.0 111.747 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -155.13 150.81 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.8 m-20 -105.68 117.63 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 110.427 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.28 -23.58 57.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 108.542 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 107' ' ' PHE . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 105' ' ' VAL . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 -119.19 126.16 50.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.39 173.31 0.03 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.3 p -64.38 -22.37 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.35 -1.088 . . . . 0.0 109.283 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.47 49.83 0.86 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -135.91 130.78 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.613 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.434 HG21 ' CAF' ' A' ' 201' ' ' 96F . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.714 ' NE2' HG12 ' A' ' 8' ' ' VAL . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.713 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -80.19 -30.72 38.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 33.96 28.17 0.01 OUTLIER Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.566 -0.709 . . . . 0.0 111.337 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 127' ' ' HIS . 60.2 t0 -140.0 110.6 6.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.837 -1.39 . . . . 0.0 109.445 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.89 39.67 3.77 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -62.61 -57.81 9.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.756 -0.849 . . . . 0.0 111.203 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 87' ' ' ILE . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.537 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . . . -70.15 -43.13 71.53 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 91.8 mt -61.66 -28.1 69.15 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 59.46 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.405 0.621 . . . . 0.0 110.961 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -121.02 82.37 0.35 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 144' ' ' GLY . 45.9 Cg_exo -53.66 141.87 62.86 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.707 2.272 . . . . 0.0 112.641 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -71.2 -43.55 12.95 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.472 -0.768 . . . . 0.0 110.161 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 142' ' ' SER . 43.2 Cg_exo -55.51 -31.9 80.35 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.691 2.261 . . . . 0.0 112.563 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -147.56 172.88 27.84 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -118.04 174.24 6.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.523 HG21 ' OAP' ' A' ' 201' ' ' 96F . 28.1 m -57.72 -35.98 71.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.91 HD11 ' CAK' ' A' ' 201' ' ' 96F . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.494 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.91 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 21.9 Cg_exo -60.1 147.68 92.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.776 2.317 . . . . 0.0 112.124 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.602 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 122' ' ' VAL . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 147' ' ' LEU . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 115' ' ' THR . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 154' ' ' ILE . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 49' ' ' PHE . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.34 -32.25 48.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.678 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -96.87 105.93 18.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 108.338 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 9.7 p90 -112.86 149.99 42.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.031 -1.043 . . . . 0.0 108.889 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.16 123.16 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.15 1.9 . . . . 0.0 112.141 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.89 128.99 10.37 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.025 1.816 . . . . 0.0 111.854 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 p -157.08 171.23 20.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.501 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -55.11 -34.87 64.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.05 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.29 136.09 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' VAL . 54.3 mt -79.02 159.57 27.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 42' ' ' LYS . 13.9 p -41.13 136.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.257 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.31 -37.45 83.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 109.309 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 40' ' ' VAL . 1.3 pttt -117.81 143.35 46.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -86.25 123.17 31.21 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.084 -1.01 . . . . 0.0 109.767 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.427 HH21 ' HA ' ' A' ' 30' ' ' ALA . 75.9 mtt180 -66.36 143.27 57.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.112 -0.992 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.56 -48.15 2.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' NH2' ' A' ' 71' ' ' ARG . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.809 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.769 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.416 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.769 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 72' ' ' ILE . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.809 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 -108.07 125.24 51.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.508 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -108.63 128.81 24.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.8 Cg_exo -30.41 154.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 122.748 2.299 . . . . 0.0 112.601 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' PRO . 69.5 Cg_exo -27.67 78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.411 2.74 . . . . 0.0 112.491 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -178.08 -42.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.55 -0.719 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 44.3 ttp180 -153.36 138.1 17.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.049 -1.461 . . . . 0.0 112.087 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.713 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.606 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 94' ' ' VAL . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.732 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.5 m-90 57.54 25.7 11.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' H ' ' H ' ' A' ' 93' ' ' SER . 1.1 pt20 176.43 9.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.367 -0.833 . . . . 0.0 108.961 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 5.2 t -56.99 -56.79 17.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 5.1 m -146.91 151.44 41.78 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 109.701 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.38 -38.16 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.405 2.07 . . . . 0.0 112.054 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -109.87 147.35 33.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.838 . . . . 0.0 109.228 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 92.0 m-20 -105.14 118.2 35.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.98 -9.11 49.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.713 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 120' ' ' ALA . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' HG12 ' A' ' 105' ' ' VAL . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 -119.8 115.75 24.5 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . 64.01 25.92 69.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER 46.53 12.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 108.976 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 111' ' ' GLY . . . -146.96 6.33 1.14 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -130.3 126.11 4.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.754 HG21 ' SG ' ' A' ' 21' ' ' CYS . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.616 HG21 ' CAF' ' A' ' 201' ' ' 96F . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.59 -22.8 56.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.85 -166.99 36.1 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.649 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.11 151.24 47.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -1.013 . . . . 0.0 109.992 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.06 63.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.52 -40.72 97.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.513 -0.993 . . . . 0.0 109.546 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 5' ' ' ILE . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.732 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.1 -43.68 94.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 89.4 mt -67.27 -23.03 65.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 4.9 t0 81.61 100.49 0.05 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.327 0.584 . . . . 0.0 110.712 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.442 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -117.6 70.5 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.76 137.76 78.79 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.057 1.838 . . . . 0.0 112.3 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.635 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -83.54 -41.81 0.8 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 109.969 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.54 -26.45 54.72 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.632 2.221 . . . . 0.0 112.386 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.93 168.58 25.0 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -103.87 164.23 11.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.254 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.496 HG21 ' OAP' ' A' ' 201' ' ' 96F . 82.0 m -57.75 -38.33 75.19 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.156 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.879 HD21 ' OAO' ' A' ' 201' ' ' 96F . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 32' ' ' TRP . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 24' ' ' VAL . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.879 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.76 147.32 92.72 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.733 2.289 . . . . 0.0 112.197 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.778 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.778 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG12 ' NE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.488 HG22 HH21 ' A' ' 116' ' ' ARG . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.617 ' NE2' HG21 ' A' ' 24' ' ' VAL . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 115' ' ' THR . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG21 ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.716 HG22 ' CD2' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -60.27 -32.7 71.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.608 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -75.45 -24.85 57.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.177 -1.577 . . . . 0.0 110.153 -178.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.602 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -49.69 -58.12 10.18 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 110.847 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 33' ' ' TRP . 1.6 Cg_endo -48.62 -57.95 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.066 1.844 . . . . 0.0 114.024 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.19 -23.58 70.05 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.495 1.463 . . . . 0.0 111.927 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 p -73.12 162.81 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.475 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 37' ' ' HIS . 58.2 t-80 -92.29 16.14 12.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 109.554 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.45 136.34 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.49 157.0 16.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.8 p -117.24 142.17 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.27 -38.77 87.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 109.11 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' VAL . 55.1 pttt -117.8 142.91 46.76 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -82.75 121.34 26.77 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.856 -1.153 . . . . 0.0 109.449 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.06 142.5 41.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.75 -47.93 1.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.254 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.716 ' CD2' HG22 ' A' ' 26' ' ' THR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 72' ' ' ILE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.832 ' CE1' HG22 ' A' ' 68' ' ' VAL . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.832 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.662 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.805 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 24.2 p-90 -104.57 130.27 52.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.7 t70 -90.49 131.96 36.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.035 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.7 Cg_exo -42.67 -46.09 8.34 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.671 2.247 . . . . 0.0 113.434 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 77' ' ' PRO . 36.6 Cg_exo -58.98 -132.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.072 1.181 . . . . 0.0 109.058 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.19 52.93 1.04 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 -136.18 132.86 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.663 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.683 ' NE1' HD12 ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.492 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 94' ' ' VAL . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.0 m-90 57.53 26.37 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.16 3.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.221 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -59.1 -58.68 7.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.272 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.488 ' O ' ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -146.94 157.03 47.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.6 -29.63 51.38 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.482 2.121 . . . . 0.0 111.375 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 97' ' ' ASP . 39.9 t0 -149.9 147.85 28.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 108.92 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 74.2 m-20 -106.21 120.59 42.22 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.289 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.57 -15.05 49.15 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 127' ' ' HIS . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.683 HD12 ' NE1' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 119' ' ' LEU . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 -114.61 126.27 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.69 171.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.0 p -64.89 -21.78 66.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -1.142 . . . . 0.0 109.022 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.77 45.75 1.08 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.425 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.75 132.18 6.34 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.615 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.488 HH21 HG22 ' A' ' 13' ' ' VAL . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.525 HG21 ' CAF' ' A' ' 201' ' ' 96F . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.882 ' ND1' HD12 ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.882 HD12 ' ND1' ' A' ' 121' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.82 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -87.14 -34.63 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 33.97 -154.11 0.01 OUTLIER Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 52.96 53.18 12.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.049 -1.265 . . . . 0.0 110.42 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.43 29.86 35.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.82 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.19 -49.02 77.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.655 -0.909 . . . . 0.0 109.775 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.413 ' HE3' HD12 ' A' ' 5' ' ' ILE . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -63.74 -43.21 97.15 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 93.5 mt -66.67 -16.38 64.17 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.581 ' OD2' ' NH1' ' A' ' 149' ' ' ARG . 6.2 t0 86.24 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.438 0.637 . . . . 0.0 110.576 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.52 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -115.12 84.5 0.37 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.26 142.95 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.475 2.117 . . . . 0.0 112.257 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.634 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -80.83 -42.83 1.24 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' SER . 18.1 Cg_exo -63.35 -70.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.635 2.223 . . . . 0.0 112.451 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.64 -178.98 45.03 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 78.0 mm-40 -122.3 165.99 15.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.478 -1.013 . . . . 0.0 109.235 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.408 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 42.0 m -57.96 -36.78 73.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.942 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 32' ' ' TRP . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.534 HD13 ' NE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.942 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.678 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.8 Cg_exo -59.35 149.49 80.87 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.438 2.092 . . . . 0.0 112.368 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.673 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.673 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' OG1' ' A' ' 115' ' ' THR . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.768 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' HG21 ' A' ' 115' ' ' THR . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.768 HG21 ' NE2' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.591 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' TRP . 37.4 t0 -55.61 -9.34 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.591 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 2.7 m0 -42.26 -40.37 2.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.637 -1.29 . . . . 0.0 109.956 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.633 ' O ' ' CD2' ' A' ' 33' ' ' TRP . 63.8 p-90 -78.9 117.49 67.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.924 -1.11 . . . . 0.0 110.281 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 36' ' ' SER . 88.2 Cg_endo -82.75 161.63 16.38 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.138 1.892 . . . . 0.0 111.098 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -40.25 83.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.312 2.008 . . . . 0.0 111.72 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 34' ' ' PRO . 95.5 p -129.72 158.76 38.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 109.92 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -56.03 -34.86 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.513 -0.742 . . . . 0.0 110.202 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -121.42 141.12 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.433 -0.792 . . . . 0.0 109.759 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.604 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -158.8 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.636 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 ' HE ' ' A' ' 44' ' ' ARG . 53.4 t -115.9 140.32 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.5 -36.34 78.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 108.671 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' H ' HG12 ' A' ' 40' ' ' VAL . 35.5 pttt -109.11 143.21 38.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -71.27 123.39 22.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.957 -1.089 . . . . 0.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HE ' HG11 ' A' ' 40' ' ' VAL . 80.3 mtt180 -84.74 141.44 30.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -112.96 -48.17 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.762 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.776 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.74 ' H ' HG22 ' A' ' 65' ' ' THR . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 91' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.776 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.646 ' C ' HD12 ' A' ' 72' ' ' ILE . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 -114.52 112.6 23.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -114.45 96.27 42.62 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.495 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 10.2 Cg_exo -57.49 -43.03 54.93 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.271 1.98 . . . . 0.0 114.003 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 77.1 Cg_exo -47.34 -17.57 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.492 2.128 . . . . 0.0 114.753 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.46 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.942 -1.724 . . . . 0.0 112.895 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 34.6 ttm180 -151.14 141.9 22.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.899 -1.751 . . . . 0.0 113.427 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 107' ' ' PHE . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 70' ' ' GLY . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.466 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.723 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.7 m-90 56.9 25.99 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.56 106.2 16.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.066 -1.021 . . . . 0.0 108.937 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -48.32 138.83 9.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.002 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -124.99 156.86 68.6 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -51.77 -29.56 34.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.4 2.067 . . . . 0.0 111.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.62 149.89 20.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' OD2' HG23 ' A' ' 94' ' ' VAL . 79.1 m-20 -105.38 117.86 35.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.15 -8.98 58.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.723 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 81' ' ' LEU . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 -119.44 125.03 47.96 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.89 173.91 0.09 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -64.5 -23.6 67.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -1.086 . . . . 0.0 109.269 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.7 50.04 0.81 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.404 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -132.35 131.16 6.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.675 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 108' ' ' VAL . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.54 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.35 -23.4 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.553 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 89.35 -166.12 33.09 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.485 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -65.3 151.21 46.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.47 -1.018 . . . . 0.0 110.15 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.51 62.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.61 -39.64 94.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -1.071 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.678 ' CH2' ' N ' ' A' ' 1' ' ' MET . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.56 -44.49 86.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 19.3 mt -67.35 -25.44 65.99 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 59.02 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 111.675 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.497 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -127.66 78.47 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' GLY . 39.0 Cg_exo -53.83 138.86 69.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.819 2.346 . . . . 0.0 112.62 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -60.21 -45.57 97.74 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.92 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 142' ' ' SER . 42.7 Cg_exo -55.06 -29.79 66.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.64 2.227 . . . . 0.0 112.385 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -142.89 136.38 7.06 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.42 173.92 6.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.515 HG21 ' OAP' ' A' ' 201' ' ' 96F . 20.1 m -57.36 -36.29 71.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.271 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.904 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.683 HH12 ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.502 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.577 HG21 ' CD1' ' A' ' 32' ' ' TRP . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.862 ' CAL' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 22.0 Cg_exo -60.69 147.02 96.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.76 2.306 . . . . 0.0 112.126 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.633 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 8' ' ' VAL . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG22 ' NE2' ' A' ' 121' ' ' HIS . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' N ' HG12 ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.731 ' NE2' HG21 ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.731 HG21 ' NE2' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 32' ' ' TRP . 20.5 t0 -57.63 -9.62 1.24 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.602 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 3.0 m0 -43.24 -37.79 2.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.638 -1.289 . . . . 0.0 109.47 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.56 139.53 96.08 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.05 152.42 45.86 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.184 1.923 . . . . 0.0 112.05 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.84 134.27 39.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.355 2.036 . . . . 0.0 111.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -151.41 159.17 44.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.95 -33.19 64.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.296 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.8 140.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 40' ' ' VAL . 40.9 tp -85.21 143.36 28.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 42' ' ' LYS . 24.2 m -43.45 145.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -61.5 -35.84 78.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.15 142.35 27.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.283 -0.886 . . . . 0.0 108.721 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 96.9 mt-10 -72.32 104.88 3.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.907 -1.121 . . . . 0.0 109.905 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' NH1' ' OD2' ' A' ' 139' ' ' ASP . 84.6 mtt180 -122.61 139.24 54.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -0.883 . . . . 0.0 110.252 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.912 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.605 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.825 ' CE2' HG22 ' A' ' 68' ' ' VAL . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.729 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.702 ' H ' HG22 ' A' ' 65' ' ' THR . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 92' ' ' GLN . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.825 HG22 ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.729 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.635 HD11 ' CE1' ' A' ' 57' ' ' TYR . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 -106.61 128.15 53.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -110.5 128.64 25.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.4 Cg_exo -29.81 153.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 122.66 2.24 . . . . 0.0 112.86 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' PRO . 99.8 Cg_exo -29.52 79.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.347 2.698 . . . . 0.0 112.225 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -179.17 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.707 -0.62 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 72.1 ttt180 -152.97 144.98 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.434 -1.307 . . . . 0.0 111.877 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.488 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 137' ' ' ALA . 4.0 m-90 55.06 47.14 22.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 89.5 mt-30 -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -97.91 139.95 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 0.0 109.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.559 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -131.63 157.1 79.09 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.761 . . . . 0.0 109.095 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -53.04 -31.09 52.16 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.534 2.156 . . . . 0.0 111.306 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.09 147.7 14.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 86.7 m-20 -105.69 118.96 37.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -68.66 -27.98 66.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 108.492 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 79' ' ' HIS . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 -116.89 126.41 52.95 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.72 172.12 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.5 p -64.51 -22.33 66.93 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.314 -1.11 . . . . 0.0 109.146 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.2 46.97 0.99 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.392 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.54 132.89 6.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.597 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.47 HG21 ' CAF' ' A' ' 201' ' ' 96F . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.709 ' NE2' HG22 ' A' ' 8' ' ' VAL . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.756 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.57 -25.06 33.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.5 -145.31 0.09 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 131' ' ' ALA . 80.5 m-20 44.89 -147.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -1.072 . . . . 0.0 109.384 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.0 53.78 1.38 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -63.16 -54.41 38.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.365 -1.079 . . . . 0.0 110.202 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.45 ' N ' HD11 ' A' ' 5' ' ' ILE . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . . . -73.2 -30.94 63.88 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -59.84 -32.9 71.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 44' ' ' ARG . 49.6 t0 -173.1 -56.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.737 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.01 64.23 4.14 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 142' ' ' SER . 36.9 Cg_endo -70.77 150.09 61.53 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.884 2.389 . . . . 0.0 113.188 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -51.76 -177.55 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.1 -12.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.329 1.352 . . . . 0.0 111.212 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -68.39 152.32 52.33 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 74.9 mm-40 -96.53 165.33 12.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.189 -1.183 . . . . 0.0 109.082 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.424 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 40.3 m -57.14 -37.7 72.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.038 -1.039 . . . . 0.0 108.825 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.737 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.585 ' NH1' ' OD1' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 32' ' ' TRP . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.424 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.617 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.62 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.4 Cg_exo -60.52 147.88 92.9 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.642 2.228 . . . . 0.0 112.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.706 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.706 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 11' ' ' SER . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 19' ' ' GLU . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 HG22 ' HD1' ' A' ' 49' ' ' PHE . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.661 ' HB1' ' CB ' ' A' ' 44' ' ' ARG . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.98 -32.2 63.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.95 111.54 23.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 109.086 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.434 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -111.92 156.15 42.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 108.893 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -38.92 98.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.042 2.495 . . . . 0.0 112.702 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.68 -7.18 8.58 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.289 1.992 . . . . 0.0 111.693 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.6 p -59.57 170.55 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.759 . . . . 0.0 110.016 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -52.4 -31.05 32.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 109.858 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.19 130.31 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.011 -1.055 . . . . 0.0 109.792 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.77 156.38 24.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.694 . . . . 0.0 109.22 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.4 t -53.71 130.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 0.0 108.756 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -61.67 -37.39 83.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.109 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -95.59 144.08 26.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -94.48 122.76 37.39 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.92 -1.112 . . . . 0.0 109.327 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.661 ' CB ' ' HB1' ' A' ' 30' ' ' ALA . 50.1 mmt-85 -62.7 142.42 58.12 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.612 -1.305 . . . . 0.0 107.916 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.29 -47.93 3.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 111.038 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.867 ' CE2' HD11 ' A' ' 72' ' ' ILE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' TYR . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.49 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.734 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.867 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.415 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 -102.06 130.23 48.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.9 t0 -91.6 130.86 37.65 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 108.917 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 78' ' ' PRO . 7.0 Cg_exo -42.06 -46.16 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.7 2.266 . . . . 0.0 113.499 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 32.5 Cg_exo -60.01 -133.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 109.01 -1.188 . . . . 0.0 109.01 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.663 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -118.4 54.14 0.95 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 -135.82 134.77 39.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.539 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD12 ' A' ' 103' ' ' ILE . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 70' ' ' GLY . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.607 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 93' ' ' SER . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.707 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.5 m-90 57.31 26.11 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 176.23 11.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.221 -0.924 . . . . 0.0 109.051 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 5.7 t -58.94 -66.24 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.36 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 1.5 m -146.57 153.47 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.011 . . . . 0.0 109.867 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 18.1 Cg_endo -62.34 -29.66 79.95 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.186 . . . . 0.0 112.414 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 87.8 m-20 -109.03 146.91 33.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -105.79 117.7 34.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.397 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -90.68 -8.86 48.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.359 -0.838 . . . . 0.0 108.806 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' HD12 ' A' ' 124' ' ' LEU . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' TRP . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.663 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -115.77 136.95 52.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.49 -176.75 5.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.92 11.04 3.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -1.128 . . . . 0.0 109.426 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.23 1.31 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 140.4 9.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.551 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.465 HG21 ' CAF' ' A' ' 201' ' ' 96F . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.687 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -83.77 -24.01 31.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' N ' ' ND1' ' A' ' 127' ' ' HIS . . . 33.65 -151.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 50.11 -144.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.992 . . . . 0.0 109.709 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.63 48.24 1.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.687 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -59.67 -48.94 79.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.441 -1.034 . . . . 0.0 109.763 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.499 ' CH2' ' N ' ' A' ' 1' ' ' MET . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.573 ' CG2' HD13 ' A' ' 87' ' ' ILE . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.96 -43.86 86.68 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 80.6 mt -65.82 -25.83 67.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 81.29 103.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.368 0.604 . . . . 0.0 110.947 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -116.68 75.08 0.27 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.22 138.4 61.14 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.784 . . . . 0.0 112.44 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.61 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -82.6 -43.45 0.94 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.08 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 142' ' ' SER . 47.1 Cg_exo -54.68 -28.35 56.15 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.643 2.229 . . . . 0.0 112.492 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.76 168.68 25.17 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 77.9 mm-40 -105.17 164.59 11.71 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.502 -0.999 . . . . 0.0 109.167 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 62.0 m -57.61 -39.53 77.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.867 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.451 HD13 ' NE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.867 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 145.82 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.695 2.263 . . . . 0.0 112.216 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.649 ' HB2' HG12 ' A' ' 122' ' ' VAL . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.587 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 115' ' ' THR . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.596 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 44' ' ' ARG . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.47 -31.97 56.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.649 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -92.4 -5.91 51.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.448 -1.408 . . . . 0.0 111.178 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.75 ' HE1' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -48.23 -44.16 61.22 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.403 -1.436 . . . . 0.0 110.635 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 14.8 Cg_exo -68.38 112.25 2.75 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.483 2.122 . . . . 0.0 112.731 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' A' ' 38' ' ' VAL . 73.1 Cg_endo -83.49 -67.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.234 1.956 . . . . 0.0 111.884 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 38' ' ' VAL . 31.4 t -172.61 142.76 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.549 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 83.0 t60 57.81 -2.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.596 -0.69 . . . . 0.0 111.661 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' H ' ' C ' ' A' ' 36' ' ' SER . 13.5 p -134.95 137.12 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.784 -1.197 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.19 147.24 49.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.75 ' H ' ' HE1' ' A' ' 33' ' ' TRP . 2.7 p -58.27 145.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -61.12 -38.96 88.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 109.291 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 40' ' ' VAL . 29.2 mtmt -94.19 143.86 26.01 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -87.26 110.08 19.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.74 -1.225 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.437 ' CD ' ' HB1' ' A' ' 30' ' ' ALA . 78.8 mtt180 -62.75 142.49 58.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.94 -48.04 2.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 111.09 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.931 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.815 ' CE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.684 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.784 ' H ' HG22 ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.684 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.756 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.931 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.402 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 50.4 m95 -101.36 130.55 47.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -92.91 123.98 59.76 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 78' ' ' PRO . 82.6 Cg_exo -33.74 -51.95 0.52 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 122.867 2.378 . . . . 0.0 113.349 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.9 Cg_endo -55.61 -149.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.147 1.088 . . . . 0.0 109.471 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.675 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.81 50.52 0.78 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 38.3 ttp180 -135.37 141.43 45.54 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.414 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.596 HH11 ' C ' ' A' ' 94' ' ' VAL . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.789 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.6 m-90 55.5 34.59 23.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.51 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.7 mt-30 -107.15 151.7 25.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.144 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -98.43 140.17 33.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.596 ' C ' HH11 ' A' ' 86' ' ' ARG . 0.0 OUTLIER -138.08 157.17 73.43 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.808 . . . . 0.0 109.077 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.51 -32.14 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.588 2.192 . . . . 0.0 111.742 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.89 147.62 24.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.812 . . . . 0.0 108.901 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 85.1 m-20 -106.32 118.33 36.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.413 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -69.29 -26.32 64.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' HG ' ' A' ' 119' ' ' LEU . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.675 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 -116.25 117.9 31.31 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.09 168.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -64.9 -17.07 64.0 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.261 -1.14 . . . . 0.0 108.917 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.09 45.0 1.15 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.759 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -144.08 133.1 5.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG21 ' CAF' ' A' ' 201' ' ' 96F . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -76.45 -21.23 56.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.466 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 90.75 -168.65 33.18 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.507 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.8 151.5 47.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.46 -11.38 65.09 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.66 -42.31 98.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.573 -0.957 . . . . 0.0 109.932 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.404 ' N ' HD11 ' A' ' 5' ' ' ILE . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.789 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -68.47 -44.39 74.91 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -64.92 -28.99 69.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.28 100.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.613 -0.679 . . . . 0.0 110.999 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.36 85.06 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 51.7 Cg_exo -53.11 148.15 31.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.78 2.32 . . . . 0.0 112.619 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -93.83 -42.13 0.32 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.44 -0.788 . . . . 0.0 110.213 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.21 -29.77 68.29 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.457 2.105 . . . . 0.0 112.327 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.68 122.18 2.99 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -53.93 151.68 6.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.33 -1.1 . . . . 0.0 109.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.654 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 53.0 m -56.53 -37.84 71.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' A' ' 146' ' ' THR . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 20' ' ' HIS . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.654 ' OAQ' HG21 ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 22.0 Cg_exo -60.63 147.25 95.31 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.872 2.381 . . . . 0.0 112.253 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.684 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.684 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' NE2' ' A' ' 121' ' ' HIS . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.486 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 115' ' ' THR . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' CD1' ' A' ' 49' ' ' PHE . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 76.8 m-20 -56.31 -32.8 64.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.726 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -94.79 111.4 23.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.996 -1.065 . . . . 0.0 108.923 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -112.51 154.35 44.64 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 109.257 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 2.8 Cg_endo -48.48 -54.72 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.446 2.097 . . . . 0.0 113.178 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 18.6 Cg_endo -59.51 139.98 91.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.84 1.693 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -62.02 -36.46 81.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.68 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 85.0 t60 -167.23 47.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.839 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.6 t -120.63 140.44 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 38' ' ' VAL . 38.5 tp -43.96 129.62 5.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.016 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 42' ' ' LYS . 22.0 m -66.61 130.07 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.93 -35.66 79.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.038 -1.039 . . . . 0.0 108.657 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.0 pttt -73.5 173.89 9.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -116.91 104.35 11.21 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.191 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.542 ' CZ ' ' OE2' ' A' ' 59' ' ' GLU . 30.8 mmt180 -125.77 141.14 52.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -135.2 -47.9 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.381 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 73' ' ' LEU . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.723 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 70' ' ' GLY . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 68' ' ' VAL . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 72' ' ' ILE . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.841 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -106.08 123.47 48.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -107.06 127.3 28.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.7 Cg_exo -30.15 153.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.642 2.228 . . . . 0.0 112.761 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' PRO . 85.8 Cg_exo -28.46 79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.412 2.742 . . . . 0.0 112.331 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.83 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.646 -0.659 . . . . 0.0 109.68 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 49.2 ttp180 -152.47 140.28 19.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.81 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 103' ' ' ILE . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.723 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.645 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.773 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 2.8 m-90 55.78 38.71 30.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.545 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 84.8 mt-30 -114.44 158.14 21.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.0 t -105.02 139.82 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -130.66 156.54 79.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.033 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 7.5 Cg_endo -52.74 -37.08 75.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.396 2.064 . . . . 0.0 111.693 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 80.2 m-20 -147.11 146.54 29.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 108.979 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.675 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 91.8 m-20 -105.88 117.46 34.08 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.191 -0.943 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -76.56 -23.33 53.57 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 124' ' ' LEU . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 85' ' ' TRP . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 -119.15 126.34 51.36 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.97 171.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.2 p -64.08 -22.75 67.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.317 -1.108 . . . . 0.0 109.125 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.94 47.13 0.99 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -134.32 132.7 6.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.473 HG21 ' CAF' ' A' ' 201' ' ' 96F . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.629 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.7 -18.7 60.97 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.37 -171.96 40.77 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.908 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.4 150.67 48.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.572 -0.957 . . . . 0.0 109.809 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.16 64.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.2 -39.15 93.81 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -1.021 . . . . 0.0 109.372 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.473 ' CE2' ' CB ' ' A' ' 1' ' ' MET . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.645 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.74 -43.54 83.92 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 65.1 mt -68.1 -15.97 63.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 61.76 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.688 . . . . 0.0 111.173 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 135' ' ' HIS . . . -122.52 81.91 0.35 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -53.6 138.35 66.83 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.622 2.215 . . . . 0.0 112.304 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -73.13 -44.12 7.85 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 0.0 110.064 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 142' ' ' SER . 35.2 Cg_exo -58.32 -70.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.426 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.78 -179.23 44.77 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -115.19 164.41 14.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.521 -0.988 . . . . 0.0 109.251 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.586 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 76.1 m -57.8 -38.36 75.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD21 ' OAO' ' A' ' 201' ' ' 96F . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 32' ' ' TRP . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.708 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG2' ' HE1' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -64.29 145.0 87.85 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.724 2.283 . . . . 0.0 112.169 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.558 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.558 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.688 ' HB2' HG12 ' A' ' 122' ' ' VAL . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' NE2' ' A' ' 121' ' ' HIS . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD22 ' A' ' 147' ' ' LEU . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG23 ' CB ' ' A' ' 151' ' ' ALA . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 20' ' ' HIS . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 115' ' ' THR . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.067 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.593 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 31.7 t0 -60.2 -31.44 70.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.68 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -91.66 120.21 32.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.813 -1.179 . . . . 0.0 110.722 -178.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.593 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.35 179.32 0.82 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 35.4 Cg_exo -56.2 139.29 85.59 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.172 1.915 . . . . 0.0 111.811 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.81 -28.05 30.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.546 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 37' ' ' HIS . 27.4 t -118.39 139.42 51.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' SER . 32.6 m80 49.74 177.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.1 t -117.89 123.63 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' O ' ' CG ' ' A' ' 139' ' ' ASP . 67.4 mt -104.95 -1.69 25.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 40' ' ' VAL . 9.4 p -91.35 105.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.94 -1.1 . . . . 0.0 109.364 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HD2' ' HZ3' ' A' ' 136' ' ' LYS . 35.8 mttp -62.84 -37.8 88.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.4 pttp -98.88 150.12 22.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.925 . . . . 0.0 109.027 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 123.42 29.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.504 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 95.5 mtt180 -66.85 138.52 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 108.646 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -112.91 -46.43 3.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.876 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.792 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.067 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.87 ' CE1' HD11 ' A' ' 72' ' ' ILE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.758 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.775 HG22 ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.758 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.788 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 57' ' ' TYR . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 -106.5 125.91 51.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -107.95 128.23 26.17 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 79' ' ' HIS . 37.0 Cg_exo -29.88 153.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.769 2.313 . . . . 0.0 112.719 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.6 Cg_exo -29.25 79.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.304 2.669 . . . . 0.0 112.194 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.37 -41.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.654 -0.654 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 65.5 ttt180 -153.91 142.28 20.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.961 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.489 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.581 HH11 ' C ' ' A' ' 95' ' ' PRO . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 6.8 m-90 56.23 26.45 10.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -100.67 123.84 45.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 109.218 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 p -64.69 151.51 44.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -146.65 157.29 48.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.242 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.581 ' C ' HH11 ' A' ' 86' ' ' ARG . 8.5 Cg_endo -53.39 -31.61 58.26 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.67 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -158.73 147.93 18.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' OD2' HG23 ' A' ' 94' ' ' VAL . 88.6 m-20 -106.02 117.94 35.32 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 110.315 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -72.23 -26.11 61.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.277 -0.89 . . . . 0.0 108.884 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.544 ' CE1' HG12 ' A' ' 105' ' ' VAL . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 -118.91 127.17 53.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 51.87 172.9 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.2 p -64.81 -22.93 67.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.235 -1.156 . . . . 0.0 109.138 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.67 46.94 1.0 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -134.3 135.21 7.84 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.668 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' CAF' ' A' ' 201' ' ' 96F . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.792 ' ND1' HD12 ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.792 HD12 ' ND1' ' A' ' 121' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -78.32 -32.65 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 34.43 38.71 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 130' ' ' GLY . 60.5 t0 -146.46 95.57 2.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.345 . . . . 0.0 109.886 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.38 38.09 2.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -61.53 -48.62 80.21 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.528 -0.983 . . . . 0.0 110.397 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.42 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.611 HD11 ' HA2' ' A' ' 89' ' ' GLY . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.667 ' HZ3' ' HD2' ' A' ' 41' ' ' LYS . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.92 -44.72 79.95 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.72 -27.09 68.07 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 1.3 m-20 60.32 99.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.667 -0.645 . . . . 0.0 110.756 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.512 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -93.67 132.7 11.32 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.491 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 46.1 Cg_endo -71.44 146.86 51.13 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.218 1.946 . . . . 0.0 112.383 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.678 ' H ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -110.57 -44.39 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.755 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 142' ' ' SER . 23.4 Cg_exo -61.97 -24.22 76.64 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.02 178.0 21.03 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -95.81 162.56 13.54 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.268 -1.136 . . . . 0.0 109.135 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.606 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 66.2 m -57.68 -39.89 78.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.977 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.9 HD21 ' OAO' ' A' ' 201' ' ' 96F . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.68 HG11 ' HB2' ' A' ' 32' ' ' TRP . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.9 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.2 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -62.53 153.68 69.71 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.799 2.333 . . . . 0.0 112.432 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HB2' HG12 ' A' ' 122' ' ' VAL . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' HG21 ' A' ' 115' ' ' THR . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.675 HG22 ' CD2' ' A' ' 49' ' ' PHE . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -56.51 -32.21 64.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.611 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.0 -10.78 46.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.568 -1.332 . . . . 0.0 110.534 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.644 ' HE1' HH22 ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.88 -51.25 80.73 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 120.561 -1.337 . . . . 0.0 110.729 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 2.3 Cg_endo -50.82 -55.48 4.03 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.369 1.379 . . . . 0.0 113.679 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 12.7 Cg_endo -58.69 -14.71 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.7 1.6 . . . . 0.0 112.324 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.579 ' OG ' ' NE ' ' A' ' 149' ' ' ARG . 31.9 t -63.11 156.05 26.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -51.71 -35.96 44.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.81 134.72 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.023 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 34' ' ' PRO . 43.7 mt -95.35 141.31 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 42' ' ' LYS . 97.6 t -61.99 137.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -60.12 -38.87 84.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.873 -1.142 . . . . 0.0 108.501 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' H ' HG12 ' A' ' 40' ' ' VAL . 42.7 mtmt -99.37 143.61 29.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.43 106.91 15.56 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.742 -1.223 . . . . 0.0 109.532 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.637 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 68.5 mtt180 -63.52 142.14 58.51 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.08 -47.66 2.26 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.138 -0.977 . . . . 0.0 111.697 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.937 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.707 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.711 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.711 ' H ' HG22 ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.697 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.882 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 60.3 p-90 -101.17 130.56 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -96.89 121.51 59.17 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 108.953 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 78' ' ' PRO . 80.2 Cg_exo -34.86 -51.58 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.994 2.463 . . . . 0.0 113.463 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.5 Cg_endo -55.08 -149.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.219 1.114 . . . . 0.0 109.72 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.0 50.8 0.79 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 62.5 ttt-85 -135.84 144.78 45.85 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 -177.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CE2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CD1' HD12 ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.697 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.624 ' OD2' HG13 ' A' ' 94' ' ' VAL . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.75 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 8.4 m-90 56.17 26.91 10.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 93' ' ' SER . 94.0 mt-30 -98.03 6.19 47.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.858 -1.151 . . . . 0.0 110.602 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 50.68 105.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.624 HG13 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -99.68 156.49 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.09 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.12 -31.59 65.82 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.598 2.199 . . . . 0.0 111.734 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -155.36 150.27 26.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -105.5 117.81 34.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 110.384 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -90.14 -8.78 50.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -119.41 143.57 47.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.8 -177.48 24.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.97 11.22 4.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -1.106 . . . . 0.0 109.418 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.17 71.89 1.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.33 139.62 8.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.621 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.93 -16.35 58.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.504 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 87.36 -164.91 35.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 129' ' ' ASP . 52.8 p30 -72.5 160.75 31.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -1.045 . . . . 0.0 109.806 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.5 77.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.53 -44.8 93.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.647 -0.914 . . . . 0.0 109.926 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.75 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.88 -44.37 81.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.561 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -66.01 -26.43 67.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 136' ' ' LYS . 1.2 m-20 61.12 98.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.681 -0.637 . . . . 0.0 110.769 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.493 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -95.37 140.29 14.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.11 143.03 70.11 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.106 1.871 . . . . 0.0 112.229 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.626 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -101.08 -42.89 0.21 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.927 . . . . 0.0 109.455 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 142' ' ' SER . 2.4 Cg_endo -77.88 -66.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.78 2.32 . . . . 0.0 111.754 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -85.75 -178.74 50.23 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -105.87 160.82 14.96 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.289 -1.124 . . . . 0.0 109.093 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.608 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 52.7 m -57.47 -38.54 74.69 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.223 -0.923 . . . . 0.0 108.92 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.846 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.644 HH22 ' HE1' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.846 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.688 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 1' ' ' MET . 24.3 Cg_exo -59.94 148.12 90.02 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.567 2.178 . . . . 0.0 112.242 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.751 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.751 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG12 ' CD2' ' A' ' 121' ' ' HIS . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' NZ ' HG21 ' A' ' 8' ' ' VAL . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.44 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' PRO . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 18' ' ' VAL . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 115' ' ' THR . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 154' ' ' ILE . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' HD1' ' A' ' 49' ' ' PHE . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -54.84 -32.54 60.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.662 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.91 108.78 20.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.825 -1.172 . . . . 0.0 108.549 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.406 ' CD1' ' NE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -112.66 156.86 41.8 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 108.839 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' VAL . 75.0 Cg_exo -40.25 100.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.595 2.197 . . . . 0.0 111.954 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.49 -0.15 9.69 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.473 2.116 . . . . 0.0 112.291 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.591 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 23.0 m -55.55 -37.05 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER 163.67 2.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' PRO . 13.7 p -133.47 140.01 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 40' ' ' VAL . 53.3 mt -111.03 150.64 29.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.743 . . . . 0.0 109.017 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG1' ' HE ' ' A' ' 44' ' ' ARG . 3.3 p -45.47 135.44 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.907 -1.121 . . . . 0.0 108.773 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -61.53 -38.13 86.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.955 -1.091 . . . . 0.0 108.943 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 61' ' ' ASP . 32.6 ttpt -88.09 143.16 27.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.7 124.29 32.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.862 -1.149 . . . . 0.0 110.025 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HE ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.67 141.58 42.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -110.62 -47.06 3.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.376 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 60' ' ' TRP . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.724 ' CE2' HD11 ' A' ' 72' ' ' ILE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CE1' HG22 ' A' ' 68' ' ' VAL . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.77 ' H ' HG22 ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.85 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.751 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.724 HD11 ' CE2' ' A' ' 57' ' ' TYR . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 -106.49 127.42 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -108.34 130.09 23.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.7 Cg_exo -30.17 153.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.802 2.334 . . . . 0.0 112.634 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.4 Cg_exo -29.21 79.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.293 2.662 . . . . 0.0 112.305 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' N ' ' O ' ' A' ' 77' ' ' PRO . 1.9 t-80 -179.3 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.586 -0.696 . . . . 0.0 109.917 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 75.4 ttt180 -151.44 143.22 23.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.162 -1.415 . . . . 0.0 112.118 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.5 m-90 56.06 29.61 14.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.535 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.4 mt-30 -101.45 154.21 19.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.072 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -100.79 139.46 36.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.527 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -134.03 156.78 78.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' O ' ' OD2' ' A' ' 96' ' ' ASP . 6.2 Cg_endo -51.67 -37.32 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.354 2.036 . . . . 0.0 111.757 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' OD2' ' O ' ' A' ' 95' ' ' PRO . 82.8 m-20 -145.99 146.57 31.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.897 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 77.3 m-20 -106.02 117.57 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.174 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -70.67 -27.77 64.28 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.88 . . . . 0.0 108.685 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 119' ' ' LEU . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 105' ' ' VAL . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 18' ' ' VAL . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -119.41 144.97 46.63 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.51 -176.22 28.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.53 14.39 4.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.514 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.99 70.27 1.28 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.65 140.76 9.78 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.44 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.653 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.68 -25.36 33.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.76 -146.3 0.08 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 48.8 t0 48.9 -138.67 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.514 -0.992 . . . . 0.0 109.765 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.546 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -82.99 51.55 4.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -59.21 -50.93 72.15 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -1.02 . . . . 0.0 109.941 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.688 ' CH2' ' N ' ' A' ' 1' ' ' MET . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.807 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -67.63 -44.78 77.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.571 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 60.7 mt -65.86 -29.67 70.16 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.43 96.29 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.582 -0.699 . . . . 0.0 111.484 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -131.99 75.22 0.43 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.05 137.99 70.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.701 2.268 . . . . 0.0 112.467 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -62.99 -45.52 86.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.984 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.2 Cg_exo -56.65 -31.34 87.01 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.585 2.19 . . . . 0.0 112.332 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.58 104.32 0.88 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -54.65 153.01 6.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -1.126 . . . . 0.0 109.005 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.607 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 58.3 m -56.68 -38.27 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.908 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.464 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.497 ' CG ' ' N ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 24' ' ' VAL . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' 96F . . . . . 0.908 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 121.454 0.522 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.733 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.733 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 ' CD2' ' A' ' 121' ' ' HIS . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG23 ' HG1' ' A' ' 115' ' ' THR . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.755 ' NE2' HG21 ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' NE2' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 59' ' ' GLU . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.733 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.823 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.513 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 HG23 ' A' ' 134' ' ' ILE . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.739 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.6 m-90 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.556 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 . . . . . 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.708 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.767 HG23 HD13 ' A' ' 87' ' ' ILE . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.739 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.544 0.688 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.778 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.729 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.729 HG13 HD21 ' A' ' 152' ' ' ASN . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.416 ' N ' HG23 ' A' ' 153' ' ' VAL . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.362 0.484 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.59 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.59 HG21 ' NE2' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.552 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.061 0.458 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.779 HD12 ' C ' ' A' ' 46' ' ' GLY . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 91' ' ' TRP . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.583 ' O ' HG13 ' A' ' 53' ' ' VAL . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.407 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.7 p-90 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.609 0.718 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.503 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 103' ' ' ILE . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.658 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.841 ' O ' HD13 ' A' ' 67' ' ' ILE . 5.0 m-90 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.511 HD12 ' NE1' ' A' ' 85' ' ' TRP . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 . . . . . 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.658 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.778 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.629 0.728 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.591 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.691 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.691 HG13 HD21 ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.428 ' N ' HG23 ' A' ' 153' ' ' VAL . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 N--CA 1.492 1.441 0 CA-C-O 121.344 0.477 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.57 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.536 ' HB2' HG12 ' A' ' 122' ' ' VAL . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 147' ' ' LEU . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 19' ' ' GLU . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.667 HG22 ' CD2' ' A' ' 49' ' ' PHE . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' HD22 ' A' ' 47' ' ' LEU . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.808 0.337 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.897 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 73' ' ' LEU . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.905 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 66' ' ' GLU . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.741 ' H ' HG22 ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 67' ' ' ILE . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 72' ' ' ILE . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.701 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 62.6 m95 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.407 HH11 ' CD ' ' A' ' 104' ' ' GLU . 53.3 ttt-85 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.698 0.761 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.727 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.727 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 89' ' ' GLY . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.775 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.5 m-90 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 105' ' ' VAL . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.604 ' NE2' HG12 ' A' ' 8' ' ' VAL . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.621 ' CG2' HD13 ' A' ' 87' ' ' ILE . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.727 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.491 1.363 0 CA-C-O 121.28 0.45 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.621 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.621 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 122' ' ' VAL . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.651 ' NE2' HG21 ' A' ' 24' ' ' VAL . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 ' NE2' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.295 0.569 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 73' ' ' LEU . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.43 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.753 ' CE1' HD11 ' A' ' 72' ' ' ILE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.751 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.797 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.733 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.733 ' H ' HG22 ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.797 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 57' ' ' TYR . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.801 0.81 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.507 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 70' ' ' GLY . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.603 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.806 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.7 m-90 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 105' ' ' VAL . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.739 ' ND1' HD12 ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.739 HD12 ' ND1' ' A' ' 121' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.899 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.899 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.432 ' N ' HD11 ' A' ' 5' ' ' ILE . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.603 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.427 0.632 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 154' ' ' ILE . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.543 HD13 ' NE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 N--CA 1.492 1.431 0 CA-C-O 121.205 0.419 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.54 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 122' ' ' VAL . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' HD22 ' A' ' 147' ' ' LEU . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.42 HG23 ' N ' ' A' ' 19' ' ' GLU . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.483 HG22 ' HD1' ' A' ' 49' ' ' PHE . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.14 0.495 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.909 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.831 ' CE2' HG22 ' A' ' 68' ' ' VAL . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.699 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.651 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.831 HG22 ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.699 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.795 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.909 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.746 ' O ' HG13 ' A' ' 53' ' ' VAL . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.403 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 57.9 p-90 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 51.5 ttt-85 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.781 0.801 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.588 ' N ' HD12 ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.616 ' OG1' HD21 ' A' ' 73' ' ' LEU . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.592 ' CD1' HD12 ' A' ' 103' ' ' ILE . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.795 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.777 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.8 m-90 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HG3' HD11 ' A' ' 73' ' ' LEU . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 . . . . . 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.538 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 121.101 0.477 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.401 ' N ' HD11 ' A' ' 5' ' ' ILE . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.777 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.418 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 47.2 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.554 0.692 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.667 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.592 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.657 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 121.409 0.504 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.72 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' N ' HG12 ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.436 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' HG21 ' A' ' 115' ' ' THR . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 49' ' ' PHE . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' VAL . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.188 0.518 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.885 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.799 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.749 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.478 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.697 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.792 ' H ' HG22 ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.751 ' C ' HD12 ' A' ' 72' ' ' ILE . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.885 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.605 0.717 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.525 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.804 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.2 m-90 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 120' ' ' ALA . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 107' ' ' PHE . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 105' ' ' VAL . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.443 ' HB3' HG13 ' A' ' 108' ' ' VAL . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CD2' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.816 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.816 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.532 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.804 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.424 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 21.4 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.424 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 121.47 0.529 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.824 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' A' ' 122' ' ' VAL . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 121' ' ' HIS . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.506 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 115' ' ' THR . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 49' ' ' PHE . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.085 0.469 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.907 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.823 ' CE1' HG22 ' A' ' 68' ' ' VAL . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.667 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.492 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.667 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.907 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 26.3 p-90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.831 0.824 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.531 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' NH1' HG21 ' A' ' 68' ' ' VAL . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.446 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.2 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 120' ' ' ALA . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 119' ' ' LEU . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 . . . . . 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.615 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.607 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.441 ' HE3' HD12 ' A' ' 5' ' ' ILE . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 89' ' ' GLY . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.666 0.746 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.47 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo . . . . . 0 N--CA 1.494 1.5 0 CA-C-O 121.337 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.739 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 19' ' ' GLU . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.477 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.552 ' NE2' HG21 ' A' ' 24' ' ' VAL . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 115' ' ' THR . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.552 HG21 ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.681 HG22 ' CD1' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 47' ' ' LEU . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.049 0.452 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.914 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.681 ' CD1' HG22 ' A' ' 26' ' ' THR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.728 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.942 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.675 ' H ' HG22 ' A' ' 65' ' ' THR . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.763 HD13 ' O ' ' A' ' 91' ' ' TRP . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.556 ' N ' HG22 ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.728 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.942 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.766 0.793 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.497 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.535 HD13 ' CG2' ' A' ' 134' ' ' ILE . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.79 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.3 m-90 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 124' ' ' LEU . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' A' ' 119' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE1' HG12 ' A' ' 105' ' ' VAL . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.479 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 22.4 t-20 . . . . . 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.124 0.488 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.43 ' N ' HD11 ' A' ' 5' ' ' ILE . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.535 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.79 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.8 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.459 0.647 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.699 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 149' ' ' ARG . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.462 HD13 ' NE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 121.293 0.455 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' HG13 ' A' ' 8' ' ' VAL . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' NE2' ' A' ' 121' ' ' HIS . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.592 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.656 HG22 ' CD2' ' A' ' 49' ' ' PHE . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.46 0.647 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HE ' HG21 ' A' ' 68' ' ' VAL . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.858 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 64' ' ' GLY . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.912 HG21 ' O ' ' A' ' 91' ' ' TRP . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.518 HG21 ' HE ' ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.858 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 122.079 0.943 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.517 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 70' ' ' GLY . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 91' ' ' TRP . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 89' ' ' GLY . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.912 ' O ' HG21 ' A' ' 67' ' ' ILE . 4.1 m-90 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.441 HD12 ' NE1' ' A' ' 85' ' ' TRP . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.6 HG22 ' HG ' ' A' ' 119' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CE1' HG12 ' A' ' 105' ' ' VAL . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.721 ' ND1' HD12 ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.721 HD12 ' ND1' ' A' ' 121' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.796 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.796 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.844 0.355 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.427 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 47.5 m . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.762 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.599 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.491 1.339 0 CA-C-O 121.348 0.478 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.792 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.63 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' SER . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 115' ' ' THR . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 HG21 ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 49' ' ' PHE . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 120.962 0.411 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.932 HG13 ' O ' ' A' ' 73' ' ' LEU . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.719 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.851 ' OD1' HD13 ' A' ' 62' ' ' ILE . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.851 HD13 ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.7 ' H ' HD13 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 70' ' ' GLY . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.693 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.538 0.685 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.684 ' CD1' HD12 ' A' ' 103' ' ' ILE . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 134' ' ' ILE . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.596 ' CZ3' HD11 ' A' ' 87' ' ' ILE . 39.7 m95 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 107' ' ' PHE . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 105' ' ' VAL . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.613 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.714 ' NE2' HG12 ' A' ' 8' ' ' VAL . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.713 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.863 0.363 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 87' ' ' ILE . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.537 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.455 0.645 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.844 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.585 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.582 HG13 HD21 ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo . . . . . 0 N--CA 1.491 1.377 0 CA-C-O 121.344 0.477 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.602 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 122' ' ' VAL . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 147' ' ' LEU . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 115' ' ' THR . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 154' ' ' ILE . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 49' ' ' PHE . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.139 0.495 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' NH2' ' A' ' 71' ' ' ARG . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.809 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.769 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.416 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.769 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 72' ' ' ILE . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.809 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.713 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.732 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.5 m-90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.713 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 120' ' ' ALA . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' HG12 ' A' ' 105' ' ' VAL . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.754 HG21 ' SG ' ' A' ' 21' ' ' CYS . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.452 ' O ' ' OG ' ' A' ' 11' ' ' SER . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 5' ' ' ILE . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.732 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.783 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 149' ' ' ARG . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 24' ' ' VAL . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo . . . . . 0 N--CA 1.493 1.446 0 CA-C-O 121.335 0.473 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.778 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.778 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG12 ' NE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.488 HG22 HH21 ' A' ' 116' ' ' ARG . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.617 ' NE2' HG21 ' A' ' 24' ' ' VAL . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 115' ' ' THR . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG21 ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.716 HG22 ' CD2' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD2' HD22 ' A' ' 47' ' ' LEU . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.345 0.593 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.716 ' CD2' HG22 ' A' ' 26' ' ' THR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 72' ' ' ILE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.832 ' CE1' HG22 ' A' ' 68' ' ' VAL . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.832 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.662 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.805 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 24.2 p-90 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.798 0.809 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.683 ' NE1' HD12 ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 134' ' ' ILE . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.0 m-90 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 127' ' ' HIS . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.683 HD12 ' NE1' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 119' ' ' LEU . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.456 ' CD1' HG22 ' A' ' 117' ' ' VAL . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.615 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.488 HH21 HG22 ' A' ' 13' ' ' VAL . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.456 HG22 ' CD1' ' A' ' 107' ' ' PHE . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.882 ' ND1' HD12 ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.882 HD12 ' ND1' ' A' ' 121' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.82 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.82 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 121.123 0.487 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.413 ' HE3' HD12 ' A' ' 5' ' ' ILE . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.609 0.719 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.712 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 149' ' ' ARG . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.534 HD13 ' NE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.326 0.469 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.673 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.673 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' OG1' ' A' ' 115' ' ' THR . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.768 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' HG21 ' A' ' 115' ' ' THR . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.768 HG21 ' NE2' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.4 t0 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.098 0.475 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.776 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.74 ' H ' HG22 ' A' ' 65' ' ' THR . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 91' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.776 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.646 ' C ' HD12 ' A' ' 72' ' ' ILE . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.145 0.974 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 107' ' ' PHE . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 70' ' ' GLY . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.466 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.723 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.7 m-90 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.723 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 81' ' ' LEU . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 . . . . . 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.675 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 108' ' ' VAL . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.904 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.622 HD21 HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.622 HG13 HD21 ' A' ' 152' ' ' ASN . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.49 1.285 0 CA-C-O 121.186 0.411 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.633 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 8' ' ' VAL . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG22 ' NE2' ' A' ' 121' ' ' HIS . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.443 ' N ' HG12 ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.731 ' NE2' HG21 ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.731 HG21 ' NE2' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.305 0.574 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.912 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.605 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.825 ' CE2' HG22 ' A' ' 68' ' ' VAL . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.729 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.702 ' H ' HG22 ' A' ' 65' ' ' THR . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.825 HG22 ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.729 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.635 HD11 ' CE1' ' A' ' 57' ' ' TYR . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.743 0.783 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.488 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 137' ' ' ALA . 4.0 m-90 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.405 ' CE1' HG12 ' A' ' 105' ' ' VAL . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.597 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.709 ' NE2' HG22 ' A' ' 8' ' ' VAL . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.756 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.935 0.398 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.45 ' N ' HD11 ' A' ' 5' ' ' ILE . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.737 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 153' ' ' VAL . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.424 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 N--CA 1.493 1.448 0 CA-C-O 121.362 0.484 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.706 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.706 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 11' ' ' SER . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 19' ' ' GLU . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 HG22 ' HD1' ' A' ' 49' ' ' PHE . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.053 0.454 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.867 ' CE2' HD11 ' A' ' 72' ' ' ILE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' TYR . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.49 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.734 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.867 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.415 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.91 0.862 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD12 ' A' ' 103' ' ' ILE . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 70' ' ' GLY . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.573 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.707 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.5 m-90 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' HD12 ' A' ' 124' ' ' LEU . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' TRP . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.551 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.687 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.687 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.401 ' HE3' HD12 ' A' ' 5' ' ' ILE . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.573 ' CG2' HD13 ' A' ' 87' ' ' ILE . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 62.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.451 HD13 ' NE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.491 1.337 0 CA-C-O 121.291 0.455 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.649 ' HB2' HG12 ' A' ' 122' ' ' VAL . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.587 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 115' ' ' THR . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.931 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.815 ' CE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.684 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.784 ' H ' HG22 ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.684 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.756 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.931 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.402 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 50.4 m95 . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.602 0.715 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 70' ' ' GLY . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.789 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.6 m-90 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' HG ' ' A' ' 119' ' ' LEU . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.483 ' CE2' HG12 ' A' ' 105' ' ' VAL . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.404 ' N ' HD11 ' A' ' 5' ' ' ILE . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.789 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.647 HG23 ' NH1' ' A' ' 149' ' ' ARG . 53.0 m . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' A' ' 146' ' ' THR . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 20' ' ' HIS . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo . . . . . 0 N--CA 1.492 1.406 0 CA-C-O 121.402 0.501 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.684 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.684 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' NE2' ' A' ' 121' ' ' HIS . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.486 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 115' ' ' THR . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' CD1' ' A' ' 49' ' ' PHE . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.453 0.644 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 73' ' ' LEU . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.723 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 70' ' ' GLY . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 68' ' ' VAL . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 72' ' ' ILE . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.841 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.575 0.702 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 103' ' ' ILE . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.723 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.645 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.773 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 2.8 m-90 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.487 1.376 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 124' ' ' LEU . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 85' ' ' TRP . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.629 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.408 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.645 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.452 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 76.1 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.639 0.733 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.694 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 149' ' ' ARG . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.491 1.331 0 CA-C-O 121.363 0.485 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.558 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.558 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.688 ' HB2' HG12 ' A' ' 122' ' ' VAL . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' NE2' ' A' ' 121' ' ' HIS . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD22 ' A' ' 147' ' ' LEU . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG23 ' CB ' ' A' ' 151' ' ' ALA . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 20' ' ' HIS . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 115' ' ' THR . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.067 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t0 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.127 0.489 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.792 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.067 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.87 ' CE1' HD11 ' A' ' 72' ' ' ILE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.758 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.775 HG22 ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.758 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.788 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 57' ' ' TYR . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 104' ' ' GLU . 65.5 ttt180 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.702 0.763 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.489 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 6.8 m-90 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.544 ' CE1' HG12 ' A' ' 105' ' ' VAL . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.668 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.792 ' ND1' HD12 ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.792 HD12 ' ND1' ' A' ' 121' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.902 0.382 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.611 HD11 ' HA2' ' A' ' 89' ' ' GLY . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 66.2 m . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.481 0.658 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.761 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 CA-C-O 121.368 0.487 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.498 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HB2' HG12 ' A' ' 122' ' ' VAL . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' HG21 ' A' ' 115' ' ' THR . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.675 HG22 ' CD2' ' A' ' 49' ' ' PHE . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 49' ' ' PHE . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 120.84 0.352 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.937 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.707 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.711 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.711 ' H ' HG22 ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.697 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.882 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 60.3 p-90 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' NE ' ' OD2' ' A' ' 106' ' ' ASP . 62.5 ttt-85 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CE2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CD1' HD12 ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.697 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.75 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 8.4 m-90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.557 ' CE2' HD11 ' A' ' 81' ' ' LEU . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 . . . . . 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.621 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 121.112 0.482 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.75 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.762 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 N--CA 1.492 1.439 0 CA-C-O 121.405 0.502 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.751 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.751 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG12 ' CD2' ' A' ' 121' ' ' HIS . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' NZ ' HG21 ' A' ' 8' ' ' VAL . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.44 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' PRO . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 18' ' ' VAL . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 115' ' ' THR . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 154' ' ' ILE . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' HD1' ' A' ' 49' ' ' PHE . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 . . . . . 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 60' ' ' TRP . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.724 ' CE2' HD11 ' A' ' 72' ' ' ILE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CE1' HG22 ' A' ' 68' ' ' VAL . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.77 ' H ' HG22 ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.85 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.751 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.724 HD11 ' CE2' ' A' ' 57' ' ' TYR . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.744 0.783 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.5 m-90 . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 119' ' ' LEU . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 105' ' ' VAL . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 18' ' ' VAL . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.44 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.653 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.932 0.396 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.408 ' HE3' HD12 ' A' ' 5' ' ' ILE . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.807 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.792 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.594 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.614 HD21 HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.614 HG13 HD21 ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 24' ' ' VAL . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.53 152.64 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.68 -29.02 70.34 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -0.788 . . . . 0.0 109.207 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.733 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.73 141.51 29.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 0.0 109.775 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.733 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 92.35 45.18 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.671 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.563 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.5 Cg_endo -76.95 166.76 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.012 1.808 . . . . 0.0 111.623 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 41.1 p30 -64.4 125.3 24.2 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG12 ' CD2' ' A' ' 121' ' ' HIS . 13.6 p -139.5 141.13 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.147 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.604 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.8 ttt180 -120.22 123.41 43.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 0.0 109.616 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -135.11 146.77 49.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.824 . . . . 0.0 109.709 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -137.31 151.31 48.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.34 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.79 155.92 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 0.0 109.463 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.6 t -103.18 133.24 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.228 -0.92 . . . . 0.0 109.112 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG23 ' HG1' ' A' ' 115' ' ' THR . 33.1 m -129.25 162.96 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.499 -0.751 . . . . 0.0 109.405 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.22 93.82 7.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.115 -0.991 . . . . 0.0 109.843 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.82 162.36 2.13 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.94 -1.1 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.4 p -98.6 155.69 17.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -60.31 -40.04 82.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.658 -1.276 . . . . 0.0 109.506 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.05 -38.21 85.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.755 ' NE2' HG21 ' A' ' 24' ' ' VAL . 36.0 t60 -63.76 -44.06 94.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 53.5 m -50.71 -45.47 58.43 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.6 m-85 -83.34 -31.0 27.03 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.72 -42.82 93.94 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.048 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' NE2' ' A' ' 20' ' ' HIS . 46.5 t -69.4 -39.91 79.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.51 -0.743 . . . . 0.0 110.175 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.8 m-30 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.48 -0.762 . . . . 0.0 110.987 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.7 p -89.83 -3.75 57.96 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -99.1 -42.04 7.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.912 -1.117 . . . . 0.0 112.007 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.61 54.88 0.07 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 120.282 -1.511 . . . . 0.0 112.618 -178.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.624 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.9 Cg_endo -57.79 -31.7 92.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.646 1.564 . . . . 0.0 112.309 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.46 -39.46 62.51 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.829 -1.169 . . . . 0.0 110.612 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' ' C ' ' A' ' 32' ' ' TRP . 42.3 t0 -55.2 -25.2 31.27 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.393 -0.817 . . . . 0.0 111.446 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 12.3 m0 -42.34 -31.87 0.45 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.752 -1.217 . . . . 0.0 108.959 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.602 ' HE1' HG22 ' A' ' 38' ' ' VAL . 17.3 t90 -48.73 126.86 13.64 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.717 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.523 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 72.2 Cg_endo -77.51 160.42 31.87 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.34 2.026 . . . . 0.0 112.34 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.62 -23.57 74.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.867 2.378 . . . . 0.0 112.483 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 37' ' ' HIS . 49.6 m -117.13 148.07 41.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.406 -0.809 . . . . 0.0 109.39 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.515 ' O ' ' O ' ' A' ' 36' ' ' SER . 76.4 t60 57.9 117.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 108.963 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG22 ' HE1' ' A' ' 33' ' ' TRP . 27.9 t -103.26 123.53 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 110.205 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.89 -30.74 65.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.51 -0.744 . . . . 0.0 109.309 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HE ' ' A' ' 44' ' ' ARG . 94.4 t -102.03 130.75 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 109.752 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -62.17 -37.39 85.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' HG12 ' A' ' 40' ' ' VAL . 48.6 mtmt -89.21 145.96 25.07 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -85.44 114.31 22.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.979 -1.075 . . . . 0.0 109.755 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.809 ' HE ' HG21 ' A' ' 40' ' ' VAL . 82.5 mtt180 -62.85 141.76 58.53 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -115.6 -48.46 2.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.846 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -156.39 173.49 34.22 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.392 -1.385 . . . . 0.0 109.851 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.0 137.94 15.45 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.217 -1.167 . . . . 0.0 109.873 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -100.17 136.9 39.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.68 127.1 19.97 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.973 -1.079 . . . . 0.0 110.507 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.74 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 28.1 mm-40 -130.79 137.03 29.87 Favored Pre-proline 0 N--CA 1.492 1.657 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.025 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -86.91 129.45 2.94 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.284 1.989 . . . . 0.0 112.527 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.74 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.51 -179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.917 . . . . 0.0 110.475 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -94.15 143.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' CA ' HH22 ' A' ' 71' ' ' ARG . . . 63.77 32.28 83.65 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 104.414 -3.475 . . . . 0.0 104.414 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.641 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.55 175.81 39.86 Favored Glycine 0 C--N 1.298 -1.579 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.148 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.589 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 59.6 mtm180 -145.87 143.71 29.76 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 122.319 1.057 . . . . 0.0 111.67 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.823 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.7 m-85 -120.66 149.8 41.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 5.8 m-85 -133.83 153.48 51.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.982 -1.074 . . . . 0.0 111.317 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.47 ' HB2' ' HE1' ' A' ' 69' ' ' TRP . 84.5 tt0 -129.0 142.82 50.79 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.56 129.22 55.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.049 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.55 136.8 45.69 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.36 -38.7 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 110.009 -178.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.52 -7.33 19.84 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.83 132.32 10.76 Favored Glycine 0 N--CA 1.482 1.741 0 CA-C-O 122.387 0.993 . . . . 0.0 110.719 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.88 -178.87 0.08 Allowed 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.343 0.592 . . . . 0.0 109.9 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 72.2 tt0 -76.68 140.51 40.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 92' ' ' GLN . 3.3 tp -149.09 155.56 8.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.802 -1.186 . . . . 0.0 110.497 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.0 p -95.56 124.88 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 59' ' ' GLU . 7.6 p-90 -109.76 3.86 21.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 111.507 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.28 -173.99 30.59 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.433 -1.842 . . . . 0.0 111.366 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.733 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.8 ttt-85 -151.18 -178.56 6.7 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.823 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -133.16 165.89 30.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.7 mt -113.95 -48.62 2.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.961 -1.087 . . . . 0.0 109.37 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -175.13 146.86 0.88 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -102.62 120.35 40.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.124 -0.985 . . . . 0.0 110.225 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -103.49 128.31 27.73 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.1 Cg_exo -30.1 153.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.676 2.251 . . . . 0.0 112.528 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' PRO . 91.1 Cg_exo -28.83 78.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 123.364 2.709 . . . . 0.0 112.495 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -176.84 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.516 -0.74 . . . . 0.0 110.028 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 47.6 ttp180 -153.0 138.76 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.511 -1.368 . . . . 0.0 111.74 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.86 126.51 21.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.591 -0.693 . . . . 0.0 109.598 178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.21 150.19 28.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.513 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.9 144.96 26.25 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 117.643 -1.623 . . . . 0.0 112.78 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 15.9 m -104.04 152.14 22.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -103.85 129.91 51.36 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.756 -1.215 . . . . 0.0 110.725 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' GLY . 63.9 ttt180 -115.4 94.55 4.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.306 -0.871 . . . . 0.0 110.133 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.767 HD13 HG23 ' A' ' 134' ' ' ILE . 20.3 tt -148.78 155.97 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.218 -0.926 . . . . 0.0 109.312 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.554 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 24.0 t70 -101.56 174.48 5.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 109.787 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.32 -37.02 91.32 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.08 41.11 1.79 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.075 -1.25 . . . . 0.0 110.748 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.739 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.6 m-90 55.16 47.36 21.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.949 -1.094 . . . . 0.0 109.698 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.554 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 23.9 mt-30 -122.0 154.74 36.84 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -98.84 151.46 20.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.146 -0.971 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 157.15 51.83 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 109.041 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.45 -30.6 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.529 2.153 . . . . 0.0 111.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.76 150.32 20.82 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.371 -0.831 . . . . 0.0 108.8 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 92.5 m-20 -105.45 117.29 33.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.282 -0.887 . . . . 0.0 109.991 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.24 -24.12 51.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.731 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -104.99 36.26 2.52 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.664 -0.647 . . . . 0.0 109.718 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.23 141.85 28.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -123.27 163.41 20.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.41 141.29 40.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 109.634 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.29 140.58 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.367 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.94 123.26 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.556 HG22 ' HG ' ' A' ' 119' ' ' LEU . 38.9 t -128.9 136.98 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.486 -0.759 . . . . 0.0 109.49 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -116.82 131.2 57.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.856 . . . . 0.0 109.654 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 67.7 m-85 -118.08 126.08 51.56 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 109.263 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.86 131.94 22.95 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.29 126.06 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.237 1.958 . . . . 0.0 112.854 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.0 t30 -119.57 126.11 50.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.79 172.77 0.08 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 -23.54 67.38 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -1.117 . . . . 0.0 109.126 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.75 50.34 0.8 Allowed Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.337 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -133.5 134.77 7.66 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.95 126.85 35.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -1.165 . . . . 0.0 110.584 -179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.583 ' NH1' ' OE1' ' A' ' 118' ' ' GLU . 34.2 ttt-85 -110.19 121.09 44.46 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG21 ' CAF' ' A' ' 201' ' ' 96F . 51.7 t -125.31 139.33 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.011 -1.056 . . . . 0.0 111.343 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.583 ' OE1' ' NH1' ' A' ' 116' ' ' ARG . 96.1 mt-10 -120.7 102.12 8.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.0 126.39 51.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.831 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.31 114.56 14.55 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.478 -0.764 . . . . 0.0 109.777 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.96 138.52 37.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.82 150.1 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.985 -1.086 . . . . 0.0 112.185 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp 52.74 31.85 11.12 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.636 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -70.73 -36.82 73.35 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 13.5 t60 -45.82 -12.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.761 -0.587 . . . . 0.0 109.617 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.7 ttm180 -51.1 -33.77 27.63 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.708 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.28 -25.64 33.84 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.179 -0.951 . . . . 0.0 109.563 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.0 -147.06 0.05 OUTLIER Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 19.4 t70 49.04 -133.29 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.47 -1.018 . . . . 0.0 109.61 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -79.87 47.08 3.25 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.708 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -59.47 -57.21 13.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.366 -1.079 . . . . 0.0 109.824 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 38.4 t-105 -59.29 -30.25 68.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.074 . . . . 0.0 108.644 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' CZ2' ' A' ' 91' ' ' TRP . 49.5 t30 -55.08 -43.43 73.91 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.767 HG23 HD13 ' A' ' 87' ' ' ILE . 88.8 mt -59.36 -44.02 91.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -62.01 -32.67 73.17 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 tttt -53.2 -34.27 56.29 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.739 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.78 -44.76 88.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.541 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 88.4 mt -68.99 -28.59 66.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 135' ' ' HIS . 0.8 OUTLIER 61.91 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.479 0.657 . . . . 0.0 111.476 178.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.507 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -130.17 75.38 0.43 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 144' ' ' GLY . 31.4 Cg_exo -55.13 142.14 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.732 2.288 . . . . 0.0 112.336 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.562 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -56.67 -45.95 99.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.56 -30.08 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.567 2.178 . . . . 0.0 112.353 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.34 134.76 6.05 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.08 173.26 6.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.166 -1.196 . . . . 0.0 109.537 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.522 HG21 ' OAP' ' A' ' 201' ' ' 96F . 18.9 m -57.41 -35.36 69.95 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.815 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -63.12 -34.12 76.92 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.252 -0.905 . . . . 0.0 109.396 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.38 -51.42 15.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.425 -0.797 . . . . 0.0 111.733 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.588 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.5 OUTLIER -65.45 -44.65 86.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.064 -1.023 . . . . 0.0 111.469 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.23 -33.59 59.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.932 -1.105 . . . . 0.0 110.738 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.706 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -69.75 -44.25 70.58 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.524 -1.36 . . . . 0.0 110.199 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.729 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -60.23 -45.02 94.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.504 -0.748 . . . . 0.0 110.506 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.729 HG13 HD21 ' A' ' 152' ' ' ASN . 17.5 m -66.95 -39.05 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 110.01 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.416 ' N ' HG23 ' A' ' 153' ' ' VAL . 58.3 mt . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.683 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.815 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.635 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.2 Cg_exo -61.89 147.08 95.97 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.673 2.249 . . . . 0.0 112.272 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.61 -27.88 69.51 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.877 . . . . 0.0 109.101 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -92.47 142.02 27.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.465 -0.772 . . . . 0.0 109.626 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.96 90.72 41.73 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.46 -0.775 . . . . 0.0 109.656 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 38.3 Cg_endo -77.76 165.92 26.08 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.071 1.847 . . . . 0.0 111.615 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 31.2 p30 -64.42 125.07 23.47 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.022 -1.049 . . . . 0.0 110.083 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG12 ' CD2' ' A' ' 121' ' ' HIS . 15.0 p -139.91 141.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -118.36 122.08 41.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -136.04 147.23 47.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.913 . . . . 0.0 109.883 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.0 p -140.25 151.6 45.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.082 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.06 155.86 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 109.573 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.53 133.34 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.264 -0.897 . . . . 0.0 108.954 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.5 163.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.409 -0.807 . . . . 0.0 109.684 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.8 93.98 7.55 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.888 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -177.24 163.1 2.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.028 -1.045 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -101.58 151.25 22.21 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 79' ' ' HIS . 11.0 m -60.18 -36.77 70.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.634 -1.291 . . . . 0.0 109.513 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -61.58 -40.02 93.27 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.59 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.6 t60 -66.95 -43.19 83.8 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.437 0.637 . . . . 0.0 109.794 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 23.1 m -51.49 -44.92 62.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.468 -0.77 . . . . 0.0 109.73 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -83.14 -30.58 27.75 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.256 -0.977 . . . . 0.0 110.814 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.49 -42.09 91.36 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.499 -1.28 . . . . 0.0 107.553 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.59 HG21 ' NE2' ' A' ' 20' ' ' HIS . 56.2 t -69.13 -41.23 81.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.8 m-30 -54.86 -46.16 74.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.23 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 54.8 p -82.06 -4.54 57.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -0.877 . . . . 0.0 110.525 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 28' ' ' ARG . 35.8 p -94.35 -69.03 0.77 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.921 -1.112 . . . . 0.0 110.225 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.552 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -169.48 68.23 0.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.002 -1.061 . . . . 0.0 110.284 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.2 Cg_endo -55.78 -30.27 75.54 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.052 1.835 . . . . 0.0 113.3 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -72.65 -36.91 68.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.615 -1.303 . . . . 0.0 109.833 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' C ' ' A' ' 32' ' ' TRP . 59.5 t0 -54.61 -18.26 4.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 0.0 110.653 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.612 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 9.9 m0 -44.95 -38.01 4.39 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.767 -1.208 . . . . 0.0 109.34 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CB ' HG23 ' A' ' 38' ' ' VAL . 52.7 m95 -100.45 114.96 65.87 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -78.11 161.03 29.73 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.012 1.808 . . . . 0.0 111.815 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.7 -25.28 59.36 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.841 2.361 . . . . 0.0 112.498 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -58.9 -39.55 81.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.618 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -160.09 120.38 2.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.138 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.985 HG11 ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -135.07 138.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.347 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.8 mt -71.02 -34.73 71.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.906 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.492 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.1 t -69.56 123.19 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.125 -0.984 . . . . 0.0 109.501 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -62.69 -37.99 88.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.558 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 34.8 ttpt -82.13 143.26 31.58 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -89.21 124.2 34.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.113 -0.992 . . . . 0.0 110.081 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.985 ' NH1' HG11 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -71.46 142.48 50.22 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -109.5 -44.48 3.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.317 -0.865 . . . . 0.0 110.653 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.779 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -161.82 175.11 38.38 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.081 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.779 HD12 ' C ' ' A' ' 46' ' ' GLY . 3.5 mp -149.3 136.44 19.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.163 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -101.39 134.33 44.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.703 ' CD1' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -140.0 124.02 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.915 -1.116 . . . . 0.0 111.961 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.803 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 20.0 mm-40 -132.31 137.46 30.03 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 68.9 Cg_endo -85.97 135.15 4.65 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 122.56 2.173 . . . . 0.0 112.938 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.803 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.32 -175.1 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.952 -1.092 . . . . 0.0 111.457 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.5 t -96.64 142.22 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.16 32.26 83.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.906 -3.678 . . . . 0.0 103.906 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.631 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -72.19 170.62 49.78 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-O 122.784 1.213 . . . . 0.0 114.869 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 56.2 mtm180 -149.52 143.82 25.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.899 1.333 . . . . 0.0 112.319 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.703 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 16.5 m-85 -121.89 153.76 37.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 13.3 m-85 -135.59 157.43 46.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.608 -1.308 . . . . 0.0 111.345 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.3 142.59 51.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.632 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.5 130.19 54.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 109.705 -179.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -102.41 135.9 43.2 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.42 -38.05 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.11 -0.994 . . . . 0.0 110.716 -178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.4 -8.31 19.26 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.37 136.53 13.57 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.9 m -61.02 -178.32 0.1 Allowed 'General case' 0 C--N 1.289 -2.035 0 O-C-N 121.922 -0.752 . . . . 0.0 109.696 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 72.9 tt0 -74.78 139.17 43.15 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 91' ' ' TRP . 44.8 mt -140.64 142.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.034 -1.041 . . . . 0.0 111.046 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 68' ' ' VAL . 7.5 p -70.75 120.98 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.898 ' CE3' ' N ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -88.14 -10.0 51.38 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.67 -0.644 . . . . 0.0 112.488 -178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.898 ' N ' ' CE3' ' A' ' 69' ' ' TRP . . . 176.73 -166.26 36.97 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.8 ttt180 -140.34 -177.56 5.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.594 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.3 mt -135.32 167.26 25.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.583 ' O ' HG13 ' A' ' 53' ' ' VAL . 8.3 mt -115.34 -52.71 2.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.11 . . . . 0.0 110.08 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 84.2 tt0 179.96 159.33 0.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.407 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.7 p-90 -107.45 130.27 54.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.016 . . . . 0.0 109.229 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.62 138.21 31.76 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.131 . . . . 0.0 109.254 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.0 Cg_exo -43.12 -53.82 3.85 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.2 2.6 . . . . 0.0 114.331 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 77' ' ' PRO . 17.8 Cg_endo -56.62 -111.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 120.906 1.071 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -137.64 59.39 1.67 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 38.2 ttp180 -136.38 138.53 41.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.472 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.4 mp -140.13 129.04 23.36 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.76 149.29 25.75 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.503 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -146.0 146.72 31.1 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.609 -1.636 . . . . 0.0 113.007 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.6 ' O ' ' C ' ' A' ' 71' ' ' ARG . 47.8 m -103.58 149.39 24.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.511 ' NE1' HD12 ' A' ' 103' ' ' ILE . 11.5 m0 -99.86 125.9 45.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.532 -1.355 . . . . 0.0 111.78 -177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 70' ' ' GLY . 59.9 ttt180 -112.84 93.25 4.33 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.658 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.3 tt -147.1 156.19 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.371 -0.83 . . . . 0.0 109.316 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 46.2 t0 -102.87 173.12 6.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.522 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.29 -34.85 86.46 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.2 41.5 1.73 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -1.199 . . . . 0.0 110.881 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.841 ' O ' HD13 ' A' ' 67' ' ' ILE . 5.0 m-90 55.07 40.7 32.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.935 -1.103 . . . . 0.0 110.242 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.9 mt-30 -113.74 154.08 27.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 109.143 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -95.75 139.86 31.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -138.17 156.9 73.63 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 109.068 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.38 -32.76 43.5 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.561 2.174 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -160.48 148.51 16.36 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.5 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 90.1 m-20 -105.84 117.65 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.367 -0.833 . . . . 0.0 110.133 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -73.14 -23.73 60.5 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.307 -0.87 . . . . 0.0 108.675 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -100.78 36.04 2.03 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.648 -0.658 . . . . 0.0 109.477 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.72 141.71 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.043 -1.036 . . . . 0.0 110.047 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 52.3 m -123.27 166.92 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.28 139.19 43.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.025 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.511 HD12 ' NE1' ' A' ' 85' ' ' TRP . 71.0 mt -126.58 137.17 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.98 130.28 55.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.489 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.0 t -133.06 132.97 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.695 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 73.0 m-20 -117.97 132.2 56.42 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.686 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 97.0 m-85 -112.78 139.33 48.49 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.411 -0.806 . . . . 0.0 109.247 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.43 122.49 14.78 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.488 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 59.7 Cg_endo -73.99 119.94 6.1 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.972 1.781 . . . . 0.0 112.264 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 52.8 t-20 -113.79 127.56 56.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.25 171.74 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 m -60.42 -31.53 70.49 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.286 -1.126 . . . . 0.0 109.149 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -130.64 49.21 0.93 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.543 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.13 136.08 8.48 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.549 ' OG1' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.72 136.41 46.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -1.204 . . . . 0.0 110.684 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -119.83 120.26 35.97 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG21 ' CAF' ' A' ' 201' ' ' 96F . 41.3 t -125.33 139.38 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 111.265 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.51 102.7 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.54 127.94 52.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.822 . . . . 0.0 109.656 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.68 114.7 15.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.615 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -105.68 136.5 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.84 152.93 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.936 -1.103 . . . . 0.0 112.127 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 23.2 mmtp 52.47 31.48 9.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.152 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.656 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.1 tp -71.19 -37.39 72.14 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -46.03 -11.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.408 0.623 . . . . 0.0 109.516 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 124' ' ' LEU . 25.4 ttm180 -51.02 -31.84 19.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.344 -0.847 . . . . 0.0 109.257 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.656 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -74.37 -11.44 60.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.883 -1.136 . . . . 0.0 110.088 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.33 -170.99 41.56 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.286 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -71.96 150.42 44.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.422 -1.046 . . . . 0.0 109.751 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.28 -7.77 60.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.416 -1.049 . . . . 0.0 109.33 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.503 ' CH2' ' N ' ' A' ' 1' ' ' MET . 28.8 t-105 -54.75 -30.56 56.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.092 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -55.13 -42.95 73.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.658 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.3 mt -59.68 -43.09 90.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.634 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -62.62 -32.46 73.49 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -52.46 -34.09 47.35 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.778 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.75 -44.51 81.29 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.559 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 89.9 mt -66.61 -29.79 69.92 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER 67.75 97.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.663 -0.648 . . . . 0.0 111.484 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -134.29 71.86 0.48 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 144' ' ' GLY . 38.5 Cg_exo -56.69 143.72 88.74 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.742 2.294 . . . . 0.0 112.206 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -55.3 -46.39 99.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.109 -0.994 . . . . 0.0 109.386 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.9 Cg_exo -56.79 -31.57 88.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.573 2.182 . . . . 0.0 112.192 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -139.41 130.33 4.74 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -98.9 172.0 7.7 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.747 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.497 HG21 ' OAP' ' A' ' 201' ' ' 96F . 28.9 m -57.4 -35.77 70.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.29 -0.881 . . . . 0.0 109.083 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.809 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -65.72 -34.97 79.43 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.6 -49.65 25.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.409 -0.807 . . . . 0.0 111.782 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.591 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -64.96 -45.98 83.46 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.983 -1.073 . . . . 0.0 111.534 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.697 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.29 -33.69 59.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.978 -1.076 . . . . 0.0 110.6 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.697 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -69.05 -44.04 73.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.599 -1.313 . . . . 0.0 110.301 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.691 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -60.75 -45.28 94.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.691 HG13 HD21 ' A' ' 152' ' ' ASN . 17.0 m -65.4 -39.08 84.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 109.877 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.428 ' N ' HG23 ' A' ' 153' ' ' VAL . 64.4 mt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 121.067 -1.021 . . . . 0.0 109.54 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.809 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.68 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 1' ' ' MET . 19.8 Cg_exo -61.44 147.12 96.28 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.437 2.091 . . . . 0.0 112.358 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.86 -27.66 69.49 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.348 -0.845 . . . . 0.0 109.036 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.57 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -92.21 141.79 28.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 0.0 109.569 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.11 90.26 41.15 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.5 -0.75 . . . . 0.0 109.539 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -80.78 166.95 18.97 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.29 1.993 . . . . 0.0 111.851 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.536 ' HB2' HG12 ' A' ' 122' ' ' VAL . 37.6 p30 -70.14 125.91 28.13 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 110.38 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.604 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.8 p -139.38 141.28 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 55.6 ttt180 -121.98 124.49 44.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.122 -0.986 . . . . 0.0 109.789 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -136.94 147.25 46.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.385 -0.822 . . . . 0.0 109.64 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.0 p -136.31 148.03 47.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.85 . . . . 0.0 109.485 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 147' ' ' LEU . 3.5 t -150.85 155.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 0.0 109.404 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.42 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 45.1 t -103.36 134.07 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.242 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 115' ' ' THR . 17.6 m -131.72 164.09 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.397 -0.814 . . . . 0.0 110.104 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.22 94.94 7.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.857 . . . . 0.0 110.059 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.47 163.44 2.45 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.086 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.0 t -100.46 146.76 26.65 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 19' ' ' GLU . 22.0 m -55.97 -40.27 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.76 -1.212 . . . . 0.0 109.844 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.485 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.06 -39.89 91.58 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.579 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.4 t60 -66.69 -39.82 88.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.483 0.659 . . . . 0.0 109.733 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.573 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.3 m -50.6 -42.59 56.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.501 -0.749 . . . . 0.0 109.189 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -82.03 -25.89 34.27 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.941 -1.103 . . . . 0.0 109.997 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.0 tt0 -60.16 -41.8 93.57 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 87.4 t -66.13 -41.02 88.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.6 -0.687 . . . . 0.0 109.739 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 4.9 m-30 -60.35 -41.56 93.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.667 HG22 ' CD2' ' A' ' 49' ' ' PHE . 47.9 p -98.08 -2.44 40.15 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.916 -1.115 . . . . 0.0 110.558 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -99.55 -40.89 7.6 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.0 111.665 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.6 ppt_? -177.15 56.09 0.11 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.365 -1.46 . . . . 0.0 111.287 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 34.1 Cg_endo -63.51 -29.33 70.85 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 121.747 1.632 . . . . 0.0 113.331 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.34 -32.61 32.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 111.528 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.6 -31.93 69.93 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.961 -1.087 . . . . 0.0 111.531 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.63 -10.21 25.49 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.643 -1.286 . . . . 0.0 111.386 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.699 ' CZ3' ' NH2' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -52.85 -41.86 86.87 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.494 -1.379 . . . . 0.0 110.722 -178.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 90.8 Cg_endo -101.44 73.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 123.729 2.953 . . . . 0.0 113.272 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 36' ' ' SER . 36.2 Cg_endo -66.67 -43.43 7.47 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.208 1.939 . . . . 0.0 111.896 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.547 ' CB ' ' O ' ' A' ' 35' ' ' PRO . 0.4 OUTLIER 158.32 -61.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -55.3 -37.04 66.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.376 -0.827 . . . . 0.0 109.613 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG11 ' NH1' ' A' ' 149' ' ' ARG . 45.9 t -108.03 132.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 mt -109.84 153.35 24.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.5 p -103.85 142.5 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.63 -38.27 84.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.889 -1.132 . . . . 0.0 108.946 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.608 ' NZ ' ' HB1' ' A' ' 137' ' ' ALA . 10.2 pttt -121.19 143.51 49.09 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -83.74 123.48 29.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.081 -1.012 . . . . 0.0 110.45 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.699 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 61.9 mtt180 -74.28 142.52 45.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 -47.86 2.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.114 -0.991 . . . . 0.0 111.901 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.14 167.61 23.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.897 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.56 131.74 13.57 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.261 -1.141 . . . . 0.0 110.722 -179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.46 134.16 50.03 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.673 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 2.9 m-85 -134.91 129.66 34.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.959 -1.088 . . . . 0.0 111.255 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.78 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 50.8 mm-40 -131.66 137.0 29.39 Favored Pre-proline 0 N--CA 1.493 1.682 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.009 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.74 131.81 2.85 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.377 2.051 . . . . 0.0 112.029 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.78 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.28 -175.77 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.898 -1.126 . . . . 0.0 111.37 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 73' ' ' LEU . 77.2 t -96.74 141.48 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.86 32.26 83.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 104.056 -3.617 . . . . 0.0 104.056 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.655 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.1 173.32 42.68 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.78 -1.21 . . . . 0.0 114.383 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.594 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 55.7 mtm180 -148.37 147.88 29.74 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 122.567 1.175 . . . . 0.0 112.204 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.905 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 14.7 m-85 -119.79 145.22 46.8 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 19.3 m-85 -127.88 151.22 49.34 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.93 -1.106 . . . . 0.0 112.393 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' OE2' ' CZ ' ' A' ' 44' ' ' ARG . 34.7 tt0 -127.08 143.41 51.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.66 129.51 55.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.325 -0.859 . . . . 0.0 108.969 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.59 136.23 43.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.5 -38.41 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.471 -0.768 . . . . 0.0 110.446 -178.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -105.06 -7.25 19.29 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.66 140.12 16.08 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-O 122.679 1.155 . . . . 0.0 111.044 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 66' ' ' GLU . 11.3 m -61.68 -179.88 0.21 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.988 -0.606 . . . . 0.0 110.078 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.741 ' H ' HG22 ' A' ' 65' ' ' THR . 77.0 tt0 -75.62 141.51 42.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.576 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.9 tt -148.86 165.84 4.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.955 -1.091 . . . . 0.0 110.779 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG12 ' OG ' ' A' ' 93' ' ' SER . 10.1 p -104.99 135.63 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 5.1 p90 -109.14 -0.18 19.48 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.206 -0.933 . . . . 0.0 111.09 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -167.95 -170.05 32.22 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.69 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 72' ' ' ILE . 16.7 ttt180 -149.21 -177.78 6.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 1.7 mp -130.47 166.28 28.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.701 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.5 mt -113.98 -50.41 2.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.836 -1.165 . . . . 0.0 109.931 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -179.22 159.82 0.98 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 62.6 m95 -101.44 130.75 47.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.958 -1.089 . . . . 0.0 109.86 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -95.2 122.16 60.46 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.095 -1.003 . . . . 0.0 108.928 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 78' ' ' PRO . 83.0 Cg_exo -34.26 -51.88 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 123.088 2.525 . . . . 0.0 113.514 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.2 Cg_endo -54.95 -150.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.192 1.104 . . . . 0.0 109.691 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -103.0 49.32 0.83 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 178.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.3 ttt-85 -136.09 146.33 46.91 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.488 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -157.2 144.54 18.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.04 152.22 23.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.502 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.7 ptm -143.69 145.11 32.19 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.242 -1.383 . . . . 0.0 112.047 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 10.6 m -103.31 148.84 25.35 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.727 ' HE1' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -106.55 123.65 48.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.859 -1.151 . . . . 0.0 110.482 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 35.0 ttm180 -114.23 111.12 21.02 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.727 ' CG2' ' HE1' ' A' ' 85' ' ' TRP . 6.0 tt -149.78 158.19 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.587 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 33.3 t0 -102.7 169.31 8.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.044 -1.035 . . . . 0.0 109.669 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -59.31 -38.0 92.71 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.161 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.01 40.62 1.55 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.985 -1.303 . . . . 0.0 110.803 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.775 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.5 m-90 55.57 48.29 19.0 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.926 -1.109 . . . . 0.0 109.666 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.587 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 80.8 mt-30 -125.84 162.04 26.05 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.554 ' OG ' HG12 ' A' ' 68' ' ' VAL . 53.7 m -103.96 146.21 29.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.024 -1.047 . . . . 0.0 109.818 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.538 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -137.05 156.81 75.5 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.0 108.939 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -52.58 -31.63 50.28 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.392 2.061 . . . . 0.0 111.456 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -161.93 148.59 13.83 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 85.8 m-20 -105.51 117.32 33.71 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.317 -0.864 . . . . 0.0 110.241 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.23 -25.52 61.66 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -101.68 36.1 2.14 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.715 -0.616 . . . . 0.0 109.502 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.33 142.94 27.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.004 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.9 m -119.06 166.62 12.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.592 -0.693 . . . . 0.0 109.144 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.33 139.89 42.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.945 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -120.89 136.81 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.582 -0.699 . . . . 0.0 109.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.3 tt0 -112.79 126.09 55.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.791 . . . . 0.0 109.342 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.553 HG12 ' CE2' ' A' ' 107' ' ' PHE . 21.4 t -131.76 132.99 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -117.9 132.64 56.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 109.684 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.673 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.3 m-85 -113.98 139.68 49.04 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.345 -0.847 . . . . 0.0 109.484 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.21 121.46 14.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.485 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 67.4 Cg_endo -76.68 123.55 7.01 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.117 1.878 . . . . 0.0 112.689 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 42.0 t30 -119.21 120.03 35.83 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 53.98 169.14 0.04 OUTLIER Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.3 p -64.46 -19.19 65.4 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.276 -1.132 . . . . 0.0 108.863 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.85 47.16 1.01 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.592 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -142.67 132.3 5.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -136.59 138.61 41.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.095 -1.238 . . . . 0.0 110.541 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 -121.39 117.59 27.31 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.422 ' CG1' ' OAO' ' A' ' 201' ' ' 96F . 94.1 t -125.3 139.22 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 111.196 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -116.72 103.19 10.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.9 127.57 51.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.86 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.625 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.46 14.34 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.425 -0.797 . . . . 0.0 110.032 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.604 ' NE2' HG12 ' A' ' 8' ' ' VAL . 7.7 p80 -102.31 125.28 48.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.6 m -130.27 157.29 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.286 1.041 . . . . 0.0 112.377 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt 57.88 31.2 20.22 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.756 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.696 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.9 mm? -71.54 -40.11 70.27 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.078 -1.014 . . . . 0.0 108.401 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 3.1 t60 -44.71 -12.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.386 0.613 . . . . 0.0 109.757 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' A' ' 124' ' ' LEU . 61.4 ttm-85 -52.04 -32.91 36.44 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.696 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.13 -18.18 60.27 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.966 -1.084 . . . . 0.0 109.676 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.97 -172.07 36.43 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.582 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -68.45 150.88 47.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.999 . . . . 0.0 109.969 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.56 -7.29 63.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.35 -44.62 94.32 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.47 -1.018 . . . . 0.0 109.516 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.68 ' CH2' ' N ' ' A' ' 1' ' ' MET . 33.0 t-105 -54.64 -28.01 43.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -55.18 -44.12 74.98 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.621 ' CG2' HD13 ' A' ' 87' ' ' ILE . 88.3 mt -60.2 -40.21 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.605 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -64.36 -33.96 77.05 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.708 -0.62 . . . . 0.0 109.459 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -52.43 -36.52 54.6 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.666 -1.271 . . . . 0.0 108.159 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.775 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.34 -44.52 91.24 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.558 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 60.9 mt -67.11 -29.41 69.14 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 1.3 t70 78.35 102.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.646 -0.659 . . . . 0.0 111.559 178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.72 148.55 38.59 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 142' ' ' SER . 33.5 Cg_endo -67.17 143.38 64.65 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.537 2.158 . . . . 0.0 113.13 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -53.12 179.74 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.421 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 142' ' ' SER . 71.4 Cg_exo -39.53 -19.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.452 1.435 . . . . 0.0 111.463 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -81.0 -178.36 52.37 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 77.2 mm-40 -98.3 162.08 13.36 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.154 -1.204 . . . . 0.0 109.028 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.456 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 31.5 m -57.14 -35.22 69.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 108.55 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.922 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.3 mp -67.7 -25.98 65.94 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 109.528 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.88 -50.17 45.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.295 -0.878 . . . . 0.0 111.916 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.709 ' NH1' HG11 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.89 -50.73 54.63 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.116 -0.99 . . . . 0.0 111.854 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.05 -35.51 80.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.83 -1.169 . . . . 0.0 109.873 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -65.31 -37.91 88.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.887 -1.133 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.64 -47.38 82.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.266 0.555 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.21 -35.49 68.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.309 -0.869 . . . . 0.0 110.21 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.483 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 86.7 mt . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.695 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.922 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.09 146.72 95.51 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.698 2.265 . . . . 0.0 112.081 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.29 -30.59 71.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.621 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.23 147.32 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.782 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.621 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.17 89.02 38.64 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.728 . . . . 0.0 109.807 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.55 166.91 28.62 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.209 1.939 . . . . 0.0 111.274 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.599 ' HB2' HG12 ' A' ' 122' ' ' VAL . 43.5 p30 -69.37 126.34 29.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.024 -1.047 . . . . 0.0 110.008 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.2 p -138.56 141.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 109.312 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 63.6 ttt180 -119.76 123.21 43.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.0 109.5 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -135.73 147.91 48.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.75 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.7 p -139.89 151.32 45.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.767 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.25 156.14 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -102.28 132.98 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 0.0 109.112 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.2 m -129.98 162.84 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.499 -0.751 . . . . 0.0 109.957 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.77 94.51 7.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.937 . . . . 0.0 109.652 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.64 163.99 2.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.944 -1.098 . . . . 0.0 110.628 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.0 p -97.17 152.62 18.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.4 m -62.01 -40.54 87.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.695 -1.253 . . . . 0.0 109.596 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.01 -37.87 84.07 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.651 ' NE2' HG21 ' A' ' 24' ' ' VAL . 28.6 t60 -64.0 -42.96 97.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.682 0.753 . . . . 0.0 109.417 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.3 m -51.7 -48.61 63.47 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.636 -0.665 . . . . 0.0 110.002 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.3 m-85 -83.98 -30.28 26.34 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.215 -0.994 . . . . 0.0 110.839 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.43 -41.91 90.64 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.677 -1.209 . . . . 0.0 107.913 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.651 HG21 ' NE2' ' A' ' 20' ' ' HIS . 81.4 t -68.33 -40.77 82.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.999 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.543 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 7.9 m-30 -55.98 -45.25 79.01 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 76.1 p -82.12 -3.47 54.87 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.399 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -98.9 -68.87 0.78 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 110.341 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.62 72.87 0.58 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 10.4 Cg_endo -57.97 -26.7 76.01 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.845 1.697 . . . . 0.0 112.705 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 47' ' ' LEU . . . -73.0 -32.59 65.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.923 -1.11 . . . . 0.0 109.446 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 33' ' ' TRP . 59.8 t0 -54.05 -28.7 40.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 110.05 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 15.0 m0 -42.35 -24.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 108.943 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' ASP . 0.6 OUTLIER -111.92 89.05 10.82 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.465 -0.772 . . . . 0.0 109.672 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -77.28 163.65 29.95 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.257 1.971 . . . . 0.0 111.869 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -44.08 130.85 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -154.31 171.34 19.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -51.26 -31.33 20.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.343 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -102.78 136.81 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 0.0 109.542 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.6 mt -82.32 154.08 25.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.705 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' LYS . 21.9 m -50.17 146.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.358 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -61.24 -36.37 79.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 109.471 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 8.7 ttpt -115.24 149.76 37.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.124 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.433 ' O ' ' CE ' ' A' ' 42' ' ' LYS . 96.4 mt-10 -63.35 114.26 3.73 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.213 -0.93 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.729 HH12 ' NH1' ' A' ' 149' ' ' ARG . 79.4 mtt180 -123.42 141.09 52.35 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.865 . . . . 0.0 108.814 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.676 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -134.92 -47.53 0.73 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.149 -0.969 . . . . 0.0 110.468 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -160.11 172.93 36.69 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -148.36 131.99 16.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -1.19 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.66 132.22 50.11 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 3.0 m-85 -132.4 134.88 45.67 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 110.541 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.817 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 71.8 tt0 -131.64 134.51 25.56 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.25 134.95 5.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.961 1.774 . . . . 0.0 112.687 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.817 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.35 -177.32 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.213 -0.929 . . . . 0.0 110.688 -178.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 73' ' ' LEU . 59.0 t -98.39 141.57 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.11 32.17 83.28 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 104.055 -3.618 . . . . 0.0 104.055 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.98 177.48 35.04 Favored Glycine 0 C--N 1.298 -1.535 0 CA-C-N 113.686 -1.257 . . . . 0.0 114.262 -175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.43 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 88.5 mtm-85 -146.81 148.62 32.08 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.228 1.013 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.753 ' CE1' HD11 ' A' ' 72' ' ' ILE . 13.1 m-85 -119.1 144.28 46.7 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.751 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.5 m-85 -123.91 143.16 50.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.49 -0.756 . . . . 0.0 111.498 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.797 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 86.2 tt0 -128.45 143.58 51.01 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.47 129.88 53.67 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.234 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.579 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.08 138.59 39.73 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.393 177.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.556 ' H ' HD12 ' A' ' 62' ' ' ILE . 3.4 mp -50.47 -43.04 22.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.299 0.571 . . . . 0.0 109.814 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -103.86 -6.58 21.23 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -113.06 138.98 15.39 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-O 122.57 1.095 . . . . 0.0 110.957 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.733 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.1 m -64.22 -179.32 0.43 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 122.109 -0.642 . . . . 0.0 109.818 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.733 ' H ' HG22 ' A' ' 65' ' ' THR . 66.1 tt0 -75.62 144.04 41.96 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -151.75 166.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.006 -1.059 . . . . 0.0 110.992 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 58' ' ' TYR . 46.6 t -102.84 123.35 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.797 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -112.31 2.82 16.7 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 119.451 -0.899 . . . . 0.0 111.615 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.23 26.82 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 118.707 -1.711 . . . . 0.0 111.085 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 84' ' ' THR . 7.0 ttp180 -150.02 -178.66 6.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 57' ' ' TYR . 31.9 mt -133.22 163.68 37.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.7 mt -113.49 -45.7 3.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.921 -1.112 . . . . 0.0 109.053 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -178.61 156.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -108.62 129.51 55.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.003 -1.061 . . . . 0.0 110.144 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -112.15 124.06 33.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.629 ' O ' ' N ' ' A' ' 79' ' ' HIS . 34.2 Cg_exo -30.82 154.41 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 122.731 2.287 . . . . 0.0 112.795 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.6 Cg_exo -29.04 79.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.448 2.766 . . . . 0.0 112.441 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.629 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.49 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.683 -0.636 . . . . 0.0 109.291 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 40.1 ttp180 -155.62 151.95 28.13 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.375 -1.33 . . . . 0.0 111.502 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.5 OUTLIER -144.51 147.21 32.97 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.05 148.94 50.12 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.507 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -149.95 143.01 24.95 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 117.327 -1.749 . . . . 0.0 112.953 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.559 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.1 m -103.15 156.71 17.5 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.584 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 11.7 t-105 -110.6 125.31 53.27 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.987 -1.071 . . . . 0.0 110.83 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 70' ' ' GLY . 75.0 ttt180 -114.33 97.61 6.43 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 0.0 108.828 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.603 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.5 tt -146.72 158.59 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 22.3 t70 -107.67 174.27 5.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.461 -0.774 . . . . 0.0 109.685 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.77 -36.2 89.03 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 42.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.199 -1.177 . . . . 0.0 110.671 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.806 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 3.7 m-90 55.96 32.94 20.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.037 . . . . 0.0 110.35 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.523 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -106.23 153.87 21.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 109.225 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.8 t -100.72 139.44 36.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.575 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -134.27 157.52 77.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.46 -0.775 . . . . 0.0 108.98 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.23 -31.4 22.0 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.525 2.15 . . . . 0.0 111.787 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -157.21 147.76 21.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 108.914 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 87.1 m-20 -106.14 117.61 34.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -74.88 -22.23 58.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 6.1 ptp85 -105.28 35.83 2.7 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.819 -0.551 . . . . 0.0 109.736 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.0 150.76 23.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.919 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.0 p -133.18 170.51 15.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.453 -0.779 . . . . 0.0 109.298 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.78 141.14 41.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.828 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.8 mt -122.53 137.4 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.08 127.17 56.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 109.039 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' O ' ' O ' ' A' ' 81' ' ' LEU . 8.3 p -134.73 139.47 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.378 -0.826 . . . . 0.0 109.526 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -121.03 131.75 54.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 79' ' ' HIS . 88.1 m-85 -116.14 127.7 55.04 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.3 120.78 27.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.304 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.97 131.55 10.06 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 121.881 1.72 . . . . 0.0 112.834 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -119.41 145.79 45.93 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.29 -175.57 26.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.488 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 59.22 15.41 4.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -1.132 . . . . 0.0 109.583 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.16 1.29 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.63 140.7 10.06 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.6 120.79 20.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -1.062 . . . . 0.0 109.568 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -104.01 120.22 40.59 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.92 139.34 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 111.259 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.71 102.63 8.34 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -105.09 129.63 53.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.842 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.37 14.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.424 -0.798 . . . . 0.0 109.362 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.739 ' ND1' HD12 ' A' ' 124' ' ' LEU . 2.8 p80 -105.39 132.4 51.62 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.599 HG12 ' HB2' ' A' ' 7' ' ' ASP . 28.6 m -131.82 154.05 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.955 0.883 . . . . 0.0 111.677 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.518 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.45 31.48 18.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.503 . . . . 0.0 111.303 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.739 HD12 ' ND1' ' A' ' 121' ' ' HIS . 11.6 mt -71.16 -44.0 66.39 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.645 -1.284 . . . . 0.0 108.353 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.0 t60 -44.52 -11.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.26 0.552 . . . . 0.0 110.343 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.8 ttm-85 -51.07 -33.39 25.55 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.145 -0.972 . . . . 0.0 109.124 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.899 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.3 -32.91 29.27 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.94 -1.1 . . . . 0.0 110.213 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 127' ' ' HIS . . . 33.97 -153.56 0.01 OUTLIER Glycine 0 N--CA 1.499 2.849 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 128' ' ' GLY . 60.8 t0 43.39 71.21 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.287 -1.125 . . . . 0.0 109.973 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 73.94 33.05 58.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.899 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -61.9 -57.24 12.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.545 -0.974 . . . . 0.0 110.209 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.432 ' N ' HD11 ' A' ' 5' ' ' ILE . 32.6 t-105 -58.67 -28.56 65.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.787 -1.196 . . . . 0.0 108.518 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -54.95 -42.02 71.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.603 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.1 mt -59.42 -43.13 89.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.11 -32.11 73.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -53.26 -36.25 60.92 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.43 -43.46 94.24 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 95.7 mt -70.13 -4.94 23.7 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 62.98 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.453 0.644 . . . . 0.0 110.555 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 135' ' ' HIS . . . -118.73 67.79 0.36 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 144' ' ' GLY . 12.1 Cg_endo -60.59 141.13 94.44 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.193 1.928 . . . . 0.0 112.377 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.567 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -71.64 -45.85 12.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.952 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.4 Cg_exo -55.03 -31.88 76.65 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.623 2.215 . . . . 0.0 112.532 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -143.96 167.05 26.9 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -115.57 175.91 5.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.48 -1.012 . . . . 0.0 109.421 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.518 HG21 ' OAP' ' A' ' 201' ' ' 96F . 20.1 m -57.55 -35.0 69.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.229 -0.92 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -63.55 -35.13 79.46 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.165 -0.96 . . . . 0.0 109.948 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.75 -51.63 26.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.335 -0.853 . . . . 0.0 112.03 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.729 ' NH1' HH12 ' A' ' 44' ' ' ARG . 0.1 OUTLIER -65.65 -45.87 81.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.098 -1.001 . . . . 0.0 111.686 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.723 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -76.37 -33.89 58.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.911 -1.118 . . . . 0.0 110.868 -178.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.723 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.81 -42.16 77.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.403 -1.436 . . . . 0.0 109.707 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.01 -47.08 87.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.608 -0.682 . . . . 0.0 111.164 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' CD1' ' A' ' 32' ' ' TRP . 31.5 m -68.04 -38.02 79.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.543 HD13 ' NE2' ' A' ' 20' ' ' HIS . 66.0 mt . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.758 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.7 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -66.5 144.48 73.26 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.728 2.285 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.83 -27.84 69.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.862 . . . . 0.0 109.165 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.54 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -90.31 139.6 30.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.54 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -119.57 89.95 41.95 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.469 -0.77 . . . . 0.0 109.724 -179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' CE1' ' A' ' 121' ' ' HIS . 55.9 Cg_endo -81.3 167.6 17.4 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.18 1.92 . . . . 0.0 111.365 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB2' HG12 ' A' ' 122' ' ' VAL . 39.4 p30 -70.79 125.73 27.63 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.088 -1.008 . . . . 0.0 110.177 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.7 p -138.89 141.13 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 109.154 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -118.21 125.33 49.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -132.95 146.12 51.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.863 . . . . 0.0 109.816 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.4 p -138.69 143.95 39.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.118 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.528 ' HB ' HD22 ' A' ' 147' ' ' LEU . 5.3 t -152.04 155.55 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.186 -0.946 . . . . 0.0 109.593 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 44.9 t -104.21 135.26 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.67 163.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.03 94.38 7.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 0.0 109.418 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.95 164.57 2.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.932 -1.105 . . . . 0.0 110.698 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.58 146.68 26.16 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 79' ' ' HIS . 29.1 m -57.08 -37.92 57.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.825 -1.172 . . . . 0.0 109.494 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.11 -39.2 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.0 t60 -65.98 -39.62 90.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.564 -0.71 . . . . 0.0 109.456 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' HG21 ' A' ' 115' ' ' THR . 89.0 m -51.04 -42.94 60.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.523 -0.736 . . . . 0.0 109.306 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.456 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.35 -26.87 32.56 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.2 tt0 -59.69 -41.06 89.88 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 84.9 t -68.23 -40.11 82.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.565 0.698 . . . . 0.0 109.395 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -57.19 -45.51 83.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.452 -0.78 . . . . 0.0 110.559 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.483 HG22 ' HD1' ' A' ' 49' ' ' PHE . 62.6 p -97.34 -3.12 41.03 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.959 -1.088 . . . . 0.0 111.333 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 51.0 m -91.46 -51.04 5.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.591 -1.318 . . . . 0.0 111.534 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -171.54 58.92 0.27 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.0 111.328 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 3.4 Cg_endo -51.72 -32.32 45.03 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 121.765 1.643 . . . . 0.0 113.515 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -76.58 -36.86 57.3 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.886 -1.134 . . . . 0.0 110.918 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 22.7 t70 -54.31 -32.51 56.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.118 -0.989 . . . . 0.0 110.155 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.629 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.39 111.95 24.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.979 -1.075 . . . . 0.0 108.103 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.587 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.99 179.62 0.77 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 22.5 Cg_exo -60.71 158.7 31.59 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.471 2.114 . . . . 0.0 111.582 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -50.99 158.92 2.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.664 2.242 . . . . 0.0 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -52.83 -29.6 28.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -0.855 . . . . 0.0 109.613 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -53.37 -41.34 65.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.065 -1.022 . . . . 0.0 109.364 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.04 131.11 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.415 -0.803 . . . . 0.0 109.376 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.1 mt -111.19 142.69 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 42' ' ' LYS . 11.4 p -61.49 139.13 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -61.39 -38.23 86.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 0.0 109.295 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 40' ' ' VAL . 19.5 pttt -118.41 145.64 45.04 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.01 123.75 28.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.96 -1.087 . . . . 0.0 109.622 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -65.32 143.2 57.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 108.834 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -108.72 -47.77 3.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -160.82 176.2 37.45 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.96 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.94 143.2 21.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.41 -1.053 . . . . 0.0 110.316 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -113.28 141.47 46.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -143.27 129.75 20.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.863 -1.148 . . . . 0.0 110.335 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.806 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 18.8 mm-40 -131.08 137.65 31.18 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.924 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -86.25 131.25 3.56 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.193 1.929 . . . . 0.0 112.058 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.806 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.83 -175.89 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.999 -1.063 . . . . 0.0 110.99 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 73' ' ' LEU . 58.0 t -98.1 141.14 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.91 33.02 86.12 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.66 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.12 176.53 33.68 Favored Glycine 0 C--N 1.297 -1.616 0 CA-C-N 113.707 -1.247 . . . . 0.0 114.255 -175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.516 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 76.1 mtm180 -146.95 145.34 29.74 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.144 0.973 . . . . 0.0 111.904 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.909 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.8 m-85 -120.09 140.3 51.25 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.831 ' CE2' HG22 ' A' ' 68' ' ' VAL . 7.4 m-85 -123.0 147.0 47.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 111.942 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.699 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.3 tt0 -128.82 142.9 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.75 129.96 54.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.602 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.75 141.06 38.61 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.373 177.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.46 -45.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.648 -0.658 . . . . 0.0 110.383 -178.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -102.97 -4.0 25.3 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.506 ' O ' ' OD2' ' A' ' 61' ' ' ASP . . . -111.94 132.55 10.88 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -61.26 -178.22 0.11 Allowed 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.326 0.584 . . . . 0.0 109.52 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.5 tt0 -78.85 142.46 36.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 19.1 tt -150.97 164.1 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.786 -1.196 . . . . 0.0 110.995 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.831 HG22 ' CE2' ' A' ' 58' ' ' TYR . 16.4 t -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.699 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.7 2.87 18.76 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.071 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.69 -173.87 27.66 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.502 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.795 HH21 HH11 ' A' ' 86' ' ' ARG . 11.4 ttp180 -153.88 -178.1 6.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.909 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -130.47 166.75 27.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 121.335 -0.853 . . . . 0.0 108.904 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.746 ' O ' HG13 ' A' ' 53' ' ' VAL . 17.3 mt -112.2 -51.53 2.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.994 -1.066 . . . . 0.0 109.063 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.4 tt0 -178.65 158.48 1.04 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.403 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 57.9 p-90 -101.84 130.59 48.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.964 -1.085 . . . . 0.0 109.786 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 1.4 t0 -93.94 122.0 62.96 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 108.927 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 78' ' ' PRO . 31.7 Cg_exo -41.53 -43.08 5.99 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.798 2.332 . . . . 0.0 113.919 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 34.9 Cg_exo -60.83 -132.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.229 0 N-CA-C 108.843 -1.253 . . . . 0.0 108.843 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.667 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.27 53.76 1.01 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 51.5 ttt-85 -136.75 141.33 43.0 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.201 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -143.45 132.11 22.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.312 0.577 . . . . 0.0 109.732 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.03 149.14 26.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.588 ' N ' HD12 ' A' ' 73' ' ' LEU . 2.7 ptp -146.56 147.3 30.97 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.564 -1.655 . . . . 0.0 112.891 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.616 ' OG1' HD21 ' A' ' 73' ' ' LEU . 97.5 m -103.8 146.16 29.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.592 ' CD1' HD12 ' A' ' 103' ' ' ILE . 7.6 m0 -104.76 126.29 51.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.836 -1.165 . . . . 0.0 111.084 -178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.795 HH11 HH21 ' A' ' 71' ' ' ARG . 39.3 ttm180 -114.22 104.53 12.18 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.603 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 13.7 tt -139.84 158.5 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 110.135 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 93' ' ' SER . 74.5 m-20 -97.15 161.84 13.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 0.0 109.494 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -63.92 -43.37 97.6 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.12 36.39 3.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.368 -1.077 . . . . 0.0 109.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.777 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.8 m-90 56.36 25.78 9.88 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.99 -1.069 . . . . 0.0 108.299 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 170.35 77.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -0.756 . . . . 0.0 109.121 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.491 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 14.0 t -124.05 -77.94 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.302 -0.874 . . . . 0.0 110.21 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' ASP . 25.1 m -126.59 150.5 71.01 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.836 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.86 -34.56 81.74 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.403 2.068 . . . . 0.0 112.1 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 94' ' ' VAL . 89.6 m-20 -109.24 146.87 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 0.0 109.011 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 94.4 m-20 -105.47 117.93 35.27 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.226 -0.921 . . . . 0.0 110.558 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -88.7 -9.39 52.16 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.7 ptt-85 -114.37 37.35 3.4 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.269 0.557 . . . . 0.0 109.511 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.35 154.54 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.15 -0.969 . . . . 0.0 109.589 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 11.5 t -124.9 171.39 10.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.565 -0.709 . . . . 0.0 110.08 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.506 ' HG3' HD11 ' A' ' 73' ' ' LEU . 79.7 tt0 -108.29 139.18 43.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.824 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.592 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.1 mt -127.62 136.58 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.407 -0.808 . . . . 0.0 109.764 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.5 tt0 -112.63 128.87 56.5 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.294 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.8 t -131.89 133.05 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.731 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 70.3 m-20 -120.41 132.07 55.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.89 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.667 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 92.0 m-85 -112.75 140.16 47.76 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.344 -0.847 . . . . 0.0 109.442 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.61 116.98 12.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.493 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 74.2 Cg_endo -79.27 132.81 10.46 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.016 1.811 . . . . 0.0 112.614 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -119.1 144.85 46.38 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.43 -175.83 23.29 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.81 15.24 4.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.258 -1.142 . . . . 0.0 109.52 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.94 70.04 1.3 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.31 140.14 9.42 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -133.97 120.92 20.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -1.057 . . . . 0.0 109.479 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -105.17 118.29 36.18 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG21 ' CAF' ' A' ' 201' ' ' 96F . 48.7 t -122.85 139.25 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.344 -0.848 . . . . 0.0 110.708 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.31 104.61 10.18 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -108.16 129.92 55.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.37 -0.831 . . . . 0.0 109.615 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.538 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.73 114.61 14.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.746 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 0.6 OUTLIER -102.6 124.65 48.54 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 ' HB2' ' A' ' 7' ' ' ASP . 31.3 m -131.61 159.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.309 -0.87 . . . . 0.0 112.004 -177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 56.14 30.46 16.48 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.942 -0.474 . . . . 0.0 111.033 179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.688 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.8 mm? -72.61 -39.77 67.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.947 -1.096 . . . . 0.0 108.471 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 4.4 t60 -44.79 -12.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.375 0.607 . . . . 0.0 109.718 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' A' ' 124' ' ' LEU . 59.7 ttm-85 -51.3 -32.71 25.89 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.345 -0.847 . . . . 0.0 109.199 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.688 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.74 -15.21 59.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.99 -1.069 . . . . 0.0 109.712 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.15 -166.5 33.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' OD2' ' C ' ' A' ' 129' ' ' ASP . 53.0 p30 -73.81 161.3 30.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.818 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 -6.44 83.59 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.533 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.496 -1.002 . . . . 0.0 110.156 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.401 ' N ' HD11 ' A' ' 5' ' ' ILE . 26.7 t-105 -57.44 -32.43 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.893 -1.129 . . . . 0.0 109.284 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -54.52 -41.16 69.34 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 73.0 mt -60.22 -43.25 92.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.56 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.24 -31.98 73.27 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -52.71 -36.61 57.66 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.777 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.53 -44.46 86.83 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 84.8 mt -67.24 -26.85 66.79 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER 79.91 105.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.727 -0.608 . . . . 0.0 110.882 178.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.413 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -123.6 79.91 0.35 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.498 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 35.9 Cg_exo -54.46 148.78 41.34 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.814 2.343 . . . . 0.0 112.376 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.607 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -95.77 -43.82 0.27 Allowed Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.1 Cg_exo -57.62 -24.69 63.77 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.607 2.205 . . . . 0.0 112.383 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -135.79 173.59 21.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -105.51 164.59 11.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.437 -1.037 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.527 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 47.2 m -57.86 -36.0 71.73 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.86 HD21 ' OAO' ' A' ' 201' ' ' 96F . 4.6 mp -67.02 -28.58 68.35 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.024 -1.048 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.19 -49.46 69.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.851 . . . . 0.0 112.196 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.592 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.86 -47.7 71.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.762 -1.211 . . . . 0.0 112.034 -177.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.71 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.55 -33.7 60.67 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.437 -1.415 . . . . 0.0 110.501 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.71 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.64 -43.55 80.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.711 -1.243 . . . . 0.0 110.304 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.657 HD21 HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -59.75 -45.49 92.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.362 -0.836 . . . . 0.0 110.161 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.657 HG13 HD21 ' A' ' 152' ' ' ASN . 11.0 m -65.13 -39.98 87.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 109.334 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.2 mt . . . . . 0 C--N 1.304 -1.383 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.534 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.86 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.9 ptt? . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.232 0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 1' ' ' MET . 14.8 Cg_endo -61.02 154.81 54.24 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.84 2.36 . . . . 0.0 112.288 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.47 -29.28 68.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.375 -0.828 . . . . 0.0 109.266 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.72 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.77 144.25 25.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.669 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -118.83 90.5 40.66 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.453 -0.779 . . . . 0.0 109.927 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.3 170.15 17.89 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.215 1.943 . . . . 0.0 111.313 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 39.5 p30 -64.24 126.99 29.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.848 -1.157 . . . . 0.0 110.891 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.7 140.9 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.417 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 67.6 ttp85 -125.01 126.75 45.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.174 -0.953 . . . . 0.0 109.591 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -137.81 147.11 44.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 0.0 110.017 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 12' ' ' VAL . 97.1 p -138.06 147.83 44.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.833 . . . . 0.0 109.236 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.5 t -153.15 156.0 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.122 -0.986 . . . . 0.0 110.14 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' N ' HG12 ' A' ' 12' ' ' VAL . 3.0 p -104.29 134.32 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.7 m -132.12 163.07 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.783 . . . . 0.0 109.806 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.73 94.64 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.975 -1.078 . . . . 0.0 109.451 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.55 164.98 2.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.107 . . . . 0.0 110.465 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.2 m -100.96 149.56 23.78 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 79' ' ' HIS . 19.5 m -57.65 -38.13 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.862 -1.149 . . . . 0.0 109.695 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.43 -40.08 93.14 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.54 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 19.7 t60 -64.86 -39.66 93.9 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.533 0.682 . . . . 0.0 109.52 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' HG21 ' A' ' 115' ' ' THR . 78.3 m -50.7 -43.18 57.68 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.506 -0.746 . . . . 0.0 109.244 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.38 -26.31 32.99 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.244 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.7 -40.47 88.04 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 98.9 t -68.11 -39.94 82.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.598 -0.688 . . . . 0.0 109.477 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -58.61 -45.03 90.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.643 -0.661 . . . . 0.0 111.1 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 49' ' ' PHE . 71.0 p -97.68 -4.83 36.53 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.901 -1.125 . . . . 0.0 111.8 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' VAL . 89.8 p -92.22 -42.35 9.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.414 -1.429 . . . . 0.0 111.279 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.83 57.45 0.1 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.503 -1.373 . . . . 0.0 111.638 -179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 6.3 Cg_endo -51.19 -21.28 9.16 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.088 1.859 . . . . 0.0 113.14 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.61 -47.35 10.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.917 -1.114 . . . . 0.0 111.857 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.57 -33.24 69.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.239 -0.913 . . . . 0.0 112.642 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.614 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -69.6 -37.64 76.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.085 -1.634 . . . . 0.0 110.009 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.569 ' NE1' ' NH2' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -49.0 108.76 1.02 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.654 -1.279 . . . . 0.0 108.975 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.8 155.64 11.7 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.288 1.992 . . . . 0.0 112.829 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -65.34 -16.67 55.5 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.615 2.21 . . . . 0.0 111.989 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.7 p -65.29 168.12 7.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.696 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 57.76 -120.92 1.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.46 -0.775 . . . . 0.0 109.546 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' CZ3' ' A' ' 33' ' ' TRP . 47.1 t -107.14 134.31 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.885 . . . . 0.0 109.472 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 39' ' ' LEU . 4.7 mp -92.56 147.25 23.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 42' ' ' LYS . 7.1 p -48.65 142.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.289 -0.882 . . . . 0.0 108.917 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.17 -38.96 88.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.076 -1.015 . . . . 0.0 109.467 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' H ' HG22 ' A' ' 40' ' ' VAL . 46.5 pttt -114.22 143.68 44.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.01 123.05 19.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.934 -1.104 . . . . 0.0 109.649 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -71.53 142.45 50.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.095 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.13 -48.18 1.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.465 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -149.64 167.57 29.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.95 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.09 135.93 13.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.091 -1.241 . . . . 0.0 110.129 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -104.66 140.34 38.18 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.92 122.19 13.92 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.067 -1.02 . . . . 0.0 110.111 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 7.9 tp10 -130.78 136.36 28.8 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.175 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 91.6 Cg_endo -84.22 137.87 7.41 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.388 2.058 . . . . 0.0 113.324 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.1 -175.78 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.237 -0.915 . . . . 0.0 110.159 -179.17 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.05 142.65 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.21 33.34 86.99 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 104.506 -3.438 . . . . 0.0 104.506 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.95 178.0 33.99 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-N 114.106 -1.047 . . . . 0.0 114.56 -175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -149.12 145.97 27.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.515 1.15 . . . . 0.0 111.702 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.885 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 18.5 m-85 -119.75 140.32 50.9 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.799 ' CE1' HG22 ' A' ' 68' ' ' VAL . 11.0 m-85 -122.13 147.32 46.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 111.849 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.749 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 81.8 tt0 -128.36 142.67 51.05 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.478 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.234 -0.916 . . . . 0.0 109.174 179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 64' ' ' GLY . 33.8 t0 -103.69 136.59 43.1 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.631 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.697 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.79 -34.98 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.677 -0.64 . . . . 0.0 110.751 -178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.64 -15.31 15.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.134 -0.979 . . . . 0.0 108.454 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.27 139.65 15.76 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-O 122.618 1.121 . . . . 0.0 110.94 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.792 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.0 m -59.91 -178.33 0.07 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.101 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.792 ' H ' HG22 ' A' ' 65' ' ' THR . 72.2 tt0 -76.65 146.17 38.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.7 pt -151.05 166.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.544 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 58' ' ' TYR . 37.4 t -103.02 125.77 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.44 2.71 17.65 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.518 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -160.41 -172.85 28.22 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.678 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.751 ' C ' HD12 ' A' ' 72' ' ' ILE . 11.3 ttp180 -153.27 -178.8 7.2 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.885 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -134.04 166.88 27.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -113.88 -52.5 2.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 109.309 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -178.11 159.43 1.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.401 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 18.9 p-90 -108.07 130.23 55.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.513 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.39 130.53 45.37 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 108.851 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.35 -46.17 9.72 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.504 2.136 . . . . 0.0 112.992 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 77' ' ' PRO . 35.4 Cg_exo -57.1 -126.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.19 1.26 . . . . 0.0 109.21 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -126.41 55.11 1.52 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 31.6 ttp180 -136.66 134.35 37.18 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.443 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 22' ' ' PHE . 4.3 mp -134.8 131.28 37.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.389 0.614 . . . . 0.0 109.997 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.02 146.05 29.6 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.525 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.1 ptp -144.13 147.29 33.53 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 117.601 -1.64 . . . . 0.0 113.1 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.592 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.1 m -103.5 150.89 23.47 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.585 ' NE1' ' O ' ' A' ' 69' ' ' TRP . 5.6 t-105 -107.63 126.17 52.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.868 -1.145 . . . . 0.0 110.346 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' NH1' HH21 ' A' ' 71' ' ' ARG . 55.6 ttm-85 -114.12 104.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.215 -0.928 . . . . 0.0 109.636 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.0 tt -148.46 157.35 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.738 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' NH1' ' A' ' 99' ' ' ARG . 23.0 t70 -109.35 174.24 5.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 0.0 109.846 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.477 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.86 -37.8 93.1 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.1 41.21 1.51 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.131 -1.217 . . . . 0.0 110.482 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.804 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.2 m-90 55.96 36.08 26.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.109 -0.994 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.533 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.6 mt-30 -110.33 156.62 20.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.784 . . . . 0.0 108.959 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.7 t -101.34 140.04 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.567 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -124.47 157.0 66.63 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.485 -0.76 . . . . 0.0 109.195 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.78 -32.72 67.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.572 2.182 . . . . 0.0 111.598 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -157.11 147.4 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' OD1' HG23 ' A' ' 94' ' ' VAL . 86.9 m-20 -106.63 117.83 35.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.347 -0.846 . . . . 0.0 110.816 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -80.2 -14.65 58.28 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' NH1' ' OD1' ' A' ' 88' ' ' ASP . 24.0 ptt-85 -111.36 35.4 3.62 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.238 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.01 142.86 27.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.223 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.9 m -119.59 161.72 20.16 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.12 139.65 42.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.962 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 120' ' ' ALA . 61.9 mt -122.77 136.79 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.601 -0.687 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -112.86 127.56 56.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.46 -0.775 . . . . 0.0 109.412 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.441 HG12 ' CE2' ' A' ' 107' ' ' PHE . 36.2 t -132.45 132.92 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.672 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 63.0 m-20 -119.45 131.98 55.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.337 -0.852 . . . . 0.0 109.474 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 39.8 m-85 -114.1 139.06 49.62 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.338 -0.852 . . . . 0.0 109.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -135.31 118.79 12.94 Favored Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.476 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 60.1 Cg_endo -76.49 137.51 18.59 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.952 1.768 . . . . 0.0 113.039 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.58 145.15 46.66 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.3 -177.28 33.56 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.17 11.37 4.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -1.179 . . . . 0.0 109.409 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.25 70.97 1.24 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.78 140.03 9.5 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -135.0 120.8 19.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.565 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.443 ' HB3' HG13 ' A' ' 108' ' ' VAL . 13.9 ttp-105 -106.4 119.83 40.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.503 HG21 ' CAF' ' A' ' 201' ' ' 96F . 60.2 t -124.01 137.65 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 110.552 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.57 102.58 9.29 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.48 127.84 52.26 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.293 -0.879 . . . . 0.0 109.488 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -131.75 126.28 34.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.487 -0.758 . . . . 0.0 109.889 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.588 ' CD2' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -115.77 144.06 44.5 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.8 m -138.77 143.76 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.539 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 52.45 41.37 30.79 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.572 177.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.649 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -72.87 -32.83 65.68 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.406 -1.434 . . . . 0.0 107.85 177.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.2 t60 -44.06 -12.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.912 -0.492 . . . . 0.0 111.025 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 124' ' ' LEU . 92.4 mtt-85 -51.14 -33.62 27.44 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.751 -1.18 . . . . 0.0 108.753 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.816 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -79.55 -32.87 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.028 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 29.43 -146.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.902 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 128' ' ' GLY . 59.8 t0 43.42 61.14 2.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.35 -1.088 . . . . 0.0 109.66 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.16 33.99 38.62 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.816 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.3 -52.43 65.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.504 -0.998 . . . . 0.0 109.772 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -59.75 -29.78 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.989 -1.069 . . . . 0.0 108.862 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -54.98 -42.62 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.532 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.3 mt -59.19 -43.8 90.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.602 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.51 -33.01 74.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -53.3 -37.02 61.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.173 -0.954 . . . . 0.0 108.754 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.804 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.03 -44.09 90.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 75.4 mt -65.37 -24.35 67.22 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 9.8 t0 85.91 98.17 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.308 0.575 . . . . 0.0 110.987 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -114.88 80.73 0.29 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.34 140.83 65.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.884 1.723 . . . . 0.0 112.39 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -80.54 -44.46 1.33 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.797 . . . . 0.0 110.072 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 142' ' ' SER . 39.6 Cg_exo -57.82 -71.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.552 2.168 . . . . 0.0 112.142 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.53 179.71 44.77 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -119.54 164.3 16.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.6 -0.941 . . . . 0.0 109.121 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.563 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 21.4 m -57.68 -38.08 74.55 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.155 -0.966 . . . . 0.0 109.004 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.3 mp -67.04 -30.94 71.15 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.443 -0.785 . . . . 0.0 109.638 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -70.37 -50.08 42.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.481 -0.762 . . . . 0.0 112.312 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.569 ' NH2' ' NE1' ' A' ' 33' ' ' TRP . 1.3 ptt180 -65.78 -51.32 60.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.957 -1.089 . . . . 0.0 111.666 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.695 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.96 -36.02 79.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.815 -1.178 . . . . 0.0 110.03 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.695 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.43 -37.87 86.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.73 -1.231 . . . . 0.0 109.648 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.41 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 90.0 m-20 -62.47 -47.92 81.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 111.053 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.3 m -66.03 -37.52 79.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.395 -0.816 . . . . 0.0 110.249 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.64 179.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.688 ' CAL' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 9.1 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 1' ' ' MET . 15.0 Cg_endo -61.59 152.58 72.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.733 2.289 . . . . 0.0 112.338 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.57 -29.77 70.23 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.0 109.152 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.824 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -97.52 142.99 28.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.824 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.0 90.74 41.94 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.445 -0.784 . . . . 0.0 109.977 -179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -78.3 166.51 24.31 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.026 1.817 . . . . 0.0 111.266 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB2' HG12 ' A' ' 122' ' ' VAL . 47.1 p-10 -64.76 125.63 25.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.983 -1.073 . . . . 0.0 109.925 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 121' ' ' HIS . 8.6 p -139.49 141.55 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 69.4 ttt180 -119.0 126.83 52.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.2 -0.937 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -133.74 146.49 50.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 109.809 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.9 p -137.73 147.21 44.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.327 -0.858 . . . . 0.0 109.234 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.67 156.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 109.662 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -102.05 133.75 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 108.879 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.8 m -130.24 162.88 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.154 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.01 94.06 7.7 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.99 164.57 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.942 -1.099 . . . . 0.0 110.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 82.7 p -98.64 151.71 20.41 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.411 HG21 ' HB3' ' A' ' 79' ' ' HIS . 28.9 m -61.6 -38.22 79.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.717 -1.239 . . . . 0.0 109.422 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.62 -38.61 88.27 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.506 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.8 t60 -65.06 -40.2 94.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.579 -0.7 . . . . 0.0 109.521 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 115' ' ' THR . 92.2 m -50.95 -42.84 60.06 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.552 -0.718 . . . . 0.0 109.118 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -82.44 -28.16 31.48 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.372 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.6 tt0 -59.61 -41.36 90.19 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.813 -1.155 . . . . 0.0 107.883 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.506 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 73.6 t -68.32 -39.89 81.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.438 0.637 . . . . 0.0 109.482 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 6.9 m-30 -55.7 -45.78 77.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.47 -0.769 . . . . 0.0 110.41 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 49' ' ' PHE . 66.1 p -97.99 -2.94 39.3 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 111.227 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.1 t -97.44 -37.11 10.12 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.709 -1.244 . . . . 0.0 112.506 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 5.9 ppt_? -179.48 55.13 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 120.387 -1.446 . . . . 0.0 111.334 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.1 Cg_endo -55.86 -37.45 95.81 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.307 2.005 . . . . 0.0 113.053 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -74.88 -37.86 62.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 111.053 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -53.33 -32.41 48.92 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.109 -0.995 . . . . 0.0 110.152 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.636 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -98.1 109.58 22.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.892 -1.13 . . . . 0.0 108.107 178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -112.91 162.94 19.35 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.111 -0.993 . . . . 0.0 109.956 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.08 154.67 47.4 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.845 2.363 . . . . 0.0 111.966 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 36' ' ' SER . 51.3 Cg_endo -72.7 -90.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.452 2.102 . . . . 0.0 111.969 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 35' ' ' PRO . 38.4 t 49.03 177.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 109.832 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -58.23 -43.74 87.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.2 t -119.44 131.49 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.393 -0.817 . . . . 0.0 109.12 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.1 mt -60.09 -45.53 92.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.497 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' LYS . 8.3 p -159.8 143.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.89 -38.75 89.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.871 -1.143 . . . . 0.0 109.013 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.517 ' H ' HG22 ' A' ' 40' ' ' VAL . 17.8 pttt -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -85.51 123.72 31.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.85 -1.156 . . . . 0.0 110.028 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.424 HH21 ' HA ' ' A' ' 30' ' ' ALA . 90.0 mtt180 -65.2 143.22 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -113.99 -48.5 2.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.982 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -154.08 172.5 32.72 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.074 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 pp -155.85 138.89 15.46 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.205 -1.174 . . . . 0.0 110.279 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -109.84 141.44 42.52 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.709 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -144.29 123.16 12.71 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.951 -1.093 . . . . 0.0 110.387 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.849 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 13.7 tp10 -130.79 136.24 28.61 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.8 Cg_endo -83.96 137.75 7.65 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.31 2.007 . . . . 0.0 113.407 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.849 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.17 -175.9 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.244 -0.91 . . . . 0.0 110.203 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.2 143.17 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.42 33.17 86.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 104.494 -3.442 . . . . 0.0 104.494 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.03 178.31 33.74 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 114.246 -0.977 . . . . 0.0 114.561 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.475 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 91.4 mtm-85 -148.67 144.33 27.07 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.431 1.11 . . . . 0.0 111.73 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.907 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -119.99 140.64 50.64 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.823 ' CE1' HG22 ' A' ' 68' ' ' VAL . 8.0 m-85 -123.82 148.33 46.82 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.216 -0.927 . . . . 0.0 112.059 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.667 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 70.2 tt0 -132.5 143.38 49.71 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.492 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -106.13 130.28 54.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.101 -178.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.47 141.15 36.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.857 -1.137 . . . . 0.0 108.234 177.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.37 -45.76 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.534 -178.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -103.26 -3.51 25.57 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.78 133.98 11.8 Favored Glycine 0 N--CA 1.478 1.489 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -62.23 -178.35 0.17 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.344 0.592 . . . . 0.0 109.521 178.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 68.5 tt0 -78.73 142.67 36.87 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.6 tt -149.61 161.51 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.797 -1.19 . . . . 0.0 110.746 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.823 HG22 ' CE1' ' A' ' 58' ' ' TYR . 17.9 t -99.05 124.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.667 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -110.76 2.88 18.67 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 111.253 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.43 -174.0 27.57 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.213 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.753 ' C ' HD12 ' A' ' 72' ' ' ILE . 22.5 ttt180 -154.69 -178.51 7.25 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.907 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.6 mp -133.61 166.55 28.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -114.88 -52.53 2.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.919 -1.113 . . . . 0.0 109.333 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -177.32 158.24 1.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 26.3 p-90 -102.42 130.52 49.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.066 -1.021 . . . . 0.0 109.836 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.74 129.32 47.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 0.0 109.016 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.6 Cg_exo -43.1 -46.09 9.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.733 2.289 . . . . 0.0 113.471 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 77' ' ' PRO . 38.8 Cg_exo -58.86 -133.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.01 1.14 . . . . 0.0 109.141 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -118.65 53.61 0.98 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 177.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 41.9 ttt180 -136.42 141.82 43.63 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.148 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.31 133.98 28.63 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.312 0.577 . . . . 0.0 109.62 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.28 145.03 30.81 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.531 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 4.6 ptp -144.72 148.57 34.32 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.72 -1.592 . . . . 0.0 112.898 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.588 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.5 m -102.66 147.26 27.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.595 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 30.2 t-105 -107.25 121.15 43.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.929 -1.107 . . . . 0.0 110.596 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' NH1' HG21 ' A' ' 68' ' ' VAL . 68.2 ttp85 -113.87 104.35 12.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.257 -0.902 . . . . 0.0 109.214 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.601 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 14.6 tt -136.48 149.36 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 93' ' ' SER . 67.1 m-20 -86.96 159.68 18.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 109.293 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.518 ' N ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.35 -44.44 95.41 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.449 ' H ' ' HB2' ' A' ' 93' ' ' SER . 0.1 OUTLIER -110.41 33.51 4.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.2 m-90 56.93 26.17 11.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 108.747 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 93' ' ' SER . 1.4 pt20 173.53 11.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.352 -0.843 . . . . 0.0 109.127 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 7.6 t -58.34 -56.82 17.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.37 -0.831 . . . . 0.0 110.497 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 11.6 m -146.72 150.89 41.13 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.802 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.518 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 25.3 Cg_endo -65.14 -37.83 30.57 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.436 2.091 . . . . 0.0 112.095 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.53 147.01 33.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.371 -0.831 . . . . 0.0 109.303 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.3 m-20 -105.57 117.99 35.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.216 -0.928 . . . . 0.0 110.405 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -90.27 -8.88 49.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.518 ' NH1' ' N ' ' A' ' 89' ' ' GLY . 26.9 ptt85 -114.73 36.5 3.8 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.79 -0.568 . . . . 0.0 109.762 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.42 141.87 28.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.115 -0.991 . . . . 0.0 109.975 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 71.0 m -111.12 170.79 7.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.638 -0.664 . . . . 0.0 109.407 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -107.69 140.34 40.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 120' ' ' ALA . 65.6 mt -119.33 139.3 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 109.706 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.98 126.43 55.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.485 -0.759 . . . . 0.0 109.006 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 119' ' ' LEU . 30.4 t -131.65 133.09 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 64.2 m-20 -117.94 132.02 56.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.476 -0.765 . . . . 0.0 109.303 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 81.7 m-85 -113.27 140.19 48.19 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.86 0.838 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t -134.82 118.0 13.14 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.1 Cg_endo -79.66 130.8 8.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.927 1.752 . . . . 0.0 112.467 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -117.93 143.94 45.92 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.83 -175.98 21.05 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.37 13.66 4.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -1.094 . . . . 0.0 109.458 -179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.28 70.77 1.22 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.26 140.11 9.11 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.11 120.95 20.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -1.104 . . . . 0.0 109.498 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -104.16 117.88 35.3 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.31 139.51 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.45 -0.781 . . . . 0.0 110.813 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -118.68 103.55 9.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -103.84 126.92 51.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.329 -0.857 . . . . 0.0 109.561 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.615 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.36 114.8 14.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.35 -0.843 . . . . 0.0 110.258 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -102.28 132.27 48.34 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.4 m -133.36 153.26 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.305 1.05 . . . . 0.0 112.292 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.413 ' O ' ' OG ' ' A' ' 101' ' ' SER . 22.4 mmtp 56.98 31.05 19.19 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.751 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.629 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 8.0 tp -73.32 -34.91 65.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.443 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 28.2 t60 -45.23 -12.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.177 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 124' ' ' LEU . 98.2 mtt180 -51.11 -33.83 28.03 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.68 -1.262 . . . . 0.0 108.071 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -82.88 -24.24 33.27 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.464 -0.772 . . . . 0.0 109.523 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' N ' ' ND1' ' A' ' 127' ' ' HIS . . . 30.51 -142.85 0.02 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 128' ' ' GLY . 79.0 m-20 42.77 -145.75 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -1.009 . . . . 0.0 109.556 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.76 47.12 0.96 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.607 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -58.99 -46.69 87.54 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.291 -1.123 . . . . 0.0 109.472 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.441 ' HE3' HD12 ' A' ' 5' ' ' ILE . 34.1 t-105 -60.29 -28.94 68.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.927 -1.108 . . . . 0.0 108.452 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -54.87 -42.61 72.26 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 89' ' ' GLY . 88.2 mt -59.29 -43.79 90.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.57 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.36 -31.95 73.24 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -52.79 -36.74 58.69 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.731 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.37 -44.07 84.18 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 77.4 mt -66.56 -27.01 67.39 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 135' ' ' HIS . 0.6 OUTLIER 75.71 106.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.423 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -122.52 80.96 0.34 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.424 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 37.9 Cg_exo -54.03 145.11 54.29 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.771 2.314 . . . . 0.0 112.49 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.621 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -86.9 -43.45 0.54 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.485 -0.759 . . . . 0.0 109.809 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 142' ' ' SER . 32.3 Cg_exo -56.71 -27.72 72.22 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.745 2.296 . . . . 0.0 112.486 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.33 173.4 23.05 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' OE1' ' OBB' ' A' ' 201' ' ' 96F . 73.8 mm-40 -108.22 165.67 11.32 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.427 -1.043 . . . . 0.0 109.204 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.502 ' OG1' ' CAW' ' A' ' 201' ' ' 96F . 25.9 m -57.62 -35.66 70.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.162 -0.961 . . . . 0.0 109.202 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.885 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -67.42 -30.75 70.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 152' ' ' ASN . . . -69.51 -49.41 54.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.441 -0.787 . . . . 0.0 112.178 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' HD2' ' HE1' ' A' ' 32' ' ' TRP . 0.7 OUTLIER -66.02 -53.0 44.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.878 -1.139 . . . . 0.0 111.62 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.79 -33.88 75.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.952 -1.092 . . . . 0.0 110.396 -178.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.692 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.39 -37.94 83.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.658 -1.276 . . . . 0.0 109.084 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 148' ' ' ALA . 95.2 m-20 -63.62 -49.92 71.39 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.271 0.558 . . . . 0.0 111.383 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.8 m -65.81 -38.89 83.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.29 -0.882 . . . . 0.0 109.83 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.47 HD13 ' NE2' ' A' ' 20' ' ' HIS . 71.3 mt . . . . . 0 C--N 1.3 -1.576 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.656 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.719 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.621 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 26.0 Cg_exo -59.65 148.91 85.65 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.751 2.3 . . . . 0.0 112.278 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.62 -29.4 70.59 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.448 -0.782 . . . . 0.0 109.376 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.739 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.01 144.5 26.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.411 -0.805 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -117.8 91.43 38.97 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 110.235 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 43.4 Cg_endo -78.63 169.44 19.75 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.023 1.815 . . . . 0.0 111.126 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 40.9 p30 -64.48 125.79 25.79 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.948 -1.095 . . . . 0.0 110.306 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.3 p -139.4 141.87 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.366 -0.834 . . . . 0.0 109.176 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.455 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 28.9 ttm180 -121.83 120.81 35.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.013 . . . . 0.0 110.321 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -138.8 144.93 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.855 . . . . 0.0 109.358 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -137.73 147.95 45.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 109.571 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.52 153.52 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.285 -0.885 . . . . 0.0 109.078 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.56 134.35 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 0.0 109.38 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 m -130.35 163.23 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 109.378 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 94.95 7.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.964 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.635 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.03 163.77 2.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.033 -1.042 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -100.03 150.85 22.02 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 ' N ' ' A' ' 19' ' ' GLU . 35.0 m -57.66 -41.03 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.877 -1.139 . . . . 0.0 110.044 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.477 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -60.06 -39.18 85.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.078 -1.014 . . . . 0.0 108.331 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.552 ' NE2' HG21 ' A' ' 24' ' ' VAL . 19.6 t60 -65.9 -40.08 91.2 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.58 -0.7 . . . . 0.0 109.624 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 115' ' ' THR . 93.2 m -51.38 -43.38 61.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -0.779 . . . . 0.0 109.571 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -82.69 -28.0 30.86 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.556 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.0 tt0 -59.68 -40.3 87.39 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.8 -1.16 . . . . 0.0 107.939 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.552 HG21 ' NE2' ' A' ' 20' ' ' HIS . 99.0 t -68.71 -40.16 81.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.688 -0.633 . . . . 0.0 109.65 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.8 m-30 -56.46 -47.1 79.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 110.962 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.681 HG22 ' CD1' ' A' ' 49' ' ' PHE . 40.1 p -95.55 -2.83 47.67 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.999 -1.063 . . . . 0.0 110.904 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 30.2 t -94.95 -44.97 7.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.786 -1.196 . . . . 0.0 111.207 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.38 59.44 0.11 Allowed Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 10.6 Cg_endo -56.46 -29.82 79.5 Favored 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 121.581 1.521 . . . . 0.0 113.636 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.01 -34.96 50.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 111.226 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -62.76 -33.17 74.6 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.945 -1.097 . . . . 0.0 112.542 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -66.61 -30.55 70.86 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.094 -1.629 . . . . 0.0 109.779 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -49.08 109.88 1.35 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.833 -1.167 . . . . 0.0 108.563 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.68 133.83 17.02 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.94 1.76 . . . . 0.0 112.193 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.99 -19.38 23.23 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.408 2.072 . . . . 0.0 112.649 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' HIS . 54.0 p -65.64 154.91 37.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.056 -1.028 . . . . 0.0 109.298 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.714 ' CD2' ' H ' ' A' ' 38' ' ' VAL . 66.4 t60 39.98 -162.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.471 -0.768 . . . . 0.0 109.175 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.714 ' H ' ' CD2' ' A' ' 37' ' ' HIS . 45.0 t -126.57 119.41 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 109.322 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 ' O ' ' OD2' ' A' ' 139' ' ' ASP . 52.2 mt -110.42 0.89 18.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.608 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG22 ' H ' ' A' ' 42' ' ' LYS . 13.6 p -129.57 139.59 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.424 -0.798 . . . . 0.0 109.054 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -61.88 -38.51 88.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 108.964 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 40' ' ' VAL . 54.5 pttt -119.65 145.12 46.75 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -77.98 111.56 13.98 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.933 -1.104 . . . . 0.0 109.654 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.85 142.86 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.85 -47.99 1.51 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.186 -0.946 . . . . 0.0 111.253 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.43 164.75 25.1 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.914 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.11 139.95 18.14 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.979 -1.307 . . . . 0.0 111.22 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.82 135.74 47.84 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.681 ' CD1' HG22 ' A' ' 26' ' ' THR . 2.0 m-85 -134.84 132.44 38.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 111.196 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.748 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 35.2 mm-40 -131.27 136.29 28.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.715 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -87.72 130.12 2.65 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.339 2.026 . . . . 0.0 112.526 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.19 179.52 0.06 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.103 -0.998 . . . . 0.0 110.855 -178.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -94.51 143.49 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.58 31.92 82.49 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 104.18 -3.568 . . . . 0.0 104.18 -176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.28 175.66 42.5 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 113.973 -1.114 . . . . 0.0 114.446 -175.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.728 ' NH1' HH11 ' A' ' 71' ' ' ARG . 83.8 mtt85 -146.93 144.86 29.54 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.314 1.054 . . . . 0.0 111.772 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.942 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 12.6 m-85 -120.25 149.29 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 10.8 m-85 -134.31 149.55 50.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.005 -1.06 . . . . 0.0 111.571 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -127.67 150.41 49.77 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.547 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -109.81 129.58 55.61 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.453 -0.78 . . . . 0.0 109.325 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 21.3 t70 -103.96 135.29 45.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.675 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -52.71 -34.57 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.7 -0.625 . . . . 0.0 110.735 -178.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -104.53 -14.85 15.52 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 61' ' ' ASP . . . -112.33 140.17 16.07 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-O 122.699 1.166 . . . . 0.0 110.932 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 66' ' ' GLU . 2.3 m -59.18 -177.52 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.015 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.675 ' H ' HG22 ' A' ' 65' ' ' THR . 73.8 tt0 -74.98 140.51 43.7 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.763 HD13 ' O ' ' A' ' 91' ' ' TRP . 78.8 mt -143.28 161.89 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.079 -1.013 . . . . 0.0 110.509 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.556 ' N ' HG22 ' A' ' 67' ' ' ILE . 13.6 p -102.03 133.72 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.0 p90 -109.35 -2.8 17.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.263 -0.898 . . . . 0.0 111.932 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.573 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -169.68 -171.85 35.68 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.728 HH11 ' NH1' ' A' ' 56' ' ' ARG . 9.1 ttt180 -143.3 -178.06 5.67 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.942 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.3 mp -131.56 165.11 32.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.2 mt -114.19 -48.23 2.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.736 -1.227 . . . . 0.0 109.782 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -175.8 153.07 1.33 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 22.3 p-90 -106.15 121.25 43.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -105.83 128.37 26.58 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 79' ' ' HIS . 41.0 Cg_exo -30.15 153.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.749 2.299 . . . . 0.0 112.655 -178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' PRO . 88.5 Cg_exo -29.61 79.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.215 2.61 . . . . 0.0 112.269 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.61 -41.48 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.575 -0.703 . . . . 0.0 109.77 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 53.8 ttp180 -150.5 138.79 20.35 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.109 -1.436 . . . . 0.0 112.065 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -137.93 126.49 23.54 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.681 -0.637 . . . . 0.0 109.422 178.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.35 151.01 26.58 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.497 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -150.26 142.8 24.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 117.671 -1.611 . . . . 0.0 112.385 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.608 ' O ' ' C ' ' A' ' 71' ' ' ARG . 5.7 m -103.78 153.77 20.33 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 15.1 m0 -103.9 128.96 51.39 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.638 -1.289 . . . . 0.0 111.157 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 70' ' ' GLY . 61.1 ttt180 -114.18 98.52 7.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.535 HD13 ' CG2' ' A' ' 134' ' ' ILE . 20.4 tt -149.07 157.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 0.0 109.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 34.0 t0 -104.64 173.07 6.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -60.12 -38.43 94.36 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.163 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.22 40.48 1.59 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.081 -1.247 . . . . 0.0 110.559 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.79 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.3 m-90 55.14 46.02 24.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.991 -1.068 . . . . 0.0 109.803 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.564 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 83.7 mt-30 -120.71 157.35 29.82 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.1 t -101.25 138.33 38.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.149 -0.969 . . . . 0.0 109.469 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.496 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -132.58 156.67 79.82 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.387 -0.82 . . . . 0.0 109.122 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -52.52 -32.1 51.84 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.521 2.148 . . . . 0.0 111.751 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -155.09 147.92 24.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.847 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 92.4 m-20 -106.03 117.51 34.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 110.333 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -75.49 -24.53 56.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.254 -0.904 . . . . 0.0 108.659 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -103.01 36.25 2.28 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.735 -0.603 . . . . 0.0 109.671 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -86.72 141.65 28.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.982 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 124' ' ' LEU . 50.4 m -123.97 165.32 17.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -108.48 140.89 41.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.0 109.766 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 ' CD1' ' A' ' 85' ' ' TRP . 76.9 mt -120.99 139.47 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.37 121.46 45.28 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.56 HG22 ' HG ' ' A' ' 119' ' ' LEU . 44.0 t -127.55 137.0 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.437 -0.79 . . . . 0.0 109.271 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -116.65 131.15 57.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 109.543 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE1' HG12 ' A' ' 105' ' ' VAL . 37.0 m-85 -113.73 125.53 54.22 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.426 -0.796 . . . . 0.0 108.972 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.11 124.5 24.6 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.602 -0.686 . . . . 0.0 109.196 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.57 121.79 6.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.029 1.819 . . . . 0.0 112.346 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 111' ' ' GLY . 22.4 t-20 -117.19 124.81 50.01 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.18 172.04 0.02 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.8 m -60.53 -30.92 70.04 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.322 -1.105 . . . . 0.0 109.25 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -129.57 51.22 0.86 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.841 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -136.66 131.91 5.83 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.74 124.13 24.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -1.229 . . . . 0.0 110.594 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -109.65 118.6 36.98 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.471 HG21 ' CAF' ' A' ' 201' ' ' 96F . 67.2 t -123.21 136.98 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 110.803 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -116.35 105.82 12.95 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.56 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.1 tt -103.17 127.47 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.734 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.8 114.47 14.76 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.515 -0.741 . . . . 0.0 109.739 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.619 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -103.89 134.67 46.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.9 m -135.72 152.78 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.925 -1.109 . . . . 0.0 112.0 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp 53.4 31.83 12.77 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.354 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.653 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.1 tp -72.01 -34.8 69.14 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.405 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.58 -12.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.257 0.551 . . . . 0.0 110.026 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.609 ' N ' ' O ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -51.43 -33.55 31.15 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.075 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.27 -33.86 32.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.0 110.916 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 30.54 -149.98 0.01 OUTLIER Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 51.31 48.88 22.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.289 -1.124 . . . . 0.0 110.248 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.96 38.12 27.59 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.647 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -54.82 -44.62 74.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.452 -1.028 . . . . 0.0 109.7 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.614 ' CH2' ' N ' ' A' ' 1' ' ' MET . 40.9 t-105 -56.79 -31.32 64.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 108.606 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.89 -43.6 73.34 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.535 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.8 mt -59.41 -43.47 90.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.624 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.2 -32.71 74.18 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -52.82 -34.33 53.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.79 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -67.59 -44.81 77.26 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.536 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.85 -30.96 71.66 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 66.88 101.26 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 111.393 178.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.471 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -125.53 78.92 0.37 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 144' ' ' GLY . 32.1 Cg_exo -54.68 144.25 65.59 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.942 2.428 . . . . 0.0 112.739 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.486 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 0.4 OUTLIER -64.42 -64.0 3.2 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.415 -0.803 . . . . 0.0 109.895 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 142' ' ' SER . 12.0 Cg_endo -57.58 -33.99 97.4 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.344 2.029 . . . . 0.0 111.9 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -114.3 117.39 4.09 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -93.31 169.04 10.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.176 -1.19 . . . . 0.0 109.718 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.45 HG21 ' OAP' ' A' ' 201' ' ' 96F . 60.8 m -57.47 -38.47 74.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.791 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.802 HD11 ' CAK' ' A' ' 201' ' ' 96F . 4.9 mp -67.83 -32.64 73.32 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.75 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.15 -43.06 88.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.372 -0.83 . . . . 0.0 112.486 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.2 OUTLIER -74.09 -53.09 10.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.763 -1.211 . . . . 0.0 111.785 -177.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.725 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.31 -33.73 75.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.656 -1.278 . . . . 0.0 110.487 -178.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.725 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -64.65 -43.75 92.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.059 . . . . 0.0 110.003 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.96 -39.82 90.99 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.438 -0.789 . . . . 0.0 109.657 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 149' ' ' ARG . 18.2 t -64.61 -40.32 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.033 -1.042 . . . . 0.0 108.24 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.462 HD13 ' NE2' ' A' ' 20' ' ' HIS . 99.3 mt . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.689 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.802 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -61.55 146.43 96.96 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.728 2.286 . . . . 0.0 112.177 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.57 -30.83 71.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.19 143.76 26.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -0.844 . . . . 0.0 109.657 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.05 90.71 41.98 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.534 -0.729 . . . . 0.0 109.833 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' HG13 ' A' ' 8' ' ' VAL . 44.6 Cg_endo -78.93 166.77 22.91 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.188 1.925 . . . . 0.0 111.571 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 41.1 p30 -65.52 126.21 27.6 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.068 -1.02 . . . . 0.0 110.185 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG22 ' NE2' ' A' ' 121' ' ' HIS . 3.7 m -138.75 141.99 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.592 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 71.8 ttp85 -122.68 122.35 38.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.269 -0.894 . . . . 0.0 109.632 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -136.7 148.47 47.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p -140.02 152.53 46.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.903 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.06 155.19 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 109.007 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.79 134.71 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.061 -1.024 . . . . 0.0 109.334 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.1 m -129.13 162.85 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -0.755 . . . . 0.0 109.82 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.72 94.77 7.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.153 -0.967 . . . . 0.0 109.616 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.68 164.36 2.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.4 t -100.1 146.54 26.67 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.4 m -54.32 -40.25 47.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 120.861 -1.149 . . . . 0.0 109.549 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.16 -39.91 91.88 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.536 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 24.3 t60 -64.93 -41.56 95.42 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.493 0.663 . . . . 0.0 109.677 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.6 m -51.05 -44.47 61.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.799 . . . . 0.0 109.488 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -83.13 -27.29 30.23 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.442 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 27' ' ' SER . 87.1 tt0 -59.76 -41.65 91.52 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.578 -1.249 . . . . 0.0 107.64 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.536 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 83.9 t -65.13 -40.17 87.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -57.22 -47.09 82.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.534 -0.729 . . . . 0.0 110.174 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.656 HG22 ' CD2' ' A' ' 49' ' ' PHE . 79.4 p -96.57 -3.07 43.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.067 -1.021 . . . . 0.0 111.147 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 42.4 t -97.38 -40.66 8.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.733 -1.229 . . . . 0.0 111.749 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -177.03 58.16 0.14 Allowed Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.402 -1.436 . . . . 0.0 111.65 -178.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 10.9 Cg_endo -57.66 -38.23 94.07 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.079 1.853 . . . . 0.0 113.177 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.52 63.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.982 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -55.56 -32.57 63.11 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.976 -1.078 . . . . 0.0 110.033 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.666 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -99.07 108.06 20.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.112 -0.993 . . . . 0.0 108.36 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.851 ' CZ2' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -112.68 160.51 30.32 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.483 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -72.72 154.28 54.21 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.624 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.56 110.01 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.267 1.978 . . . . 0.0 112.025 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.1 p -154.57 163.56 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -54.57 -31.96 57.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.156 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 40' ' ' VAL . 47.8 t -100.11 140.45 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.194 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.851 HD11 ' CZ2' ' A' ' 33' ' ' TRP . 41.2 tp -47.72 -41.99 24.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.371 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 33' ' ' TRP . 30.1 m -134.51 124.28 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.286 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -62.48 -36.55 82.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 151.65 21.75 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.502 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 96.9 mt-10 -76.15 103.22 6.08 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.872 -1.142 . . . . 0.0 110.034 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 59' ' ' GLU . 84.7 mtt180 -123.73 132.49 53.83 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -133.34 -41.25 0.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 110.16 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.53 169.35 24.61 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 pp -154.89 139.97 17.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.544 -1.562 . . . . 0.0 112.06 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -116.1 133.14 56.34 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.3 m-85 -133.97 134.9 43.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.942 -1.099 . . . . 0.0 111.06 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.779 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.9 mm-40 -131.05 136.54 29.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.87 130.29 3.07 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.363 2.042 . . . . 0.0 112.519 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.779 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.48 179.97 0.06 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.081 -1.012 . . . . 0.0 110.649 -178.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.84 143.84 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.5 31.1 79.12 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.78 175.36 41.35 Favored Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.765 -1.217 . . . . 0.0 114.339 -175.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HE ' HG21 ' A' ' 68' ' ' VAL . 73.9 mtp180 -144.92 143.71 30.7 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.202 1.001 . . . . 0.0 111.714 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.858 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 16.7 m-85 -120.01 142.12 49.1 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 11.4 m-85 -129.06 143.74 50.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 111.33 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 2.2 mt-10 -128.04 146.35 50.7 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.578 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -103.65 129.72 51.0 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.136 -0.978 . . . . 0.0 109.836 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' OD2' ' O ' ' A' ' 43' ' ' GLU . 64.9 m-20 -92.83 136.91 32.83 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.31 -39.39 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.83 -0.544 . . . . 0.0 110.5 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -104.61 -15.9 15.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 108.894 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.67 143.68 17.73 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 66' ' ' GLU . 18.9 m -60.88 178.57 0.23 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 122.172 -0.605 . . . . 0.0 109.604 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 65' ' ' THR . 1.6 pp20? -82.43 150.69 26.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.912 HG21 ' O ' ' A' ' 91' ' ' TRP . 45.2 mt -149.77 155.68 7.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.518 HG21 ' HE ' ' A' ' 56' ' ' ARG . 10.7 p -85.27 130.29 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 6.0 p90 -104.23 0.21 29.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.211 -0.931 . . . . 0.0 111.004 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -170.69 -171.42 36.01 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.973 -1.585 . . . . 0.0 110.842 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.673 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.4 ttp180 -142.85 -177.86 5.53 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.858 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.4 mp -132.12 164.76 33.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.2 mt -115.22 -52.21 2.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.763 -1.211 . . . . 0.0 108.363 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -160.27 159.26 31.18 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 7.2 p-90 -134.56 111.95 10.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.354 -1.339 . . . . 0.0 112.439 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -115.42 96.19 45.17 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 176.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 16.6 Cg_exo -57.39 -43.52 51.07 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 122.532 2.155 . . . . 0.0 114.788 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 58.5 Cg_endo -76.55 11.27 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.81 1.673 . . . . 0.0 115.21 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 107' ' ' PHE . 1.2 t-80 -176.78 -48.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 119.765 -1.834 . . . . 0.0 113.54 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 21.9 ttm180 -144.24 144.74 31.65 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.156 -1.59 . . . . 0.0 113.061 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.1 mp -139.38 124.78 19.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.11 152.33 26.13 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.517 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 3.9 ptp -149.43 143.99 26.07 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.474 -1.69 . . . . 0.0 112.906 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.615 ' O ' ' C ' ' A' ' 71' ' ' ARG . 9.4 m -103.79 153.04 21.17 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.46 ' HA ' ' H ' ' A' ' 71' ' ' ARG . 12.7 m0 -103.76 127.79 51.2 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.553 -1.342 . . . . 0.0 111.444 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 70' ' ' GLY . 55.6 ttt180 -114.54 98.81 7.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 91' ' ' TRP . 19.6 tt -148.3 158.9 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.867 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 20.2 t0 -106.34 171.83 7.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 109.544 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 88' ' ' ASP . . . -57.41 -35.88 74.09 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.97 41.72 1.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.173 -1.193 . . . . 0.0 110.332 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.912 ' O ' HG21 ' A' ' 67' ' ' ILE . 4.1 m-90 55.82 26.64 9.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.715 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 92.1 mt-30 -98.59 150.51 21.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 109.403 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.4 p -86.22 150.58 24.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.675 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -146.45 156.73 49.34 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.358 -0.839 . . . . 0.0 109.114 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.556 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 9.7 Cg_endo -55.19 -32.94 82.54 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.445 2.097 . . . . 0.0 111.69 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 56.1 m-20 -159.27 146.93 17.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.472 -0.768 . . . . 0.0 109.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 87.3 m-20 -105.69 117.85 35.08 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.884 . . . . 0.0 110.213 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.1 -26.37 62.11 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.286 -0.884 . . . . 0.0 108.835 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -98.83 35.36 1.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.627 -0.671 . . . . 0.0 109.486 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.83 142.44 27.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.134 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.6 m -125.8 170.04 12.0 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.53 139.85 42.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.05 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.441 HD12 ' NE1' ' A' ' 85' ' ' TRP . 74.5 mt -121.56 140.09 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.65 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.829 . . . . 0.0 109.482 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.6 HG22 ' HG ' ' A' ' 119' ' ' LEU . 22.7 t -130.29 135.84 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -117.17 132.02 56.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -0.906 . . . . 0.0 109.854 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 79' ' ' HIS . 38.7 m-85 -115.35 121.87 44.14 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.331 -0.856 . . . . 0.0 109.405 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.09 122.23 26.98 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HB3' HG22 ' A' ' 18' ' ' VAL . 79.2 Cg_endo -80.7 132.8 8.97 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.937 1.758 . . . . 0.0 112.82 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -119.42 140.64 50.08 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.95 -179.77 21.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.15 12.75 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -1.08 . . . . 0.0 109.582 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.08 67.44 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.55 141.23 10.87 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -134.26 120.4 19.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -1.046 . . . . 0.0 109.206 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -104.29 117.4 34.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.412 HG21 ' CAF' ' A' ' 201' ' ' 96F . 67.0 t -122.38 138.68 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.416 -0.802 . . . . 0.0 110.795 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -119.86 103.7 9.57 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.76 124.76 49.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.266 -0.896 . . . . 0.0 109.908 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.27 114.09 14.02 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.482 -0.761 . . . . 0.0 109.257 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.721 ' ND1' HD12 ' A' ' 124' ' ' LEU . 21.0 p80 -105.57 135.0 47.77 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.1 m -131.64 152.99 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 122.227 1.013 . . . . 0.0 111.957 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt 58.64 31.73 21.42 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.515 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.721 HD12 ' ND1' ' A' ' 121' ' ' HIS . 21.3 mt -70.94 -38.01 72.85 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.817 -1.177 . . . . 0.0 107.9 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 32.8 t60 -45.63 -11.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.861 -0.525 . . . . 0.0 110.045 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.5 tpt180 -50.1 -35.07 24.08 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 108.47 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.796 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -86.53 -27.17 24.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.981 . . . . 0.0 109.546 179.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 131' ' ' ALA . . . 38.23 -147.37 0.11 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 131' ' ' ALA . 79.8 m-20 48.92 -140.46 0.7 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 109.285 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.16 44.6 0.9 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.796 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.95 -57.09 14.34 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.627 -0.925 . . . . 0.0 110.412 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -59.04 -29.55 67.37 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.157 . . . . 0.0 108.828 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 -54.89 -43.36 73.14 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 89.6 mt -59.39 -42.53 87.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.57 -32.32 73.91 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.8 -37.62 60.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.05 -43.63 86.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 93.6 mt -67.64 -6.61 21.25 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 61.99 101.58 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.593 0.711 . . . . 0.0 111.575 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.5 82.09 0.34 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -53.8 145.11 51.74 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.711 2.274 . . . . 0.0 112.466 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.645 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -83.03 -41.96 0.85 Allowed Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 142' ' ' SER . 7.3 Cg_exo -69.62 -68.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.69 2.26 . . . . 0.0 112.132 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -90.78 179.78 43.04 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -120.03 171.69 8.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.474 -1.015 . . . . 0.0 109.392 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.481 HG21 ' OAP' ' A' ' 201' ' ' 96F . 47.5 m -57.88 -36.75 72.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.935 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.1 mp -66.36 -32.0 73.12 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.076 -1.015 . . . . 0.0 110.27 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.79 -49.95 59.61 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.156 -0.965 . . . . 0.0 112.352 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.599 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.3 ptt180 -66.06 -47.14 75.31 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.906 -1.121 . . . . 0.0 112.144 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -75.49 -33.73 60.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.498 -1.376 . . . . 0.0 110.517 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.85 -41.67 82.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.805 -1.184 . . . . 0.0 110.158 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.8 -45.6 91.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 0.0 110.616 -178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.526 HG13 HD21 ' A' ' 152' ' ' ASN . 15.9 m -65.94 -39.81 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.887 -1.133 . . . . 0.0 109.262 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 20' ' ' HIS . 62.8 mt . . . . . 0 C--N 1.303 -1.431 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.576 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.935 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.96 146.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.705 2.27 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.08 -29.52 70.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.792 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -97.08 142.28 29.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 109.731 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.792 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.17 94.03 45.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 109.704 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.94 165.46 31.32 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.841 1.694 . . . . 0.0 111.373 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.516 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 42.4 p30 -64.83 125.85 26.13 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.008 -1.058 . . . . 0.0 110.446 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG12 ' NE2' ' A' ' 121' ' ' HIS . 12.4 p -139.19 141.31 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.63 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 54.3 ttt180 -119.52 125.35 48.65 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.194 -0.941 . . . . 0.0 109.747 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -133.59 146.79 51.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.377 -0.827 . . . . 0.0 109.387 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 12' ' ' VAL . 95.5 p -142.87 148.95 37.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.824 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' SER . 24.9 t -154.25 155.81 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.39 -0.819 . . . . 0.0 109.413 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 47.4 t -100.68 133.22 44.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 109.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.74 162.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.564 -0.71 . . . . 0.0 109.507 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.63 8.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 109.642 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 115' ' ' THR . . . -175.98 163.63 2.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.997 -1.065 . . . . 0.0 110.194 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.3 t -101.27 147.59 26.12 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG23 ' N ' ' A' ' 19' ' ' GLU . 33.0 m -55.1 -40.55 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.932 -1.105 . . . . 0.0 109.877 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.05 -39.95 91.78 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 108.45 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.597 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.6 t60 -64.96 -41.03 95.82 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.47 0.652 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' HG21 ' A' ' 115' ' ' THR . 88.2 m -51.57 -44.09 62.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.512 -0.742 . . . . 0.0 109.681 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.21 -29.17 28.72 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.654 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.1 tt0 -59.33 -41.52 89.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 HG21 ' NE2' ' A' ' 20' ' ' HIS . 70.7 t -67.46 -39.81 83.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.471 0.653 . . . . 0.0 109.463 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 6.1 m-30 -55.85 -45.97 78.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.404 -0.81 . . . . 0.0 110.263 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 HG22 ' HD2' ' A' ' 49' ' ' PHE . 60.1 p -98.61 -3.34 36.43 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.006 -1.059 . . . . 0.0 111.228 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 43.5 t -97.9 -37.61 9.75 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.621 -1.299 . . . . 0.0 112.366 -178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.57 55.99 0.1 Allowed Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.344 -1.472 . . . . 0.0 111.363 -178.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 12.0 Cg_endo -57.84 -41.27 71.18 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.353 2.035 . . . . 0.0 113.319 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -73.93 -32.45 63.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.066 -1.021 . . . . 0.0 110.847 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -56.23 -32.01 64.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.953 -1.092 . . . . 0.0 110.34 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.624 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.12 111.59 23.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.601 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.3 p90 -112.5 153.53 44.88 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 33' ' ' TRP . 59.3 Cg_exo -31.28 155.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.67 2.246 . . . . 0.0 112.754 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.1 -30.13 89.35 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.483 2.122 . . . . 0.0 112.545 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.3 m -66.61 153.02 44.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.369 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -57.55 -44.09 84.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.022 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.84 140.36 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 108.95 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.0 tp -169.52 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.118 -0.989 . . . . 0.0 110.088 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 40' ' ' VAL . 9.8 p -60.07 128.05 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.952 -1.093 . . . . 0.0 109.109 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -62.3 -34.76 77.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 40' ' ' VAL . 55.5 pttt -117.73 143.8 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.503 -0.748 . . . . 0.0 109.222 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.592 ' HB2' HD12 ' A' ' 62' ' ' ILE . 96.6 mt-10 -79.51 117.86 20.84 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.95 -1.094 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 30' ' ' ALA . 83.3 mtt180 -70.84 142.21 51.26 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.53 -48.0 1.95 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -0.965 . . . . 0.0 111.114 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -146.92 171.63 27.6 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.059 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 pp -155.65 136.52 13.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -1.234 . . . . 0.0 111.488 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -111.91 131.14 55.57 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 2.6 m-85 -138.33 128.61 25.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.973 -1.079 . . . . 0.0 110.663 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -132.12 138.3 32.03 Favored Pre-proline 0 N--CA 1.497 1.884 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.889 178.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -84.55 134.42 5.61 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.469 2.113 . . . . 0.0 113.275 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.65 179.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.712 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.932 HG13 ' O ' ' A' ' 73' ' ' LEU . 55.1 t -92.48 141.91 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.98 85.99 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 104.4 -3.48 . . . . 0.0 104.4 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.62 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.66 178.33 32.31 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 113.939 -1.131 . . . . 0.0 113.978 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.576 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 81.7 mtm180 -148.13 144.87 28.1 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 122.497 1.142 . . . . 0.0 111.347 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.848 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 21.8 m-85 -120.75 153.03 37.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.576 ' OH ' ' NE ' ' A' ' 56' ' ' ARG . 35.8 m-85 -142.49 151.15 41.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.754 -1.216 . . . . 0.0 112.439 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.719 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 98.1 mt-10 -133.96 153.67 51.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -112.04 129.79 56.09 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.189 -0.945 . . . . 0.0 109.69 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.851 ' OD1' HD13 ' A' ' 62' ' ' ILE . 1.2 t0 -104.42 135.27 46.17 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.851 HD13 ' OD1' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -53.48 -35.27 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.497 -0.752 . . . . 0.0 110.357 -177.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.7 ' H ' HD13 ' A' ' 62' ' ' ILE . 96.6 m-20 -104.47 -10.76 17.45 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' A' ' 61' ' ' ASP . . . -112.64 136.72 13.7 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-O 122.597 1.109 . . . . 0.0 111.254 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -59.98 -177.89 0.07 Allowed 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 114.914 -0.643 . . . . 0.0 109.754 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -83.1 139.98 32.9 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -149.11 166.89 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.81 -1.181 . . . . 0.0 110.469 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 70' ' ' GLY . 9.1 p -96.23 141.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 108.987 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 14.4 m95 -109.18 -3.94 16.91 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 111.337 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -176.75 -171.43 40.38 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.724 -1.703 . . . . 0.0 110.707 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.693 ' C ' HD12 ' A' ' 72' ' ' ILE . 5.5 ttp180 -138.34 -178.22 5.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.848 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -130.89 161.95 39.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 53' ' ' VAL . 7.4 mt -113.83 -49.53 2.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.072 -1.018 . . . . 0.0 108.881 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -177.88 151.9 0.72 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.477 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.9 p-90 -105.31 121.76 44.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.049 -1.032 . . . . 0.0 110.099 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -100.77 130.59 25.01 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 79' ' ' HIS . 46.4 Cg_exo -30.0 153.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.69 2.26 . . . . 0.0 112.459 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.9 Cg_exo -29.38 78.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.34 2.693 . . . . 0.0 112.373 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.654 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.98 -40.38 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.602 -0.686 . . . . 0.0 109.841 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 35.4 ttm180 -152.31 139.74 19.56 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.247 -1.381 . . . . 0.0 111.706 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -138.84 126.0 21.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.565 -0.709 . . . . 0.0 109.359 178.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.13 151.04 25.92 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 2.3 ptp -149.73 145.18 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.098 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -102.87 157.78 16.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.684 ' CD1' HD12 ' A' ' 103' ' ' ILE . 4.8 m0 -107.91 121.79 45.48 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 111.25 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.503 ' H ' ' C ' ' A' ' 70' ' ' GLY . 29.9 ttm180 -115.73 111.73 20.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.486 -0.759 . . . . 0.0 109.117 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.669 HD13 HG23 ' A' ' 134' ' ' ILE . 19.4 tt -148.65 163.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 0.0 110.694 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 23.3 t70 -87.64 -176.56 5.6 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.548 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -98.07 -40.93 3.4 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.168 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -112.04 41.74 1.9 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.309 -1.113 . . . . 0.0 110.804 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.596 ' CZ3' HD11 ' A' ' 87' ' ' ILE . 39.7 m95 56.07 47.78 18.99 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 109.756 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.586 ' O ' ' CB ' ' A' ' 93' ' ' SER . 84.3 mt-30 -117.93 -88.8 0.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.825 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.586 ' CB ' ' O ' ' A' ' 92' ' ' GLN . 1.5 t 153.04 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.77 62.25 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 109.337 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.96 -31.73 94.04 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.544 2.163 . . . . 0.0 111.747 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -155.13 150.81 27.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 93.8 m-20 -105.68 117.63 34.52 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 110.427 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -75.28 -23.58 57.43 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 108.542 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -96.38 34.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.591 0.71 . . . . 0.0 109.094 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.55 24.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 110.42 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.7 p -133.33 171.3 14.22 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -108.27 141.58 39.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 109.731 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.684 HD12 ' CD1' ' A' ' 85' ' ' TRP . 70.1 mt -121.07 140.96 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.484 -0.76 . . . . 0.0 109.1 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.8 122.24 47.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 107' ' ' PHE . 37.1 t -128.91 135.66 61.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.423 -0.798 . . . . 0.0 109.246 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -117.14 131.49 56.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -0.892 . . . . 0.0 109.632 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 105' ' ' VAL . 30.5 m-85 -114.3 125.22 53.64 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.463 -0.773 . . . . 0.0 108.932 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.28 123.4 25.94 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.519 -0.738 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.43 121.34 5.59 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.095 1.863 . . . . 0.0 112.342 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 114' ' ' GLY . 24.7 t-20 -119.19 126.16 50.9 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.39 173.31 0.03 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.3 p -64.38 -22.37 66.93 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.35 -1.088 . . . . 0.0 109.283 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.47 49.83 0.86 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.474 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -135.91 130.78 5.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.613 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.93 131.72 39.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.104 -1.233 . . . . 0.0 110.599 -179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -114.95 118.51 33.64 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.434 HG21 ' CAF' ' A' ' 201' ' ' 96F . 44.9 t -124.24 139.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 111.46 -177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -121.19 102.25 8.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.2 tt -104.95 127.66 52.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 110.022 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.38 114.21 14.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.844 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.714 ' NE2' HG12 ' A' ' 8' ' ' VAL . 15.9 p80 -100.01 129.38 46.06 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -130.41 152.75 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 122.375 1.084 . . . . 0.0 112.645 -177.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt 59.01 31.6 21.51 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.936 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.713 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 38.7 mt -69.61 -38.69 77.37 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.654 -1.279 . . . . 0.0 107.74 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.7 t60 -44.99 -11.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.326 0.584 . . . . 0.0 109.707 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.627 ' N ' ' O ' ' A' ' 124' ' ' LEU . 56.2 ttm-85 -50.08 -32.96 16.96 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.713 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -80.19 -30.72 38.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.689 178.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 33.96 28.17 0.01 OUTLIER Glycine 0 N--CA 1.498 2.791 0 O-C-N 121.566 -0.709 . . . . 0.0 111.337 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.58 ' N ' ' O ' ' A' ' 127' ' ' HIS . 60.2 t0 -140.0 110.6 6.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.837 -1.39 . . . . 0.0 109.445 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.89 39.67 3.77 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -62.61 -57.81 9.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.756 -0.849 . . . . 0.0 111.203 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -57.68 -27.59 63.02 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.727 -1.233 . . . . 0.0 108.903 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -54.33 -43.53 71.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.669 HG23 HD13 ' A' ' 87' ' ' ILE . 87.1 mt -58.74 -40.86 80.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.588 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -66.06 -30.44 70.96 Favored 'General case' 0 C--N 1.29 -1.983 0 O-C-N 120.693 -1.254 . . . . 0.0 109.005 177.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -52.25 -39.71 60.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.652 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.537 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . . . -70.15 -43.13 71.53 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.092 -1.443 . . . . 0.0 108.203 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.532 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 91.8 mt -61.66 -28.1 69.15 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 59.46 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.405 0.621 . . . . 0.0 110.961 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -121.02 82.37 0.35 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.492 ' O ' ' O ' ' A' ' 144' ' ' GLY . 45.9 Cg_exo -53.66 141.87 62.86 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.707 2.272 . . . . 0.0 112.641 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -71.2 -43.55 12.95 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.472 -0.768 . . . . 0.0 110.161 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 142' ' ' SER . 43.2 Cg_exo -55.51 -31.9 80.35 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.691 2.261 . . . . 0.0 112.563 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -147.56 172.88 27.84 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -118.04 174.24 6.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.523 HG21 ' OAP' ' A' ' 201' ' ' 96F . 28.1 m -57.72 -35.98 71.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.91 HD11 ' CAK' ' A' ' 201' ' ' 96F . 4.9 mp -63.97 -31.81 73.13 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.131 -0.98 . . . . 0.0 109.783 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -47.78 61.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.314 -0.866 . . . . 0.0 112.122 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.585 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.0 OUTLIER -72.03 -49.54 35.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.872 -1.142 . . . . 0.0 111.865 -177.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.724 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.36 -33.09 74.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.711 -1.243 . . . . 0.0 110.065 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.724 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.53 -43.69 80.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.922 -1.111 . . . . 0.0 110.141 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.585 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -62.03 -45.79 92.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -178.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.582 HG13 HD21 ' A' ' 152' ' ' ASN . 15.6 m -65.64 -40.07 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.045 -1.034 . . . . 0.0 109.496 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.7 mt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.56 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.91 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' NZ ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 21.9 Cg_exo -60.1 147.68 92.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.776 2.317 . . . . 0.0 112.124 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.43 -26.86 68.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.251 -0.906 . . . . 0.0 109.133 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.7 tt0 -94.41 139.59 30.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 109.775 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.602 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -119.84 90.49 43.78 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.503 -0.748 . . . . 0.0 109.747 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.39 165.76 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.964 1.776 . . . . 0.0 111.255 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 122' ' ' VAL . 44.2 p30 -64.74 125.96 26.42 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.06 -1.025 . . . . 0.0 109.99 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.6 141.24 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.188 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.654 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 61.5 ttp180 -121.64 120.5 34.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.273 -0.892 . . . . 0.0 109.815 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttm -136.44 147.43 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.815 . . . . 0.0 109.258 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 117' ' ' VAL . 21.0 t -139.92 141.08 36.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' HB ' HD22 ' A' ' 147' ' ' LEU . 11.3 t -142.04 155.27 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.431 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.7 p -104.07 137.47 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.124 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.57 164.62 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.498 -0.751 . . . . 0.0 109.819 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 96.3 7.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.828 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 113' ' ' GLY . . . -176.16 163.74 2.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.076 -1.015 . . . . 0.0 109.567 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.4 t -102.21 146.66 27.67 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 19' ' ' GLU . 34.8 m -52.61 -43.84 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.842 -1.161 . . . . 0.0 109.548 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.1 -39.97 91.95 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.485 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.6 t60 -67.03 -39.83 87.07 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.603 0.716 . . . . 0.0 109.547 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' HG21 ' A' ' 115' ' ' THR . 99.8 m -50.84 -42.94 59.0 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.518 -0.739 . . . . 0.0 109.225 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' CE1' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -82.4 -25.25 33.9 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.036 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 27' ' ' SER . 85.9 tt0 -59.82 -40.37 88.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.607 HG21 HD11 ' A' ' 154' ' ' ILE . 55.5 t -67.46 -40.22 84.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.486 0.66 . . . . 0.0 109.307 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -56.57 -47.09 80.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.662 -0.649 . . . . 0.0 110.851 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 49' ' ' PHE . 67.2 p -96.91 -2.88 42.89 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.951 -1.093 . . . . 0.0 110.943 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 29.9 t -92.17 -47.47 7.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.761 -1.212 . . . . 0.0 111.497 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -172.98 56.77 0.21 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.502 -1.374 . . . . 0.0 111.682 -178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' CE1' ' A' ' 49' ' ' PHE . 6.1 Cg_endo -51.68 -33.04 47.66 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 121.986 1.791 . . . . 0.0 113.23 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HA ' HH21 ' A' ' 44' ' ' ARG . . . -76.96 -39.45 50.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.949 -1.094 . . . . 0.0 111.129 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.34 -32.25 48.21 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.072 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.678 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -96.87 105.93 18.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 108.338 178.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 9.7 p90 -112.86 149.99 42.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.031 -1.043 . . . . 0.0 108.889 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.16 123.16 10.57 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.15 1.9 . . . . 0.0 112.141 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.89 128.99 10.37 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 122.025 1.816 . . . . 0.0 111.854 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.1 p -157.08 171.23 20.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.501 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -55.11 -34.87 64.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.05 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.29 136.09 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.346 -0.846 . . . . 0.0 109.385 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' VAL . 54.3 mt -79.02 159.57 27.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 42' ' ' LYS . 13.9 p -41.13 136.39 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.423 -0.798 . . . . 0.0 109.257 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.31 -37.45 83.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.981 . . . . 0.0 109.309 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 40' ' ' VAL . 1.3 pttt -117.81 143.35 46.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -86.25 123.17 31.21 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.084 -1.01 . . . . 0.0 109.767 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.427 HH21 ' HA ' ' A' ' 30' ' ' ALA . 75.9 mtt180 -66.36 143.27 57.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.112 -0.992 . . . . 0.0 108.584 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.56 -48.15 2.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.35 -0.844 . . . . 0.0 110.943 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.21 169.45 28.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.01 131.81 11.56 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.621 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.95 133.85 48.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.6 m-85 -141.05 124.04 16.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.995 -1.066 . . . . 0.0 110.848 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.787 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -131.53 137.55 30.7 Favored Pre-proline 0 N--CA 1.494 1.761 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.678 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 67.5 Cg_endo -85.43 136.08 5.41 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.392 2.061 . . . . 0.0 113.671 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.787 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.85 -175.97 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.205 -0.934 . . . . 0.0 110.469 -179.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.98 142.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' HA2' ' NH2' ' A' ' 71' ' ' ARG . . . 64.58 32.85 85.58 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 104.775 -3.33 . . . . 0.0 104.775 -176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.606 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.61 177.35 37.48 Favored Glycine 0 N--CA 1.481 1.7 0 CA-C-O 122.283 0.935 . . . . 0.0 114.269 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -148.55 144.31 27.21 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.516 1.15 . . . . 0.0 111.926 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.809 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 19.0 m-85 -121.07 144.33 48.6 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 9.4 m-85 -128.48 150.6 50.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.139 -0.976 . . . . 0.0 111.101 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.769 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -131.21 142.9 50.25 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.602 -0.687 . . . . 0.0 109.483 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.52 ' CE2' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -108.09 130.16 55.11 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 0.0 110.086 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.609 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.94 139.25 39.36 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.9 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -177.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -104.4 -8.11 19.41 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.66 134.43 12.1 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.721 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.51 -179.21 0.23 Allowed 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 60' ' ' TRP . 0.1 OUTLIER -93.49 144.05 25.72 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.198 -0.938 . . . . 0.0 109.862 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.416 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 19.3 tt -149.49 158.83 5.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.1 p -86.49 125.41 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.769 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -109.61 3.53 21.18 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 110.927 -178.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.84 -173.8 26.73 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.0 -1.571 . . . . 0.0 110.622 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 72' ' ' ILE . 21.3 ttt-85 -154.92 -177.9 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.809 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.5 mp -135.33 166.19 28.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.5 mt -114.16 -50.48 2.81 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.891 -1.131 . . . . 0.0 109.222 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -173.66 151.57 1.91 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.461 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.5 p-90 -108.07 125.24 51.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.508 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -108.63 128.81 24.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.8 Cg_exo -30.41 154.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.041 0 C-N-CA 122.748 2.299 . . . . 0.0 112.601 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' PRO . 69.5 Cg_exo -27.67 78.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.411 2.74 . . . . 0.0 112.491 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -178.08 -42.12 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.55 -0.719 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 44.3 ttp180 -153.36 138.1 17.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.049 -1.461 . . . . 0.0 112.087 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.4 mp -138.46 126.01 22.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.561 -0.712 . . . . 0.0 109.719 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.526 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -105.39 149.8 25.79 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -147.89 143.53 27.45 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 117.769 -1.573 . . . . 0.0 112.373 -178.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.587 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.8 m -102.91 157.82 16.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.713 ' HE1' ' H ' ' A' ' 101' ' ' SER . 0.7 OUTLIER -123.73 126.46 46.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.842 -1.161 . . . . 0.0 111.337 -178.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.93 111.04 20.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.331 -0.856 . . . . 0.0 109.357 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.606 ' N ' ' OD2' ' A' ' 97' ' ' ASP . 9.7 tt -141.72 156.24 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.414 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 94' ' ' VAL . 65.3 m-20 -96.29 160.29 14.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.13 -0.981 . . . . 0.0 109.485 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -62.29 -44.41 97.71 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.32 32.48 5.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.422 -1.046 . . . . 0.0 109.296 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.732 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.5 m-90 57.54 25.7 11.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.044 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.424 ' H ' ' H ' ' A' ' 93' ' ' SER . 1.1 pt20 176.43 9.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.367 -0.833 . . . . 0.0 108.961 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.475 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 5.2 t -56.99 -56.79 17.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.342 -0.849 . . . . 0.0 110.33 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 5.1 m -146.91 151.44 41.78 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 109.701 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.38 -38.16 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.405 2.07 . . . . 0.0 112.054 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -109.87 147.35 33.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.358 -0.838 . . . . 0.0 109.228 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.606 ' OD2' ' N ' ' A' ' 87' ' ' ILE . 92.0 m-20 -105.14 118.2 35.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -89.98 -9.11 49.94 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -116.27 36.48 4.07 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.849 -0.532 . . . . 0.0 109.67 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.88 145.34 26.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.066 -1.022 . . . . 0.0 109.935 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.713 ' H ' ' HE1' ' A' ' 85' ' ' TRP . 61.9 m -114.66 170.83 8.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.476 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -107.47 146.1 32.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 0.0 109.652 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 120' ' ' ALA . 66.9 mt -121.89 140.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -111.21 124.25 51.83 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 81' ' ' LEU . 39.4 t -131.0 137.18 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.399 -0.813 . . . . 0.0 109.911 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -117.38 131.61 56.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' HG12 ' A' ' 105' ' ' VAL . 17.1 m-85 -112.96 126.74 55.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.284 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.06 125.73 25.74 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.607 -0.683 . . . . 0.0 109.485 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.8 119.99 4.95 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.235 1.957 . . . . 0.0 112.319 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 114' ' ' GLY . 51.1 t30 -119.8 115.75 24.5 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.696 -0.627 . . . . 0.0 109.371 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . 64.01 25.92 69.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER 46.53 12.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -1.196 . . . . 0.0 108.976 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 111' ' ' GLY . . . -146.96 6.33 1.14 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -130.3 126.11 4.87 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.754 HG21 ' SG ' ' A' ' 21' ' ' CYS . 58.2 m -115.83 129.65 56.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -1.099 . . . . 0.0 110.404 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 33.5 ttp180 -104.81 118.87 37.63 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.616 HG21 ' CAF' ' A' ' 201' ' ' 96F . 48.8 t -121.91 135.21 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.762 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -114.7 101.62 9.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -104.27 126.79 51.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.654 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.41 114.56 14.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.604 -0.685 . . . . 0.0 109.498 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.6 p80 -102.82 129.69 49.58 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.2 m -132.34 164.05 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 112.212 -176.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 52.01 29.09 5.85 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.663 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -75.19 -40.61 59.16 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.949 -1.094 . . . . 0.0 108.244 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.504 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 10.3 t60 -45.03 -11.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 124' ' ' LEU . 97.8 mtt180 -50.8 -34.1 26.19 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.812 -1.18 . . . . 0.0 108.935 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.663 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -75.59 -22.8 56.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.066 -1.021 . . . . 0.0 109.582 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.85 -166.99 36.1 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.649 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -66.11 151.24 47.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.478 -1.013 . . . . 0.0 109.992 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.06 63.45 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.52 -40.72 97.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.513 -0.993 . . . . 0.0 109.546 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.417 ' HE3' HD12 ' A' ' 5' ' ' ILE . 28.0 t-105 -55.92 -29.56 60.27 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.834 -1.146 . . . . 0.0 108.175 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -55.02 -42.96 73.25 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.483 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 67.8 mt -60.0 -42.75 90.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.591 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -62.63 -33.69 75.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.739 179.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 68.8 mttm -53.03 -37.72 61.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.833 -1.167 . . . . 0.0 108.386 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.732 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -64.1 -43.68 94.62 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 89.4 mt -67.27 -23.03 65.64 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.522 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 4.9 t0 81.61 100.49 0.05 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.327 0.584 . . . . 0.0 110.712 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.442 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -117.6 70.5 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.76 137.76 78.79 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.057 1.838 . . . . 0.0 112.3 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.635 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -83.54 -41.81 0.8 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.374 -0.829 . . . . 0.0 109.969 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.54 -26.45 54.72 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.632 2.221 . . . . 0.0 112.386 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.93 168.58 25.0 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -103.87 164.23 11.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.254 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.496 HG21 ' OAP' ' A' ' 201' ' ' 96F . 82.0 m -57.75 -38.33 75.19 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.221 -0.924 . . . . 0.0 109.156 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.879 HD21 ' OAO' ' A' ' 201' ' ' 96F . 4.7 mp -68.18 -27.45 66.41 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 109.729 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.54 49.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.312 -0.867 . . . . 0.0 111.867 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.59 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -66.73 -52.12 48.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.98 -1.075 . . . . 0.0 111.669 -177.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.49 -33.98 76.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.548 -1.345 . . . . 0.0 110.424 -178.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -66.83 -46.01 76.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.843 -1.161 . . . . 0.0 110.222 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.38 -39.88 80.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.455 -179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 32' ' ' TRP . 43.3 t -66.07 -40.88 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.607 HD11 HG21 ' A' ' 24' ' ' VAL . 85.0 mt . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.787 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.879 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -59.76 147.32 92.72 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.733 2.289 . . . . 0.0 112.197 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.06 -29.99 71.25 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.292 -0.88 . . . . 0.0 109.347 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.778 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.2 tt0 -96.14 147.57 23.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.399 -0.813 . . . . 0.0 109.787 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.778 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -118.91 90.62 41.27 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.565 -0.71 . . . . 0.0 110.018 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.69 163.02 29.55 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.199 1.933 . . . . 0.0 111.516 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.6 p30 -65.0 125.97 26.56 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.095 -1.003 . . . . 0.0 110.042 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG12 ' NE2' ' A' ' 121' ' ' HIS . 11.2 p -139.45 141.22 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.461 -0.774 . . . . 0.0 109.428 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.601 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 41.8 ttm180 -120.23 119.74 34.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -136.76 147.21 46.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -138.33 150.92 47.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.428 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -148.46 155.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.488 HG22 HH21 ' A' ' 116' ' ' ARG . 46.3 t -103.46 133.96 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.13 -0.981 . . . . 0.0 109.325 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.1 162.99 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.755 . . . . 0.0 109.367 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.33 7.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 115' ' ' THR . . . -177.04 164.36 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.047 -1.033 . . . . 0.0 110.246 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -98.74 152.62 19.48 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 23.7 m -61.35 -37.81 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.802 -1.186 . . . . 0.0 110.199 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.2 mt-10 -61.1 -39.41 89.85 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.617 ' NE2' HG21 ' A' ' 24' ' ' VAL . 16.8 t60 -64.05 -40.05 95.42 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.549 0.69 . . . . 0.0 109.511 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 115' ' ' THR . 71.7 m -51.5 -43.86 62.36 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.528 -0.733 . . . . 0.0 109.672 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.26 -28.6 29.05 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.546 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.9 tt0 -59.5 -41.22 89.41 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.006 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG21 ' NE2' ' A' ' 20' ' ' HIS . 84.5 t -68.47 -39.99 81.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.68 -0.638 . . . . 0.0 109.552 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 6.5 m-30 -55.53 -47.66 75.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.612 -0.68 . . . . 0.0 110.936 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.716 HG22 ' CD2' ' A' ' 49' ' ' PHE . 33.9 p -95.71 -3.34 46.14 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.996 -1.065 . . . . 0.0 111.016 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 68.4 m -94.28 -44.61 7.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.751 -1.218 . . . . 0.0 111.237 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.93 59.23 0.11 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.58 -1.325 . . . . 0.0 111.585 -178.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HA ' ' CE3' ' A' ' 32' ' ' TRP . 12.3 Cg_endo -58.53 -28.11 84.57 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 121.375 1.383 . . . . 0.0 113.131 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.36 -34.89 58.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 110.845 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -60.27 -32.7 71.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.947 -1.096 . . . . 0.0 112.237 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.608 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.1 OUTLIER -75.45 -24.85 57.07 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.177 -1.577 . . . . 0.0 110.153 -178.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.602 ' CD1' ' C ' ' A' ' 33' ' ' TRP . 0.3 OUTLIER -49.69 -58.12 10.18 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.546 -1.346 . . . . 0.0 110.847 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 33' ' ' TRP . 1.6 Cg_endo -48.62 -57.95 2.05 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.066 1.844 . . . . 0.0 114.024 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.19 -23.58 70.05 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.495 1.463 . . . . 0.0 111.927 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 54.3 p -73.12 162.81 29.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.858 . . . . 0.0 109.475 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 37' ' ' HIS . 58.2 t-80 -92.29 16.14 12.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.25 -0.906 . . . . 0.0 109.554 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.1 t -105.45 136.34 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.524 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.6 mt -92.49 157.0 16.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.91 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 42' ' ' LYS . 9.8 p -117.24 142.17 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -61.27 -38.77 87.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 109.11 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' HG22 ' A' ' 40' ' ' VAL . 55.1 pttt -117.8 142.91 46.76 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -82.75 121.34 26.77 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.856 -1.153 . . . . 0.0 109.449 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -76.06 142.5 41.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 108.849 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.75 -47.93 1.39 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.254 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -136.14 163.82 25.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.05 138.71 16.96 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.933 -1.333 . . . . 0.0 110.831 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -105.24 141.19 37.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.716 ' CD2' HG22 ' A' ' 26' ' ' THR . 1.6 m-85 -140.99 125.31 17.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.767 -1.208 . . . . 0.0 111.503 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.758 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -131.89 136.68 28.72 Favored Pre-proline 0 N--CA 1.494 1.737 0 C-N-CA 119.224 -0.99 . . . . 0.0 108.693 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' CD2' ' A' ' 52' ' ' PHE . 58.6 Cg_endo -86.96 135.79 4.04 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.68 2.254 . . . . 0.0 113.783 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.758 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.26 -176.77 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.206 -0.934 . . . . 0.0 110.719 -179.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.66 143.34 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.403 ' HA2' ' NH1' ' A' ' 71' ' ' ARG . . . 64.56 32.55 84.56 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.465 -3.454 . . . . 0.0 104.465 -176.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.616 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -72.95 175.91 44.32 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.486 1.048 . . . . 0.0 114.383 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' CD ' HH21 ' A' ' 86' ' ' ARG . 93.5 mtm-85 -147.45 144.41 28.6 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 122.592 1.187 . . . . 0.0 111.765 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 72' ' ' ILE . 17.9 m-85 -120.31 144.66 47.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.832 ' CE1' HG22 ' A' ' 68' ' ' VAL . 10.2 m-85 -124.38 146.31 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -0.958 . . . . 0.0 111.893 -176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' C ' ' CD ' ' A' ' 59' ' ' GLU . 3.3 tm-20 -124.99 143.05 51.1 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.495 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.35 129.1 54.95 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.299 -0.876 . . . . 0.0 108.649 178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.601 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -103.63 136.46 43.3 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.24 -38.37 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 110.433 -178.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -104.63 -8.43 18.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.82 138.24 14.83 Favored Glycine 0 N--CA 1.48 1.58 0 CA-C-O 122.695 1.164 . . . . 0.0 110.798 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' OD2' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -62.81 -178.8 0.23 Allowed 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.339 0.59 . . . . 0.0 109.781 178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.495 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 71.3 tt0 -76.56 141.63 41.09 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 17.0 tt -151.29 166.03 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.945 -1.097 . . . . 0.0 110.408 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.832 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.5 t -97.38 129.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.54 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 3.0 p90 -102.14 -9.28 20.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.051 -1.031 . . . . 0.0 110.397 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -163.92 -172.5 31.48 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 118.955 -1.593 . . . . 0.0 111.033 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.662 ' C ' HD12 ' A' ' 72' ' ' ILE . 2.2 ttp85 -143.04 -178.16 5.7 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.805 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -132.43 165.42 32.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' HG22 ' A' ' 72' ' ' ILE . 7.3 mt -114.34 -52.53 2.72 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.699 -1.25 . . . . 0.0 109.607 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.5 tt0 -178.55 156.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.404 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 24.2 p-90 -104.57 130.27 52.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.129 -0.982 . . . . 0.0 109.499 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.7 t70 -90.49 131.96 36.69 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.028 -1.045 . . . . 0.0 109.035 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 78' ' ' PRO . 6.7 Cg_exo -42.67 -46.09 8.34 Favored 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.671 2.247 . . . . 0.0 113.434 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 77' ' ' PRO . 36.6 Cg_exo -58.98 -132.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.072 1.181 . . . . 0.0 109.058 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.668 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -119.19 52.93 1.04 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' CD ' ' OD1' ' A' ' 106' ' ' ASP . 23.0 ttp180 -136.18 132.86 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.663 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.64 138.81 46.11 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.381 0.61 . . . . 0.0 109.562 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.24 151.42 23.4 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -146.01 140.83 27.13 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 117.63 -1.628 . . . . 0.0 112.94 -178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.614 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.6 m -103.84 149.3 25.19 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.683 ' NE1' HD12 ' A' ' 103' ' ' ILE . 24.9 m0 -102.15 125.39 48.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.578 -1.326 . . . . 0.0 111.569 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.633 ' H ' ' C ' ' A' ' 70' ' ' GLY . 69.1 ttt180 -114.37 94.89 5.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.394 -0.816 . . . . 0.0 108.803 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.492 ' O ' ' OD1' ' A' ' 97' ' ' ASP . 14.9 tt -135.22 151.45 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.488 ' OD2' ' O ' ' A' ' 94' ' ' VAL . 10.7 m-20 -84.98 156.82 20.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.284 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.4 -43.8 98.86 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.59 31.23 6.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -1.114 . . . . 0.0 109.444 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 7.0 m-90 57.53 26.37 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.235 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 177.16 3.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.221 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 t -59.1 -58.68 7.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.272 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.488 ' O ' ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -146.94 157.03 47.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.557 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.6 -29.63 51.38 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.482 2.121 . . . . 0.0 111.375 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 97' ' ' ASP . 39.9 t0 -149.9 147.85 28.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 108.92 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.492 ' OD1' ' O ' ' A' ' 87' ' ' ILE . 74.2 m-20 -106.21 120.59 42.22 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.289 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -62.57 -15.05 49.15 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 127' ' ' HIS . 2.9 mtp85 -83.42 25.89 0.71 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.84 141.72 29.42 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 123' ' ' LYS . 48.1 m -115.28 172.04 7.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.31 139.7 40.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.111 -0.993 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.683 HD12 ' NE1' ' A' ' 85' ' ' TRP . 64.1 mt -120.75 140.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.889 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -111.77 128.47 56.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.422 -0.799 . . . . 0.0 109.072 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 119' ' ' LEU . 39.5 t -130.62 134.25 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' OD1' ' CD ' ' A' ' 80' ' ' ARG . 66.7 m-20 -119.48 132.08 55.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.364 -0.835 . . . . 0.0 109.475 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.668 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 54.7 m-85 -113.76 140.36 48.35 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.927 0.87 . . . . 0.0 109.461 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.95 121.97 15.0 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.483 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 64.9 Cg_endo -75.92 119.93 5.58 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.083 1.855 . . . . 0.0 112.406 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.5 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 54.4 t-20 -114.61 126.27 54.71 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.69 171.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.0 p -64.89 -21.78 66.88 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.259 -1.142 . . . . 0.0 109.022 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.77 45.75 1.08 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.425 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.75 132.18 6.34 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.615 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.06 139.03 49.85 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.147 -1.208 . . . . 0.0 110.693 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.488 HH21 HG22 ' A' ' 13' ' ' VAL . 45.6 ttt85 -124.4 118.25 26.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.525 HG21 ' CAF' ' A' ' 201' ' ' 96F . 58.7 t -124.17 138.41 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.828 . . . . 0.0 110.933 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.35 103.01 9.39 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.95 126.04 50.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 109.667 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -131.7 114.74 15.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.379 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.882 ' ND1' HD12 ' A' ' 124' ' ' LEU . 17.7 p80 -106.99 135.78 47.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 7' ' ' ASP . 27.7 m -132.22 153.26 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 0.0 112.112 -177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' O ' ' OG ' ' A' ' 101' ' ' SER . 4.2 mmtt 58.15 31.97 21.42 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.484 177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.882 HD12 ' ND1' ' A' ' 121' ' ' HIS . 13.1 mt -71.2 -41.4 70.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.697 -1.252 . . . . 0.0 108.285 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 16.7 t60 -44.45 -11.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.313 0.578 . . . . 0.0 110.134 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.636 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.1 tpt180 -50.54 -34.13 24.29 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.243 -0.911 . . . . 0.0 109.037 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.82 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -87.14 -34.63 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.887 -1.133 . . . . 0.0 111.297 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 33.97 -154.11 0.01 OUTLIER Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 52.96 53.18 12.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.049 -1.265 . . . . 0.0 110.42 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.43 29.86 35.21 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.794 -1.723 . . . . 0.0 108.794 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.82 ' HB1' ' CE1' ' A' ' 127' ' ' HIS . . . -57.19 -49.02 77.3 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.655 -0.909 . . . . 0.0 109.775 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.413 ' HE3' HD12 ' A' ' 5' ' ' ILE . 43.8 t-105 -57.94 -30.46 65.98 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 108.943 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -55.22 -43.62 74.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 86.9 mt -59.72 -42.02 87.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.614 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.9 -33.75 76.4 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.792 -0.567 . . . . 0.0 109.723 179.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -53.26 -38.28 62.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.905 -1.122 . . . . 0.0 108.763 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.714 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -63.74 -43.21 97.15 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.575 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 93.5 mt -66.67 -16.38 64.17 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.581 ' OD2' ' NH1' ' A' ' 149' ' ' ARG . 6.2 t0 86.24 90.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.438 0.637 . . . . 0.0 110.576 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.52 ' CA ' ' CE1' ' A' ' 135' ' ' HIS . . . -115.12 84.5 0.37 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.26 142.95 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.475 2.117 . . . . 0.0 112.257 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.634 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.3 OUTLIER -80.83 -42.83 1.24 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.702 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 142' ' ' SER . 18.1 Cg_exo -63.35 -70.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.635 2.223 . . . . 0.0 112.451 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.64 -178.98 45.03 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 78.0 mm-40 -122.3 165.99 15.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.478 -1.013 . . . . 0.0 109.235 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.408 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 42.0 m -57.96 -36.78 73.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.942 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.3 mp -67.54 -30.01 69.55 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.15 -0.969 . . . . 0.0 109.688 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.47 83.71 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.258 -0.901 . . . . 0.0 112.272 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.586 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.1 OUTLIER -72.14 -53.13 13.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.699 -1.25 . . . . 0.0 111.74 -177.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.713 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.35 -33.7 75.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.571 -1.331 . . . . 0.0 110.39 -178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.713 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -67.31 -44.7 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.97 -1.081 . . . . 0.0 110.154 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -58.69 -40.29 83.19 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.352 -0.842 . . . . 0.0 109.54 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 32' ' ' TRP . 22.3 t -65.09 -40.53 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.534 HD13 ' NE2' ' A' ' 20' ' ' HIS . 88.3 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.726 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.942 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.678 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.8 Cg_exo -59.35 149.49 80.87 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.438 2.092 . . . . 0.0 112.368 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.99 -26.48 67.62 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.273 -0.892 . . . . 0.0 109.071 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.673 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -94.71 142.99 26.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.663 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.673 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.28 90.9 43.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.828 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 41.9 Cg_endo -78.81 165.25 24.72 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.038 1.825 . . . . 0.0 111.673 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 35.3 p30 -64.81 125.95 26.44 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.149 -0.969 . . . . 0.0 110.358 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 121' ' ' HIS . 9.1 p -139.11 141.49 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.082 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 77.9 ttt180 -122.94 124.95 44.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -138.36 144.82 40.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.8 m -140.9 147.93 39.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.49 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -150.92 156.33 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.151 -0.968 . . . . 0.0 109.389 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.36 136.29 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.074 -1.016 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' OG1' ' A' ' 115' ' ' THR . 32.5 m -130.38 162.79 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.531 -0.73 . . . . 0.0 109.349 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.32 94.19 7.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.872 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.46 162.78 2.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.964 -1.085 . . . . 0.0 109.808 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.2 p -97.66 157.09 16.23 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 19' ' ' GLU . 28.3 m -60.95 -39.46 82.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 120.616 -1.303 . . . . 0.0 109.431 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.2 tt0 -61.18 -38.06 85.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.768 ' NE2' HG21 ' A' ' 24' ' ' VAL . 33.0 t60 -63.83 -43.19 96.94 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' HG21 ' A' ' 115' ' ' THR . 96.7 m -50.77 -47.3 59.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.453 -0.779 . . . . 0.0 109.566 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.1 m-85 -84.19 -31.04 25.31 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.263 -0.975 . . . . 0.0 111.37 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -59.48 -41.34 89.56 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 118.489 -1.284 . . . . 0.0 107.951 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.768 HG21 ' NE2' ' A' ' 20' ' ' HIS . 97.9 t -68.89 -39.62 80.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.519 -0.738 . . . . 0.0 110.165 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.7 m-30 -52.49 -44.75 65.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.984 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 60.4 p -91.04 -2.88 57.59 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.24 -0.913 . . . . 0.0 110.57 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -94.1 -48.52 6.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.711 -1.243 . . . . 0.0 111.516 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -179.14 57.92 0.1 Allowed Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.526 -1.359 . . . . 0.0 111.664 -178.5 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.591 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 9.9 Cg_endo -55.65 -20.9 29.37 Favored 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 121.945 1.763 . . . . 0.0 112.048 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.54 -51.64 6.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.57 -1.331 . . . . 0.0 110.519 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 32' ' ' TRP . 37.4 t0 -55.61 -9.34 0.5 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.562 -0.711 . . . . 0.0 111.948 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.591 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 2.7 m0 -42.26 -40.37 2.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.637 -1.29 . . . . 0.0 109.956 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.633 ' O ' ' CD2' ' A' ' 33' ' ' TRP . 63.8 p-90 -78.9 117.49 67.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.924 -1.11 . . . . 0.0 110.281 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.586 ' O ' ' N ' ' A' ' 36' ' ' SER . 88.2 Cg_endo -82.75 161.63 16.38 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 122.138 1.892 . . . . 0.0 111.098 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -40.25 83.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.312 2.008 . . . . 0.0 111.72 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 34' ' ' PRO . 95.5 p -129.72 158.76 38.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 109.92 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -56.03 -34.86 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.513 -0.742 . . . . 0.0 110.202 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.0 m -121.42 141.12 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.433 -0.792 . . . . 0.0 109.759 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.604 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -158.8 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.636 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 ' HE ' ' A' ' 44' ' ' ARG . 53.4 t -115.9 140.32 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -60.5 -36.34 78.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 108.671 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' H ' HG12 ' A' ' 40' ' ' VAL . 35.5 pttt -109.11 143.21 38.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -71.27 123.39 22.16 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.957 -1.089 . . . . 0.0 109.64 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HE ' HG11 ' A' ' 40' ' ' VAL . 80.3 mtt180 -84.74 141.44 30.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -112.96 -48.17 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.762 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.58 175.96 36.4 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.466 -1.35 . . . . 0.0 109.878 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.915 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.57 138.11 15.97 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.103 -1.234 . . . . 0.0 110.376 179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -103.2 134.77 46.06 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.691 ' CD2' ' CD1' ' A' ' 57' ' ' TYR . 1.9 m-85 -140.41 130.05 24.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -0.981 . . . . 0.0 110.639 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.682 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 22.7 mm-40 -131.25 136.25 28.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 119.589 -0.844 . . . . 0.0 108.8 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -87.2 126.88 2.41 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.205 1.937 . . . . 0.0 113.026 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.718 ' CD2' ' N ' ' A' ' 52' ' ' PHE . 0.0 OUTLIER 171.29 178.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.279 -0.888 . . . . 0.0 110.425 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.4 m -92.11 143.74 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.41 31.37 80.63 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 104.663 -3.375 . . . . 0.0 104.663 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.624 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -74.68 178.35 45.74 Favored Glycine 0 N--CA 1.479 1.504 0 CA-C-N 114.176 -1.012 . . . . 0.0 113.481 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 72.8 mtm180 -148.57 143.71 26.79 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.041 0.924 . . . . 0.0 111.221 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.836 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 13.8 m-85 -121.19 152.23 39.04 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.602 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.4 m-85 -136.49 154.09 50.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.0 111.821 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.776 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 84.2 tt0 -128.68 147.07 50.72 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.33 128.77 55.36 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.128 -0.983 . . . . 0.0 109.49 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -102.51 136.36 42.48 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.65 -38.4 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.725 . . . . 0.0 111.108 -177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.85 -11.45 16.75 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 61' ' ' ASP . . . -112.49 138.16 14.78 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-O 122.388 0.993 . . . . 0.0 110.863 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.0 m -60.11 -179.14 0.1 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 121.289 0.566 . . . . 0.0 109.861 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.74 ' H ' HG22 ' A' ' 65' ' ' THR . 3.6 tt0 -91.78 146.23 23.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.459 -0.776 . . . . 0.0 109.138 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.593 HD13 ' O ' ' A' ' 91' ' ' TRP . 1.8 mt -151.58 167.62 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 6.3 p -88.79 133.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.637 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.776 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 9.3 m95 -109.96 2.65 19.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 0.0 110.692 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -172.35 -170.14 35.84 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.056 -1.545 . . . . 0.0 110.715 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.646 ' C ' HD12 ' A' ' 72' ' ' ILE . 19.9 ttt180 -152.77 -177.33 6.19 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.836 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 3.4 mp -135.3 166.62 27.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 120.979 -1.076 . . . . 0.0 109.201 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.5 mt -115.73 -51.35 2.67 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.285 1.041 . . . . 0.0 108.678 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -170.85 143.61 2.09 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.462 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 13.4 p-90 -114.52 112.6 23.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 0.0 111.639 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' H ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -114.45 96.27 42.62 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.495 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 10.2 Cg_exo -57.49 -43.03 54.93 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.271 1.98 . . . . 0.0 114.003 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 77' ' ' PRO . 77.1 Cg_exo -47.34 -17.57 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.492 2.128 . . . . 0.0 114.753 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER 178.46 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.942 -1.724 . . . . 0.0 112.895 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 34.6 ttm180 -151.14 141.9 22.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.899 -1.751 . . . . 0.0 113.427 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 107' ' ' PHE . 5.0 mp -130.08 127.36 39.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.08 151.74 23.63 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.455 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.4 ptp -150.19 141.05 22.8 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 117.611 -1.635 . . . . 0.0 112.172 -178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.613 ' O ' ' C ' ' A' ' 71' ' ' ARG . 18.0 m -103.23 148.76 25.4 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.61 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -112.06 128.46 56.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.633 -1.292 . . . . 0.0 110.944 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 70' ' ' GLY . 76.3 ttt180 -114.41 111.28 21.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.466 HD13 ' CG2' ' A' ' 134' ' ' ILE . 15.7 tt -148.1 162.12 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 22.2 t70 -111.03 168.56 9.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 0.0 110.605 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.723 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -64.26 -49.68 64.59 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 35.81 2.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.046 -1.267 . . . . 0.0 109.516 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 5.7 m-90 56.9 25.99 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.808 . . . . 0.0 110.362 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -105.56 106.2 16.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.066 -1.021 . . . . 0.0 108.937 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -48.32 138.83 9.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.002 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -124.99 156.86 68.6 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -51.77 -29.56 34.44 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.4 2.067 . . . . 0.0 111.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -158.62 149.89 20.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' OD2' HG23 ' A' ' 94' ' ' VAL . 79.1 m-20 -105.38 117.86 35.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -85.15 -8.98 58.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.723 ' NH1' ' H ' ' A' ' 89' ' ' GLY . 1.7 ptt180 -111.39 35.25 3.68 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.576 0.703 . . . . 0.0 109.182 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.53 149.99 24.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.07 -1.019 . . . . 0.0 109.976 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 122' ' ' VAL . 17.2 t -133.16 171.67 13.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.561 -0.712 . . . . 0.0 109.399 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -107.27 139.71 41.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.333 -0.854 . . . . 0.0 109.464 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.5 mt -123.19 136.09 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.587 -0.696 . . . . 0.0 109.472 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.76 122.85 48.92 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 107' ' ' PHE . 41.2 t -128.13 140.55 48.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.464 -0.773 . . . . 0.0 109.256 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -115.99 131.23 57.0 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.097 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 81' ' ' LEU . 64.5 m-85 -120.66 122.63 40.89 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.484 -0.76 . . . . 0.0 109.046 178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -133.09 129.51 20.99 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -75.88 124.88 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.111 1.874 . . . . 0.0 112.725 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 114' ' ' GLY . 54.1 t-20 -119.44 125.03 47.96 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.89 173.91 0.09 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.9 p -64.5 -23.6 67.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -1.086 . . . . 0.0 109.269 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.7 50.04 0.81 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.825 -1.179 . . . . 0.0 110.404 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -132.35 131.16 6.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.675 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -131.53 127.53 37.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.327 -1.102 . . . . 0.0 110.628 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.442 ' HB3' HG13 ' A' ' 108' ' ' VAL . 18.0 ttp180 -111.85 120.32 41.56 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.54 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.7 t -125.02 139.29 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.158 -0.964 . . . . 0.0 111.356 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -120.31 102.16 8.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.7 tt -104.07 128.42 51.68 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.16 -0.962 . . . . 0.0 109.998 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.47 114.76 14.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.0 110.174 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -100.8 132.51 46.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' O ' ' OG ' ' A' ' 101' ' ' SER . 27.8 m -136.84 154.26 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 118.855 -1.138 . . . . 0.0 112.075 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 55.16 31.0 15.49 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.432 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 tp -71.65 -37.17 70.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 7.4 t60 -45.66 -10.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.414 0.626 . . . . 0.0 109.665 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 124' ' ' LEU . 15.8 tpt180 -49.98 -32.66 15.62 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.1 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.65 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.35 -23.4 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 109.705 179.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.553 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 89.35 -166.12 33.09 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.96 -1.115 . . . . 0.0 110.485 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -65.3 151.21 46.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.47 -1.018 . . . . 0.0 110.15 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.51 62.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.61 -39.64 94.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.38 -1.071 . . . . 0.0 109.644 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.678 ' CH2' ' N ' ' A' ' 1' ' ' MET . 46.8 t-105 -57.51 -33.59 68.2 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.96 -1.087 . . . . 0.0 108.865 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -55.64 -44.13 76.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.743 -1.223 . . . . 0.0 107.915 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 134' ' ' ILE . 1.9 mp -59.82 -41.86 87.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.6 OUTLIER -63.3 -31.9 73.17 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -52.44 -35.43 52.19 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.56 -44.49 86.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.55 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 19.3 mt -67.35 -25.44 65.99 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 59.02 97.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 111.675 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.497 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -127.66 78.47 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' O ' ' O ' ' A' ' 144' ' ' GLY . 39.0 Cg_exo -53.83 138.86 69.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.819 2.346 . . . . 0.0 112.62 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.575 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.2 OUTLIER -60.21 -45.57 97.74 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.807 . . . . 0.0 109.92 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 142' ' ' SER . 42.7 Cg_exo -55.06 -29.79 66.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.64 2.227 . . . . 0.0 112.385 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 141' ' ' PRO . . . -142.89 136.38 7.06 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.42 173.92 6.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.515 HG21 ' OAP' ' A' ' 201' ' ' 96F . 20.1 m -57.36 -36.29 71.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 109.271 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.904 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -61.94 -33.91 75.13 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.371 -0.83 . . . . 0.0 109.587 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.83 11.07 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.35 -0.843 . . . . 0.0 111.556 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.683 HH12 ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -65.76 -44.55 85.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.15 -0.969 . . . . 0.0 111.861 -177.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.703 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -76.28 -33.91 59.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.78 -1.2 . . . . 0.0 110.973 -178.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.703 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -70.2 -42.57 72.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.406 -1.434 . . . . 0.0 110.209 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.622 HD21 HG13 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -61.71 -44.82 96.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.756 . . . . 0.0 110.464 -178.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.622 HG13 HD21 ' A' ' 152' ' ' ASN . 16.0 m -66.12 -38.94 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.09 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.488 HD13 ' NE2' ' A' ' 20' ' ' HIS . 68.7 mt . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.07 -1.019 . . . . 0.0 109.681 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.862 ' CAL' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.444 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 22.0 Cg_exo -60.69 147.02 96.21 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.76 2.306 . . . . 0.0 112.126 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.48 -29.29 70.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.397 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.633 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -93.6 143.09 26.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.823 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.03 90.09 40.55 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.747 -179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 8' ' ' VAL . 55.0 Cg_endo -80.97 168.38 17.33 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.255 1.97 . . . . 0.0 111.223 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 38.0 p30 -64.78 126.23 27.3 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 109.91 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG22 ' NE2' ' A' ' 121' ' ' HIS . 4.8 m -138.39 141.7 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.429 -0.794 . . . . 0.0 109.484 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 22.6 ttm180 -124.11 120.72 33.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.307 -0.87 . . . . 0.0 109.293 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -137.08 147.08 45.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 109.755 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -136.45 148.21 47.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.59 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 13' ' ' VAL . 49.7 t -148.8 155.42 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.767 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' N ' HG12 ' A' ' 12' ' ' VAL . 46.2 t -102.08 131.62 49.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.94 162.58 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 109.624 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.43 94.33 7.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 0.0 109.577 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' OG1' ' A' ' 115' ' ' THR . . . -176.4 163.84 2.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.013 -1.054 . . . . 0.0 109.751 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -102.11 149.84 23.87 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 19' ' ' GLU . 32.3 m -53.92 -38.73 37.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.746 -1.221 . . . . 0.0 109.366 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.1 mt-10 -61.35 -39.9 92.29 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.731 ' NE2' HG21 ' A' ' 24' ' ' VAL . 32.6 t60 -63.89 -43.53 95.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.703 . . . . 0.0 109.588 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.617 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 52.7 m -51.12 -45.18 61.49 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.426 -0.796 . . . . 0.0 109.696 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.97 -31.29 27.66 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.962 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -59.38 -41.61 89.74 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.43 -1.308 . . . . 0.0 107.582 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.731 HG21 ' NE2' ' A' ' 20' ' ' HIS . 91.3 t -69.24 -40.17 80.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.678 -0.639 . . . . 0.0 110.21 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -53.39 -44.96 69.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.192 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 49' ' ' PHE . 51.0 p -91.24 -2.83 57.37 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.061 -1.024 . . . . 0.0 110.561 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.0 t -95.51 -47.04 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.894 -1.129 . . . . 0.0 111.35 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.74 57.47 0.1 Allowed Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.467 -1.395 . . . . 0.0 112.082 -178.381 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 3.1 Cg_endo -52.45 -24.07 20.79 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 121.561 1.507 . . . . 0.0 112.268 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.91 -45.44 12.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.414 -1.429 . . . . 0.0 110.878 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 32' ' ' TRP . 20.5 t0 -57.63 -9.62 1.24 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.477 -0.764 . . . . 0.0 111.983 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.602 ' CE3' ' O ' ' A' ' 29' ' ' PRO . 3.0 m0 -43.24 -37.79 2.3 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.638 -1.289 . . . . 0.0 109.47 -178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.56 139.53 96.08 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.067 -1.021 . . . . 0.0 109.115 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.05 152.42 45.86 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.184 1.923 . . . . 0.0 112.05 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.84 134.27 39.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.355 2.036 . . . . 0.0 111.917 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 82.8 p -151.41 159.17 44.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.987 . . . . 0.0 109.664 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.95 -33.19 64.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.332 -0.855 . . . . 0.0 109.296 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.8 140.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.395 -0.816 . . . . 0.0 109.68 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 40' ' ' VAL . 40.9 tp -85.21 143.36 28.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.416 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 42' ' ' LYS . 24.2 m -43.45 145.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -61.5 -35.84 78.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.15 142.35 27.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.283 -0.886 . . . . 0.0 108.721 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 96.9 mt-10 -72.32 104.88 3.86 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.907 -1.121 . . . . 0.0 109.905 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' NH1' ' OD2' ' A' ' 139' ' ' ASP . 84.6 mtt180 -122.61 139.24 54.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -0.883 . . . . 0.0 110.252 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -159.88 176.14 36.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.912 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -154.86 134.3 12.61 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.914 -1.345 . . . . 0.0 110.131 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -102.98 140.71 36.9 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 57' ' ' TYR . 1.7 m-85 -141.73 124.89 16.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.204 -0.935 . . . . 0.0 109.872 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.851 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 12.6 tp10 -130.81 136.43 28.91 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 97.1 Cg_endo -84.12 138.0 7.59 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.36 2.04 . . . . 0.0 113.314 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.851 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -175.98 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.283 -0.885 . . . . 0.0 109.958 -179.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.71 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.33 33.43 87.21 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 104.368 -3.493 . . . . 0.0 104.368 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.605 ' H ' ' HB ' ' A' ' 72' ' ' ILE . . . -70.52 179.31 29.95 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 113.915 -1.143 . . . . 0.0 114.736 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.575 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 85.7 mtm180 -147.89 145.67 28.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.369 1.08 . . . . 0.0 111.739 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.698 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 19.3 m-85 -119.22 142.21 48.22 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.825 ' CE2' HG22 ' A' ' 68' ' ' VAL . 14.4 m-85 -123.94 145.22 49.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.371 -0.831 . . . . 0.0 111.927 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.729 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.7 tt0 -128.72 143.05 50.84 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -107.96 130.12 55.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.73 138.29 41.24 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.225 177.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.66 -42.53 22.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.269 0.557 . . . . 0.0 110.012 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -103.86 -6.45 21.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.8 138.58 15.08 Favored Glycine 0 N--CA 1.484 1.844 0 CA-C-O 122.627 1.126 . . . . 0.0 110.945 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 66' ' ' GLU . 6.6 m -63.47 -179.68 0.37 Allowed 'General case' 0 C--N 1.288 -2.069 0 O-C-N 122.073 -0.663 . . . . 0.0 109.925 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.702 ' H ' HG22 ' A' ' 65' ' ' THR . 71.9 tt0 -76.6 143.97 39.88 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 92' ' ' GLN . 2.1 tp -151.33 156.54 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.763 -1.21 . . . . 0.0 110.674 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.825 HG22 ' CE2' ' A' ' 58' ' ' TYR . 17.2 t -95.42 124.08 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.729 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.05 3.31 18.52 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.207 -178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.31 -172.14 28.26 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.107 -1.52 . . . . 0.0 110.405 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.632 ' CZ ' ' NH1' ' A' ' 86' ' ' ARG . 21.9 ttt85 -153.14 -178.32 6.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.635 HD11 ' CE1' ' A' ' 57' ' ' TYR . 84.8 mt -130.07 166.61 27.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.6 mt -113.14 -52.08 2.79 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.867 -1.146 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -174.33 154.89 2.24 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.452 ' CG ' ' O ' ' A' ' 75' ' ' TRP . 56.1 p-90 -106.61 128.15 53.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.0 110.252 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.2 OUTLIER -110.5 128.64 25.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.4 Cg_exo -29.81 153.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 122.66 2.24 . . . . 0.0 112.86 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' PRO . 99.8 Cg_exo -29.52 79.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.347 2.698 . . . . 0.0 112.225 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.0 t-80 -179.17 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.707 -0.62 . . . . 0.0 109.571 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.479 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 72.1 ttt180 -152.97 144.98 23.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.434 -1.307 . . . . 0.0 111.877 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.66 127.13 15.03 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.74 24.28 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.488 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 1.2 ptp -148.05 142.2 26.07 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.144 -179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.603 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.0 m -103.85 148.09 26.54 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -107.42 127.16 53.34 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.702 -1.249 . . . . 0.0 110.501 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.632 ' NH1' ' CZ ' ' A' ' 71' ' ' ARG . 25.0 ttm180 -115.01 109.67 18.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.221 -0.924 . . . . 0.0 109.716 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.1 tt -148.48 156.15 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 0.0 109.404 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 44.8 t0 -106.93 173.31 6.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.253 -0.904 . . . . 0.0 109.673 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -61.18 -37.32 93.78 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.21 39.33 1.83 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.007 -1.29 . . . . 0.0 110.604 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 137' ' ' ALA . 4.0 m-90 55.06 47.14 22.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.991 -1.068 . . . . 0.0 109.804 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.54 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 89.5 mt-30 -120.02 151.93 38.26 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -97.91 139.95 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 0.0 109.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.559 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -131.63 157.1 79.09 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.761 . . . . 0.0 109.095 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -53.04 -31.09 52.16 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.534 2.156 . . . . 0.0 111.306 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -161.09 147.7 14.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.72 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 86.7 m-20 -105.69 118.96 37.93 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 110.183 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -68.66 -27.98 66.47 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.147 -0.971 . . . . 0.0 108.492 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -100.94 34.79 2.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.671 -0.643 . . . . 0.0 109.686 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -88.1 150.85 23.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.965 -1.084 . . . . 0.0 109.923 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.0 p -133.12 170.33 15.56 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.38 141.49 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 0.0 109.826 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.1 mt -118.34 138.88 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -111.46 123.5 50.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' HG ' ' A' ' 119' ' ' LEU . 25.7 t -128.22 136.39 60.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.445 -0.784 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -116.42 131.16 57.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.388 -0.82 . . . . 0.0 109.337 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 79' ' ' HIS . 81.7 m-85 -115.8 125.68 53.03 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.48 -0.762 . . . . 0.0 109.288 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.53 126.37 25.02 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.81 120.88 5.65 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.074 1.85 . . . . 0.0 112.319 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.496 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 50.4 t30 -116.89 126.41 52.95 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.72 172.12 0.03 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.5 p -64.51 -22.33 66.93 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.314 -1.11 . . . . 0.0 109.146 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.2 46.97 0.99 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.392 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -133.54 132.89 6.67 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.597 ' OG1' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -131.41 131.09 43.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.187 -1.184 . . . . 0.0 110.572 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -115.22 118.42 33.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.47 HG21 ' CAF' ' A' ' 201' ' ' 96F . 46.9 t -125.13 139.41 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 111.579 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -121.11 102.44 8.32 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.575 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.22 127.67 51.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 0.0 110.383 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.32 114.29 14.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.435 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.709 ' NE2' HG22 ' A' ' 8' ' ' VAL . 19.7 p80 -106.26 134.52 49.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.2 m -132.85 155.54 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 122.377 1.085 . . . . 0.0 112.469 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt 59.08 31.0 20.93 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.009 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.65 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 42.0 mt -73.28 -36.69 66.37 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.62 -1.3 . . . . 0.0 108.165 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 24.9 t60 -45.27 -12.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.877 -0.514 . . . . 0.0 111.223 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 124' ' ' LEU . 80.4 mtt-85 -51.18 -33.89 29.23 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.761 -1.212 . . . . 0.0 108.523 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.756 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.57 -25.06 33.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.227 -0.921 . . . . 0.0 109.397 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.5 -145.31 0.09 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 131' ' ' ALA . 80.5 m-20 44.89 -147.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -1.072 . . . . 0.0 109.384 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.0 53.78 1.38 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -63.16 -54.41 38.07 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.365 -1.079 . . . . 0.0 110.202 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.45 ' N ' HD11 ' A' ' 5' ' ' ILE . 29.5 t-105 -59.09 -34.47 72.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 0.0 109.256 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -54.9 -39.4 68.71 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.228 -0.92 . . . . 0.0 108.623 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.555 ' HA ' ' CZ2' ' A' ' 91' ' ' TRP . 91.2 mt -58.53 -45.71 90.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 122.379 1.085 . . . . 0.0 108.149 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.573 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -66.02 -32.84 74.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.27 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.2 tttt -57.54 -40.56 79.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 111.427 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . . . -73.2 -30.94 63.88 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 118.271 -1.372 . . . . 0.0 107.507 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -59.84 -32.9 71.11 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.586 ' OD2' ' NH1' ' A' ' 44' ' ' ARG . 49.6 t0 -173.1 -56.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.737 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.01 64.23 4.14 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 142' ' ' SER . 36.9 Cg_endo -70.77 150.09 61.53 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.884 2.389 . . . . 0.0 113.188 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -51.76 -177.55 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.1 -12.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.329 1.352 . . . . 0.0 111.212 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 142' ' ' SER . . . -68.39 152.32 52.33 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 74.9 mm-40 -96.53 165.33 12.21 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.189 -1.183 . . . . 0.0 109.082 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.424 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 40.3 m -57.14 -37.7 72.41 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.038 -1.039 . . . . 0.0 108.825 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.737 HD12 ' H ' ' A' ' 147' ' ' LEU . 5.0 mp -65.09 -32.3 73.94 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.561 -0.712 . . . . 0.0 109.194 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.55 -51.51 14.44 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.376 -0.827 . . . . 0.0 111.842 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.585 ' NH1' ' OD1' ' A' ' 139' ' ' ASP . 0.1 OUTLIER -65.66 -46.86 77.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.009 . . . . 0.0 112.057 -177.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -75.75 -34.86 60.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.912 -1.118 . . . . 0.0 111.003 -178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -68.56 -41.85 79.19 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.455 -1.403 . . . . 0.0 110.195 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -61.66 -46.83 88.06 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.344 -0.848 . . . . 0.0 110.974 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 32' ' ' TRP . 16.9 m -64.1 -37.99 81.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.491 -0.756 . . . . 0.0 110.477 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.424 HD13 ' NE2' ' A' ' 20' ' ' HIS . 73.1 mt . . . . . 0 C--N 1.301 -1.508 0 O-C-N 120.951 -1.093 . . . . 0.0 109.607 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.617 ' CAD' ' CZ ' ' A' ' 150' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.62 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 1' ' ' MET . 23.4 Cg_exo -60.52 147.88 92.9 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.642 2.228 . . . . 0.0 112.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.38 -27.85 69.59 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.33 -0.856 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.706 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -95.63 140.93 29.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.807 . . . . 0.0 109.781 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.706 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.33 89.54 40.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.887 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 6.3 Cg_exo -72.3 166.13 30.64 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.194 1.929 . . . . 0.0 111.443 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -65.15 125.75 25.96 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.189 -0.945 . . . . 0.0 109.914 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' CD2' ' A' ' 121' ' ' HIS . 11.0 p -139.29 141.69 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 59.8 ttt85 -116.31 126.6 53.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 109.653 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -134.68 145.96 49.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 109.806 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.8 p -143.22 145.5 32.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 109.152 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 11' ' ' SER . 28.3 t -155.11 155.75 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.161 -0.962 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 48.3 t -100.69 133.31 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.32 -0.863 . . . . 0.0 108.89 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.0 m -130.8 164.21 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.67 94.58 6.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.16 -0.962 . . . . 0.0 109.579 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -176.8 164.64 2.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.166 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.2 t -103.75 146.46 28.59 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 19' ' ' GLU . 17.0 m -56.48 -39.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.746 -1.221 . . . . 0.0 109.373 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.48 -40.08 93.24 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' NE2' HG21 ' A' ' 24' ' ' VAL . 23.0 t60 -65.92 -41.19 91.71 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.522 0.677 . . . . 0.0 109.492 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' A' ' 115' ' ' THR . 86.3 m -51.24 -43.27 61.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.599 -0.688 . . . . 0.0 109.473 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.82 -29.05 29.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.42 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.4 tt0 -59.25 -41.36 88.58 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG21 ' NE2' ' A' ' 20' ' ' HIS . 68.3 t -66.65 -40.06 85.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 21' ' ' CYS . 7.0 m-30 -56.84 -45.44 82.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 110.074 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 HG22 ' HD1' ' A' ' 49' ' ' PHE . 63.7 p -98.05 -3.39 38.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.081 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.7 t -98.86 -38.52 9.0 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.733 -1.229 . . . . 0.0 112.109 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.505 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.63 57.42 0.12 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.379 -1.45 . . . . 0.0 111.146 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 18.0 Cg_endo -60.71 -42.08 41.73 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.263 1.975 . . . . 0.0 113.069 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.661 ' HB1' ' CB ' ' A' ' 44' ' ' ARG . . . -73.88 -31.31 63.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.889 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.98 -32.2 63.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.919 -1.113 . . . . 0.0 110.174 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.631 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -97.95 111.54 23.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.001 -1.062 . . . . 0.0 109.086 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.434 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -111.92 156.15 42.18 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 108.893 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -38.92 98.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.042 2.495 . . . . 0.0 112.702 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.68 -7.18 8.58 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.289 1.992 . . . . 0.0 111.693 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 59.6 p -59.57 170.55 1.03 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.486 -0.759 . . . . 0.0 110.016 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -52.4 -31.05 32.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 109.858 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.19 130.31 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.011 -1.055 . . . . 0.0 109.792 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.0 mt -114.77 156.38 24.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.589 -0.694 . . . . 0.0 109.22 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.4 t -53.71 130.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.993 -1.067 . . . . 0.0 108.756 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 mttp -61.67 -37.39 83.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.109 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -95.59 144.08 26.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -94.48 122.76 37.39 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.92 -1.112 . . . . 0.0 109.327 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.661 ' CB ' ' HB1' ' A' ' 30' ' ' ALA . 50.1 mmt-85 -62.7 142.42 58.12 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.612 -1.305 . . . . 0.0 107.916 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.29 -47.93 3.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 111.038 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -148.12 173.14 28.24 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.282 -1.437 . . . . 0.0 109.938 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 pp -155.87 136.1 13.01 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.159 -1.201 . . . . 0.0 110.548 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.43 135.27 49.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' CE1' ' CD1' ' A' ' 57' ' ' TYR . 2.0 m-85 -140.83 129.44 22.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.047 -1.033 . . . . 0.0 110.599 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 45.6 mm-40 -131.26 137.38 30.47 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.847 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -86.53 131.67 3.47 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.362 2.041 . . . . 0.0 112.588 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.794 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.36 -177.09 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.042 -1.037 . . . . 0.0 110.822 -178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.74 142.88 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 32.67 84.97 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 104.274 -3.53 . . . . 0.0 104.274 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -71.14 174.38 40.96 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.906 -1.147 . . . . 0.0 114.583 -175.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' NH1' HH22 ' A' ' 86' ' ' ARG . 98.8 mtt180 -144.81 143.03 30.43 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.339 1.066 . . . . 0.0 111.661 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.867 ' CE2' HD11 ' A' ' 72' ' ' ILE . 23.3 m-85 -121.0 144.17 48.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.612 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 6.2 m-85 -133.2 149.23 52.03 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 0.0 111.761 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG3' ' HE1' ' A' ' 69' ' ' TRP . 46.5 mt-10 -130.82 144.49 51.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -104.38 129.25 52.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.38 -0.825 . . . . 0.0 108.88 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.3 OUTLIER -106.08 142.28 36.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.449 178.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -51.39 -45.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.578 -0.702 . . . . 0.0 109.849 -178.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -102.85 -3.63 26.01 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.93 126.35 7.61 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.67 -177.26 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' HB2' ' NE1' ' A' ' 60' ' ' TRP . 60.6 tt0 -76.53 136.64 39.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 15.8 tt -150.03 158.06 5.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 120.926 -1.109 . . . . 0.0 110.248 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' TYR . 4.1 p -98.12 128.92 49.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.49 ' HE1' ' HG3' ' A' ' 59' ' ' GLU . 4.2 p-90 -109.06 2.66 21.33 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.789 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -159.56 -173.31 27.86 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.031 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.734 ' C ' HD12 ' A' ' 72' ' ' ILE . 8.9 ttp180 -151.72 -178.86 6.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.867 HD11 ' CE2' ' A' ' 57' ' ' TYR . 2.2 mp -131.97 166.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 8.3 mt -114.16 -52.32 2.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.923 -1.111 . . . . 0.0 109.681 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.34 158.58 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.415 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 25.2 p-90 -102.06 130.23 48.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.0 109.612 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.9 t0 -91.6 130.86 37.65 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 108.917 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 78' ' ' PRO . 7.0 Cg_exo -42.06 -46.16 7.12 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 122.7 2.266 . . . . 0.0 113.499 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 77' ' ' PRO . 32.5 Cg_exo -60.01 -133.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 N-CA-C 109.01 -1.188 . . . . 0.0 109.01 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.663 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -118.4 54.14 0.95 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' CD ' ' OD2' ' A' ' 106' ' ' ASP . 27.8 ttp180 -135.82 134.77 39.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.539 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mp -135.96 133.9 38.06 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.347 0.594 . . . . 0.0 109.621 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.41 147.69 27.27 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.65 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -145.24 147.34 32.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 117.571 -1.651 . . . . 0.0 112.852 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.573 ' O ' ' C ' ' A' ' 71' ' ' ARG . 40.1 m -103.15 145.46 29.89 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD12 ' A' ' 103' ' ' ILE . 16.1 m0 -102.81 125.98 49.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.828 -1.17 . . . . 0.0 110.975 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 70' ' ' GLY . 74.6 ttt180 -115.11 100.25 8.03 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.607 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 16.8 tt -136.61 150.59 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.158 -0.964 . . . . 0.0 109.771 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 93' ' ' SER . 64.7 m-20 -84.8 159.2 20.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.096 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.37 -43.91 98.39 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 31.59 5.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.381 -1.07 . . . . 0.0 109.758 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.707 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 9.5 m-90 57.31 26.11 11.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.216 -0.928 . . . . 0.0 109.125 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 176.23 11.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.221 -0.924 . . . . 0.0 109.051 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 5.7 t -58.94 -66.24 0.54 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 110.36 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 1.5 m -146.57 153.47 47.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.011 . . . . 0.0 109.867 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 18.1 Cg_endo -62.34 -29.66 79.95 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.58 2.186 . . . . 0.0 112.414 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' OD1' ' NH1' ' A' ' 86' ' ' ARG . 87.8 m-20 -109.03 146.91 33.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 109.487 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.607 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -105.79 117.7 34.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.397 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -90.68 -8.86 48.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.359 -0.838 . . . . 0.0 108.806 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -116.13 36.75 3.93 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.416 0.627 . . . . 0.0 109.45 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.18 149.25 25.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.044 -1.035 . . . . 0.0 110.116 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.568 ' OG ' HD12 ' A' ' 124' ' ' LEU . 87.1 p -124.85 171.17 10.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.652 -0.655 . . . . 0.0 109.3 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -107.93 140.01 41.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.256 -0.902 . . . . 0.0 109.967 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 85' ' ' TRP . 73.7 mt -122.61 139.06 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.598 -0.688 . . . . 0.0 109.687 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -112.55 129.33 56.4 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 0.0 109.025 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.9 t -132.97 134.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.32 -0.863 . . . . 0.0 109.929 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' CD ' ' A' ' 80' ' ' ARG . 62.3 m-20 -118.06 132.09 56.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.827 . . . . 0.0 109.3 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.663 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 46.1 m-85 -113.86 139.78 48.88 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.89 119.34 13.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 71.7 Cg_endo -79.93 128.87 7.72 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.975 1.783 . . . . 0.0 112.614 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -115.77 136.95 52.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.49 -176.75 5.0 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.92 11.04 3.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -1.128 . . . . 0.0 109.426 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.05 70.23 1.31 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.75 140.4 9.18 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.551 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -133.53 120.85 21.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -1.104 . . . . 0.0 109.431 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -102.96 117.48 34.69 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.465 HG21 ' CAF' ' A' ' 201' ' ' 96F . 61.9 t -122.55 139.1 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.445 -0.784 . . . . 0.0 110.627 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -118.33 102.49 9.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -105.79 127.71 53.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.503 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.0 114.42 14.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.395 -0.816 . . . . 0.0 109.7 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.1 OUTLIER -99.76 134.11 43.14 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.81 153.52 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.976 -1.077 . . . . 0.0 112.189 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp 54.17 31.19 13.49 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.334 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.633 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.7 tp -71.16 -36.47 72.03 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 18.3 t60 -45.53 -12.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.188 0.518 . . . . 0.0 109.724 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 124' ' ' LEU . 27.6 tpt180 -50.9 -33.93 26.21 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.687 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -83.77 -24.01 31.26 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.388 -0.82 . . . . 0.0 109.61 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' N ' ' ND1' ' A' ' 127' ' ' HIS . . . 33.65 -151.54 0.01 OUTLIER Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 50.11 -144.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.992 . . . . 0.0 109.709 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.63 48.24 1.24 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.687 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -59.67 -48.94 79.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.441 -1.034 . . . . 0.0 109.763 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.499 ' CH2' ' N ' ' A' ' 1' ' ' MET . 32.1 t-105 -60.05 -31.2 69.76 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.018 -1.051 . . . . 0.0 108.885 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -55.18 -43.67 74.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.629 -1.295 . . . . 0.0 107.589 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.573 ' CG2' HD13 ' A' ' 87' ' ' ILE . 73.0 mt -59.15 -43.18 88.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.594 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.38 -32.37 73.78 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -53.04 -37.18 61.35 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.707 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -65.96 -43.86 86.68 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.554 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 80.6 mt -65.82 -25.83 67.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER 81.29 103.58 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.368 0.604 . . . . 0.0 110.947 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 135' ' ' HIS . . . -116.68 75.08 0.27 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -64.22 138.4 61.14 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.977 1.784 . . . . 0.0 112.44 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.61 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -82.6 -43.45 0.94 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 110.08 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 142' ' ' SER . 47.1 Cg_exo -54.68 -28.35 56.15 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.643 2.229 . . . . 0.0 112.492 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.76 168.68 25.17 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.504 ' OE2' ' OBB' ' A' ' 201' ' ' 96F . 77.9 mm-40 -105.17 164.59 11.71 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.502 -0.999 . . . . 0.0 109.167 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HA ' ' HE ' ' A' ' 149' ' ' ARG . 62.0 m -57.61 -39.53 77.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.867 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.0 mp -67.78 -28.19 67.4 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.242 -0.911 . . . . 0.0 109.604 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.57 -48.94 58.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.31 -0.868 . . . . 0.0 112.116 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 146' ' ' THR . 1.6 ptt180 -68.76 -51.07 45.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.896 -1.127 . . . . 0.0 111.76 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.715 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.68 -33.52 75.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.896 -1.127 . . . . 0.0 110.203 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.715 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.11 -37.9 84.7 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.713 -1.242 . . . . 0.0 109.029 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -61.32 -49.46 76.89 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.287 0.565 . . . . 0.0 111.219 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.04 -38.24 79.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.227 -0.92 . . . . 0.0 109.657 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.451 HD13 ' NE2' ' A' ' 20' ' ' HIS . 65.8 mt . . . . . 0 C--N 1.3 -1.551 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.597 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.867 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -62.8 145.82 94.88 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.695 2.263 . . . . 0.0 112.216 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.42 -29.63 70.89 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.4 tt0 -92.64 141.41 28.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.758 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.17 90.46 41.78 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.68 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.54 163.46 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.03 1.82 . . . . 0.0 111.456 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.649 ' HB2' HG12 ' A' ' 122' ' ' VAL . 40.2 p30 -65.17 126.5 28.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.102 -0.999 . . . . 0.0 109.873 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.15 140.95 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.587 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.3 ttt-85 -121.53 127.07 50.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.292 -0.88 . . . . 0.0 109.559 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -135.2 146.3 48.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.413 -0.805 . . . . 0.0 109.668 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.8 p -136.91 146.82 45.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.393 -0.817 . . . . 0.0 109.3 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.44 155.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.888 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.66 133.7 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.156 -0.965 . . . . 0.0 109.018 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 115' ' ' THR . 28.7 m -129.95 162.82 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.442 -0.787 . . . . 0.0 110.102 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.25 94.67 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.966 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.73 163.44 2.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.016 -1.052 . . . . 0.0 110.237 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.8 t -99.75 146.71 26.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 19' ' ' GLU . 19.5 m -56.06 -39.13 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.846 -1.159 . . . . 0.0 109.794 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 18' ' ' VAL . 98.0 mt-10 -61.12 -40.25 93.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.567 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 17.9 t60 -67.04 -39.66 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.619 -0.676 . . . . 0.0 109.707 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 115' ' ' THR . 97.1 m -50.45 -42.49 54.33 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.385 -0.822 . . . . 0.0 109.008 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' CE2' HD21 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.35 -26.05 35.86 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.937 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' A' ' 27' ' ' SER . 86.6 tt0 -60.21 -40.79 91.37 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.913 -1.115 . . . . 0.0 107.992 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 92.2 t -67.76 -41.05 84.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.655 -0.653 . . . . 0.0 109.825 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -60.73 -41.15 94.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.668 . . . . 0.0 110.693 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 49' ' ' PHE . 70.4 p -96.36 -3.28 44.03 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 120.848 -1.157 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 64.5 m -97.72 -42.71 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.769 -1.207 . . . . 0.0 111.595 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.04 56.38 0.1 Allowed Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 120.635 -1.291 . . . . 0.0 111.057 -178.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.596 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 21.0 Cg_endo -59.72 -22.14 66.32 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 C-N-CA 121.54 1.494 . . . . 0.0 113.069 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 44' ' ' ARG . . . -84.98 -41.25 16.03 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.0 111.951 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -54.47 -31.97 56.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.091 -1.005 . . . . 0.0 112.052 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.649 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -92.4 -5.91 51.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.448 -1.408 . . . . 0.0 111.178 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.75 ' HE1' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -48.23 -44.16 61.22 Favored Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 120.403 -1.436 . . . . 0.0 110.635 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 33' ' ' TRP . 14.8 Cg_exo -68.38 112.25 2.75 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.483 2.122 . . . . 0.0 112.731 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' HG13 ' A' ' 38' ' ' VAL . 73.1 Cg_endo -83.49 -67.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.234 1.956 . . . . 0.0 111.884 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 38' ' ' VAL . 31.4 t -172.61 142.76 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.549 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 83.0 t60 57.81 -2.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.596 -0.69 . . . . 0.0 111.661 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' H ' ' C ' ' A' ' 36' ' ' SER . 13.5 p -134.95 137.12 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.784 -1.197 . . . . 0.0 110.445 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 75.3 mt -125.19 147.24 49.14 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.75 ' H ' ' HE1' ' A' ' 33' ' ' TRP . 2.7 p -58.27 145.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.148 -0.97 . . . . 0.0 108.984 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -61.12 -38.96 88.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.983 -1.073 . . . . 0.0 109.291 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 40' ' ' VAL . 29.2 mtmt -94.19 143.86 26.01 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -87.26 110.08 19.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.74 -1.225 . . . . 0.0 109.847 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.437 ' CD ' ' HB1' ' A' ' 30' ' ' ALA . 78.8 mtt180 -62.75 142.49 58.14 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.94 -48.04 2.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.324 -0.86 . . . . 0.0 111.09 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 60' ' ' TRP . . . -155.57 171.75 33.63 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.032 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.921 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -155.12 141.04 18.25 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -1.148 . . . . 0.0 110.16 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.5 141.28 38.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.708 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 1.6 m-85 -143.49 121.72 12.25 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 110.083 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.816 ' O ' ' CE1' ' A' ' 52' ' ' PHE . 46.4 mm-40 -130.85 137.71 31.39 Favored Pre-proline 0 N--CA 1.496 1.834 0 C-N-CA 119.267 -0.973 . . . . 0.0 108.99 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -84.59 135.82 6.1 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.395 2.063 . . . . 0.0 113.051 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.816 ' CE1' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.91 -176.2 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.202 -0.936 . . . . 0.0 110.536 -179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.46 142.19 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 33.04 86.16 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 104.329 -3.508 . . . . 0.0 104.329 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE1' ' A' ' 52' ' ' PHE . . . -70.69 176.57 35.61 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-N 114.001 -1.099 . . . . 0.0 114.438 -175.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.52 145.72 29.2 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.378 1.085 . . . . 0.0 111.975 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.931 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 17.8 m-85 -120.0 139.45 52.47 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.815 ' CE2' HG22 ' A' ' 68' ' ' VAL . 8.9 m-85 -122.29 149.03 44.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 112.13 -177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.684 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -129.67 142.8 50.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.505 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -107.94 129.44 55.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.937 . . . . 0.0 109.604 -179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.605 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -106.92 137.88 44.15 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.871 -1.131 . . . . 0.0 107.969 177.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.49 -38.85 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 110.486 -178.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 64' ' ' GLY . 49.4 p30 -104.13 -8.63 19.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -111.06 130.03 9.56 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-O 122.591 1.106 . . . . 0.0 110.405 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 66' ' ' GLU . 28.4 m -59.42 -178.24 0.06 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.784 ' H ' HG22 ' A' ' 65' ' ' THR . 70.3 tt0 -76.26 141.11 41.79 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.7 pt -146.53 166.33 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.883 -1.136 . . . . 0.0 111.013 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 58' ' ' TYR . 20.6 t -105.89 125.23 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.684 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.28 2.71 17.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.191 -0.943 . . . . 0.0 111.537 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -158.91 -173.54 27.44 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 118.775 -1.678 . . . . 0.0 110.84 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.756 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.9 ttp180 -153.36 -178.68 7.14 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.931 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.2 mp -132.97 165.77 31.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.7 mt -113.03 -52.8 2.76 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.853 -1.154 . . . . 0.0 110.184 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.7 tt0 -177.77 159.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.402 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 50.4 m95 -101.36 130.55 47.57 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.046 -1.034 . . . . 0.0 110.037 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -92.91 123.98 59.76 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 108.78 179.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 78' ' ' PRO . 82.6 Cg_exo -33.74 -51.95 0.52 Allowed 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 122.867 2.378 . . . . 0.0 113.349 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.557 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.9 Cg_endo -55.61 -149.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.147 1.088 . . . . 0.0 109.471 177.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.675 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.81 50.52 0.78 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 38.3 ttp180 -135.37 141.43 45.54 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.414 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -151.09 142.94 23.85 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.89 153.86 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.526 ' CE ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -140.94 148.23 40.06 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.111 -1.435 . . . . 0.0 112.49 -178.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.584 ' O ' ' C ' ' A' ' 71' ' ' ARG . 1.8 m -103.06 150.35 23.68 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.6 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 25.1 t-105 -105.59 123.34 47.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 110.638 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.596 HH11 ' C ' ' A' ' 94' ' ' VAL . 66.3 ttt180 -109.85 92.56 4.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 134' ' ' ILE . 14.9 tt -143.14 156.78 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.814 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 38.3 t0 -111.77 174.92 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.516 -0.74 . . . . 0.0 109.541 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.85 -34.91 84.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.94 41.59 1.68 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.285 -1.126 . . . . 0.0 110.639 -179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.789 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.6 m-90 55.5 34.59 23.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.463 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.51 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 91.7 mt-30 -107.15 151.7 25.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.144 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.7 t -98.43 140.17 33.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.698 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.596 ' C ' HH11 ' A' ' 86' ' ' ARG . 0.0 OUTLIER -138.08 157.17 73.43 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.408 -0.808 . . . . 0.0 109.077 -179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.51 -32.14 33.7 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.588 2.192 . . . . 0.0 111.742 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.89 147.62 24.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.402 -0.812 . . . . 0.0 108.901 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 85.1 m-20 -106.32 118.33 36.37 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.413 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -69.29 -26.32 64.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -102.03 36.15 2.18 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.347 0.594 . . . . 0.0 109.652 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -86.95 149.17 24.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.907 -1.121 . . . . 0.0 110.192 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.0 p -131.51 170.76 14.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.87 139.45 42.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.102 -0.999 . . . . 0.0 110.009 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.4 mt -125.83 137.05 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.547 -0.721 . . . . 0.0 109.266 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.32 126.36 51.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.378 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.491 HG22 ' HG ' ' A' ' 119' ' ' LEU . 20.8 t -131.25 134.24 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 0.0 109.331 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -117.36 132.29 56.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.675 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 20.9 m-85 -113.21 139.09 49.07 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.413 -0.804 . . . . 0.0 109.42 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG13 ' CE1' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -135.61 121.59 14.05 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.9 Cg_endo -77.52 121.34 5.56 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.049 1.832 . . . . 0.0 112.498 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 57.7 t-20 -116.25 117.9 31.31 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 54.09 168.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -64.9 -17.07 64.0 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.261 -1.14 . . . . 0.0 108.917 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -133.09 45.0 1.15 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.759 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -144.08 133.1 5.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -137.95 132.66 32.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.1 -1.235 . . . . 0.0 110.39 -179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -116.31 117.09 29.01 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG21 ' CAF' ' A' ' 201' ' ' 96F . 59.2 t -125.51 139.25 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.83 . . . . 0.0 111.002 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.505 ' OE2' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -118.25 103.93 10.29 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.3 tt -103.64 125.83 50.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.87 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.45 114.79 14.73 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.417 -0.802 . . . . 0.0 110.071 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 1.5 p80 -107.01 127.49 53.51 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -132.35 164.73 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.206 -0.934 . . . . 0.0 111.984 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.0 OUTLIER 53.17 28.77 7.38 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.281 -179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.657 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.2 tp -73.81 -40.14 63.59 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.515 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.5 t60 -45.5 -11.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.357 0.599 . . . . 0.0 109.752 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 124' ' ' LEU . 24.3 ttm180 -50.84 -32.1 19.2 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.657 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -76.45 -21.23 56.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 0.0 109.727 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.466 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 90.75 -168.65 33.18 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.507 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.8 151.5 47.1 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -1.003 . . . . 0.0 110.19 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.46 -11.38 65.09 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.66 -42.31 98.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.573 -0.957 . . . . 0.0 109.932 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.404 ' N ' HD11 ' A' ' 5' ' ' ILE . 30.0 t-105 -54.1 -28.92 42.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.774 -1.171 . . . . 0.0 107.965 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -54.91 -43.0 72.88 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.529 ' CG2' HD13 ' A' ' 87' ' ' ILE . 86.8 mt -59.59 -41.94 86.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.587 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -64.35 -31.77 73.11 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -52.29 -35.67 50.93 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.789 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -68.47 -44.39 74.91 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -64.92 -28.99 69.91 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.28 100.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.613 -0.679 . . . . 0.0 110.999 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -120.36 85.06 0.38 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 51.7 Cg_exo -53.11 148.15 31.98 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.78 2.32 . . . . 0.0 112.619 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -93.83 -42.13 0.32 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.44 -0.788 . . . . 0.0 110.213 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 142' ' ' SER . 44.6 Cg_exo -55.21 -29.77 68.29 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.457 2.105 . . . . 0.0 112.327 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -133.68 122.18 2.99 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -53.93 151.68 6.41 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.33 -1.1 . . . . 0.0 109.041 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.654 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 53.0 m -56.53 -37.84 71.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.681 HD12 ' H ' ' A' ' 147' ' ' LEU . 4.5 mp -67.02 -26.85 66.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.607 -0.683 . . . . 0.0 109.253 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -52.7 17.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.436 -0.79 . . . . 0.0 112.244 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.647 ' NH1' HG23 ' A' ' 146' ' ' THR . 1.4 ptt180 -65.79 -49.4 68.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.082 . . . . 0.0 111.812 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.62 -36.32 80.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.93 -1.106 . . . . 0.0 109.959 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -64.51 -37.67 88.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.901 -1.124 . . . . 0.0 109.407 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -61.58 -46.9 87.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.652 -0.655 . . . . 0.0 111.269 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.54 -35.04 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 110.516 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.461 HG23 ' NE2' ' A' ' 20' ' ' HIS . 87.7 mt . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.597 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.654 ' OAQ' HG21 ' A' ' 146' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' H2 ' ' HD3' ' A' ' 2' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HD3' ' H2 ' ' A' ' 1' ' ' MET . 22.0 Cg_exo -60.63 147.25 95.31 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.872 2.381 . . . . 0.0 112.253 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.24 -28.49 70.07 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.411 -0.806 . . . . 0.0 109.372 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.684 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.27 140.51 30.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.357 -0.839 . . . . 0.0 109.632 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.684 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.58 90.5 43.04 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.768 . . . . 0.0 109.965 -179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.41 165.63 25.14 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.967 1.778 . . . . 0.0 111.069 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' OD1' ' O ' ' A' ' 7' ' ' ASP . 27.4 p30 -64.94 125.63 25.48 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.886 -1.134 . . . . 0.0 110.135 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG12 ' NE2' ' A' ' 121' ' ' HIS . 13.0 p -140.58 141.61 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.739 -0.601 . . . . 0.0 109.527 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 58.1 ttp180 -118.6 124.56 47.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.202 -0.936 . . . . 0.0 109.623 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 29.0 mttm -135.12 147.56 49.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 109.824 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.3 p -137.7 149.75 46.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 0.0 109.577 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.52 152.67 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 109.165 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' NH2' ' A' ' 116' ' ' ARG . 44.8 t -102.42 133.71 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.06 -1.025 . . . . 0.0 108.994 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -131.22 162.9 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.833 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.09 94.26 7.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.002 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.93 163.51 2.21 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.972 -1.08 . . . . 0.0 110.041 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.5 p -97.5 154.77 17.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.1 m -61.05 -39.94 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.832 -1.168 . . . . 0.0 109.86 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -60.76 -39.03 87.22 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.057 -1.027 . . . . 0.0 108.405 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.486 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 20.7 t60 -65.72 -40.05 91.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.525 0.679 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 115' ' ' THR . 94.7 m -51.15 -43.8 61.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' A' ' 81' ' ' LEU . 1.2 m-85 -82.51 -26.39 32.56 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.329 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.8 tt0 -59.81 -42.9 94.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 53.1 t -65.42 -40.32 87.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.542 -0.724 . . . . 0.0 109.437 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -57.15 -45.6 83.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.543 -0.723 . . . . 0.0 109.93 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' CD1' ' A' ' 49' ' ' PHE . 68.9 p -98.92 -3.56 34.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.063 -1.023 . . . . 0.0 111.4 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 40.6 t -100.15 -37.9 8.75 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.627 -1.295 . . . . 0.0 112.216 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -177.02 58.12 0.14 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.391 -1.443 . . . . 0.0 111.276 -178.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 19.7 Cg_endo -61.22 -34.91 87.63 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 122.239 1.959 . . . . 0.0 113.58 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 33' ' ' TRP . . . -78.71 -32.66 46.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.021 -1.049 . . . . 0.0 111.403 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 76.8 m-20 -56.31 -32.8 64.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.758 -1.214 . . . . 0.0 110.461 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.726 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -94.79 111.4 23.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.996 -1.065 . . . . 0.0 108.923 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.497 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -112.51 154.35 44.64 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.315 -0.865 . . . . 0.0 109.257 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 35' ' ' PRO . 2.8 Cg_endo -48.48 -54.72 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.446 2.097 . . . . 0.0 113.178 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 18.6 Cg_endo -59.51 139.98 91.89 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.84 1.693 . . . . 0.0 112.496 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.4 m -62.02 -36.46 81.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.68 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 85.0 t60 -167.23 47.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.839 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 39' ' ' LEU . 32.6 t -120.63 140.44 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.13 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 38' ' ' VAL . 38.5 tp -43.96 129.62 5.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.016 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 42' ' ' LYS . 22.0 m -66.61 130.07 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -61.93 -35.66 79.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.038 -1.039 . . . . 0.0 108.657 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 40' ' ' VAL . 47.0 pttt -73.5 173.89 9.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -116.91 104.35 11.21 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.191 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.542 ' CZ ' ' OE2' ' A' ' 59' ' ' GLU . 30.8 mmt180 -125.77 141.14 52.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.363 -0.835 . . . . 0.0 109.397 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 60' ' ' TRP . . . -135.2 -47.9 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.381 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.545 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -142.23 174.13 23.44 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.86 136.69 13.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.88 -1.365 . . . . 0.0 111.662 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.77 132.21 55.34 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.8 m-85 -133.21 135.27 44.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 110.561 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 13.4 mm-40 -131.38 137.08 29.72 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 119.471 -0.891 . . . . 0.0 108.97 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -86.94 131.96 3.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.337 2.025 . . . . 0.0 112.399 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.789 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.34 -176.66 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.029 -1.044 . . . . 0.0 110.886 -178.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 73' ' ' LEU . 87.9 t -97.2 141.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.0 32.93 85.83 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 104.102 -3.599 . . . . 0.0 104.102 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.45 175.7 36.3 Favored Glycine 0 C--N 1.298 -1.577 0 CA-C-N 113.667 -1.267 . . . . 0.0 114.397 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.723 ' NH1' HH22 ' A' ' 86' ' ' ARG . 89.5 mtt180 -144.32 145.0 31.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.26 1.028 . . . . 0.0 111.493 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.913 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 20.7 m-85 -119.8 146.54 45.6 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 58' ' ' TYR . 49.1 m-85 -136.2 150.29 48.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.074 -1.016 . . . . 0.0 112.655 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' CB ' ' HE1' ' A' ' 69' ' ' TRP . 97.9 mt-10 -134.12 153.1 52.03 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.616 ' O ' ' N ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -109.39 129.41 55.54 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.213 -0.93 . . . . 0.0 108.763 -179.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -97.09 135.97 38.31 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.077 -1.449 . . . . 0.0 107.135 177.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -51.48 -37.2 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.562 -0.711 . . . . 0.0 110.351 -177.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 62' ' ' ILE . 89.0 m-20 -107.39 -6.74 16.94 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.54 143.21 17.57 Favored Glycine 0 N--CA 1.482 1.738 0 CA-C-O 122.572 1.095 . . . . 0.0 110.762 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.742 HG22 ' H ' ' A' ' 66' ' ' GLU . 8.8 m -65.26 179.91 0.68 Allowed 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 121.463 0.649 . . . . 0.0 110.457 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' H ' HG22 ' A' ' 65' ' ' THR . 66.9 tt0 -80.95 139.84 35.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 69' ' ' TRP . 1.4 mt -151.47 167.85 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.121 -0.987 . . . . 0.0 110.285 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 70' ' ' GLY . 14.4 p -99.4 137.93 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.481 -0.762 . . . . 0.0 109.457 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.544 ' HE1' ' CB ' ' A' ' 59' ' ' GLU . 6.3 m95 -109.86 2.87 20.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.35 -0.843 . . . . 0.0 111.189 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 68' ' ' VAL . . . -175.13 -171.36 39.1 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 118.739 -1.696 . . . . 0.0 110.646 -177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 72' ' ' ILE . 7.2 ttp180 -144.44 -177.97 5.75 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.0 mp -129.57 163.73 34.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.841 ' O ' HG13 ' A' ' 53' ' ' VAL . 9.3 mt -113.18 -46.21 3.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 0.0 108.958 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . 84.5 tt0 -178.08 150.91 0.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -106.08 123.47 48.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.053 -1.03 . . . . 0.0 110.137 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -107.06 127.3 28.24 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.636 ' O ' ' N ' ' A' ' 79' ' ' HIS . 39.7 Cg_exo -30.15 153.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.057 0 C-N-CA 122.642 2.228 . . . . 0.0 112.761 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' PRO . 85.8 Cg_exo -28.46 79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.412 2.742 . . . . 0.0 112.331 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.636 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.2 t-80 -177.83 -42.29 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.646 -0.659 . . . . 0.0 109.68 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 49.2 ttp180 -152.47 140.28 19.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.325 -1.35 . . . . 0.0 111.81 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.93 127.07 21.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.74 151.29 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.501 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.72 144.15 25.89 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 117.692 -1.603 . . . . 0.0 112.545 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 71' ' ' ARG . 4.3 m -103.44 149.54 24.72 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 103' ' ' ILE . 9.6 m0 -103.23 128.13 50.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.584 -1.322 . . . . 0.0 111.351 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.723 HH22 ' NH1' ' A' ' 56' ' ' ARG . 53.8 ttt180 -113.76 97.94 6.73 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.39 -0.819 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.645 HD13 ' CG2' ' A' ' 134' ' ' ILE . 16.2 tt -148.37 157.82 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.297 -0.877 . . . . 0.0 109.508 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 26.9 t0 -108.56 172.78 6.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.363 -0.835 . . . . 0.0 109.581 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . -59.57 -37.48 92.27 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.053 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.31 41.92 1.41 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.013 -1.286 . . . . 0.0 110.664 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.773 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 2.8 m-90 55.78 38.71 30.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.026 -1.046 . . . . 0.0 110.226 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.545 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 84.8 mt-30 -114.44 158.14 21.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.486 -0.759 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 26.0 t -105.02 139.82 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG23 ' OD2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -130.66 156.54 79.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.458 -0.776 . . . . 0.0 109.033 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' O ' ' OD1' ' A' ' 96' ' ' ASP . 7.5 Cg_endo -52.74 -37.08 75.36 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.396 2.064 . . . . 0.0 111.693 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 95' ' ' PRO . 80.2 m-20 -147.11 146.54 29.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 108.979 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.675 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 91.8 m-20 -105.88 117.46 34.08 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.191 -0.943 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -76.56 -23.33 53.57 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 108.728 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -107.52 35.88 2.92 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.77 -0.581 . . . . 0.0 109.539 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.675 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.89 150.88 23.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.489 ' OG ' HD12 ' A' ' 124' ' ' LEU . 85.9 p -132.83 169.93 16.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.513 -0.742 . . . . 0.0 109.066 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -108.65 142.87 38.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 85' ' ' TRP . 71.0 mt -120.82 138.07 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.548 -0.72 . . . . 0.0 109.298 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.2 121.73 46.05 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.569 HG22 ' HG ' ' A' ' 119' ' ' LEU . 21.6 t -128.34 135.22 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -117.11 131.41 56.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.516 ' CE1' HG12 ' A' ' 105' ' ' VAL . 62.0 m-85 -115.65 126.65 54.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.365 -0.834 . . . . 0.0 109.352 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.53 127.03 24.16 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.558 -0.714 . . . . 0.0 109.496 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -76.74 122.92 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.212 1.942 . . . . 0.0 112.442 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.498 ' O ' ' CA ' ' A' ' 114' ' ' GLY . 49.2 t30 -119.15 126.34 51.36 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 52.97 171.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 86.2 p -64.08 -22.75 67.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.317 -1.108 . . . . 0.0 109.125 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.94 47.13 0.99 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 110' ' ' ASN . . . -134.32 132.7 6.48 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -133.2 130.26 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.153 -1.204 . . . . 0.0 110.597 -179.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.528 ' NH2' ' CG2' ' A' ' 13' ' ' VAL . 53.7 ttt85 -114.87 117.75 31.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.473 HG21 ' CAF' ' A' ' 201' ' ' 96F . 60.2 t -124.84 138.93 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 111.108 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -118.45 102.25 8.78 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.569 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -104.01 126.97 51.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.87 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.629 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.1 113.89 13.87 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.439 -0.788 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 121' ' ' HIS . 2.7 p80 -101.63 128.03 48.09 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 7' ' ' ASP . 35.0 m -130.14 153.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.245 1.022 . . . . 0.0 112.554 -177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 123' ' ' LYS . 1.0 OUTLIER 58.89 31.74 21.58 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.503 178.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.645 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 3.3 tp -73.15 -35.16 66.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 125' ' ' HIS . 5.6 t60 -44.78 -12.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.977 -0.452 . . . . 0.0 110.659 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 124' ' ' LEU . 86.2 mtt180 -51.77 -33.25 34.33 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.146 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.7 -18.7 60.97 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.737 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.37 -171.96 40.77 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.908 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.4 150.67 48.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.572 -0.957 . . . . 0.0 109.809 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.16 64.39 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.51 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.2 -39.15 93.81 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.464 -1.021 . . . . 0.0 109.372 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.473 ' CE2' ' CB ' ' A' ' 1' ' ' MET . 25.2 t-105 -54.59 -30.16 53.74 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.712 -1.195 . . . . 0.0 108.1 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -54.68 -43.24 72.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.645 ' CG2' HD13 ' A' ' 87' ' ' ILE . 80.7 mt -59.92 -42.44 89.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.564 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.23 -32.02 73.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 132' ' ' TRP . 12.0 tttm -52.6 -36.56 56.47 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.773 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.74 -43.54 83.92 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 65.1 mt -68.1 -15.97 63.81 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 61.76 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.544 0.688 . . . . 0.0 111.173 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 135' ' ' HIS . . . -122.52 81.91 0.35 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -53.6 138.35 66.83 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.622 2.215 . . . . 0.0 112.304 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -73.13 -44.12 7.85 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 0.0 110.064 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 142' ' ' SER . 35.2 Cg_exo -58.32 -70.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.562 2.175 . . . . 0.0 112.426 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -89.78 -179.23 44.77 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -115.19 164.41 14.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.521 -0.988 . . . . 0.0 109.251 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.586 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 76.1 m -57.8 -38.36 75.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.219 -0.926 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.708 HD21 ' OAO' ' A' ' 201' ' ' 96F . 5.0 mp -68.07 -27.74 66.76 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.059 -1.025 . . . . 0.0 109.618 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -47.49 57.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.304 -0.873 . . . . 0.0 111.959 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -67.23 -51.81 48.68 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.872 -1.143 . . . . 0.0 111.583 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -67.36 -33.98 76.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.574 -1.329 . . . . 0.0 110.025 -178.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.693 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -63.89 -44.99 91.37 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.095 -1.003 . . . . 0.0 109.931 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.1 OUTLIER -61.15 -39.88 91.73 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 109.417 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 32' ' ' TRP . 32.4 t -63.09 -40.78 90.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 20' ' ' HIS . 93.0 mt . . . . . 0 C--N 1.301 -1.524 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.784 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.708 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG2' ' HE1' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -64.29 145.0 87.85 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.724 2.283 . . . . 0.0 112.169 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.07 -30.35 71.43 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.558 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.1 tt0 -94.22 143.91 25.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.728 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.558 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -118.3 89.88 36.93 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.525 -0.734 . . . . 0.0 109.473 -179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -81.17 166.3 18.59 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.333 2.022 . . . . 0.0 111.877 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.688 ' HB2' HG12 ' A' ' 122' ' ' VAL . 42.2 p30 -70.23 126.89 30.96 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 110.567 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 HG12 ' NE2' ' A' ' 121' ' ' HIS . 14.5 p -138.17 141.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.492 -0.755 . . . . 0.0 109.001 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.652 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.0 ttt180 -120.75 120.12 34.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 109.946 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -137.79 145.02 41.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.185 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 m -130.78 145.68 52.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.657 ' HB ' HD22 ' A' ' 147' ' ' LEU . 16.4 t -139.32 155.49 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 4.4 p -101.5 138.29 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.12 -0.987 . . . . 0.0 109.444 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG23 ' CB ' ' A' ' 151' ' ' ALA . 2.8 p -131.59 153.4 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.646 -0.659 . . . . 0.0 109.65 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' N ' HG22 ' A' ' 14' ' ' VAL . . . -82.8 93.41 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.11 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.2 163.14 2.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.86 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.8 p -92.63 155.6 17.64 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.6 m -58.42 -40.33 77.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.734 -1.229 . . . . 0.0 109.475 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.3 tt0 -61.28 -39.13 89.26 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' A' ' 20' ' ' HIS . 22.5 t60 -65.62 -40.37 92.51 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.469 -0.769 . . . . 0.0 109.682 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 115' ' ' THR . 69.1 m -50.74 -42.77 57.77 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.377 -0.827 . . . . 0.0 108.993 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -82.23 -25.01 34.53 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' OG ' ' A' ' 27' ' ' SER . 85.8 tt0 -59.84 -39.66 85.88 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 79.8 t -67.53 -40.22 83.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 121.584 0.707 . . . . 0.0 109.348 179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' O ' ' CD1' ' A' ' 49' ' ' PHE . 5.5 m-30 -59.69 -44.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.63 -0.669 . . . . 0.0 111.177 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.6 p -97.87 -5.06 35.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.62 -1.3 . . . . 0.0 111.266 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 23' ' ' GLU . 99.0 p -99.04 -35.58 9.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.708 -1.245 . . . . 0.0 111.911 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -178.82 56.76 0.09 OUTLIER Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 120.523 -1.361 . . . . 0.0 110.917 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 23.7 Cg_endo -62.28 -43.55 22.87 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 C-N-CA 121.938 1.759 . . . . 0.0 114.041 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.067 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -77.65 -24.41 49.46 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.864 -1.148 . . . . 0.0 110.762 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.593 ' O ' ' CE2' ' A' ' 33' ' ' TRP . 31.7 t0 -60.2 -31.44 70.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.951 -1.093 . . . . 0.0 111.065 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.68 ' HB2' HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -91.66 120.21 32.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.813 -1.179 . . . . 0.0 110.722 -178.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.593 ' CE2' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -111.35 179.32 0.82 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 33' ' ' TRP . 35.4 Cg_exo -56.2 139.29 85.59 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.172 1.915 . . . . 0.0 111.811 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.81 -28.05 30.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.546 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 37' ' ' HIS . 27.4 t -118.39 139.42 51.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.365 -0.835 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 36' ' ' SER . 87.3 m-70 49.74 177.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.873 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.1 t -117.89 123.63 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' O ' ' CG ' ' A' ' 139' ' ' ASP . 67.4 mt -104.95 -1.69 25.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.728 ' O ' HG13 ' A' ' 40' ' ' VAL . 9.4 p -91.35 105.95 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.94 -1.1 . . . . 0.0 109.364 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HD2' ' HZ3' ' A' ' 136' ' ' LYS . 35.8 mttp -62.84 -37.8 88.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -0.986 . . . . 0.0 109.723 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 40' ' ' VAL . 4.4 pttp -98.88 150.12 22.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.925 . . . . 0.0 109.027 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -84.01 123.42 29.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.504 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HD3' ' HB1' ' A' ' 30' ' ' ALA . 95.5 mtt180 -66.85 138.52 57.38 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 108.646 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.666 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -112.91 -46.43 3.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 109.876 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.792 ' C ' HD13 ' A' ' 47' ' ' LEU . . . -164.5 175.91 40.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.067 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -153.39 138.19 17.06 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.961 -1.317 . . . . 0.0 110.196 179.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 136.11 47.76 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 2.3 m-85 -138.06 132.65 32.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.117 -0.989 . . . . 0.0 110.671 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.783 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 34.8 mm-40 -130.68 137.34 30.58 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -85.75 130.11 3.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 0.0 112.706 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.783 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.69 179.64 0.06 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.143 -0.973 . . . . 0.0 110.577 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.36 143.22 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.17 33.26 86.76 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 104.275 -3.53 . . . . 0.0 104.275 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.642 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.88 177.99 33.75 Favored Glycine 0 N--CA 1.479 1.553 0 CA-C-N 114.091 -1.055 . . . . 0.0 114.35 -175.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.58 ' NE ' ' OH ' ' A' ' 58' ' ' TYR . 63.7 mtm180 -145.4 142.57 29.45 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.277 1.037 . . . . 0.0 111.551 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.87 ' CE1' HD11 ' A' ' 72' ' ' ILE . 23.5 m-85 -120.62 140.04 52.13 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 8.8 m-85 -124.49 147.3 48.44 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 111.563 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.758 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.0 tt0 -124.54 143.2 50.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.666 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -105.06 129.68 53.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -109.07 138.92 44.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.743 -1.183 . . . . 0.0 108.237 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.667 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.78 -38.88 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 110.396 -178.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 64' ' ' GLY . 48.9 p30 -104.11 -8.55 19.39 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 61' ' ' ASP . . . -110.72 128.17 8.65 Favored Glycine 0 N--CA 1.479 1.517 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.775 HG22 ' H ' ' A' ' 66' ' ' GLU . 23.2 m -59.21 -178.18 0.05 Allowed 'General case' 0 C--N 1.286 -2.153 0 O-C-N 122.208 -0.584 . . . . 0.0 109.496 178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 65' ' ' THR . 68.1 tt0 -77.45 137.47 38.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 pt -149.4 166.53 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.161 . . . . 0.0 110.81 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 68' ' ' VAL . 9.1 p -105.71 123.99 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.758 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -111.64 3.85 18.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.402 -0.811 . . . . 0.0 111.689 -178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -157.29 -173.21 25.43 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.247 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.788 ' C ' HD12 ' A' ' 72' ' ' ILE . 6.6 ttp180 -150.88 -178.3 6.51 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.704 -0.88 . . . . 0.0 108.857 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 57' ' ' TYR . 2.4 mp -134.24 165.27 32.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 ' N ' HG22 ' A' ' 72' ' ' ILE . 9.8 mt -113.57 -51.36 2.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.877 -1.139 . . . . 0.0 109.63 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -175.11 154.71 1.83 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.416 ' O ' ' CG ' ' A' ' 75' ' ' TRP . 43.2 p-90 -106.5 125.91 51.59 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.133 -0.98 . . . . 0.0 110.285 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.3 OUTLIER -107.95 128.23 26.17 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 79' ' ' HIS . 37.0 Cg_exo -29.88 153.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 122.769 2.313 . . . . 0.0 112.719 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 96.6 Cg_exo -29.25 79.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.304 2.669 . . . . 0.0 112.194 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' PRO . 2.1 t-80 -178.37 -41.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.654 -0.654 . . . . 0.0 109.624 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 65.5 ttt180 -153.91 142.28 20.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.961 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.32 128.88 24.43 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.34 151.08 26.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.489 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -146.99 144.41 29.15 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.516 -179.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.579 ' O ' ' C ' ' A' ' 71' ' ' ARG . 2.0 m -103.57 155.67 18.36 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.597 ' CE2' ' O ' ' A' ' 69' ' ' TRP . 24.6 t-105 -109.35 126.08 53.03 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.941 -1.099 . . . . 0.0 110.794 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.581 HH11 ' C ' ' A' ' 95' ' ' PRO . 63.5 ttt180 -114.53 96.84 5.96 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.343 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.0 tt -144.97 156.7 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.991 -1.068 . . . . 0.0 109.888 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.484 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 18.5 t70 -109.11 169.65 8.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.315 -0.866 . . . . 0.0 110.201 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -59.87 -37.19 92.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.55 35.96 3.0 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.212 -1.169 . . . . 0.0 110.457 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 6.8 m-90 56.23 26.45 10.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.234 -0.916 . . . . 0.0 110.637 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -100.67 123.84 45.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 109.218 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 p -64.69 151.51 44.81 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.024 . . . . 0.0 109.341 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.527 ' O ' ' NH1' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -146.65 157.29 48.05 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.242 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.581 ' C ' HH11 ' A' ' 86' ' ' ARG . 8.5 Cg_endo -53.39 -31.61 58.26 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.67 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -158.73 147.93 18.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 108.939 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.484 ' OD2' HG23 ' A' ' 94' ' ' VAL . 88.6 m-20 -106.02 117.94 35.32 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.37 -0.831 . . . . 0.0 110.315 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -72.23 -26.11 61.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.277 -0.89 . . . . 0.0 108.884 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.51 35.3 2.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.639 -0.663 . . . . 0.0 109.403 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.54 147.81 25.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.035 -1.041 . . . . 0.0 110.124 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 60.6 p -133.19 171.16 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.06 140.82 40.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.9 mt -118.72 140.3 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG3' HH11 ' A' ' 80' ' ' ARG . 84.7 tt0 -111.67 123.92 51.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 108.956 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG22 ' HG ' ' A' ' 119' ' ' LEU . 24.4 t -131.23 135.11 60.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.411 -0.806 . . . . 0.0 109.197 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -116.96 131.99 56.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.833 . . . . 0.0 109.792 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.544 ' CE1' HG12 ' A' ' 105' ' ' VAL . 27.1 m-85 -114.18 122.39 46.67 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.401 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.04 125.51 27.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.96 121.51 6.25 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 121.908 1.739 . . . . 0.0 112.222 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 114' ' ' GLY . 55.2 t30 -118.91 127.17 53.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 110' ' ' ASN . . . 51.87 172.9 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.2 p -64.81 -22.93 67.09 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.235 -1.156 . . . . 0.0 109.138 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -135.67 46.94 1.0 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 110' ' ' ASN . . . -134.3 135.21 7.84 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.668 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -137.75 122.41 18.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.085 -1.244 . . . . 0.0 110.527 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -105.41 120.35 41.38 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' CAF' ' A' ' 201' ' ' 96F . 88.3 t -125.25 138.86 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.305 -177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -116.86 102.68 9.59 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.9 tt -103.93 128.48 51.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.063 -1.023 . . . . 0.0 110.087 -179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.652 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.23 114.45 14.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 109.92 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.792 ' ND1' HD12 ' A' ' 124' ' ' LEU . 4.9 p80 -98.72 126.45 44.34 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.688 HG12 ' HB2' ' A' ' 7' ' ' ASP . 26.9 m -131.15 157.39 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.237 1.018 . . . . 0.0 112.291 -177.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER 58.59 29.8 18.96 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.972 177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.792 HD12 ' ND1' ' A' ' 121' ' ' HIS . 24.1 mt -72.35 -40.08 67.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.56 -1.338 . . . . 0.0 107.69 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 22.3 t60 -44.96 -11.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.19 0.519 . . . . 0.0 110.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.614 ' N ' ' O ' ' A' ' 124' ' ' LEU . 19.9 tpt180 -49.72 -33.43 16.01 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 108.447 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -78.32 -32.65 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.005 . . . . 0.0 109.426 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 34.43 38.71 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 130' ' ' GLY . 60.5 t0 -146.46 95.57 2.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.345 . . . . 0.0 109.886 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 129' ' ' ASP . . . 42.38 38.09 2.72 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -61.53 -48.62 80.21 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.528 -0.983 . . . . 0.0 110.397 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.42 ' HE1' ' HG2' ' A' ' 1' ' ' MET . 28.8 t-105 -56.85 -29.73 63.15 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 118.757 -1.177 . . . . 0.0 108.575 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -54.79 -43.08 72.54 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.611 HD11 ' HA2' ' A' ' 89' ' ' GLY . 77.7 mt -59.34 -43.55 90.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.592 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -63.84 -31.9 73.23 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.667 ' HZ3' ' HD2' ' A' ' 41' ' ' LYS . 49.3 tttm -52.69 -36.84 57.87 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.92 -44.72 79.95 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.566 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 73.1 mt -65.72 -27.09 68.07 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 39' ' ' LEU . 1.3 m-20 60.32 99.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.667 -0.645 . . . . 0.0 110.756 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.512 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -93.67 132.7 11.32 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.491 ' O ' ' CBA' ' A' ' 201' ' ' 96F . 46.1 Cg_endo -71.44 146.86 51.13 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.218 1.946 . . . . 0.0 112.383 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.678 ' H ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -110.57 -44.39 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.391 -0.818 . . . . 0.0 109.755 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.678 ' CD ' ' H ' ' A' ' 142' ' ' SER . 23.4 Cg_exo -61.97 -24.22 76.64 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.627 2.218 . . . . 0.0 112.059 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -142.02 178.0 21.03 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -95.81 162.56 13.54 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.268 -1.136 . . . . 0.0 109.135 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.606 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 66.2 m -57.68 -39.89 78.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.136 -0.977 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.9 HD21 ' OAO' ' A' ' 201' ' ' 96F . 5.2 mp -67.73 -25.22 65.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 109.454 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.62 76.64 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.209 -0.932 . . . . 0.0 112.039 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.555 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 0.8 OUTLIER -74.12 -50.08 21.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.747 -1.22 . . . . 0.0 111.867 -177.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.717 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.11 -31.76 72.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.556 -1.34 . . . . 0.0 109.757 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.717 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -60.67 -45.27 94.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.79 -39.28 88.31 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.616 -0.678 . . . . 0.0 109.641 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.68 HG11 ' HB2' ' A' ' 32' ' ' TRP . 15.3 t -66.21 -40.29 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 108.926 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.467 ' CD1' ' CE1' ' A' ' 150' ' ' PHE . 81.4 mt . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.671 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.9 ' OAO' HD21 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 2.2 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.0 Cg_endo -62.53 153.68 69.71 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.799 2.333 . . . . 0.0 112.432 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.06 -28.89 69.4 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 108.936 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' C ' HD13 ' A' ' 5' ' ' ILE . 83.9 tt0 -91.74 141.61 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.425 -0.797 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.43 90.59 42.79 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.518 -0.739 . . . . 0.0 109.922 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.23 165.93 18.69 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.087 1.858 . . . . 0.0 111.416 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HB2' HG12 ' A' ' 122' ' ' VAL . 41.1 p30 -66.92 127.46 32.62 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 110.276 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 121' ' ' HIS . 12.6 p -137.73 141.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 109.256 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 79.5 ttt-85 -121.82 126.14 48.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.329 -0.857 . . . . 0.0 109.854 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -136.24 146.68 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.9 p -137.24 148.19 46.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.142 -0.974 . . . . 0.0 109.475 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 t -156.36 155.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.281 -0.887 . . . . 0.0 109.281 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.34 133.85 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.11 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 115' ' ' THR . 34.5 m -128.93 163.39 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.465 -0.772 . . . . 0.0 110.132 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.76 94.11 7.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.262 -0.899 . . . . 0.0 109.806 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.65 164.06 2.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.023 -1.048 . . . . 0.0 110.335 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 83.7 p -97.82 152.75 18.85 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 19' ' ' GLU . 27.5 m -61.5 -40.96 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.741 -1.224 . . . . 0.0 109.636 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 18' ' ' VAL . 84.4 tt0 -61.06 -38.33 85.82 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 18.0 t60 -66.1 -39.89 90.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.547 0.689 . . . . 0.0 109.396 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' HG21 ' A' ' 115' ' ' THR . 72.0 m -51.08 -43.37 61.01 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.566 -0.709 . . . . 0.0 109.276 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.39 -26.23 33.02 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.115 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.9 tt0 -60.0 -41.38 91.97 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.759 -1.177 . . . . 0.0 107.845 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' CG2' ' NE2' ' A' ' 20' ' ' HIS . 77.6 t -66.64 -40.79 87.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.655 -0.653 . . . . 0.0 109.702 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 5.6 m-30 -60.17 -42.32 94.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.506 -0.746 . . . . 0.0 110.494 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.675 HG22 ' CD2' ' A' ' 49' ' ' PHE . 44.4 p -97.07 -3.43 41.32 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.861 -1.149 . . . . 0.0 110.625 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 74.7 m -97.74 -46.79 5.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.724 -1.235 . . . . 0.0 111.272 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.541 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -171.08 58.25 0.27 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 120.672 -1.268 . . . . 0.0 111.065 -178.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' O ' ' CE3' ' A' ' 32' ' ' TRP . 19.0 Cg_endo -60.12 -36.73 87.86 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 121.593 1.529 . . . . 0.0 112.957 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.38 -35.41 47.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 111.617 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -56.51 -32.21 64.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.044 -1.035 . . . . 0.0 111.725 -177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.611 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.0 -10.78 46.32 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.568 -1.332 . . . . 0.0 110.534 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.644 ' HE1' HH22 ' A' ' 149' ' ' ARG . 0.2 OUTLIER -60.88 -51.25 80.73 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 120.561 -1.337 . . . . 0.0 110.729 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' O ' ' CD2' ' A' ' 39' ' ' LEU . 2.3 Cg_endo -50.82 -55.48 4.03 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.369 1.379 . . . . 0.0 113.679 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 34' ' ' PRO . 12.7 Cg_endo -58.69 -14.71 22.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.7 1.6 . . . . 0.0 112.324 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.579 ' OG ' ' NE ' ' A' ' 149' ' ' ARG . 31.9 t -63.11 156.05 26.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -51.71 -35.96 44.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -104.81 134.72 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.023 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 34' ' ' PRO . 43.7 mt -95.35 141.31 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 110.048 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 42' ' ' LYS . 97.6 t -61.99 137.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -60.12 -38.87 84.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.873 -1.142 . . . . 0.0 108.501 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' H ' HG12 ' A' ' 40' ' ' VAL . 42.7 mtmt -99.37 143.61 29.43 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.43 106.91 15.56 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.742 -1.223 . . . . 0.0 109.532 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.637 ' NH2' ' CZ3' ' A' ' 33' ' ' TRP . 68.5 mtt180 -63.52 142.14 58.51 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.08 -47.66 2.26 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.138 -0.977 . . . . 0.0 111.697 -177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' H ' ' HB2' ' A' ' 60' ' ' TRP . . . -133.42 170.57 22.25 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.937 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -151.24 131.5 13.63 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.271 -1.135 . . . . 0.0 110.627 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -106.58 132.87 52.08 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.684 ' CE2' ' CD2' ' A' ' 57' ' ' TYR . 3.0 m-85 -138.2 124.23 20.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.895 -1.128 . . . . 0.0 111.465 -178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.843 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 26.6 tp10 -131.65 136.1 27.93 Favored Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' C ' ' CG ' ' A' ' 52' ' ' PHE . 84.0 Cg_endo -85.07 137.59 6.33 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 122.403 2.068 . . . . 0.0 113.336 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.843 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 170.59 -175.99 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.114 -0.991 . . . . 0.0 110.887 -178.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 143.0 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.49 32.71 85.09 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 104.407 -3.477 . . . . 0.0 104.407 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.602 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -71.66 176.72 38.72 Favored Glycine 0 N--CA 1.48 1.616 0 CA-C-N 114.218 -0.991 . . . . 0.0 114.654 -175.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 98.4 mtt180 -150.41 145.88 26.34 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.648 1.213 . . . . 0.0 112.169 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.882 ' CZ ' HD11 ' A' ' 72' ' ' ILE . 15.0 m-85 -120.43 146.37 46.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.631 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 16.5 m-85 -129.24 150.7 50.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.841 -1.162 . . . . 0.0 112.116 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.16 142.78 51.29 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.457 ' NE1' ' HB2' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -107.32 129.59 54.88 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.88 . . . . 0.0 108.864 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' O ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER -102.97 135.82 43.94 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.96 178.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.707 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.61 -39.27 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.488 -0.758 . . . . 0.0 110.205 -178.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -105.94 -6.35 18.91 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.511 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.25 137.82 14.53 Favored Glycine 0 N--CA 1.483 1.788 0 CA-C-O 122.526 1.07 . . . . 0.0 110.951 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.711 HG22 ' H ' ' A' ' 66' ' ' GLU . 10.7 m -59.95 179.66 0.13 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-O 121.422 0.629 . . . . 0.0 109.98 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.711 ' H ' HG22 ' A' ' 65' ' ' THR . 78.3 tt0 -75.4 141.01 43.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 91' ' ' TRP . 12.4 tt -146.54 162.01 9.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.955 -1.09 . . . . 0.0 110.762 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.63 132.73 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CD1' ' C ' ' A' ' 69' ' ' TRP . 4.4 p90 -107.37 -6.23 17.27 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 111.101 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 86' ' ' ARG . . . -161.91 -171.97 28.7 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.058 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.697 ' CZ ' HH11 ' A' ' 86' ' ' ARG . 20.2 ttt180 -147.69 -178.12 6.09 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.882 HD11 ' CZ ' ' A' ' 57' ' ' TYR . 2.1 mp -131.53 166.72 28.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.512 ' N ' ' HA ' ' A' ' 83' ' ' MET . 7.1 mt -114.13 -50.92 2.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.841 -1.162 . . . . 0.0 110.166 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 75' ' ' TRP . 85.1 tt0 -177.37 159.92 1.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' N ' ' HG2' ' A' ' 74' ' ' GLU . 60.3 p-90 -101.17 130.56 47.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 0.0 110.157 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.9 OUTLIER -96.89 121.51 59.17 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 0.0 108.953 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 78' ' ' PRO . 80.2 Cg_exo -34.86 -51.58 0.71 Allowed 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.994 2.463 . . . . 0.0 113.463 -178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.564 ' O ' ' O ' ' A' ' 77' ' ' PRO . 11.5 Cg_endo -55.08 -149.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 CA-C-N 120.219 1.114 . . . . 0.0 109.72 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.67 ' ND1' ' O ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -104.0 50.8 0.79 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 62.5 ttt-85 -135.84 144.78 45.85 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.884 0.849 . . . . 0.0 110.799 -177.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CE2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -154.6 141.31 19.01 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' C ' ' SD ' ' A' ' 83' ' ' MET . . . -104.8 151.96 23.16 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.596 ' SD ' ' N ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -144.1 146.16 32.62 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.001 -1.479 . . . . 0.0 112.504 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.594 ' O ' ' C ' ' A' ' 71' ' ' ARG . 16.7 m -103.69 153.24 20.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.782 ' CD1' HD12 ' A' ' 103' ' ' ILE . 5.6 m0 -107.73 125.6 51.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.781 -1.199 . . . . 0.0 110.98 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.697 HH11 ' CZ ' ' A' ' 71' ' ' ARG . 61.0 ttm-85 -114.8 109.34 18.03 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.396 -0.815 . . . . 0.0 109.012 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 134' ' ' ILE . 17.8 tt -144.55 154.43 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.624 ' OD2' HG13 ' A' ' 94' ' ' VAL . 21.8 t70 -88.29 164.41 15.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.138 -0.976 . . . . 0.0 110.126 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 134' ' ' ILE . . . -67.94 -45.01 76.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 37.24 2.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.349 -1.089 . . . . 0.0 109.921 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.75 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 8.4 m-90 56.17 26.91 10.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.889 . . . . 0.0 110.524 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 93' ' ' SER . 94.0 mt-30 -98.03 6.19 47.9 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.858 -1.151 . . . . 0.0 110.602 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER 50.68 105.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.158 -0.964 . . . . 0.0 109.981 179.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.624 HG13 ' OD2' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -99.68 156.49 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.09 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.12 -31.59 65.82 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.598 2.199 . . . . 0.0 111.734 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -155.36 150.27 26.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -105.5 117.81 34.97 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.279 -0.888 . . . . 0.0 110.384 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -90.14 -8.78 50.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -113.67 35.86 3.87 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.51 152.0 22.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.946 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.57 ' OG ' HD12 ' A' ' 124' ' ' LEU . 86.4 p -124.65 170.59 10.81 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -108.24 139.53 42.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.868 . . . . 0.0 109.807 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.782 HD12 ' CD1' ' A' ' 85' ' ' TRP . 64.8 mt -123.87 136.63 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.587 -0.696 . . . . 0.0 109.511 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' CD ' HH11 ' A' ' 80' ' ' ARG . 84.2 tt0 -114.12 126.45 55.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 109.116 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.512 HG12 ' CE2' ' A' ' 107' ' ' PHE . 17.0 t -133.25 134.06 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.19 -0.944 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.471 ' OD2' ' NE ' ' A' ' 80' ' ' ARG . 56.4 m-20 -117.89 132.46 56.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.67 ' O ' ' ND1' ' A' ' 79' ' ' HIS . 10.5 m-85 -113.63 139.05 49.35 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.411 -0.806 . . . . 0.0 109.321 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.66 120.65 13.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' CD ' ' CD2' ' A' ' 79' ' ' HIS . 73.4 Cg_endo -79.21 133.39 10.86 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.996 1.797 . . . . 0.0 112.851 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -119.41 143.57 47.39 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.8 -177.48 24.29 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.97 11.22 4.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -1.106 . . . . 0.0 109.418 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.17 71.89 1.16 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -146.33 139.62 8.22 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.591 HG23 ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -134.59 120.91 20.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.12 . . . . 0.0 109.403 179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -103.75 117.97 35.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.435 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.6 t -125.25 139.26 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.466 -0.771 . . . . 0.0 110.791 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' OE1' ' NH1' ' A' ' 9' ' ' ARG . 95.6 mt-10 -117.05 103.08 9.88 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.5 tt -103.94 126.29 50.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.763 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.621 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.4 14.37 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -0.818 . . . . 0.0 109.844 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.506 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 0.8 OUTLIER -101.77 124.52 47.55 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 7' ' ' ASP . 34.4 m -130.74 164.67 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.905 0.86 . . . . 0.0 111.848 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 122' ' ' VAL . 0.2 OUTLIER 53.25 28.77 7.56 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.175 0.512 . . . . 0.0 110.176 -179.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.641 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.8 tp -73.3 -39.66 65.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 3.7 t60 -45.92 -11.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.435 0.636 . . . . 0.0 109.512 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 23.1 ttm180 -50.79 -32.32 19.58 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.641 ' CE1' ' O ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -77.93 -16.35 58.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.504 ' N ' ' HD1' ' A' ' 127' ' ' HIS . . . 87.36 -164.91 35.19 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 129' ' ' ASP . 52.8 p30 -72.5 160.75 31.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.424 -1.045 . . . . 0.0 109.806 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.5 77.08 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.535 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . . . -63.53 -44.8 93.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.647 -0.914 . . . . 0.0 109.926 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -56.4 -30.15 62.41 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.557 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -54.91 -43.15 73.02 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 87' ' ' ILE . 81.4 mt -59.65 -43.22 90.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 177.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.59 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.3 OUTLIER -63.78 -31.99 73.35 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' O ' ' OD1' ' A' ' 139' ' ' ASP . 15.4 tttt -52.61 -36.38 56.26 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.75 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -66.88 -44.37 81.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.781 -1.168 . . . . 0.0 107.899 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.561 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 69.6 mt -66.01 -26.43 67.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 136' ' ' LYS . 1.2 m-20 61.12 98.44 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.681 -0.637 . . . . 0.0 110.769 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.493 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -95.37 140.29 14.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -66.11 143.03 70.11 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.106 1.871 . . . . 0.0 112.229 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.626 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -101.08 -42.89 0.21 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.927 . . . . 0.0 109.455 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 142' ' ' SER . 2.4 Cg_endo -77.88 -66.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.78 2.32 . . . . 0.0 111.754 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -85.75 -178.74 50.23 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -105.87 160.82 14.96 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.289 -1.124 . . . . 0.0 109.093 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.608 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 52.7 m -57.47 -38.54 74.69 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.223 -0.923 . . . . 0.0 108.92 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.846 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.4 mp -67.71 -26.93 66.4 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.647 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.59 -50.41 21.35 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.314 -0.866 . . . . 0.0 111.908 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.644 HH22 ' HE1' ' A' ' 33' ' ' TRP . 0.1 OUTLIER -65.65 -49.87 67.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.942 -1.099 . . . . 0.0 111.584 -177.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.38 -35.96 80.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.945 -1.097 . . . . 0.0 109.681 -179.058 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.708 ' N ' ' CD1' ' A' ' 150' ' ' PHE . . . -65.18 -37.93 88.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.01 -1.056 . . . . 0.0 109.501 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -59.14 -46.6 87.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 110.826 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.81 -36.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.253 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 20' ' ' HIS . 75.9 mt . . . . . 0 C--N 1.302 -1.482 0 CA-C-O 117.946 -1.025 . . . . 0.0 109.651 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.846 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.688 ' N ' ' CH2' ' A' ' 132' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 1' ' ' MET . 24.3 Cg_exo -59.94 148.12 90.02 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.567 2.178 . . . . 0.0 112.242 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.86 -28.38 69.99 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.328 -0.857 . . . . 0.0 109.399 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.751 ' C ' HD13 ' A' ' 5' ' ' ILE . 84.3 tt0 -96.28 142.6 28.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.424 -0.797 . . . . 0.0 109.736 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.751 HD13 ' C ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -119.07 91.75 44.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.464 -0.772 . . . . 0.0 109.903 -179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' O ' ' NE2' ' A' ' 121' ' ' HIS . 39.0 Cg_endo -77.69 166.53 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.055 1.837 . . . . 0.0 111.425 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 32.9 p30 -64.28 125.53 24.86 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.113 -0.992 . . . . 0.0 110.11 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG12 ' CD2' ' A' ' 121' ' ' HIS . 10.0 p -139.62 141.43 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' A' ' 120' ' ' ALA . 64.3 ttt180 -120.32 124.1 44.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.192 -0.943 . . . . 0.0 109.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' NZ ' HG21 ' A' ' 8' ' ' VAL . 26.6 mttp -134.92 147.03 49.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.88 . . . . 0.0 109.838 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 98.3 p -135.67 149.36 49.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.16 155.36 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -0.944 . . . . 0.0 109.397 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.44 ' CG2' HH21 ' A' ' 116' ' ' ARG . 47.5 t -103.47 133.66 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.219 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 115' ' ' THR . 27.4 m -130.94 163.42 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.0 110.121 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.54 94.41 7.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.158 -0.964 . . . . 0.0 109.596 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 115' ' ' THR . . . -176.67 164.66 2.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.054 -1.029 . . . . 0.0 110.199 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.0 m -101.62 147.4 26.47 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 109' ' ' PRO . 35.7 m -53.86 -40.07 42.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.847 -1.158 . . . . 0.0 109.439 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' N ' HG23 ' A' ' 18' ' ' VAL . 72.2 mm-40 -61.62 -39.4 91.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.076 -1.015 . . . . 0.0 108.355 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' NE2' ' CG2' ' A' ' 24' ' ' VAL . 23.7 t60 -65.96 -40.39 91.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.552 -0.718 . . . . 0.0 109.602 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' HG21 ' A' ' 115' ' ' THR . 80.9 m -50.59 -42.5 55.88 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 108.842 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.1 -25.09 34.77 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.98 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 27' ' ' SER . 86.5 tt0 -59.7 -41.67 91.27 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 154' ' ' ILE . 85.4 t -65.83 -40.37 87.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.556 0.693 . . . . 0.0 109.145 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -58.2 -45.83 86.91 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.554 -0.716 . . . . 0.0 110.159 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.516 HG22 ' HD1' ' A' ' 49' ' ' PHE . 51.3 p -96.55 -4.0 42.09 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.918 -1.114 . . . . 0.0 111.047 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 71.5 m -94.07 -46.98 6.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.598 -1.314 . . . . 0.0 111.256 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -173.56 59.82 0.24 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.575 -1.328 . . . . 0.0 111.289 -178.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 10.5 Cg_endo -56.63 -43.32 56.17 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 121.919 1.746 . . . . 0.0 114.097 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' H ' HD23 ' A' ' 47' ' ' LEU . . . -74.26 -33.87 63.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.922 -1.111 . . . . 0.0 111.237 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -54.84 -32.54 60.71 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.857 -1.152 . . . . 0.0 110.257 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.662 ' CG ' ' O ' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -94.91 108.78 20.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.825 -1.172 . . . . 0.0 108.549 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.406 ' CD1' ' NE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -112.66 156.86 41.8 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.074 -1.016 . . . . 0.0 108.839 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' VAL . 75.0 Cg_exo -40.25 100.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.595 2.197 . . . . 0.0 111.954 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HG3' HD21 ' A' ' 152' ' ' ASN . 55.6 Cg_endo -83.49 -0.15 9.69 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.473 2.116 . . . . 0.0 112.291 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.591 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 23.0 m -55.55 -37.05 67.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 36' ' ' SER . 0.5 OUTLIER 163.67 2.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' PRO . 13.7 p -133.47 140.01 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 40' ' ' VAL . 53.3 mt -111.03 150.64 29.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.743 . . . . 0.0 109.017 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.612 ' CG1' ' HE ' ' A' ' 44' ' ' ARG . 3.3 p -45.47 135.44 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.907 -1.121 . . . . 0.0 108.773 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -61.53 -38.13 86.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.955 -1.091 . . . . 0.0 108.943 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 61' ' ' ASP . 32.6 ttpt -88.09 143.16 27.23 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.7 124.29 32.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.862 -1.149 . . . . 0.0 110.025 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HE ' ' CG1' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.67 141.58 42.72 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 60' ' ' TRP . . . -110.62 -47.06 3.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.376 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' HB2' ' A' ' 60' ' ' TRP . . . -156.39 173.55 34.22 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.928 ' N ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -153.74 131.55 11.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.159 -1.201 . . . . 0.0 109.851 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . . . -107.4 137.67 45.01 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 1.8 m-85 -138.18 133.06 32.81 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 110.179 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.81 ' O ' ' CE2' ' A' ' 52' ' ' PHE . 45.5 mm-40 -130.72 137.42 30.75 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.782 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.18 131.6 3.67 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.209 1.939 . . . . 0.0 112.313 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.81 ' CE2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER 171.71 -178.56 0.06 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.025 -1.047 . . . . 0.0 110.531 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.82 143.12 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.03 32.95 85.91 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 104.112 -3.595 . . . . 0.0 104.112 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.649 ' CA ' ' CE2' ' A' ' 52' ' ' PHE . . . -70.62 178.55 31.78 Favored Glycine 0 C--N 1.299 -1.5 0 CA-C-N 113.865 -1.167 . . . . 0.0 114.475 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' N ' ' CE2' ' A' ' 52' ' ' PHE . 98.7 mtt180 -146.29 146.84 30.87 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.222 1.01 . . . . 0.0 111.776 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.724 ' CE2' HD11 ' A' ' 72' ' ' ILE . 16.8 m-85 -119.22 143.97 46.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.85 ' CE1' HG22 ' A' ' 68' ' ' VAL . 15.1 m-85 -126.71 145.25 50.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.825 . . . . 0.0 111.516 -177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HE1' ' A' ' 69' ' ' TRP . 85.3 tt0 -128.85 142.44 50.97 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.62 130.29 54.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 109.421 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' N ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -104.34 136.73 43.37 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.659 ' N ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -51.57 -38.44 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.981 . . . . 0.0 110.582 -177.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -104.7 -7.88 19.25 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 61' ' ' ASP . . . -112.24 137.9 14.59 Favored Glycine 0 N--CA 1.482 1.73 0 CA-C-O 122.562 1.09 . . . . 0.0 110.636 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 66' ' ' GLU . 16.9 m -63.47 -179.11 0.32 Allowed 'General case' 0 C--N 1.288 -2.089 0 O-C-N 122.004 -0.703 . . . . 0.0 109.836 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.77 ' H ' HG22 ' A' ' 65' ' ' THR . 71.0 tt0 -76.5 144.57 39.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -149.46 164.48 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.965 -1.084 . . . . 0.0 110.842 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.85 HG22 ' CE1' ' A' ' 58' ' ' TYR . 21.3 t -103.35 120.48 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.751 ' HE1' ' N ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -112.13 4.01 17.65 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.464 -178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -158.32 -172.18 25.14 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.671 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.673 ' NH2' ' NH1' ' A' ' 86' ' ' ARG . 11.7 ttp180 -156.04 -177.59 6.69 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.724 HD11 ' CE2' ' A' ' 57' ' ' TYR . 97.2 mt -133.98 166.99 27.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' N ' HG22 ' A' ' 72' ' ' ILE . 8.3 mt -113.7 -52.19 2.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.811 -1.181 . . . . 0.0 109.389 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -175.83 154.31 1.5 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.455 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 59.9 p-90 -106.49 127.42 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.0 110.11 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.499 ' O ' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -108.34 130.09 23.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 79' ' ' HIS . 42.7 Cg_exo -30.17 153.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.802 2.334 . . . . 0.0 112.634 -178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' PRO . 82.4 Cg_exo -29.21 79.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.293 2.662 . . . . 0.0 112.305 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.642 ' N ' ' O ' ' A' ' 77' ' ' PRO . 1.9 t-80 -179.3 -42.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.586 -0.696 . . . . 0.0 109.917 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 75.4 ttt180 -151.44 143.22 23.74 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.162 -1.415 . . . . 0.0 112.118 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.91 127.64 19.22 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.04 151.46 25.81 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -150.92 139.99 21.1 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 117.866 -1.533 . . . . 0.0 111.899 -179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.595 ' O ' ' C ' ' A' ' 71' ' ' ARG . 17.4 m -103.23 150.11 24.03 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.607 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -121.06 127.92 52.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.773 -1.205 . . . . 0.0 111.179 -178.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.673 ' NH1' ' NH2' ' A' ' 71' ' ' ARG . 94.0 mtt180 -114.5 119.82 38.16 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.191 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' A' ' 134' ' ' ILE . 18.2 tt -148.51 156.92 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.535 ' HB3' ' H ' ' A' ' 92' ' ' GLN . 25.9 t0 -103.01 169.79 8.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -0.955 . . . . 0.0 109.599 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . -57.58 -35.55 73.77 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.85 42.1 1.57 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.155 -1.203 . . . . 0.0 110.524 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.807 ' CZ2' ' HB2' ' A' ' 137' ' ' ALA . 4.5 m-90 56.06 29.61 14.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.15 -0.969 . . . . 0.0 110.595 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.535 ' H ' ' HB3' ' A' ' 88' ' ' ASP . 90.4 mt-30 -101.45 154.21 19.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.131 -0.981 . . . . 0.0 109.072 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -100.79 139.46 36.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.527 HG23 ' OD1' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -134.03 156.78 78.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' O ' ' OD2' ' A' ' 96' ' ' ASP . 6.2 Cg_endo -51.67 -37.32 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.354 2.036 . . . . 0.0 111.757 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.497 ' OD2' ' O ' ' A' ' 95' ' ' PRO . 82.8 m-20 -145.99 146.57 31.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 108.897 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.67 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 77.3 m-20 -106.02 117.57 34.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.174 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -70.67 -27.77 64.28 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.293 -0.88 . . . . 0.0 108.685 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -101.92 35.91 2.23 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.63 -0.669 . . . . 0.0 109.677 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . . . -87.23 147.82 25.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 110.017 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.0 p -132.69 170.09 15.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.443 -0.786 . . . . 0.0 109.157 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.91 144.06 37.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.977 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.62 136.89 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.457 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -112.37 121.58 45.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG22 ' HG ' ' A' ' 119' ' ' LEU . 42.5 t -128.74 137.28 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.388 -0.82 . . . . 0.0 109.701 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -116.6 131.46 56.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.341 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.495 ' CE2' HG12 ' A' ' 105' ' ' VAL . 55.5 m-85 -114.74 125.9 54.24 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.415 -0.803 . . . . 0.0 109.468 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -123.71 118.94 27.08 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 18' ' ' VAL . 74.5 Cg_endo -78.52 132.56 11.16 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.989 1.792 . . . . 0.0 112.838 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -119.41 144.97 46.63 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.51 -176.22 28.52 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 112' ' ' SER . 0.0 OUTLIER 60.53 14.39 4.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -1.128 . . . . 0.0 109.514 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.99 70.27 1.28 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -143.65 140.76 9.78 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 21' ' ' CYS . 0.1 OUTLIER -134.83 120.72 19.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.302 -1.117 . . . . 0.0 109.598 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.44 HH21 ' CG2' ' A' ' 13' ' ' VAL . 50.5 ttt85 -105.16 117.4 33.91 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.438 HG21 ' CAF' ' A' ' 201' ' ' 96F . 57.8 t -122.78 139.1 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 110.854 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.84 103.53 10.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.528 ' HG ' HG22 ' A' ' 105' ' ' VAL . 7.6 tt -103.61 128.25 50.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.862 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . . . -132.3 114.39 14.35 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 110.013 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.598 ' O ' ' CD2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -100.86 135.72 41.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.51 151.3 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.916 -1.115 . . . . 0.0 112.466 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 123' ' ' LYS . 12.9 mmtp 53.9 31.61 13.63 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.394 178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 7.4 tp -70.31 -36.05 74.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 12.3 t60 -45.78 -12.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.412 0.625 . . . . 0.0 109.479 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 124' ' ' LEU . 16.3 tpt180 -50.95 -33.91 26.53 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.653 ' NE2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -82.68 -25.36 33.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.467 -0.77 . . . . 0.0 109.871 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.76 -146.3 0.08 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.546 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 48.8 t0 48.9 -138.67 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.514 -0.992 . . . . 0.0 109.765 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.546 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . -82.99 51.55 4.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB1' ' NE2' ' A' ' 127' ' ' HIS . . . -59.21 -50.93 72.15 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.465 -1.02 . . . . 0.0 109.941 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.688 ' CH2' ' N ' ' A' ' 1' ' ' MET . 39.1 t-105 -60.09 -31.21 69.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.087 . . . . 0.0 109.117 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -55.01 -43.69 73.88 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' A' ' 87' ' ' ILE . 84.4 mt -59.27 -42.82 88.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.633 ' O ' ' ND1' ' A' ' 135' ' ' HIS . 0.5 OUTLIER -63.48 -32.63 74.14 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -52.38 -33.87 45.26 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.807 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . . . -67.63 -44.78 77.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.571 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 60.7 mt -65.86 -29.67 70.16 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.43 96.29 0.06 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.582 -0.699 . . . . 0.0 111.484 178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' N ' ' CE1' ' A' ' 135' ' ' HIS . . . -131.99 75.22 0.43 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.05 137.99 70.11 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.701 2.268 . . . . 0.0 112.467 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.576 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.1 OUTLIER -62.99 -45.52 86.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.984 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 142' ' ' SER . 31.2 Cg_exo -56.65 -31.34 87.01 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.585 2.19 . . . . 0.0 112.332 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -122.58 104.32 0.88 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -54.65 153.01 6.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -1.126 . . . . 0.0 109.005 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.607 HG21 ' OAQ' ' A' ' 201' ' ' 96F . 58.3 m -56.68 -38.27 72.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.169 -0.957 . . . . 0.0 108.999 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.908 HD11 ' CAK' ' A' ' 201' ' ' 96F . 5.2 mp -67.98 -26.61 66.01 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.68 35.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.38 -0.825 . . . . 0.0 111.915 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.594 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 1.4 ptt180 -66.19 -50.89 62.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.999 -1.063 . . . . 0.0 111.882 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.705 ' CD2' ' N ' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -67.98 -33.75 75.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.714 -1.241 . . . . 0.0 110.249 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' N ' ' CD2' ' A' ' 150' ' ' PHE . . . -67.41 -43.99 79.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.917 -1.115 . . . . 0.0 110.283 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.614 HD21 HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -61.01 -45.87 93.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.551 -0.718 . . . . 0.0 110.461 -178.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.614 HG13 HD21 ' A' ' 152' ' ' ASN . 15.6 m -65.78 -39.25 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.995 . . . . 0.0 109.222 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.503 HD11 HG21 ' A' ' 24' ' ' VAL . 51.8 mt . . . . . 0 C--N 1.303 -1.446 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.608 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' 96F . . . . . 0.908 ' CAK' HD11 ' A' ' 147' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_